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ABSTRACT 
FACULTY OF MEDICAL SCIENCE 
DOCTOR OF PHILOSOPHY 
MOTIVATIONAL INTERVIEWING FOR ANTIRETROVIRAL THERAPY ADHERENCE IN 
NIGERIA: A FEASIBILITY STUDY 
OLAKUNLE LEKAN KAYODE 
JULY 2018 
Background: Motivational Interviewing (MI) is a person-centred directive approach that can 
support HIV patients to improve antiretroviral therapy (ART) adherence. Although MI has a 
growing literature within HIV contexts, studies have not yet examined the feasibility of using it 
for ART adherence counselling in Nigerian clinical contexts. 
Methods: A mixed method approach was used for this study. Counsellors and a sample of 
HIV patients were recruited from a HIV clinic in Abuja, Nigeria between March and June 2017. 
The counsellors received five hours training, then used MI in audiotaped sessions with 
patients. Following the clinical encounters, counsellors and patients were interviewed about 
the process. Fidelity of counsellors to MI was assessed using the OnePass system which is a 
tool for measuring the competence of practitioners in MI, while the interviews data were 
analysed thematically to explore the experiences of study participants.   
Findings: All clinicians in the clinic participated in the study and attended the training. 
Nineteen sessions were recorded from the interactions between 18 patients and seven 
counsellors in English, Pidgin and Yoruba. The counsellors did not achieve the threshold for 
competency described in literature, however interview responses revealed that MI improved 
the consultation practices of the counsellors and was well-accepted by patients. Interviews 
also revealed significant challenges during routine consultations, such as low clinic capacity, 
perception of counsellors about adherence support, stigma, bribing, religious/traditional 
beliefs, privacy issues in the clinic and economic barriers; this may prevent the routine 
application of the approach in Nigerian hospitals.  
Conclusions: This study indicates that MI has potential to be used for ART adherence support 
within Nigerian context. It is acceptable to clinicians and patients and perceived as being 
different from current practice. However, for future implementation, time needs to be dedicated 
to MI training and further professional development around patient-centred approaches to 
adherence support. 
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CHAPTER ONE: INTRODUCTION 
1.0 Chapter Overview 
This chapter presents an outline of the research problem and the focus of the study as well as 
the research question. The chapter also ends with an outline of the remaining nine chapters 
of the thesis.  
1.1 Statement of the Research Problem 
With 160,000 deaths in 2016, Nigeria bears the highest burden of Acquired Immune Deficiency 
Syndrome (AIDS)-related deaths ahead of South Africa and India (Joint United Nations 
Programme on HIV/AIDS [UNAIDS], 2017). The number of deaths related to Human 
Immunodeficiency Virus (HIV) and or AIDS in Nigeria can be attributed to lack of access to 
antiretroviral therapy (ART) (Baggaley et al., 2015; Granich et al., 2015; UNAIDS, 2017). 
However, adherence to the ART and not just access to the drug predicts disease progression, 
emergence of HIV drug resistance and death (Bangsberg et al., 2001; Paterson et al., 2000; 
World Health Organisation [WHO], 2016, pp.255). Therefore, billions of dollars invested on 
HIV/AIDS control from both international and domestic sources (Nigerian National Agency for 
the Control of AIDS [NACA], 2014, p.44) will only increase access to the drug while the patients 
may continue to die due to non-adherence. 
There are several evidence-based interventions to enhance ART adherence such as peer 
counselling, mobile phone text messages, reminder devices, cognitive behavioural therapy, 
behavioural skills training and medication adherence training, and fixed-dose combinations as 
well as once-daily regimen (WHO, 2016, p.255). These interventions are recommended for 
people on ART (WHO, 2016). However, this recommendation places the responsibility for ART 
adherence solely on the patient with the assumption that the conduct of the clinicians during 
the consultation for adherence will not affect the determination of the patient to carry out the 
drug-taking consistently afterwards. This assumption reinforces the gap reported in 2003 by 
the WHO that the focus of adherence interventions continues to be directed at patient-related 
factors despite evidence pointing to the contrary (WHO, 2003, p.19). In the report, the WHO 
stressed that the misplaced priority on patient-related factors occurs with relative neglect of 
health provider and health system-related determinants, even though these latter factors have 
a considerable effect on adherence (WHO, 2003, p.19). Based on this gap the WHO stated 
that interventions that target these other relevant factors in the health care environment are 
urgently required (WHO, 2003, p.19). Consistent with this recommendation made 15 years 
ago, the current global strategy on people-centred and integrated health services emphasise 
the need to build health providers’ skills for effective communication with people as well as to 
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provide information and support to people to make informed decisions and for their active 
engagement in their own care and self-management (WHO, 2016, p.280). Similarly, evidence 
from a systematic review and a meta-analysis has revealed the need for clinicians to be 
compassionate, to establish trust and a supportive clinical environment to motivate the HIV 
patients to adhere to their drugs (Katz et al., 2013; Langebeek et al., 2014a). A survey has 
also shown that by improving the communication and relationship building skills of health 
providers, retention of HIV patients in care may be improved (Flickinger et al., 2013). Taken 
together, this bodies of evidence emphasise the need for increased attention to be paid to the 
skills and conduct of health providers during clinical consultation for ART adherence in respect 
of communication and fostering of a non-judgemental adherence support context.  
Although the current WHO guideline emphasises the importance of counselling to promote 
ART adherence (WHO, 2016, p.258), there is currently no recommendation for the standard 
counselling approach to use with patients during the clinical consultation for treatment 
adherence. Motivational Interviewing (MI) is a patient-centred approach to counselling with a 
collaborative conversation style for strengthening a person’s own motivation and commitment 
to change (Miller and Rollnick, 2013 p.12). Hence, it is a counselling method that has the 
potential to promote a more acceptable quality of communication during a clinical consultation 
for ART between health providers and HIV patients. Despite the availability of considerable 
evidence supporting the use of MI as an effective behaviour change method to promote ART 
adherence (Dillard, Zuniga and Holstad, 2016; Hill and Kavookjian, 2012), there is little or no 
evidence for its routine applications for ART adherence counselling or consultation in Nigeria. 
Therefore, little is known about whether MI can be used in the clinical context in Nigeria for 
ART adherence support, since it is an approach developed within the cultural context of the 
UK and USA with relatively higher-resource context (Koken et al., 2012). 
Against this background, it could be argued that to practise MI in the Nigerian context, one 
needs to adapt it to both community and organisational culture. The need for cultural 
adaptation of behavioural interventions arose from the evidence of reduced effect in usual 
practice setting compared to controlled settings. However, Lau (2006) pointed out that endless 
proliferation of adapted variants of such intervention approaches for various target 
communities may be unwarranted. Hence, there is a need to establish whether cultural 
adaptation is needed in the first place and to identify the cultural or contextual barriers to the 
implementation of the approach in the local setting. Therefore, this study is focused on 
determining the feasibility of using MI for ART adherence consultation in Nigeria from both 





Is the use of Motivational Interviewing (MI) acceptable and feasible for HIV drug adherence 
counselling or consultation in Nigeria? 
1.2 Outline of Chapters 
The content of the remaining chapters of this thesis are as presented below. 
Chapter Two: This chapter presents a background to the research problem through a 
comprehensive review of literature that examines the state of adherence to ART and the 
predictors of adherence in Nigeria and a discussion of the major factors in promoting 
adherence to HIV treatment in Nigeria.   
Chapter Three: This chapter presents a review of literature that investigates the decision-
making approaches used in clinical consultation for HIV treatment and adherence.  
Chapter Four: This chapter presents another review of literature that investigates the 
applicability of motivational interviewing in developing countries, with a focus on Nigeria. 
Chapter Five: This chapter presents the methodology and research design employed to meet 
the research objectives. 
Chapter Six: This chapter presents the quantitative findings from the study. 
Chapter Seven: This chapter presents the qualitative findings from the study. 
Chapter Eight: This chapter presents an integrated synthesis of both quantitative and 
qualitative findings from this study to meet the research objectives. 
Chapter Nine: This chapter presents the discussion of the research findings. 
Chapter Ten: This chapter presents the recommendations based on the study findings and a 
conclusion to the study. 
1.3 Chapter Summary 
This chapter has presented the statement of the research problem and the focus of the study. 
It has also presented a breakdown of the study activities into chapters with brief description of 




CHAPTER TWO: BACKGROUND TO THE RESEARCH PROBLEM 
2.0 Chapter Overview 
This chapter presents a review of the global burden of Human Immunodeficiency Virus (HIV) 
and Acquired Immune Deficiency Syndrome (AIDS) and the impact of antiretroviral therapy 
(ART) on the morbidity and mortality associated with the epidemic. The chapter also evaluates 
the burden of the epidemic in sub-Saharan Africa with a focus on Nigeria. The chapter 
presents the definition of adherence and methods of its assessment. The chapter explores 
the prevalence of ART adherence in Nigeria and the factors that determine adherence to ART 
in the country. The chapter ends with a discussion based on existing evidence and 
recommendations regarding factors that may be prioritised for ART adherence support in 
Nigeria.  
2.1 Introduction to the Chapter 
Acquired Immune Deficiency Syndrome (AIDS) is a leading cause of infectious disease 
mortality (Kaplan, 2013, p.7). While about 37.6 million people live with the Human 
Immunodeficiency Virus (HIV), about 5,000 new infections occur daily (UNAIDS, 2017, pp.12-
13). Sub-Saharan Africa bears a disproportionate burden of the HIV/AIDS epidemic with 71% 
of the global infections in the region (UNAIDS, 2014, p.18). Despite the overall number of 
people living with HIV/AIDS, there has however, been a significant decline in the morbidity 
and mortality associated with HIV/AIDS globally (Granich et al., 2015; UNAIDS, 2017). For 
instance, since 2010, the annual number of new HIV infections has declined by 16% to 1.8 
million [1.6 million–2.1 million], while there were also about one million AIDS-related deaths 
[830,000–1.2 million] in 2016 compared to 1.5 million in 2013 (UNAIDS, 2017). This significant 
decline in the HIV/AIDS related morbidity and mortality has been associated with the 
increased access to antiretroviral therapy (ART) (Baggaley et al., 2015; Granich et al., 2015; 
UNAIDS, 2017). Specifically, a recent report from the United Nations revealed that increased 
access to ART for people living with HIV [PLHIV] resulted in a 48% reduction in AIDS-related 
death from its peak of 1.9 million in 2005 (UNAIDS, 2017, p.4). This evidence, therefore 
highlights the importance of ART to prevent the millions of lives lost due to the epidemic. 
Although ART does not cure HIV, it works by blocking the replication of the virus and reduce 
the plasma viral load, thereby strengthening the lymphatic T-helper cells [cluster of 
differentiation 4 [CD4]) to fight off opportunistic infections (Wilson and Sereti, 2013). This is 
because the CD4 T lymphocytes are the coordinators of the body’s immune system (WHO, 
2007, p.11). The advent of ART has therefore succeeded in changing the normal progression 
of the infection from the deadly stage of AIDS, to one which increases the life expectancy of 
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people living with HIV (PLHIV) (Hanif et al., 2013; Langebeek et al., 2014a). In this regard, the 
availability of ART has shifted the status of HIV to a chronic disease that requires management 
with daily treatment rather than an imminent life-threatening health condition (Adefolalu and 
Nkosi, 2013; Hanif et al., 2013).  
Besides disease management potential, ART has well-established preventive use as 
evidenced in its use for prevention of mother to child transmission (PMTCT) and for pre-and 
post-exposure prophylaxis (Baggaley et al., 2015; Choopanya et al., 2013; Cohen et al., 2011; 
Granich et al., 2009; Grant et al., 2010). Due to the management and preventive benefits 
embedded in the ART, in 2015 the WHO recommended a greater access to ART for all PLHIV 
irrespective of the CD4 cell count and a broader use of antiretroviral drugs for pre-exposure 
prophylaxis (WHO, 2016, p.74). Despite the significant global benefits recorded due to the 
widespread access to ART for PLHIV, sub-Saharan Africa still contribute about 64% to new 
infections globally and Nigeria which bears the second highest burden of HIV globally (figure 
2.1) still contributes over 20% to the reported new infections in 2016 (UNAIDS, 2017). 
Figure 2.1: Prevalence of HIV among Top 10 Countries in 2016 
 
Data Source: UNAIDS (2017). 
While South Africa recorded a significant decline in new HIV infections from 380,000 in 2010 
to 270,000 in 2016, Nigeria recorded a smaller reduction in new infections within the same 
period from 230,000 to 220,000 (UNAIDS, 2017, pp.40-70). Although there was a reduction 
in the number of AIDS-related deaths in Nigeria from 200,000 in 2010 to 160,000 in 2016, 
South Africa reduced the number of deaths by 100,000 within the same period from 210,000 
deaths in 2010 to 110,000 deaths in 2016 (UNAIDS, 2017 pp.40-70). The significant reduction 
in AIDS-related deaths in South Africa was attributed by the United Nations to the rapid scale-













significant improvement in the scale-up of ART in Nigeria in recent times. For instance, the 
number of PLHIV on ART in Nigeria increased from 639,397 PLHIV in 2013 to 970,000 in 
2016 (Nigerian National Agency for The Control of AIDS [NACA], 2014, p.37; UNAIDS, 2017, 
p.70). This represents an 88% coverage among the 1.1 million PLHIV in the country who are 
aware of their status contrary to the total estimate of 3.2 million people living with the virus 
(UNAIDS, 2017, p.70), most of whom are assumed not to know their status. Hence, the actual 
need for total coverage of ART among the PLHIV who are aware of their status is a total of 
130,000, which is significantly lower than the difference of 2.2 million in South Africa between 
PLHIV who know their status and those who do not (UNAIDS, 2017, p.40).  
Unfortunately, these data might have either underestimated or overestimated the coverage of 
ART in Nigeria due to poor registration and surveillance. Apart from South Africa, other sub-
Saharan African countries where the burden of HIV is concentrated have been reported to 
have very poor registration and incomplete disease notification systems (Murray et al., 2014). 
This data unreliability could also occur because many people with HIV positive status might 
have avoided being tested for HIV to determine their status due to the fear of stigma attached 
to the disease in Nigeria (Afolabi et al., 2013; Aransiola et al., 2014; Olowokere, Fatiregun and 
Adewole, 2012). Despite the challenges with the available statistics, the data suggests that 
there is need for more effort to avert significant numbers of AIDS related deaths occurring in 
Nigeria. 
Based on this background, one significant gap in the available data on HIV treatment in Nigeria 
is that only 780,000 PLHIV are reported to be virally supressed (UNAIDS, 2017, p.70). 
Therefore, it can be assumed that apart from those who are not aware of their status 190,000 
PLHIV who are on treatment are still at risk of progressing to the latter stage of the disease 
(AIDS) and ultimately dying. Hence, beyond access to the ART, there is a need to ensure that 
the PLHIV take the drugs as recommended to suppress the virus. 
2.2 Medication-Taking Behaviour and Adherence  
Adherence and compliance are two terms commonly used interchangeably in literature to 
describe the medication-taking behaviour of patients (Horne et al., 2005, pp.12-13). However, 
these two terms examine medication-taking behaviour from different perspectives. 
Compliance is the oldest term used for the description of medication-taking behaviour and it 
is defined as the extent to which a patient’s behaviour (in terms of taking medications, following 
diets or executing other lifestyle changes) matches the clinician’s prescription (Ahmed and 
Aslani, 2014; Chakrabarti, 2014; De las Cuevas, 2011; European Patient’s Forum, 2015; 
Horne et al., 2005, p.33; Lehane and McCarthy, 2009; Nunes et al., 2009, p.58; Vrijens et al., 
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2012). However, the term has been widely criticised for its paternalistic undertones that denote 
a relationship where the role of the clinician is to decide and the role of the patient is to 
passively follow “the doctor’s orders” (Ahmed and Aslani, 2014; Brown and Bussell, 2011; 
Horne et al., 2005, p.33; Lehane and McCarthy, 2009; Mullen, 1997; Nunes et al., 2009, p.58; 
Segal, 2007). Critics argued that the term fails to define whether it is good to take the drug or 
not, but simply considers patient’s behaviour on a dichotomous scale that compliance is good, 
and non-compliance is bad (Chakrabarti, 2014; De las Cuevas, 2011; Horne et al., 2005, 
p.34). The term is considered pejorative as non-compliance suggests that the patient is 
unwilling to behave as instructed by a prescriber who knows what the patient needs best 
(Chakrabarti, 2014; Horne et al., 2005, p.34; Nunes et al., 2009, p.58).  
On the other hand, the term adherence has been used as an alternative to compliance to 
emphasise that the patient is free to decide whether to accept the doctor’s recommendations 
and that failure to do so should not be a reason to blame the patient (Horne et al., 2005, p.35). 
The term “adherence” was coined to avoid the normative problem in the definition of 
compliance by emphasising the need for shared agreement (Horne et al., 2005, p.35). The 
WHO defined adherence as “the extent to which a person’s behaviour in respect of taking a 
medication, following a diet and/or executing lifestyle changes, corresponds with agreed 
recommendations from a healthcare provider” (WHO, 2003, p.3). This definition aims to 
emphasise active patient involvement while choosing the most suitable treatment, where both 
parties need to participate in a discussion which yields the most appropriate medication 
regimen to be followed (Ahmed and Aslani, 2014; Chakrabarti, 2014). Unlike compliance, the 
term adherence is intended to be non-judgmental; to serve as an observation of a fact and not 
intended to blame either the clinician or the patient (Chakrabarti, 2014). Even though 
compliance and adherence share the same property of being quantifiable parameters, due to 
the emphasis on patients’ involvement in treatment decisions, adherence is considered more 
patient-centred than the clinician-centred concept of compliance, thereby making it more 
favoured by many experts in the field in recent times (Ahmed and Aslani, 2014; Chakrabarti, 
2014; Horne et al., 2005; Nunes et al., 2009; Vrijens et al., 2012). Consistent with this 
background, the term “adherence” was adopted to describe medication-taking behaviour of 
PLHIV in this study.  
2.2.1 Antiretroviral Therapy Adherence and Assessment of Adherence  
Antiretroviral therapy (ART) refers to the use of a combination of three or more antiretroviral 
(ARV) drugs for treating HIV infection (International Association of Providers of AIDS Care 
[IAPAC], 2014, Fact Sheet 403; WHO, 2016). High level of adherence to HIV treatment has 
long been found to be a key factor in the treatment success of HIV infection by predicting 
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virological failure, disease progression, emergence of HIV drug resistance and death 
(Bangsberg et al., 2001; Paterson et al., 2000; WHO, 2012, p.10). Specifically, poor 
adherence to ART has been associated with repeated hospitalization, opportunistic infections, 
poor quality of life, loss of productivity and premature mortality (Adefolalu and Nkosi, 2013; 
Cruciani and Melani, 2015). Like other chronic diseases, poor adherence to ART is common 
among PLHIV (Adefolalu and Nkosi, 2013; Langebeek et al., 2014b; WHO, 2003; Williams et 
al., 2014). However, unlike other chronic diseases such as hypertension and diabetes where 
moderate adherence could be sufficient for treatment outcomes (Adefolalu and Nkosi, 2013), 
rapid rate of replication of HIV requires that a high level of adherence to the ART needs to be 
maintained to suppress the viral load (Adefolalu and Nkosi, 2013; WHO, 2012, p.9; Williams 
et al., 2014). 
There are currently numerous methods for assessing ART adherence globally. Although self-
report is the most commonly used means of adherence assessment especially in resource-
limited settings due to its affordability, it is highly susceptible to recall bias, reporting bias and 
social desirability bias (McRae-Clark et al., 2015; Sahay, Reddy and Dhayarkar, 2011). 
Despite the high susceptibility of this subjective measure to overestimation, some studies have 
shown that adherence assessed by self-report can be strongly associated with virological 
outcomes (Nieuwkerk and Oort, 2005; Simoni et al., 2006).  
Meanwhile, there are also some objective measures of ART adherence that are considered to 
have relatively higher reliability than self-report such as electronic medication event monitoring 
systems (MEMS), pharmacy refill, pill counts and directly observed therapy (DOT) (McRae-
Clark et al., 2015; Sahay, Reddy and Dhayarkar, 2011; Sangeda et al., 2014; Shi et al., 2010). 
Despite being deemed as relatively more reliable, each of these objective methods also have 
certain drawbacks. For instance, while observing patient’s ingestion of a medication through 
DOT is expected to ensure optimum adherence, it places significant time burden on both 
patients and providers (McRae-Clark et al., 2015), thereby making it less practical than self-
report. Although the total number of medications ingested could be estimated through pill 
count, this method may also be unreliable, as it is not possible to confirm that the patient 
actually took the medication as prescribed (McRae-Clark et al., 2015; Sangeda et al., 2014). 
While pharmacy refill is a measure that is commonly available in clinical care and not subject 
to recall bias, it may be less accurate to predict virological outcome when applied over a short 
time (Heneger et al., 2014; Sangeda et al., 2014). In addition, pharmacy refill does not 
measure actual medication taking behaviour (Charurat et al., 2010). Lastly, even though 
MEMS is usually considered the gold standard for adherence measurement, apart from the 
high cost attached to its use, the system is limited to registering date and times when the 
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medication container is opened and when it is closed (McRae-Clark et al., 2015; Shi et al., 
2010). Therefore, actual medication ingestion by patients may not also be ascertained 
(McRae-Clark et al., 2015). Hence, MEMS has been described as the imperfect gold standard 
(Shi et al., 2010).  
Based on these highlighted shortcomings of the numerous measures of adherence, there is 
currently no universally accepted gold standard for measurement of ART adherence (Sahay, 
Reddy and Dhayarkar, 2011; Sangeda et al., 2014). Hence, emphasis has been placed on 
the need to use viral load assessment to validate measurement of ART adherence (Heneger 
et al., 2014; Sangeda et al., 2014). 
2.3 Antiretroviral Therapy Adherence in Nigeria 
Evidence from a meta-analysis demonstrated that HIV patients in sub-Saharan Africa have a 
high tendency to adhere to ART, especially when compared with patients in North America 
(Mills et al., 2006a). Findings from the review contradicted some initial concerns about the 
ability of African PLHIV to adhere to the treatment (Attaran, 2007; Gills et al., 2005). However, 
findings from recent studies also revealed that rates of adherence are not consistently high 
within the sub-Saharan African region (Adefolalu, Nkosi and Olorunju, 2014; Denison et al., 
2015; Elhers and Tshisuyi, 2015; El-Khatib et al., 2011; Nabukeera-Barungi et al., 2015; 
Peltzer et al., 2010; Wiens et al., 2012). This can be attributed to the different level of 
associations that studies reported between factors predicting adherence and adherence rates. 
For instance, findings from a recently published meta-analysis and systematic review of 146 
qualitative and quantitative studies from the sub-Saharan African region show that main 
predictors of non-adherence to ART include use of alcohol, male gender; use of 
traditional/herbal medicine; dissatisfaction with healthcare facility and healthcare workers; 
depression; discrimination and stigmatisation; and poor social support (Heestermans et al., 
2016). On the other hand, the predictors of optimum adherence include: counselling and 
education interventions, memory aids, and disclosure of HIV status (Heestermans et al., 
2016). Despite these identified associations, 14 studies in the review did not find significant 
association between the determinants and ART adherence (Heestermans et al., 2016). It can 
therefore be argued that a similar pattern of inconsistent adherence rates or the association 
between adherence and the factors influencing it will be obtainable in Nigeria. Unfortunately, 
there is currently no standard report for non-adherence to ART. It is worthy of note that the 
review and meta-analysis by Heestermans et al. (2016) that included studies published till 
2014 was limited to study search within electronic databases without further search through 
references or manual search through relevant local journals. Hence, there is a need to review 
the current state of knowledge from existing literature about ART adherence and the 
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influencing factors in Nigeria, to identify key factors to target to promote better adherence 
rates. 
Methods of this Review 
To manage the inclusion and exclusion of studies into this review of literature, the PEO format 
(Bettany-Saltikov, 2012, p.21) was adopted. Limits for the Population, Exposure and Outcome 
components of the PEO are as specified below: 
Population: This refers to individuals living with HIV and/or their caregivers. This population 
ranges from children to adults living with HIV. 
Exposure: This refers to the initiation of the individual living with HIV on ART.  
Outcome: This refers to the level of adherence to ART reported in the studies and or the 
factors influencing adherence to the ART. However, studies that tested the effectiveness of 
an intervention for adherence to ART was excluded from this review. Lastly, quantitative 
studies which did not report the threshold used to assess the ART adherence were also 
excluded from the review.  
To carry out this review, a comprehensive search for relevant articles was conducted through 
four electronic databases which include PubMed, Medline, ASSIA and Web of Science. Study 
search was limited to articles published from 2008 till 2018. The reason for this time range is 
to identify studies published within the last decade in order to include recent state of 
knowledge in the topic area. Relevant studies were searched for in the four electronic 
databases with the keywords in the following format: [adherence or non-adherence or 
compliance] and [antiretroviral therapy or highly active antiretroviral therapy or antiretroviral 
or HIV drug or HIV treatment] and [Nigeria]. Study search through the electronic databases 
was supplemented with manual search for relevant articles through relevant local and 
international journals within the specified time interval. This include search through: Journal 
of Antivirals and Antiretrovirals; Journal of AIDS and HIV Research; Global Journal of Medical 
Research; The Nigerian Journal of General Practice; The Nigerian Health Journal; 
International Journal of Medicine and Medical Sciences; International Journal of Infection 
Control; Journal of HIV and Human Reproduction; Journal of Acquired Immune Deficiency 
Syndromes; Journal of Advances in Medicine and Medical Research; and African Journal of 
Primary HealthCare and Family Medicine. Relevant studies were also searched for within the 
reference list of some of the retrieved studies from the electronic databases. Summary of the 
literature search are as presented in Table 2.1. 
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Table 2.1: Summary of Study Search 
S/N Study Sources Total Hit Relevant Titles 
1 ASSIA 118 3 
2 Web of Science 99 24 
3 MEDLINE 129 32 
4 PubMed 170 33 
5 Journal of Antivirals and Antiretrovirals Not Applicable 1 
6 Journal of AIDS and HIV Research Not Applicable 1 
7 Global Journal of Medical Research Not Applicable 1 
8 The Nigerian Journal of General Practice Not Applicable 1 
10 International Journal of Medicine and 
Medical Sciences 
Not Applicable 1 
11 International Journal of Infection Control Not Applicable 1 
13 Journal of Advances in Medicine and 
Medical Research 
Not Applicable 1 
14 African Journal of Primary HealthCare 
and Family Medicine 
Not Applicable 1 
15 Reference Search Not Applicable 2 
 Total 516 102 
A total of 516 articles were retrieved from the search through the electronic databases. After 
excluding irrelevant titles based on the specification of the PEO search, 92 relevant articles 
were retained for further screening. The manual search through journals yielded additional 
eight articles: Shittu et al. (2013) [Journal of Antivirals and Antiretrovirals]; Pennap, Abdullah 
and Bako (2013) [Journal of AIDS and HIV Research]; Bello (2011) [Global Journal of Medical 
Research]; Chineke et al. (2015) [The Nigerian Journal of General Practice]; Igwegbe, 
Ugboaja and Nwajiaku (2010) [International Journal of Medicine and Medical Sciences]; 
Kasumu and Balogun (2014) [International Journal of Infection Control]; Akinboro et al. (2014) 
[Journal of Advances in Medicine and Medical Research]; and Sekoni, Balogun and Obidike 
(2013) [African Journal of Primary HealthCare and Family Medicine]. In addition, search 
through the reference lists also produced two more studies (Afolabi et al., 2009; Asekomeh, 
Ebong and Onwucheka, 2010) from two of the retained articles (Oku et al., 2014; Maduka and 
Tobin-West, 2015) respectively. Hence, a total of 102 relevant articles were retained for further 
screening. 
After duplicates were excluded, 51 articles with relevant titles were retained for abstract 
screening. The abstract screening led to the exclusion of seven articles leaving 44 relevant 
articles for full-text screening. Justification for the exclusion of the seven articles (Al-Mahmood, 
2017; Ashraf et al., 2017; Ejekam et al., 2014; Maduka and Tobin-West, 2015; Ndembi, 2015; 
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Olowokere, Fatiregun and Osagbemi, 2009; Olowokere, Fatiregun and Adewole, 2012) are 
detailed in Appendix 1.  
Full text reading of the remaining articles also led to the exclusion of twelve more articles 
(Adewuya et al., 2010; Aransiola et al., 2014; Asekomeh, Ebong and Onwucheka, 2010; 
Cornelius et al., 2018; Ebonyi et al., 2015; Ekwunife, Oreh and Ubaka, 2012; Goar et al., 2015; 
Meloni et al., 2015; Odili, Obieche and Amibor 2016; Torpey et al., 2012; Uzochukwu et al., 
2009; Yunusa, Njoku and Obembe, 2014). Reasons for the exclusion of studies at this stage 
are detailed in Appendix 1. These include: focus on stigma and survival challenges and not 
on adherence (Aransiola et al., 2014); unclear threshold for adherence (Adewuya et al., 2010; 
Ekwunife, Oreh and Ubaka, 2012; Odili, Obieche and Amibor 2016; Uzochukwu et al., 2009; 
Yunusa, Njoku and Obembe, 2014); unavailability of full-text (Asekomeh, Ebong and 
Onwucheka, 2010; Torpey et al., 2012); discrepancy between the number of recruited 
participants and the population in results (Goar et al., 2015); focus on loss-to-follow up (Meloni 
et al., 2015) or focus on ART interruption (Ebonyi et al., 2015) not on ART adherence; and 
uncertainty about how much of the evidence was contributed by PLHIV (Cornelius et al., 
2018). After the full-text reading, 32 articles were retained for review. Twenty-five of the articles 
were studies carried out with descriptive cross-sectional survey (Afolabi et al., 2013; Akahara 
et al., 2017; Akinboro et al., 2014; Alakija et al., 2010; Avong et al., 2015; Bello, 2011; Chineke 
et al., 2015; Ekama et al., 2012; Erah and Arute, 2008; Falang, Akubaka and Jimam, 2012; 
Iroha et al., 2010; Igwegbe, Ugboaja and Nwajiaku, 2010; Kasumu and Balogun, 2014; 
Pennap, Abdullahi and Bako, 2013; Oku et al., 2014; Okoronkwo et al., 2013; Oku et al., 
2013a; Olisah, Baiyewu and Sheikh, 2010; Olowokere et al., 2008; Omosanya et al., 2013; 
Suleiman and Momo, 2016; Shittu et al., 2013; Shaahu, Lawoyin and Sangowawa, 2008; 
Ugwu and Eneh, 2013; Ukwe et al., 2010). The rest were carried out as cohort studies 
(Adejumo et al., 2015; Charurat et al., 2010; Habib et al., 2008); Qualitative studies (Audu, 
Morgan and Rutter, 2013; Okoror et al., 2013), and mixed-method studies (Afolabi et al., 2009; 
Sekoni, Obidike and Balogun, 2012).  
There is a need to critically assess the quality of the evidence in each of the retained studies 
to determine the overall worth of the body of evidence included in this review (Polit and Beck, 
2017, p.115). To carry out the critical assessment, Mixed Methods Assessment Tool (MMAT) 
designed by Pluye et al. (2011) was adopted because it allows the assessment of quantitative, 





Critical Assessment of Retained Studies  
Critical assessment of the 32 studies revealed that sampling bias and lack of reliability are 
predominant, while few of the studies had challenges with credibility. In respect of sampling 
bias, there was insufficient evidence about how many eligible patients were invited to 
participate in 15 quantitative studies (Akahara et al., 2017; Akinboro et al., 2014; Alakija et al., 
2010; Chineke et al., 2015; Habib et al., 2008; Igwegbe, Ugboaja and Nwajiaku, 2010; 
Okoronkwo et al., 2013; Oku et al., 2013a; Olowokere et al., 2008; Omosanya et al., 2013; 
Pennap, Abdullahi and Bako, 2013; Ukwe et al., 2010; Shaahu, Lawoyin and Sangowawa, 
2008; Shittu et al., 2013). Although the number of participants who consented to these studies 
were reported, without knowing how many other patients were eligible for the study, one 
cannot ascertain whether the study samples were representative samples. Similar sampling 
bias was evident in the qualitative aspect of the mixed method study carried out by Afolabi et 
al. (2009). The author stated that a total of 28 clients were randomly selected from the clinic 
register and 24 people consented to participate. They further stated that six to eight clients 
who had not answered the questionnaire (survey phase of the study) were included in each 
focus group discussion. However, there was no sufficient information about who the qualitative 
participants were. Similarly, the identity of one of the seven participants in the qualitative 
phase of the study carried out by Sekoni, Obidike and Balogun (2012) was not reported. As 
defined by Polit and Beck (2017, p.203) an appropriate sample results from the selection of 
participants who can best supply information that meets the conceptual requirement of the 
study. Based on this definition, it is not certain if the sample population for the qualitative phase 
of the two studies (Afolabi et al., 2009; Sekoni, Obidike and Balogun, 2012) were the 
appropriate samples. 
Furthermore, the authors of ten studies did not provide sufficient evidence to ascertain the 
validity or reliability of the questionnaires that were used for the data collection in respect of 
ART adherence or predictors of adherence in the surveys (Afolabi et al., 2009; Akinboro et al., 
2014; Alakija et al., 2010; Habib et al., 2008; Olisah, Baiyewu and Sheikh, 2010; Oku et al., 
2014; Oku et al., 2013a; Pennap, Abdullahi and Bako, 2013; Shaahu, Lawoyin and 
Sangowawa, 2008; Shittu et al., 2013). Meanwhile, the credibility of the qualitative phase of 
the mixed methods study carried out by Sekoni, Obidike and Balogun (2012) was also limited. 
In this regard, the authors did not report how the qualitative data was analysed (Sekoni, 
Obidike and Balogun, 2012). The authors only stated that “information collected was analysed 
manually”. The manual analysis is not compatible with the qualitative research tradition such 
as thematic or content analysis (Polit and Beck, 2017, p.292). 
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Lastly, dependability is an integral element of the rigour of qualitative studies (Ryan, Coughlan 
and Cronin, 2007). A way of establishing the dependability of the qualitative study is to provide 
the readers with evidence of the decisions and choices made in respect of the theoretical and 
methodological issues throughout the study (Ryan, Coughlan and Cronin, 2007). In this 
regard, lack of evidence in the study carried out by Sekoni, Obidike and Balogun (2012) about 
the influence of the authors on the findings and limitations associated with the integration of 
methods reduced the dependability of the study.  
As presented in Table 2.2, the quality scores for the studies were calculated with Likert scores 
“zero”, “one” and “two” allocated for responses to each of the MMAT questions (see Appendix 
7) such as “No”, “Can’t tell” and “Yes” respectively. The maximum achievable quality score by 
any of the studies is eight. Therefore, a total Likert score of four was assumed to be the 
medium quality score and any lower score suggests a poor methodological quality. Based on 
the methodological limitations highlighted above, 16 studies have quality scores of eight 
(Adejumo et al., 2015; Afolabi et al., 2009; Afolabi et al., 2013; Audu, Morgan and Rutter, 
2013; Avong et al., 2015; Bello, 2011; Charurat et al., 2010; Ekama et al., 2012; Erah and 
Arute, 2008; Falang, Akubaka and Jimam, 2012; Iroha et al., 2010; Kasumu and Balogun, 
2014; Okoror et al., 2013; Suleiman and Momo, 2016; Ugwu and Eneh, 2013). Nine studies 
also have quality scores of seven (Akahara et al., 2017; Igwegbe, Ugboaja and Nwajiaku, 
2010; Okoronkwo et al., 2013; Oku et al., 2014; Olisah, Baiyewu and Sheikh, 2010; Olowokere 
et al., 2008; Omosanya et al., 2013; Sekoni, Obidike and Balogun, 2012; Ukwe et al., 2010). 
While the remaining eight studies have total quality scores of six (Habib et al., 2008; Oku et 
al., 2013a; Alakija et al., 2010; Akinboro et al., 2014; Chineke et al., 2015; Shittu et al., 2013; 
Pennap, Abdullahi and Bako, 2013; Shaahu, Lawoyin and Sangowawa, 2008). Since the 
quality scores of the reviewed studies were all above the medium benchmark, it can be argued 
that the overall methodological quality of the review is high. Findings from this review should 
therefore be interpreted with regards to the highlighted methodological limitations and the 
quality scores of the studies contributing to the findings. The data collected from the retained 
studies after the critical assessment are as presented in Table 2.2. 
Overview of Reviewed Studies 
Numerous studies have been carried out to assess adherence of PLHIV to ART and the 
factors predicting adherence from different settings across all age groups in Nigeria. The 
minimum threshold of adherence in the studies in this review that reported ART adherence 
rates was 95%. The 32 studies in the review were carried out in five out of the six geopolitical 
regions in the country (Figure 2.2). These include: South-South (Erah and Arute, 2008; Oku 
et al., 2014; Oku et al., 2013a; Suleiman and Momo, 2016; Ugwu and Eneh, 2013); South-
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East (Akahara et al., 2017; Chineke et al., 2015; Igwegbe, Ugboaja and Nwajiaku, 2010; 
Okoronkwo et al., 2013; Ukwe et al., 2010); South West (Adejumo et al., 2015; Afolabi et al., 
2009; Afolabi et al., 2013; Akinboro et al., 2014; Ekama et al., 2012; Iroha et al., 2010; Kasumu 
and Balogun, 2014; Okoror et al., 2013; Olowokere et al., 2008; Omosanya et al., 2013; 
Sekoni, Balogun and Obidike, 2012); North-Central (Alakija et al., 2010; Audu, Morgan and 
Rutter, 2013; Avong et al., 2015; Bello, 2011; Falang, Ubaka and Jimam, 2012; Pennap, 
Abdullah and Bako, 2013; Shaahu, Lawoyin and Sangowawa, 2008; Shittu, 2011); and North-
West (Habib et al., 2008; Olisah, Baiyewu and Sheikh, 2010). One of the studies that was not 
carried out in a single region (Charurat et al., 2010) was carried out in five teaching hospitals 
across the five regions. The only region without any study representation in this review is the 
North-Eastern part of Nigeria, which has been deeply affected by the Boko Haram insurgence 
which started in 2009. The insurgence could have made the region unsafe for research 
activities leading to the dearth of evidence in respect of the objectives of this review from the 
region. In this regard, it can be argued that the studies included in this review represent 
available evidence from all the viable regions in Nigeria. 
Figure 2.2: States and Geographical Regions of Nigeria 
Source: Gayawan, Arogunadade and Adebayo (2014) 
 
As presented in table 2.2, a total of 12,713 adult men and women living with HIV participated 
in 29 of the reviewed studies (Adejumo et al., 2015; Afolabi et al., 2013; Afolabi et al., 2009; 
Alakija et al., 2010; Akinboro et al., 2014; Audu Morgan and Rutter, 2013; Avong et al., 2015; 
Bello, 2011; Charurat et al., 2010; Chineke et al., 2015; Ekama et al., 2012; Erah and Arute, 
2008; Falang, Akubaka and Jimam, 2012; Habib et al., 2008; Igwegbe, Ugboaja and Nwajiaku, 
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2010; Kasumu and Balogun, 2014; Okoronkwo et al., 2013; Okoror et al., 2013; Oku et al., 
2013a; Oku et al., 2014; Olisah, Baiyewu and Sheikh, 2010; Olowokere et al., 2008; 
Omosanya et al., 2013; Shittu et al., 2013; Pennap, Abdullahi and Bako, 2013; Sekoni, Obidike 
and Balogun, 2012; Shaahu, Lawoyin and Sangowawa, 2008; Suleiman and Momo, 2016; 
Ukwe et al., 2010). In addition, 635 children living with HIV also participated in three of the 
reviewed studies (Akahara et al., 2017; Iroha et al., 2010; Ugwu and Eneh, 2013), while 538 
pregnant women living with HIV also participated in two studies (Ekama et al., 2011; Igwegbe, 
Ugboaja and Nwajiaku, 2010). Hence, the state of knowledge contributed by the reviewed 
studies cuts across all age groups of patients including pregnant mothers in Nigeria.   
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Table 2.2: Reported ART Adherence Rates in Nigerian Studies 











Adherence Measure Quality Score 
Falang, Akubaka and Jimam, 
2012 
461 (men and 
women) 
≥95 87.9 12.1 Self-report 8 
Shittu et al., 2013 170 (men and 
women) 
≥95 81.2 18.8 Self-report 6 
Olowokere et al., 2008 318 (men and 
women) 
≥95 62.9 37.1 Self-report 7 
Alakija et al., 2010 253 (men and 
women) 
≥95 70.8 29.2 Self-report 6 
Avong et al., 2015 502 (men and 
women) 
≥95 97.3 2.7 Self-report 8 
Pennap, Abdullahi and Bako, 
2013 
250 (men and 
women) 
≥95 62.8 37.2 Self-report 6 
Bello, 2011 213 (men and 
women) 
≥95 73.3 26.7 Self-report/Pill count 8 
Shaahu, Lawoyin and 
Sangowawa, 2008 
428 (men and 
women) 
100 62.6 38.4 Self-report 6 











































Adherence Measure Quality Score 

















Not reported Self-Report 6 
Ekama et al., 2012 170 (pregnant 
women) 
≥95 80.6 19.4 Self-report 8 
Sekoni, Obidike and Balogun, 
2012 









≥95 89.4 10.6 Self-report 7 
Omosanya et al., 2013 100 (men and 
women) 
≥95 88 12 Self-report 7 
Kasumu and Balogun, 2014 361 (men and 
women) 
≥95 78.4 21.6 Self-report 8 
Akinboro et al., 2014 270 (men and 
women) 
≥95 62.6 37.4 Pill count 6 
Iroha et al., 2010 212 Children 100  86 14 Self-report 8 
Afolabi et al., 2013 379 (men and 
women) 
≥95 95.5 4.5 Self-report/Pill count 8 
19 
  











Adherence Measure Quality Score 
Okoronkwo et al., 2013 221 (men and 
women) 
≥95 14.9 85.1 Self-report/Pill count 7 
Ukwe et al., 2010 310 (men and 
women) 
≥95 70.2 29.8 Self-report 7 
**Adejumo et al., 2015 
 
 
453 (men and 
women) 
100 90.3% in the 
preceding 
week. 










Chineke et al., 2015 400 (men and 
women) 
≥95 96.2 3.8 Self-report 6 
Igwegbe, Ugboaja and Nwajiaku, 
2010 
368 (men and 
women) 
≥95 79.3 21.7 Self-report 7 
Akahara et al., 2017 210 (infected 
children) 
≥95 91 9 Self-report 7 
Erah and Arute, 2008 102 (men and 
women) 
≥95 58.1 41.9 Self-report/Pill count 8 
Okoror et al., 2013 35 (men and 
women) 
N/A N/A N/A N/A 8 
Audu, Morgan and Rutter, 2013 In-depth interview 







N/A N/A N/A N/A 8 
Oku et al., 2013a 411 (men and 
women) 
≥95 59.9 40.1 Self-report 6 
Suleiman and Momo, 2016 601 (men and 
women) 
 
≥95 73.4 26.6 Self-report 8 
20 
  
N: B: * Out of 5760 patients, the reported adherence was among 4529 who returned for follow-up. **Seven and Eight participants did not report adherence in 
the study period respectively. N/A refers to “Not Applicable”. 
  











Adherence Measure Quality Score 




≥95 76.1 23.9 Self-report 8 
*Charurat et al., 2010 4529 (men and 
women) 
≥95 25.8 74.2 Pharmacy refill 8 
Oku et al., 2014 393 (men and 
women) 
≥95 50.4 49.6 Self-report 7 
Afolabi et al., 2009 120 (men and 
women) 




2.3.1 Level of Adherence to ART in Nigeria 
As presented in table 2.2 evidence from the reviewed studies shows that adherence rates 
ranged between 14.9% and 97.3% across all age groups including pregnant women, children 
and adolescents. Poor adherence to the HIV treatment could also be as high as 85.1% and 
as low as 2.7%. It is worthy of note that report of ART adherence above 77%, which is the 
average adherence rate in sub-Saharan Africa region (Mills et al., 2006a) were based on self-
report (Adejumo et al., 2015; Akahara et al., 2017; Avong et al., 2015; Chineke et al., 2015; 
Ekama et al., 2012; Falang, Akubaka and Jimam, 2012; Habib et al., 2008; Igwegbe, Ugboaja 
and Nwajiaku, 2010; Iroha et al., 2010; Kasumu and Balogun, 2014; Olisah, Baiyewu and 
Sheikh, 2010; Omosanya et al., 2013; Sekoni, Obidike and Balogun, 2012; Shittu et al., 2013). 
However, the 95.5% adherence reported by Afolabi et al. (2013) presents an exception to this 
observation as it was measured with the combination of self-report and pill count.  
Meanwhile, other studies that combined self-report with pill count also reported adherence 
levels below the sub-Saharan African average: 14.9% (Okoronkwo et al., 2013); 58.1% (Erah 
and Arute, 2008); 73.3% (Bello, 2011); and 44% (Afolabi et al., 2009). Interestingly, a study 
that utilized only pill count for ART adherence assessment reported 62.6% adherence 
(Akinboro et al., 2014) and another study which assessed adherence with pharmacy refill 
reported 25.8% adherence (Charurat et al., 2010). These rates are lower than the values 
reported from most studies that employed self-reported adherence in Nigeria. Considering the 
unreliability of self-report and the limitations of other objective adherence assessment 
methods, there is high likelihood that ART adherence from studies and across Nigeria may be 
poorer than is reported. Even if high non-adherence is not reported in all studies, it is important 
to consider that PLHIV who disrupt treatment for even short periods face the possibility of 
increasing viral load over time as well as increasing the risk of drug resistance (Genberg et 
al., 2014). Therefore, the PLHIV in Nigeria who do not achieve optimum adherence still need 
support to improve adherence to their medications to prevent new infections and death. 
2.3.2 Predictors of Antiretroviral Therapy Adherence in Nigeria  
To develop appropriate support to maintain adherence to treatment among PLHIV, there is 
need for insight into the factors influencing adherence or non-adherence to ART (Langebeek 
et al., 2014a). Evidence from systematic reviews has shown that predictors of ART adherence 
can be categorized into many ways such as patient-related factors, medication-related factors, 
interpersonal relationship factors, clinical setting and health system factors (Mills et al., 2006b; 




studies from Nigeria are therefore categorised under the same categories as presented in 
table 2.3.  
Table 2.3: Predictors of Antiretroviral Therapy Adherence in Nigeria 




















F; T; BS; D; PV; R; 
H; CS; S; A; NAT 
SE C Not reported Not reported 
Shittu et al., 
2013 
F; T; BS; DC; FH SE; PB Not reported SD SO 
Olowokere et 
al., 2008 
F; FH;  N/A Not reported SD Not reported 
Alakija et al., 
2010 
U; PV; DC; A; G N/A Not reported Not reported Not reported 
Avong et al., 
2015 








F; T; DC; PV; O; E; 
CS 
SE Not reported Not reported Not reported 





LD; CS; PV Not 
reported 
NJH Not reported SO 
Olisah, Baiyewu 
and Sheik, 2010 
F; D; LD Not 
reported 
Not reported Not reported SO 
Ekama et al., 
2012 
F; BS; R; NR; PM; 
EM; D; K;  
Not 
reported 




LD; T; FH SE Not reported SD Not reported 
Omosanya et 
al., 2013 
Not reported Not 
reported 
Not reported SD Not reported 
Kasumu and 
Balogun, 2014 
T; A  Not 
reported 
Not reported Not reported LW 
Akinboro et al., 
2014 
Not reported Not 
reported 
Not reported DS Not reported 
Iroha et al., 
2010 
LD; CSA; G; CS Not 
reported 
Not reported Not reported Not reported 
Afolabi et al., 
2013 
Not reported Not 
reported 
Not reported FS Not reported 
Afolabi et al., 
2009 
PV; E; HMI CD NJH FS AC 
Okoronkwo et 
al., 2013 
F; BS; A; LD; E; U SE C SD LW 




Not reported Not reported Not reported 
Chineke et al., 
2015 




























F; A; PP; E; O; LD; 
FH; DC 
SE Not reported DS Not reported 
Akahara et al., 
2017 
F; H; T; FH; PV; PM   SE C SD; FS; SG Not reported 
Erah and Arute, 
2008 
E; PV; O SE LCT FS Not reported 










NJH SD Not reported 
Oku et al., 
2013a 
F; BS; D; T; R; PV; 
DC; FH; HM 
INT; SE; PB NJH SD LW 
Suleiman and 
Momo, 2016 
F; BS; FH SE Not reported Not reported Not reported 
Ugwu and Eneh, 
2013 
F; T; BS; R; FH; E; 
PV; RA; A; PC; M  
PB; SE C FS SO 
Charurat et al., 
2010 
A; E; U;  Not 
reported 
Not reported DS Not reported 
Oku et al., 2014 FS; BS; R; T; D; PV; 
HMI; FH; HM 
NR Not reported Not reported Not reported 
Notations: AC-Adherence Counselling at the Clinic; A-Age; BS-Busy Schedule; C-Poor 
Communication/Unclear Dosage Instruction; CSA-Child Sleeping During Drug Administration; CD-
Characteristic of Drug; CS-Missing/Keeping Clinic Session; D-Depression; DC-Distance to the Clinic; 
DS-Disclosure of Status; E-Educational attainment; EM-External Motivation; FH-Feeling Healthy; FS-
Family Support; G-Gender; F-Forgetfulness; H-Hospitalisation/Illness; INT-Inconvenient Timing of 
Drug; HM-Herbal Medicine; HMI-High Monthly Income; K-Knowledge of HIV/ART; L-Loss of Drugs 
Armed Robbers; LCT-Lack of Confidentiality; LD-Length of Diagnoses/Drug-Taking Fatigue; LW-Long 
Waiting at the Clinic; M-Marital Status; NAT-Non-Taking of Alcohol; NJH-Non-Judgmental Health 
Workers; NR-Nutritional Requirement; O-Occupation; PB-Pill Burden; PC-Comorbidity; PM-Personal 
Motivation; PP-Pregnancy Parity; PV-Poverty; R-Religious Activity; RA-Reminder Aid; T-Travelled; TS-
Treatment Supporter; SE-Side Effects of Drug; SG-Support Group; SD-Stigma and Discrimination; SO-
Stock Out of ARV; U-Unemployment/Employment. 
Patient-Related Factors: Predictors found under this category include: gender; age; 
depression; level of education; employment status; marital status; patients’ health beliefs, 
forgetfulness; travelling without drugs; busy daily tasks; motivation for adherence and self-
efficacy. These are the factors that were reported by more than one study.  
Gender: Evidence from a survey in Nigeria among adults has shown that male PLHIV were 
more likely to adhere to their HIV medications than the female PLHIV (Alakija et al., 2010). 
Another survey among 212 children in Nigeria has also shown that male children were more 
likely to adhere to ART than female children (Iroha et al., 2010). Although evidence from these 
two studies may not be sufficient for generalization for the whole of Nigerian population, 
evidence from other settings in other countries has revealed similar patterns (Beer and 




al., 2011; Tapp et al., 2011). Some socio-cultural factors may contribute to the polarised 
adherence rate between the genders which mostly favours the male gender. For instance, the 
Nigerian society is male dominated and disclosure of HIV status especially to an HIV-negative 
husband may come with dire consequences for the women (Alakija et al., 2010). Moreover, 
women in Africa usually play many roles in caring for the family and such responsibilities may 
leave them with little or no time to care for themselves or remember to take their medications 
(Oku et al., 2013b). Even though ART adherence for children is managed by their adult 
caregivers, likelihood of higher adherence rates among male children could be a reflection of 
the more socio-cultural value placed on the male child compared to female child in most 
settings in Nigeria (Iroha et al., 2010). 
Age: Some studies in Nigeria have reported that older age of adult PLHIV and children living 
with HIV predict optimum ART adherence (Alakija et al., 2010; Charurat et al., 2010; Falang, 
Akubaka, and Jimam, 2012; Igwegbe, Ugboaja and Nwajiaku, 2010; Kasumu and Balogun, 
2014; Okoronkwo et al., 2013; Ugwu and Eneh, 2013). This pattern is consistent with 
adherence behaviour in other contexts. For instance, in a meta-analysis by Ghidhei et al. 
(2013) older adults over the age of 50 were found to be more adherent to ART than the 
younger adults. This is consistent with the findings by Nachega et al. (2009) from a cohort 
study involving 7,622 adults and 154 adolescents living with PLHIV in South Africa. In the 
study, adolescents in South Africa tend to be less adherent than adults. It has however been 
pointed out that the age impact on ART adherence may be due to the possibility of higher 
familiarity of the older PLHIV with usage of correct medications or increasing awareness of 
the necessity of optimal ART adherence among the older patients (Falang, Akubaka and 
Jimam, 2012; Kasumu and Balogun, 2014).  
Depression: Surveys from Nigeria have reported that depression or depressive symptoms 
predict non-adherence to ART (Falang, Akubaka and Jimam, 2012; Oku et al., 2014; Oku et 
al., 2013a; Olisah, Baiyewu and Sheik, 2010). Consistent with the findings from these studies 
in Nigeria, evidence from a systematic review and meta-analysis of studies from high-, middle- 
and low-income countries has established that the likelihood of achieving optimum ART 
adherence among PLHIV with depressive symptoms is 42% lower than among those without 
such symptoms (Uthman et al., 2014).  
Level of Education and Employment Status: Patients’ level of education and employment 
status have been found to influence ART adherence differently in Nigeria. Evidence from some 
surveys has shown that employment and better source of income were associated with good 
adherence (Afolabi et al., 2009; Alakija et al., 2010; Charurat et al., 2010; Erah and Arute, 




the employed patients have a source of income to transport themselves to the clinic most of 
the time (Falang, Akubaka and Jimam, 2012). However, the findings from the survey by 
Okoronkwo et al. (2013) suggests that the association between employment and ART 
adherence may not be consistent with every population in Nigeria. This study reported that 
employed patients tend to miss their drugs more than the unemployed and artisans by citing 
forgetfulness, busy schedule, and stigma as reasons for non-adherence.  
In respect of the influence of educational status of PLHIV with ART adherence, evidence has 
shown that higher literacy level of PLHIV is associated with higher ART adherence when 
compared to the adherence found among those who are not educated (Afolabi et al., 2009; 
Bello, 2011; Erah and Arute, 2008; Pennap, Abdullahi and Bako, 2013). This association was 
also found in the study by Igwegbe, Ugboaja and Nwajiaku (2010) which reported that all the 
female HIV students in their study were adherent, while the women who were artisans and full 
housewives were non-adherent to their therapy. Igwegbe, Ugboaja and Nwajiaku (2010) also 
reported that apart from the low educational level of the women, low level of education of their 
husbands were associated with increased likelihood of the women to non-adherence. This 
report underscores the importance of the role of the husbands and family in supporting the 
women living with HIV to adhere to their treatment. Overall these findings suggest that poor 
educational level of PLHIV may affect their communication with health workers and decrease 
their retention of information provided by the health workers, thereby inhibiting the patients’ 
implementation of the clinicians’ recommendations. It is therefore, not surprising that in a 
survey by Okoronkwo et al. (2013) patients with no formal education were reported to be more 
likely to attribute their non-adherence to ART to poor communication.  
Marital Status: The survey by Pennap, Abdullahi and Bako (2013) demonstrated that being 
married is associated with significantly higher ART adherence than being single, widowed or 
divorced. The survey by Ekama et al. (2012) among pregnant women also showed that having 
treatment partners which in most cases are the husbands whom the women could disclose 
their HIV status to was associated with higher level of ART adherence. On the other hand, 
marital problems have been associated with non-adherence among some PLHIV in another 
study by Falang, Akubaka and Jimam (2012). This contrasting evidence emphasise the 
importance of family members on the patients towards ART adherence.  
Patients’ Health Beliefs: Evidence from a qualitative study by Audu, Morgan and Rutter 
(2014) has shown that some patients believe in the effectiveness of ART because they 
described it as “life drugs”. This belief could determine whether the patient will adhere to the 
treatment or not as has been reported in a meta-analysis by Mills et al. (2006b) that doubts 




in the effectiveness of ART contribute to poor adherence. In this regard, surveys in Nigeria 
have reported the use of herbal-medicine by PLHIV due to their growing lack of faith in the 
curative capacity of ART and beliefs in the claims of instant cure for HIV by traditional medicine 
practitioners and prayer houses or spiritual healing. The studies show that concurrent use of 
herbal-medicine and spiritual healing with ART or their use as absolute replacement for ART 
predicts non-adherence to ART (Bello, 2011; Oku et al., 2013a; Oku et al., 2014; Ugwu and 
Eneh, 2013).  
Poor health beliefs associated with patients’ poor understanding of HIV and its treatment has 
also been reported to predict non-adherence to ART in Nigeria (Akahara et al., 2017; Ekama 
et al., 2012; Ugwu and Eneh, 2013). For instance, Ugwu and Eneh (2013) reported that some 
patients fail to adhere to ART because they share their ARVs with their child.  
Meanwhile, some studies have also shown that religious beliefs of PLHIV influence their 
thinking in relation to the disease and adherence to its treatment. For instance, Audu, Morgan 
and Rutter (2013) reported that some PLHIV believe God has the power to cure HIV and 
viewed it as “God’s will” and as a “punishment from God”. Some of the PLHIV in the qualitative 
study also believed that their HIV diagnosis brought them closer to God and to cope with their 
status. These views are common among PLHIV in Nigeria as it has also been reported in a 
survey that some PLHIV believe that HIV/AIDS is a punishment for previous immoral 
behaviour and that PLHIV have no hope of a better future (Olowokere, Fatiregun and Adewole, 
2012). These views have the possibility of inhibiting PLHIV from implementing ART adherence 
recommendations from their health workers as they believe that their religious belief could 
heal them rather than the ART. For instance, in a survey among 1,177 PLHIV initiating ART 
in Ethiopia, patients’ belief in the capacity of holy water to cure HIV was found to increase the 
risk of ART non-adherence among some patients (Tymejczyk et al., 2015). 
Religious constraints or activities such as fasting or attending church programmes have also 
been found to predict poor ART adherence in Nigeria (Falang, Akubaka and Jimam, 2012; 
Oku et al., 2014; Oku et al., 2013a). Charurat et al. (2010) also found from a cohort study that 
patients with Quranic education were at an increased risk of being non-adherent to ART. 
These findings highlight the value placed on religious beliefs in Nigeria where such views 
among Christians and Muslims play important roles in determining health behaviours 
(Olowokere et al., 2008).  
However, religious beliefs do not always predict a negative impact on patients’ ART taking 
behaviours. For instance, Kremer, Ironson and Porr (2009) reported in a qualitative study 




treatment side effects were more likely to adhere optimally. Lyimo et al. (2014) also reported 
in a survey involving 158 PLHIV in Tanzania that religious coping could serve as a buffering 
resource in the experience of HIV related stigma which may predict better ART adherence. 
Similarly, Vyas et al. (2014) found in a longitudinal study among 350 PLHIV that patients who 
reported that their religion was a positive influence during their recovery period showed greater 
adherence. Conversely, patients who adopt passive deferral by believing that God/higher 
power is in control of their disease and how it progresses or that he will not turn his back on 
them as forms of religious coping are more likely to report suboptimal adherence (Kremer, 
Ironson and Porr, 2009; Finocchario-Kessler et al., 2011; Vyas et al., 2014). Based on these 
evidence, the potential impact of religious beliefs on health outcomes depends on the 
interpretation of the individuals on whether they view God as a source of inspiration and 
strength to do what needs to be done or as a reason to abdicate full responsibility for their 
illness to God (Finocchario-Kessler et al., 2011). It is therefore not surprising that evidence 
from a cohort study carried out by Habib et al. (2008) in Nigeria shows increased rate of 
optimum adherence during the fasting month for the Muslim cohort. 
Motivation: Evidence from some studies in Nigeria has revealed that certain patients’ 
perceptions motivate them to take the drugs or not. For instance, self-discouragement has 
been reported as a barrier to ART adherence in a study in Nigeria (Chineke et al., 2015). In 
this regard, improvement in health condition is commonly reported as a key motivator for 
PLHIV to adhere to their drugs, while lack of improvement in health since the commencement 
of the treatment discouraged the patients from taking the treatment, because they felt the drug 
was not helpful (Akahara et al., 2017; Avong et al., 2015; Igwegbe, Ugboaja and Nwajiaku, 
2010; Okoror et al., 2013; Oku et al., 2013a; Oku et al., 2014; Suleiman and Momo, 2016; 
Ugwu and Eneh, 2013). However, influence of the perceived improvement in health on the 
medication taking behaviour of the patients could vary. For instance, it has been reported that 
improvement in health enhanced the motivation of some PLHIV because they felt that ART 
provided them with the opportunity to regain their health and improve their physical 
appearance, to enable them to engage in their daily activities (Okoror et al., 2013). 
Conversely, it has also been reported that improvement in health could lead to the patients 
being unable to continue taking the drug (Akahara et al., 2017; Igwegbe, Ugboaja and 
Nwajiaku, 2010; Olowokere et al., 2008; Sekoni, Obidike and Balogun, 2012; Shittu et al., 
2013). Hence, it cannot be assumed that all PLHIV will be motivated to adhere to their drugs 
because their health improved.  
Furthermore, desire to live is a potential motivation among PLHIV leading to increased 




Avong et al., 2015). Similarly, pregnant women may also be more motivated to adhere to the 
HIV treatment compared with other members of the general population because of their 
concerns for the foetus. As reported by Ekama et al. (2012) the desire to protect the unborn 
child was the greatest motivation for the pregnant PLHIV to adhere to their drugs. However, 
evidence from the study by Igwegbe, Ugboaja and Nwajiaku (2010) suggests that the 
motivation reported by Ekama et al. (2012) may not be consistent in Nigeria as they reported 
that a significant number of pregnant PLHIV in their study missed their drugs because they 
felt healthy. Meanwhile, besides the influence of intrinsic motivation, the motivation to adhere 
to ART among some PLHIV in Nigeria is dependent on external sources which include 
adherence counselling that they receive from the clinic (Afolabi et al., 2009) or following 
instruction from the health counsellors (Ekama et al., 2012) or availability of support groups 
(Akahara et al., 2017; Avong et al., 2015). 
Patient Duration on ART: Evidence from some surveys in Nigeria has also shown that the 
length of time PLHIV have been on ART may predict their adherence to the treatment. The 
studies showed that PLHIV who have been on ART for long time were more likely not to 
adhere to the treatment (Igwegbe, Ugboaja and Nwajiaku, 2010; Okoronkwo et al., 2013; 
Shaahu, Lawoyin and Sangowawa, 2008). This finding contradicts evidence reported in a 
survey in Zambia that ART adherence was significantly higher for people who had been on 
treatment longer (Carlucci et al., 2008). However, the association found in the Nigerian studies 
suggests that the patients’ behaviour could be due to dwindling enthusiasm for those who had 
been on the therapy for longer time compared with those who newly commenced the treatment 
(Igwegbe, Ugboaja and Nwajiaku, 2010). This is consistent with the finding of Sekoni, Obidike 
and Balogun (2012) in Nigeria who reported that majority of the non-adherent patients in their 
study cited being tired of taking the medication as the main reason for skipping their drug. The 
dwindling enthusiasm may also be associated with the need to cope with daily living with HIV 
and stressors associated with it such as stigma and adherence to the ART (Kamau et al., 
2011). 
Self-Efficacy: Self efficacy is described as people’s beliefs that determine how well they 
motivate themselves and persevere in difficult situations when pursuing specific goals that 
they set for themselves (Bandura, 2012, p.13). It determines whether people will make good 
use of their capabilities when approaching certain tasks and whether they will be successful 
or not (Bandura, 2012; Colbert, Sereika and Erlen, 2012). Hence, self-efficacious people have 
the tendency to be more successful in learning new skills to perform specific tasks or 
behaviours, because they have the capability to persevere when faced with challenges that 




further asserted that people’s beliefs in their coping capabilities is central to the self-regulation 
of their emotional states, which in turn affects the quality of their emotional life and their 
vulnerability to depression and stress.   
In respect of self-efficacy, while some studies from Nigeria have demonstrated that social 
support from family members and society for PLHIV may predict better adherence levels 
(Afolabi et al., 2013; Afolabi et al., 2009; Avong et al., 2015; Erah and Arute, 2008), a survey 
suggests that self-reliance of PLHIV may have similar or greater influence on their medication 
taking behaviour (Odili, Obieche and Amibor, 2016). For instance, Odili, Obieche and Amibor 
(2016) demonstrated that among the PLHIV who were adherent to ART, 92.1% were self-
reliant compared with 83.7% who relied on family support. However, the adherence threshold 
in the study was not clear. Hence it could not be determined if the adherent participants are 
comparable to adherent participants in the other studies. Despite the limitation of the study, 
similar relationship between self-efficacy and ART adherence has been reported in other 
settings. For example, evidence from a survey among 354 PLHIV in Kenya has reported 
significant association between the self-efficacy to cope with daily living and HIV related 
stressors such as stigma and adherence to ART (Kamau et al., 2011). Interestingly, the 
adherence threshold in the study was 100%, which is comparable to the findings of some 
studies in this review.  
Other Priorities: Some other patient-related factors that have been commonly reported to 
inhibit ART adherence in Nigeria include: forgetfulness; travelling without drug; and busy daily 
schedule (Avong et al., 2015; Bello, 2011; Ekama et al., 2012; Igwegbe, Ugboaja, Nwajiaku, 
2010; Olowokere et al., 2008; Pennap, Abdullahi and Bako, 2013; Okoronkwo et al., 2013; 
Oku et al., 2013a; Sekoni, Obidike and Balogun, 2012; Shittu et al., 2013). Among these 
barriers, forgetfulness is the most commonly cited (Avong et al., 2015; Bello, 2011; Ekama et 
al., 2012; Falang, Akubaka and Jimam, 2012; Pennap, Abdullahi and Bako, 2013; Olisah, 
Baiyewu and Sheikh, 2010; Okoronkwo et al., 2013; Oku et al., 2013a; Oku et al., 2014; Shittu 
et al., 2013; Suleiman and Momo, 2016; Ugwu and Eneh, 2013). Forgetfulness as the most 
frequently cited barriers in the Nigerian studies, reflects a pattern that is consistent with the 
findings of a systematic review and meta-analysis of 125 studies (Shubber et al., 2016). 
Overall, evidence from the Nigerian studies suggests that the patients may place higher 
priorities to other aspects of their lives than the HIV treatment leading to non-adherence.  
Access to Care: Cost of transportation and distance to medical centre are reported as 
significant barriers to ART adherence among patients in some studies in Nigeria (Alakija et 
al., 2010; Pennap, Abdullahi and Bako, 2013). This is consistent with the findings of a 




distance to clinic is a common barrier in low and middle-income countries in Africa, South East 
Asia, and Western Pacific regions. However, Okoye, Diekedie and Afemikhe (2015) have 
argued that cost of transportation may not necessarily be a barrier to all HIV patients. Based 
on a study among 540 PLHIV in Nigeria, they found that some of the patients who complained 
about cost of transportation as barrier to ART adherence actually travelled to ART centres far 
from their place of residence due to fear of stigmatization. Therefore, distance and cost of 
transportation to the clinic may become a barrier for such patients and not for others. This 
argument is consistent with the finding from the study by Alakija et al. (2010) which revealed 
that cost of transportation correlates with higher adherence. 
Medication-Related Factors: In studies from Nigeria, common barriers to ART adherence 
associated with the medication include drug adverse events, strict nutritional restriction, drug 
dosing frequency and pill load burden (Afolabi et al., 2009; Akahara et al., 2017; Bello, 2011; 
Falang, Akubaka and Jimam, 2012; Igwegbe, Ugboaja and Nwajiaku, 2010; Okoronkwo et al., 
2013; Oku et al., 2013a; Pennap, Abdullahi and Bako, 2013; Sekoni, Obidike and Balogun, 
2012; Suleiman and Momo, 2016). This is consistent with the findings from a systematic 
review and meta-analysis of 19 studies from countries other than Nigeria (Al-Dakkak et al., 
2013). In the review, adherence to ART was significantly lower in patients with non-specific 
and some specific adverse event than in patients who did not experience adverse events. The 
specific adverse events identified in the review include: fatigue; confusion; taste disturbances; 
and nausea. However, evidence of the systematic review and meta-analysis carried out by 
Shubber et al. (2016) shows that frequency of the reporting of drug toxicity, pill burden, and 
being sick as barriers to ART adherence have reduced over time. This could be associated 
with the changes that have been made in respect of ART adherence delivery and therapy 
formulations over the years (Shubber et al., 2016; WHO, 2016). The simplicity and tolerability 
associated with such changes could have accounted for the reduction in the frequency of the 
reporting of the medication-related barriers (Shubber et al., 2016) in the Nigerian studies.  
Interpersonal Relationship Factors: This category includes factors specific to health 
providers and community factors as discussed below: 
Health Provider-Related Factors: Trust or satisfactory relationship with healthcare providers 
has been consistently associated with good ART adherence (Brion, 2014; Corless et al., 2013; 
Mills et al., 2006b; Wasti et al., 2012). In this review, evidence from Nigerian studies shows 
that poor communication and stigma from the health workers (Okoronkwo et al., 2013) as well 
as lack of confidentiality in the clinic (Erah and Arute, 2008) are predictors of ART non-
adherence. Conversely, non-judgemental (Shaahu, Lawoyin and Sangowawa, 2008) and 




optimum adherence to ART in Nigeria. HIV stigma and judgemental approach by health 
workers have been established in a systematic review as aspects of poor patient-provider 
relationship (Colvin et al., 2014). Such attitude from the health workers induce fear in the 
patients that the health workers may inadvertently breach their confidentiality by disclosing 
their status to others (Colvin et al., 2014; Erah and Arute, 2008). Based on this perceived 
threat, evidence from Nigeria and other settings shows that PLHIV avoid going to nearby 
treatment centres to avoid fellow community members knowing their status, due to stigma 
related risk (Colvin et al., 2014; Lyimo et al., 2012; Okoye, Diekedie and Afemikhe, 2015). 
Therefore, stigmatization or discrimination of PLHIV by some Nigerian health workers can lead 
to non-adherence or lack of retention in care. 
Community Factors: Central factors in this category are the concepts of stigma and 
disclosure of HIV status as potential predictors of ART adherence (Lyimo et al. 2012). Despite 
various efforts targeted at changing the public perceptions of HIV, there is little or no change 
in the perception of Nigerians about the disease (Aransiola et al., 2014), hence stigma or 
discrimination towards HIV/AIDS has been reported to predict poor ART adherence in many 
studies (Akahara et al., 2017; Audu, Morgan and Rutter, 2014; Bello, 2011; Omosanya et al., 
2013; Sekoni, Obidike and Balogun, 2012; Shittu et al., 2013). Stigma or discrimination in 
respect of HIV in Nigeria is due to many cultural beliefs and perceptions. Typically, HIV status 
continues to be attributed to patients’ promiscuity and waywardness (Aransiola et al., 2014; 
Olowokere, Fatiregun and Osagbemi, 2009). Due to this perception, PLHIV have reported 
being alienated and not being accepted by the society. For instance, PLHIV commonly 
experience neglect and avoidance from family and community members (Afolabi et al., 2013; 
Audu, Morgan and Rutter, 2013; Okoror et al., 2013). In some instance, community knowledge 
of the health status of the PLHIV may result in loss of job for the individual (Aransiola et al., 
2014; Audu, Morgan and Rutter, 2013).  
There appears to be a significant difference in the pattern in which general society and family 
and friends react to the health status of the PLHIV in Nigeria. While attitude of the general 
society and some health workers in Nigeria is negative, the attitudes of family members and 
close friends of PLHIV usually tend to change from the initial negative reaction towards being 
positive (Okoror et al., 2013). However, evidence from the qualitative study by Okoror et al. 
(2013) indicated that beyond family and close friends, some other member of the society (such 
as business customers) may also change their attitude from negative to positive over time 
towards the PLHIV. This change in stigma and discriminatory reaction from the family and 




physical appearance of the PLHIV due to their initiation of ART (Okoror et al., 2013), because 
Nigerians tend to assume that someone is healthy based on their physical appearance. 
Apart from the enacted stigma and discrimination arising from the society and family members, 
PLHIV may also self-stigmatize themselves (anticipated stigma) (Okoror et al., 2013; Sekoni, 
Obidike and Balogun, 2012; Shittu et al., 2013). This anticipated stigma may increase the risk 
of non-adherence to ART. For instance, PLHIV who self-stigmatize themselves by believing 
that taking the drug will expose their HIV status (Ekama et al., 2012; Oku et al., 2013a; Sekoni, 
Obidike and Balogun, 2012), may probably not be adherent to their medication. It was reported 
in the study by Shittu et al. (2013) that due to self-stigma, some PLHIV in Nigeria feel 
embarrassed when taking their medical folders to pharmacy for prescription refill. This attitude 
was reported by the PLHIV even though their folders were not different from the folders used 
by other patients in the hospital. Due to this fear of anticipated stigma, PLHIV could resort to 
secrecy, not taking their medication in the presence of people, storing their medication to 
prevent other household members from easily finding them and taking the medication when 
others are not around (Kunapareddy et al., 2014). However, evidence from focus group 
sessions among 23 adolescents in Kenya shows that these actions could also result in missed 
or delayed doses of ART (Kunapareddy et al., 2014). This is consistent with findings from 
studies in Nigeria that have reported that some PLHIV tend to discard their drug packaging 
before leaving the hospital or keeping the drug in unlabelled pillboxes (Audu, Morgan and 
Rutter, 2013; Sekoni, Obidike and Balogun, 2012), to avoid others knowing their status. Such 
practice may make it difficult for them to remember what dose or drug to take, thereby limiting 
their ability to adhere to their drugs (Audu, Morgan and Rutter, 2013). Ironically, some PLHIV 
in Nigeria have also been reported to stick to their medication because of anticipated stigma 
to avoid HIV-related complications or sickly appearance that could engender enacted stigma 
from their friends and families (Okoror et al., 2013).  
The fear of stigma therefore, makes it difficult for PLHIV to disclose their status. Even after 
family, friends and some community members have returned to the PLHIV when their physical 
appearance has improved, the patients still find it difficult to disclose their status, due to fear 
of stigma (Okoror et al., 2013). Although disclosure to trusted family members and friends who 
would not divulge the information is imperative to ensure their support, some PLHIV in Nigeria 
do not disclose their status to anyone (Charurat et al., 2010; Ekama et al., 2012). Not 
surprisingly, non-disclosure of HIV status has been reported to predict poor-adherence to ART 
among PLHIV in Nigeria (Ekama et al., 2012; Olowokere et al., 2008). This could be attributed 
to the fear that disclosure of HIV status to spouse or partner or family members can either 




et al., 2013; Audu, Morgan and Rutter, 2013; Hodgson et al., 2014). The negative outcome of 
status disclosure to sexual partner or family members can occur if they embrace the 
community’s norm around stigma which may result in discrimination and social isolation of the 
infected individual (Rachlis, Mills and Cole, 2011).  
Despite the widely reported impact of stigma on ART adherence, a mixed method study in 
Nigeria has found no significant association between stigmatization and ART adherence 
(Sekoni, Obidike and Balogun, 2012). Sekoni, Obidike and Balogun (2012) reported that 87% 
of the patients who experienced stigmatization in their study were adherent to ART, while 
90.8% of the patients who were not stigmatized were also adherent. A similar pattern has 
been reported in a mixed method study in Nigeria by Atibioke and Osinowo (2015). The study 
involved a cross sectional survey and focus group sessions with 548 PLHIV. The authors 
found that 77.9% of patients who did not feel stigmatized in the study were adherent to ART 
while 69.9% of the patients who experienced stigmatization were adherent. Although the 
threshold of adherence in the study by Atibioke and Osinowo (2015) was not reported, this 
pattern of evidence suggests that PLHIV may still adhere to their treatment regardless of 
whether they experience stigmatization or not, but this may depend on their ability to cope 
with the negative emotions arising from stigma and discrimination.  
Clinical Setting and Health System Factor: Cost of ART, inadequate numbers of health 
workers and health facilities resources such as non-availability of ART and laboratory testing 
facilities have been implicated in Nigerian studies to result in the inability to cope with needs 
of the PLHIV, long waiting period, repeated visit to the clinic and delay on clinic days (Audu, 
Morgan and Rutter, 2013; Chineke et al., 2015; Kasumu and Balogun, 2014; Shaahu, Lawoyin 
and Sangowawa, 2008). These factors hinder adherence to ART among PLHIV in Nigeria in 
different ways. For instance, cost of ART was cited as a predictor of ART non-adherence in 
studies carried out in the last decade (Erah and Arute, 2008; Shaahu, Lawoyin and 
Sangowawa, 2008), but due to widespread provision of free ART to PLHIV, cost of ART was 
not found to be a barrier to ART adherence in recent studies (Afolabi et al., 2009; Afolabi et 
al., 2013; Akinboro et al., 2014; Okoronkwo et al., 2013; Oku et al., 2013a; Olowokere et al., 
2008).  
Furthermore, some surveys in this review have established that long waiting time in the clinic 
predicts poor adherence to ART in Nigeria (Kasumu and Balogun, 2014; Okoronkwo et al., 
2013; Oku et al., 2013a). This could be associated with inadequacy of hospital resources 
which increases the likelihood of patient’s status being revealed due to delay or repeated visit 
which may also pose the threat of job loss to the PLHIV if they have not disclosed their health 




stigma, some PLHIV may avoid visiting the clinic for their ART. For instance, the in-depth 
interview with 15 PLHIV in Nigeria Aransiola et al. (2014) has shown that PLHIV usually fear 
that they might meet people that they know at the clinic, which may result in being fired at 
work or that customers may stop patronizing them. Hence, the PLHIV are always in a hurry to 
leave the clinic when they come for the drug refill (Aransiola et al., 2014). This has been 
corroborated by the findings of a cross-sectional survey with 318 PLHIV which showed that 
some patients feel that they may be seen in the ART clinic and would therefore prefer to avoid 
visiting the clinic because of the concern that their status may become public knowledge 
(Olowokere, Fatiregun and Adewole, 2012).  
Even though the hospital delay on clinic day may be strictly attributable to hospital system 
failure such as chaotic patients’ registration or non-functional laboratory machine, evidence 
from a qualitative study has shown that patients were threatened by clinicians with the 
possibility of denying them necessary care due to the structural challenges of the clinic 
(Chiegil, Zungu and Jooste, 2014). For instance, the study which involved focus group 
sessions with 64 PLHIV from the six geopolitical zones of Nigeria, shows that where the CD4 
count machine was not functional in a hospital the patients were informed by clinicians that 
“without your CD4 count at the next appointment, no drug” (Chiegil, Zungu and Jooste, 2014). 
In the same study, poor movement of patients’ records between departments (i.e. from doctors 
to pharmacy) was also found to create delays experienced by the PLHIV. The anxiety and 
stress experienced due to these types of delays have been reported in one of the studies in 
this review to result in some patients arriving at the hospital night before clinic day to sleep at 
the hospital (Audu, Morgan and Rutter, 2013). This experience frustrates patients and may 
prevent them from attending the clinic for their medication replenishment. 
This evidence in this review suggests that the clinical system in Nigeria operates within a 
culture of higher provider power and authority while the patients are passive. The findings also 
suggest a widespread system breakdown that fails to address the structural barriers that may 
be preventing the PLHIV from having access to the drugs and resources that could save their 
lives. For instance, inadequate resources such as stock out in the hospitals (Chineke et al., 
2015; Shaahu, Lawoyin and Sangowawa, 2008) have been reported to lead to rationing of 
ART by the clinicians for the patients (Audu, Morgan and Rutter, 2013). This means that some 
patients may not have the drugs for a considerable length of time and they will not be deemed 
adherent to the ART through no fault of their own. This led to the improvisation by some 
patients to reduce the dose of ARV to last till the next clinical appointment for them to get more 
medications (Ugwu and Eneh, 2013). Unfortunately, this method leads to poor adherence to 




Nigerian context. For example, the systematic review and meta-analysis carried out by 
Shubber et al. (2016) revealed that stock out of the ART is common in low and middle-income 
countries with few instances in the USA.   
Lastly, while the delays and inadequate resources at the hospitals could be attributed in some 
cases to the sheer number of PLHIV present on clinic days which may place too much strain 
on available resources (Audu, Morgan and Rutter, 2013), these challenges may not also be 
unconnected with the impact of widespread societal corruption. For instance, about $4million 
which was part of the money that Nigeria received from the Global Fund to fight AIDS, 
tuberculosis and malaria to prevent and treat HIV was reported in a Nigerian Daily Newspaper 
(Punch) to have been diverted by some Nigerian health officials in 2016 (Akinkuotu, 2016). 
These types of contextual barriers therefore, directly or indirectly contribute to ART non-
adherence in Nigeria. 
2.4 Target Factors for Antiretroviral Therapy Adherence Intervention 
The numerous factors influencing ART adherence in Nigeria suggest several areas for 
intervention to improve adherence. However, it is evident from this review of evidence that the 
drug-taking behaviour of PLHIV in Nigeria is influenced by numerous and some inconsistent 
factors (i.e patient’ health belief, distance to clinic and stigma) and it will be unreasonable to 
assume that a perfect intervention can be designed to address all the identified barriers to 
adherence. In this regard, a recent meta-analysis of 207 studies has explored the relative 
impact of similar factors to the identified factors in Nigeria on ART adherence (Langebeek et 
al., 2014a). In the analysis, the factor with the strongest association with ART adherence was 
patient’s self-efficacy for adherence with standardized mean difference [SMD] 0.603. Factors 
with small to medium effect on ART adherence were substance use (SMD=-0.395), concerns 
about the treatment (SMD=-0.389), trust or satisfaction with the healthcare provider 
(SMD=0.377), patient’s belief about the necessity of treatment (SMD=0.357), depressive 
symptoms (SMD=-305), HIV stigma (SMD=-0.282) and social support (SMD=0.237). Based 
on these findings, Langebeek et al. (2014a) recommended that interventions should mainly 
target psychological factors such as patient’s self-efficacy and their belief about the necessity 
or concerns about ART. They based this suggestion on the fact that ART adherence predictors 
were more strongly associated with patient related beliefs. Implication of this recommendation 
is that despite the importance of contextual factors and interpersonal factors, the major 
responsibility for ART adherence depends on the individual patient. This is consistent with the 
findings from the Nigerian context by Sekoni, Obidike and Balogun (2012) that with adequate 
self-efficacy, stigma and discrimination may not be strong enough to stop the patient from 




Consistent with the recommendation from Langebeek et al. (2014a) some experts have 
recommended that health providers should work with PLHIV to improve their self-efficacy for 
medication adherence (Nokes et al. 2012; Colbert, Sereika and Erlen, 2012). In respect of the 
importance of patient’s health beliefs, Langebeek et al. (2014a) also suggested the need for 
health providers to elicit and address patients’ health beliefs to improve ART adherence. 
These recommendations indicate that health providers should be considered as essential 
mediators to address the core patient-related barriers to ART adherence. 
However, stigma plays an important role in ART non-adherence in Nigeria, this should not be 
overlooked as a primary target to address in any ART adherence intervention. This was 
emphasised in a survey in USA by Sayles et al. (2009) where they concluded that to identify 
effective target for ART adherence intervention, there is a need to understand the 
interrelationship between stigma and other factors such as social support, self-efficacy and 
patient’s health beliefs. In this regard, evidence from some systematic reviews has shown that 
stigma primarily influence ART adherence by deflating the coping capabilities (self-efficacy) 
of the PLHIV and undermine their social support (Katz et al., 2013; Sweeney and Vanables, 
2015). Therefore, patients will need to be helped to identify how stigma affects them and 
undermines their social ties to improve ART adherence. This process may be especially 
important in resource limited countries like Nigeria where the impact of social support network 
on ART adherence may be more significant because the PLHIV rely heavily on their social 
support to overcome structural and economic barriers to care (Katz et al., 2013). Hence, the 
key target for enhancing ART adherence may not be only patient health beliefs and self-
efficacy but also requires focus on improving their social support by addressing the impact of 
enacted and anticipated stigma. 
Evidence has shown that positive health provider communication skills may be a key target 
factor through which patients can be supported to overcome significant impact of stigma on 
their social support network. This may be especially important in Nigeria where the reactions 
to HIV status from family and friends or other community members of PLHIV tend to become 
positive when the physical appearance of the patient improve due to ART initiation. A helpful 
health provider communication with the HIV patients while supporting them with ART might 
therefore help them to overcome some enacted and anticipated stigma that may arise from 
the social construct of HIV status that the society attach to physical appearance. In this regard, 
evidence from the systematic review and meta-synthesis by Katz et al. (2013) has also shown 
that compassionate human capital could help to establish a supportive clinical environment 
for patients and to establish bonds of trust and empower patients to overcome medication-




providers to respect and listen to PLHIV have been revealed as strategies that may improve 
the retention of patients in care (Flickinger et al., 2013). This is consistent with the finding of 
Corless et al. (2013) from a multi-site survey which showed that the importance of PLHIV 
regular and positive engagement with healthcare providers in respect of ART adherence 
cannot be overstated. They emphasized the importance of not just listening to the patients but 
also making them feel heard to ensure that they are engaged with the healthcare provider on 
ART adherence (Corless et al., 2013).  
These bodies of evidence highlight the importance of considering the communication 
approach of the health provider when working with HIV patients to improve their self-efficacy, 
addressing their health beliefs and enhancing their social support in respect of ART and HIV. 
This is significant in Nigeria, as Langebeek et al. (2014a) had found that trust or satisfaction 
with health providers was more strongly and positively associated with ART adherence in 
resource limited countries. Therefore, improvement of the support given to patients during 
clinical consultation or counselling sessions for ART adherence via communication and 
enhancement of the self-efficacy of the patients appears to be a reasonable factor to enhance 
adherence in Nigeria. 
2.5 ART Adherence Counselling in Nigeria 
Findings from a recent meta-analysis to promote adherence to ART in Africa has shown that 
compared to standard care, enhanced standard care (standard care with intensified 
adherence counselling), enhanced standard of care and SMS messages, and treatment 
supporters were more effective (Mills et al., 2014). The authors based their findings on 
interventions data obtained from 14 randomised controlled trials involving a total of 7,110 
patients. Evidence from this meta-analysis highlights the importance of adherence counselling 
in Africa, which has been found as a positive predictor of ART adherence in Nigeria. While the 
standard care in the ART clinic includes provision of treatment, counselling and psychosocial 
support for HIV patients (Aransiola et al., 2014), it is through the ART adherence counselling 
that clinicians will inform patients about the treatment options, psychosocial and social support 
available to them (FMOH, 2016, p. 91). This is also implied in the definition in the Nigerian 
guideline for HIV Counselling and Testing (FMOH, 2011, p.19) which described adherence 
counselling as a process that involves engagement and participation of the patient in the plan 
of care and provision of opportunity for discussion about the various factors in the patient’s life 
that may influence the ability to adhere to treatment. However, evidence of actual practice 
suggests that certain significant challenges persist with the adherence counselling or 




Some studies have shown that adherence counselling is offered regularly to patients before 
and after ART initiation in Nigeria (Afolabi et al., 2013; Alakija et al., 2010; Akinboro et al., 
2014; Avong et al., 2015; Charurat et al., 2010; Ekama et al., 2012; Igwebe, Ugboaja and 
Nwajiaku, 2010; Kasumu and Balogun, 2014; Omosanya et al., 2013; Ugwu and Eneh, 2013). 
However, while high ART adherence rates were attributed to regular and comprehensive ART 
adherence counselling in some studies (Afolabi et al., 2013; Avong et al., 2015; Kasumu and 
Balogun, 2014), there has been suggestions on the need to improve the adherence 
counselling technique in Nigeria in some other studies (Ekama et al., 2012; Igwebe, Ugboaja 
and Nwajiaku, 2010; Okoronkwo et al., 2013). For instance, Okoronkwo et al. (2013) 
suggested the need for health workers to spend more time with patients during adherence 
counselling to ensure adequate patient-provider communication and assessment of 
understanding at every visit. Igwebe, Ugboaja and Nwajiaku (2010) also pointed out that poor 
adherence counselling quality could be associated with the non-adherence to ART observed 
in their study, because all the non-adherent pregnant women in their study were enrolled in 
PMTCT program where they had access to pre-ART initiation adherence counselling.  
Although the adherence counselling definition by the FMOH suggests that HIV treatment plan 
should be approached through a shared decision-making approach between the counsellor 
and the patient, available evidence about practice in Nigeria suggests otherwise. For instance, 
the study by Kasumu and Balogun (2014) showed that some patients have complained that 
they were feeling forced to take the drug. The fact that busy schedule was commonly attributed 
to non-adherence to ART in Nigeria suggests that patients have difficulty fitting in medication-
taking with their daily activities (Okoronkwo et al., 2013; Oku et al., 2013a; Oku et al., 2014). 
This also shows that clinicians might have failed to assist the patient to tailor their treatment 
plan with their lifestyle. This evidence suggests that such patients might not have been 
properly involved in the decision-making about their treatment during consultation/counselling 
sessions. However, shared-decision making is increasingly considered as an essential 
element in any effective approach to promote adherence (Clyne, Granby and Picton, 2007; 
Cribb, 2011; European Patient’s Forum, 2015; Snowden and Marland, 2012).  
It is however, worthy of note that evidence about the counselling or consultation approach 
adopted by the health practitioners for ART adherence in Nigeria till this point has been based 
only on inferences drawn from feedbacks from patients or recommendations from research 
authors and not the report of actual practice of the clinicians. In view of the need to understand 
the actual practice adopted by clinicians, description by Maduka and Tobin-West (2013) in a 
randomised controlled trial shows that standard counselling approach in Nigeria might be 




for patients on ART in a tertiary hospital in Nigeria involves group health education and 
information on the importance of adherence delivered by counsellors before the 
commencement of every clinic day. This has been corroborated by Avong et al. (2015) who 
reported that HIV patients first attend a mandatory one-hour health talk on every clinic day, 
where the health workers give health tips and encourage PLHIV to be adherent to their 
medications. Meanwhile, Maduka and Tobin-West (2013) further reported that the standard 
care for PLHIV includes occasional admonitions by the doctors (during clinic consultation) to 
the patients to take their medications as prescribed. Unfortunately, this evidence is based on 
the observations of the authors and not from the patients and clinicians, which may not be a 
reliable or credible representation of events in the clinic. Despite the lack of reliable and 
sufficient knowledge about the actual practice of the health practitioners during ART 
consultation or counselling session, the sequence of practice reported by the authors occur 
even though evidence from an overview of systematic reviews has shown that interventions 
solely based on information or education strategies are not effective to improve medication 
adherence (Ryan et al., 2014).  
This review has identified that there is limited evidence on the effectiveness of the current 
adherence counselling approach for ART in Nigeria. However, it appears to be consistent with 
a traditional patient-provider relationship, characterized by high provider control and authority 
(Dewing et al., 2014), rather than conform to a patient-centred approach. In addition, it 
appears to allow the health providers to judge the patients; an approach which contradicts the 
normative construct of the “adherence” term. Unfortunately, such judgemental approach has 
the tendency to elicit resistance to change from the patients (Miller and Rollnick, 2004; 
Dellasega, Añel-Tiangco and Gabbay, 2011). Hence, PLHIV in Nigeria may benefit from an 
ART adherence counselling or consultation approach that is not judgemental, based on 
patient-centred counselling philosophy, facilitates shared decision-making (SDM) and 
promotes patients’ self-efficacy.  
2.6 Chapter Summary 
This chapter explored the general burden of HIV/AIDS globally with a focus on Nigeria. The 
definition of adherence and methods of assessment of adherence were presented. The 
prevalence of ART adherence in Nigeria was also presented. Within the limit of the available 
evidence in this review, it is difficult to draw any reliable conclusions about the prevalence of 
ART adherence in the HIV context in Nigeria largely because of the high variability in how 
adherence is defined in each of the included studies. However, factors that influence ART 
adherence or non-adherence in Nigeria were discussed in the chapter, while various barriers 




predictors of adherence that should be prioritised for intervention were discussed in the light 
of existing evidence and evidence-based recommendations. Based on the evidence-based 
recommendations, this chapter ended by evaluating the approach used by clinicians to 
support HIV patients with ART adherence during clinical consultation or counselling sessions 
in Nigeria. Within the limit of the available evidence, the chapter found that the current 
approach to counselling or consultation used by clinicians in Nigeria to support PLHIV to 
adhere to their treatment appears to be judgemental and paternalistic and needs to be 
improved to achieve a widespread high level of adherence to ART.  
Finally, this chapter provides a background to the research question by demonstrating the 
importance of understanding how clinicians currently discuss adherence to ART with HIV 
patients in the Nigerian context plagued with contextual challenges such as stigma, negative 
religious and traditional beliefs, corruption among the clinical administrators, and clinical 














CHAPTER THREE: DECISION MAKING APPROACH IN CLINICAL CONSULTATION 
FOR HIV TREATMENT AND ADHERENCE-LITERATURE REVIEW 
3.0 Chapter Overview  
This chapter focuses on how to enhance the HIV patient’s likelihood to adhere to treatment 
through evidence-based consultation approaches that promotes patient-centred philosophy. 
The chapter examines through a comprehensive review of literature how treatment decisions 
are made in clinical consultation to promote ART adherence for the management of HIV/AIDS 
and the factors that influence the choice of the decision-making approaches used. Findings 
from this chapter are intended to inform ways to improve ART adherence consultation in 
Nigeria in respect of treatment decision-making. 
3.1 Introduction to the Chapter 
In 2002, the WHO expanded the definition of chronic conditions beyond the traditional non-
communicable diseases such as heart disease, diabetes, cancer, asthma, chronic obstructive 
pulmonary disease (COPD) to include persistent communicable diseases such as HIV/AIDS 
and tuberculosis (WHO, 2002, p.12). This expanded definition can be attributed to public 
health successes which now allow patients to live with health conditions previously regarded 
as terminal illnesses for decades (Bloomfield et al., 2014; Bolduc et al., 2016; WHO, 2002, 
p.12). For instance, with the advent of antiretroviral therapy (ART) and improved access to 
care, the average life expectancy of HIV patients who are receiving optimal treatment now 
approaches that of patients in the general population (Bloomfield et al., 2014; Bolduc et al., 
2016). However, only 50% of people living with chronic diseases in developed countries or 
lesser in developing countries follow medication and dietary regimes and/or make lifestyle 
changes as recommended (WHO, 2003, p.7). In addition, adherence is usually lower in 
chronic conditions than in acute conditions (Beena and Jimmy, 2011). As the principal 
underlying cause of ineffective treatment, non-adherence also worsens the course and 
outcome of chronic conditions and impairs the quality of life of the patient (Chakrabarti, 2014; 
WHO, 2003, p.12). Due to non-adherence, healthcare professionals as well as the health care 
systems worldwide struggle to meet their targets, even after making treatment services 
accessible for patients (Chakrabarti, 2014; WHO, 2003, p.12). 
Moreover, non-adherence to recommended therapy or lifestyle changes is costly not only to 
the patients but also to the health care system (Chakrabarti, 2014; European Patient’s Forum 
[EPF], 2015, p.3; Zullig, Peterson and Bosworth, 2013). For instance, in the US poor use of 
prescription medication results in $213.2 billion of avoidable costs to the healthcare system 
each year, with $105.4 billion ascribed to non-adherence to medication and $20 billion to 




Union (EU) non-adherence is estimated to cost the EU around €1.25bn each year (EPF, 2015, 
p.3). These figures result in millions of avoidable hospital admissions, outpatient treatments, 
pharmaceutical prescriptions and emergency room visits for patients, reduced productivity and 
waste of resources funded by public health system (EPF, 2015, p.3; IMS Institute of 
Healthcare Informatics, 2013). Therefore, enhancing adherence among patients living with 
chronic conditions will not only improve the quality of patients’ life but also reduce health 
professionals’ frustration and save unnecessary health care cost. The WHO emphasized this 
by stating that “increasing the effectiveness of adherence interventions may have a far greater 
impact on health of the population than any improvement in specific medical treatment” (WHO, 
2003, p.21). 
However, evidence supporting interventions focused towards improving adherence is 
inconclusive (Cushing and Metcalfe, 2007; Nunes at al., 2009; Ryan et al., 2011; Ryan et al., 
2014; Snowden and Marland, 2012). Previous efforts to improve adherence were mostly 
focused on providing clearer education and instruction about medicines (Clyne, Granby and 
Picton, 2007). Conversely, it is becoming increasingly recognised that the key to making better 
use of medicines is by involving patients as partners in decisions about their medications 
(Clyne, Granby and Picton, 2007; Cribb, 2011). It has been argued that the main limitation of 
previous adherence interventions is the underlying assumption that the clinician is right 
(Snowden and Marland, 2012). Hence, the traditional paternalistic model where clinicians “do 
things to” and make decisions for patients is increasingly being questioned and, in its place, 
shared decision-making (SDM) is more advocated (Da Silva, 2012, p.1; Kaplan and Frosch, 
2005). 
Shaded decision-making describes a process in which clinicians and patients work together 
to select tests, treatments, management or support packages, based on clinical evidence and 
the patient’s informed preferences (Da Silva, 2012, p.2). It involves the provision of evidence-
based information about options, preferred outcomes and uncertainties, with the aim of 
reaching mutual-agreement on the best course of action to take (Coulter and Collins, 2011, 
p.2; Da Silva, 2012, p.2). A defining characteristic of SDM is the fostering of a real partnership, 
where the health professional is the expert in medicine and the patient is the expert about 
themselves, their circumstances, attitudes to illness and risk, values, preferences and the 
extent to which treatment options might fit with their lifestyle (Coulter and Collins, 2011, pp.2-
3; Da Silva, 2012, p.2; Russell, Abidi and Abidi, 2014). Both parties need to be willing to share 
certain information in the decision-making process and accept responsibility for the decision 
made (Barry and Edgman-Levitan, 2012; Da Silva, 2012, p.2). The role of the clinician in SDM 




available options and to provide professional guidance where appropriate (Elwyn et al., 2014). 
On the other hand, the role of the patient is to express their preferences and values (Barry 
and Edgman-Levitan, 2012). Hence, both clinician and patient are armed in SDM with a better 
understanding of the relevant factors (Barry and Edgman-Levitan, 2012).  
The SDM concept rests on the assumption that patients are more likely to be committed to the 
treatment which follows from a process where they are encouraged to state their preferences 
and to actively participate in the process of decision-making about chronic illness 
management (Clyne and Colin-Thome, 2008; Pollock, 2005, pp. 2-3). There is compelling 
evidence that patients who are active participants in managing their health and health care 
have better outcomes than patients who are passive recipients of care (Coulter and Collins, 
2011). It is therefore, not surprising why SDM is regarded as the pinnacle of patient-centred 
care (Barry and Edgman-Levitan, 2012). Unfortunately, while SDM is often talked or written 
about it is less common in day-to-day clinical practice (Coulter and Collins, 201, p.32; Coulter 
et al., 2015; Da Silva, 2012, p.34). In this regard, evidence from some studies carried out in 
Norway, Ireland, Canada, USA and England has shown that SDM is not consistently practised 
in making treatment decisions for many chronic conditions, even when the health care policy 
supports SDM (Aasen, Kvangarsnes and Heggen, 2011; Allen, Wainwright and Hutchinson, 
2011; Coyne et al., 2014; Fried, Tinetti and Iannone, 2011; Kucukarslan et al., 2012; Mishra 
et al., 2011; Upton et al., 2011).  
Unlike other chronic conditions that usually have many alternative options of treatment, the 
treatment of HIV/AIDS is only through ART. While SDM is commonly assumed to be 
necessary when there are more than one reasonable healthcare options, it has been argued 
that SDM should be applied more broadly even in situations where there is clearly one superior 
option (Barry and Edgman-Levitan, 2012; Elwyn et al., 2014; Kaplan and Frosch, 2005), such 
as with HIV/AIDS. Given the extent of uncertainty about the effectiveness of medical care and 
the presence of side-effects, there is often more than one possible course of action, which 
includes the option of “doing nothing” (Barry and Edgman-Levitan, 2012; Coulter and Collins, 
2011, p.13; Kaplan and Frosch, 2005). In view of the limited treatment options for HIV/AIDS, 
which includes treatment with ART or doing nothing, clinicians may tend to be more 
paternalistic as it is common with other chronic conditions. Yet, there are also numerous 
medication varieties that can be combined to formulate an ART regimen (Cruciani and Malena, 
2015; WHO, 2016, pp. 97-102). However, little is known about the extent to which decisions 
are shared between clinicians and patients about the different treatment formulations for 
HIV/AIDS. Hence, there is need for further evidence to understand how ART decisions are 




This chapter focuses on Nigeria as a country with high rate of poor adherence to ART (Afolabi 
et al., 2009; Erah and Arute, 2008; Okoronkwo et al., 2013; Oku et al., 2013a; Oku et al., 
2014). It is also the country with the highest number of AIDS-related mortality globally 
(UNAIDS, 2017). Findings from a descriptive cross-sectional survey in Nigeria have shown 
that there is a likelihood that HIV patients may not be involved in making decisions about their 
treatment (Kasumu and Balogun, 2014). Other surveys from the country have also shown that 
busy schedule is a common predictor of non-adherence to ART among HIV patients 
(Okoronkwo et al., 2013; Oku et al., 2013a). This indicates that the patients’ might be finding 
it difficult to fit the medication-taking with their daily activities. Taken together, these reports 
suggest that such patients might not have been properly involved in decision making about 
their treatment during the treatment consultation or counselling sessions. Unfortunately, 
further evidence to verify these practice approaches in Nigeria is currently scarce. However, 
evidence from other settings may provide valuable information to understand the common 
practice in ART consultation contexts which may help to inform how to improve practice in 
Nigeria. Therefore, the purpose of this chapter is to carry out a review of literature to determine 
how decisions are made about HIV treatment and adherence, and to explore the factors that 
influence the identified decision-making processes.   
3.2 Methods of this Review 
A comprehensive review of literature was conducted. The search for relevant literature was 
undertaken in seven electronic databases from 2002 to 2018. The searched databases 
include: CINAHL; MEDLINE; Psychology and Behavioural Sciences Collection (PBSC); 
PsycARTICLE; PsycINFO; PubMed; and Web of Science. The 2002 to 2018 time-period was 
chosen to ensure that relevant studies were selected starting from a year after the Institute of 
Medicine recommended shared decision making as one of the 10 strategies to improve the 
delivery of care in 2001. The following key terms were stringed together to search for the 
relevant studies in the databases: (HIV or AIDS or HIV/AIDS) AND (treatment or intervention 
or antiretroviral therapy or care) AND (decision making or decision-making) AND (adherence 
or compliance or concordance) AND (counsellor or nurse or doctor or pharmacist or health 
provider or health personnel). The terms adherence, compliance and concordance were used 
because they are the most commonly used terms to describe patient’s medication taking 
behaviours in literature. However, unlike adherence and compliance that measure patients’ 
medication-taking behaviour, the term concordance is focused on defining the consultation 
outcome after negotiations between a patient and a healthcare provider and not patients’ 
medication-taking behaviour (Horne et al., 2005, p.12; Kelham and Shaw, 2006). Despite the 
misapplication of the terms in literature, it is necessary to search the databases with the three 




Studies published in English language were also preferred for selection due to lack of time for 
translation of studies published in other languages. Informed by a scope search, Journal of 
the Association of Nurses in AIDS Care was also manually checked within the same period 
for relevant articles and two more relevant studies (Fuller et al., 2016; Vervoort et al., 2010) 
were retrieved. Although the Journal of the International Association of Providers of AIDS Care 
was also searched within the same time frame, no relevant studies were retrieved. A total of 
353 citations were yielded from all sources. After removing irrelevant titles, 23 articles were 
retained for screening. The study search summary is as presented in table 3.1 
Table 3.1: Summary of Study Search for the Review 
S/N Study Sources Total Hit Relevant Titles 
1 CINAHL 36 3 
2 MEDLINE 35 4 
3 PsycARTICLE 0 0 
4 PBSC 7 0 
5 PsycINFO 28 2 
6 Web of Science 112 6 
7 PubMed 135 6 
8 Journal of the International Association 
of Providers of AIDS Care  
N/A 0 
9 Journal of the Association of Nurses in 
AIDS care  
N/A 2 
 Total 353 23 
Twelve articles were further removed because of duplications, leaving 11 articles for abstract 
screening. After studying the abstracts, three articles were excluded for not focusing on the 
objectives of the review as highlighted below:   
1. Focused on exploring the view of people living with HIV about clinical communication 
in respect of their self-care and not on treatment decision-making (Laws et al., 2012); 
2. Focused on assessing the knowledge, attitudes, and practices of physicians with 
respect to patient decision aids and not on treatment decision-making (Alden, Friend 
and Chun, 2013); and 
3. Focused on comparing patient and provider perspective of aspects of treatment quality 
such as effectiveness, quality of life and further treatment options and not on treatment 
decision-making (Muhlbacher et al., 2013). 
After excluding studies that are not relevant to the objectives of this review, the literature 
search produced six relevant qualitative studies (Fuller et al., 2016; Gourlay et al., 2014; 
Griffiths et al., 2007; Marelich et al., 2002; Mulder et al., 2016; Vervoort et al., 2010), a 
quantitative study [a survey] (Clucas et al., 2011) and a mixed method study (Fehr et al., 




for or that aid treatment decision-making (Clucas et al., 2011; Fehr et al., 2005; Gourlay et al., 
2014; Griffiths et al., 2007; Vervoort et al., 2010), clinical communication experiences of 
patients about treatment decision-making (Mulder et al., 2016), factors that may inhibit or 
promote patients’ engagement in SDM (Fuller et al., 2016) and patients’ involvement in 
treatment decision-making (Marelich et al., 2002). However, there is a need to evaluate the 
methodological quality of the studies included in a literature review to draw conclusions about 
the strength of the overall body of evidence included in it (Polit and Beck, 2008, pp.127-130). 
Hence, before extracting data from the retained studies, the methodological quality 
assessment of the eight studies was carried out. 
Methodological Quality Assessment 
Although there are numerous existing frameworks for the critical appraisal of qualitative 
studies (Ryan, Coughlan and Cronin, 2007; Walsh and Downe, 2006), the Mixed Method 
Appraisal Tool (MMAT) developed by Pluye et al. (2011) was used for the methodological 
assessment for the retained studies in this review. The MMAT was adopted because it was 
designed for use at the appraisal stage of complex literature reviews that include quantitative, 
qualitative and mixed method studies.  
Evaluation of the methodological rigour of qualitative studies requires that the study should be 
assessed in respect of its credibility, transferability, dependability and confirmability (Bryman, 
2016, pp.48-49; Ryan, Coughlan and Cronin, 2007). The retained qualitative studies were 
therefore assessed on each of these dimensions of methodological rigour. On the other hand, 
focus on the methodological quality of quantitative studies is mainly on the reliability and 
validity (Bryman, 2016, p.48). The only quantitative study and the quantitative strand of the 
only mixed method study in this review were therefore assessed in respect of reliability and 
validity. In similar manner, the qualitative strand of the only mixed method study was also 
assessed in respect of credibility, transferability, dependability and confirmability to ascertain 
the overall quality of the study.  
Dependability as a methodological rigour could be achieved when another researcher can 
clearly replicate the procedure used by a researcher and arrive at similar conclusions (Ryan, 
Coughlan, and Cronin, 2007). In this regard, dependability was found to be a major weakness 
to two of the reviewed studies (Marelich et al., 2002; Griffiths et al., 2007). For instance, there 
was no mention of the setting for data collection by Marelich et al. (2002), while Griffiths et al. 
(2007) did not also provide any detail about how semi-structured interview was used to collect 
data for the study. Hence, it may be difficult for other researchers to replicate the procedures 




In respect of credibility, a major strength identified in the reviewed studies are data collection 
triangulation (Vervoort et al., 2010) and investigator triangulation (Fehr et al., 2005; Fuller et 
al., 2016; Gourlay et al., 2014; Mulder et al., 2016). Data triangulation refers to the use of 
different sources of data as opposed to one, while investigator triangulation refers to the use 
of different observers or interviewers to detect or minimize biases resulting from the 
researcher as a person (Flick, 2014, pp.183-184; Sarantakos, 2013, pp.159-160). 
Triangulation has the potential to increase the depth and consistency in methodological 
process, thereby enhancing the credibility and validity of the study findings (Flick, 2014, p.183; 
Sarantakos, 2013, pp.159-160). Hence, use of triangulation in four qualitative studies 
enhanced their credibility (Fuller et al., 2016; Gourlay et al., 2014; Mulder et al., 2016; Vervoort 
et al., 2010), while also enhancing the credibility of the qualitative strand of the mixed method 
study (Fehr et al., 2005). Another dimension to the enhancement of study credibility was 
demonstrated by the study carried by Fehr et al. (2005) when the authors involved one of their 
patients in the thematic analysis of their data. This is an approach to ensure that the 
researchers’ representation of the participants’ views is consistent with the actual views of the 
participant (Ryan, Coughlan and Cronin, 2007). 
Another common strength of the reviewed studies is the extensive use of verbatim quotes 
from the source data to support data interpretation (Fehr et al., 2005; Fuller et al., 2016; 
Gourlay et al., 2014; Griffiths et al., 2007; Marelich et al., 2002; Mulder et al., 2016). This 
approach allows the reader to verify that the researchers’ conclusions or inferences were 
derived from the study data (Polit and Beck, 2008, p.130). Therefore, this approach enhanced 
the credibility of the reviewed studies. 
Apart from the strengths some other characteristics of the studies also threatened their 
credibility. For example, constant comparative analysis is a data collection approach that is 
typically associated with grounded theory approach to inquiry (Flick, 2014, p.535; Polit and 
Beck, 2008, p.522; Ryan, Coughlan and Cronin, 2007). However, this approach was used by 
Vervoort et al. (2010) to analyse their data in a study which did not use a grounded theory 
approach. As pointed out by Polit and Beck (2008, p.531) a researcher who claims to have 
undertaken an ethnography but used a grounded theory approach to analysis may not be well 
informed about the underlying goals and philosophies of the two research traditions. Hence, 
this mismatch in research method and data analysis limits the believability and credibility of 
the study.  
Another common issue found among most of the studies (Griffiths et al., 2007; Fuller et al., 
2016; Marelich et al., 2002; Vervoort et al., 2010) is the use of convenience sampling for 




be easy and efficient, it is not necessarily the preferred strategy in qualitative study as it does 
not guarantee data collection from the most information-rich sources and may lead to sample 
bias in favour of certain group (Gray, 2014, pp.223-224; Polit and Beck, 2017, p.199). The use 
of convenience sampling also suggest that the transferability of study may be limited, because 
the views of the participants who were not recruited through convenience means may differ 
from those of the participants used in the four studies. A more preferred approach in qualitative 
study is the use of purposive sampling which has higher credibility than convenience sampling 
(Gray, 2014, p.224). Therefore, use of purposive sampling by Mulder et al. (2016) and Gourlay 
et al. (2014) enhances the credibility of the studies.   
Furthermore, data collection setting and sample characteristics also reduced the possibility 
that the findings of some of the studies could fit into other contexts (Fuller et al., 2016; Fehr et 
al., 2005; Griffiths et al., 2007; Marelich et al., 2002; Mulder et al., 2016; Gourlay et al., 2017). 
For instance, since the study by Vervoort et al. (2010) was carried out only among HIV nurse 
consultants in Netherlands, the findings of the study may not apply to other settings beyond 
the country. Similar challenges might have affected the transferability of the findings of the 
study by Mulder et al. (2016) where samples were recruited from two academic hospitals from 
two large cities in Netherland. There is high likelihood that the clinical experience of patients 
from these settings may differ from patients from other hospitals in the country, thereby 
reducing the possibility that the findings of the study could be assumed to be obtainable in all 
other settings. This limitation could also affect the findings of the study by Fuller et al. (2016) 
which was carried out in a patient-centred medical home (PCMH) initiative setting. Obviously, 
the views and clinical experiences of patients from this study may not be transferable to other 
clinical settings where the PCMH initiative is not practiced. For the qualitative strand of the 
mixed method study carried out by Fehr et al. (2005) which was carried out in one clinic in 
Germany and three clinics in Switzerland, data was only collected from 12 patients from the 
patients in Switzerland out of a total of 75 patients. The authors stated that the purpose of 
carrying out in-depth interviews with the 12 patients was to further explore their experience 
(Fehr et al., 2005). It cannot be assumed that the experience of the patients from Switzerland 
will represent the experience of patients from Germany. This limitation might have reduced 
the transferability of the qualitative finding from the study. However, since the qualitative data 
in the study by Fehr et al. (2005) was collected with the view to enhance the quantitative data 
from the same study, limited transferability is not a challenge for the study. Lastly, the study 
by Gourlay et al. (2014) was carried out in a relatively poor rural area in North-West Tanzania. 
The practice and views of participants recruited from this setting may not represent the 
experience of others from relatively richer areas of Tanzania. Hence, the findings from the 




Confirmability as a methodological rigour criterion for qualitative studies is usually achieved 
when credibility, transferability and dependability have been achieved (Ryan, Coughlan and 
Cronin, 2007). Since each of the qualitative studies has been found to have at least limited 
transferability of findings, their confirmability might therefore be considered limited.  
For the quantitative study (Clucas et al., 2011) and the quantitative strand of the mixed method 
study (Fehr et al., 2005), the sampling process and measurement instruments present 
challenges to the reliability and validity of the findings. For instance, although 86% of the 
eligible patient populations was recruited into the study carried out by Clucas et al. (2011) and 
93% of the eligible patient population in the study carried out by Fehr et al. (2005) were 
recruited, the sampling approaches involved the exclusion of patients who could not speak 
English and German to carry out the studies activities respectively. Hence the findings of the 
studies might not account for the views and experiences of minority patients. This suggests 
the possibility of sampling bias (Coughlan, Cronin and Ryan, 2007), which might have affected 
the reliability as well as the generalisability of the study findings. In addition, the authors did 
not provide evidence to determine whether the validity of some of the measuring tools that 
they used to collect data for the two studies were established, even though they reported that 
they adapted some of the tools from standard or already validated tools (Clucas et al., 2011; 
Fehr et al., 2005). This limitation has the potential of weakening the validity and the reliability 
of the findings of the two studies.  
Overall, two of the retained studies (Gourlay et al., 2014; Mulder et al., 2016) have very high 
methodological qualities scores of 10/10. Judgement of the methodological quality of the 
retained studies were based on the allocation of Likert scores zero, one and two to answers 
categories “no”, “can’t tell” and “yes” respectively on the adopted critique framework (see 
Appendix 7) (Pluye et al., 2011). Since the highest achievable quality score was 10, it was 
assumed that the medium quality score will be five and any quality score below that 
benchmark was low. While one of the other studies have a total score of nine (Fuller et al., 
2016) and four studies have scores of eight (Clucas et al., 2011; Fehr et al., 2005; Griffiths et 
al., 2007; Marelich et al., 2002), one of the retained studies have the lowest score of seven 
(Vervoort et al., 2010). Since the quality scores of the studies were well above the median 
benchmark, it could be argued that the overall methodological quality of the reviewed studies 
is high. Total quality scores allocated to each study out of a total of 10 are presented along 
with the extracted data in table 3.2. However, findings from this review should be interpreted 
with regards to the highlighted methodological limitations and the quality scores of the studies 
contributing to the overall findings. After the methodological quality assessment, full texts of 




treatment-related decisions were made and the factors that influenced the choice of the 
identified decision-making approach. Relevant data were extracted from the selected studies 
and analysed thematically.  
3.3 Findings from the Review 





Table 3.2: Extracted Data from Reviewed Studies in Chapter Three 
S/N Authors Country Number of 
Participants 
Characteristic of Participants Decision-
Making 
Approach 




1 Griffiths et 
al., 2007 
UK HIV patients 
(n=17). 
[Observation 







Black-African women (n=4), Black-
Caribbean (n=2) women and White 
men (n=11). 
IA to facilitate 
PDM  
Not reported 8 
2 Vervoort et 
al., 2010 
Netherland HIV Nurse 
Consultants 
[HNC] (n=23) 










Male (n=13) and Female (n=10) 
nurses in semi-structured 
interviews. Male (n=14) and female 
(n=5) nurses in focus group 
sessions. The nurses were all white 
Caucasians. 
IA to facilitate 
PDM; SDM 
when starting 






Persistent Non-Adherence 7 
3 Mulder et 
al., 2016 




Caribbean background (n=8); Dutch 
background (n=11); and African 
background (n=9). 
Tailored LDI; 




Perception of patient’s treatment 
TDM preferences; Cultural view 
about TDM; Patient’s health 
literacy; Trust in health provider; 
Patient’s TDM preference; 
Length of experience and 






S/N Authors Country Number of 
Participants 
Characteristic of Participants Decision-
Making 
Approach 




4 Fuller et al., 
2016 
USA HIV patients 
(n=53). 
African-Americans (n=17); Asian-
Pacific Islanders (n=2); Latinos 
(n=18), non-Hispanic White (n=12), 
and from other ethnic groups (n=4).  
Few instances 
of SDM; PDM 
without 
guidance; CPA 
Trust in health providers; Limited 
option for treatment;  
Patients’ perception of health 
knowledge; Patient’s preference 
for LDI 
9 











All but one of the patients were 
Swiss Germans or Germans.  
Without ART (n=34); Starters 
(n=21); and Non-starters (n=13). 
Thirty-three were Changers (n=33); 
and Non-changers (n=8). 
SDM; CDM; and 
CPA 
Poor communication; and Lack 
of understanding. 
8 














from the PLA 















Patients’ views about LDI; Trust 
in health providers; and Patients’ 





S/N Authors Country Number of 
Participants 
Characteristic of Participants Decision-
Making 
Approach 




7 Marelich et 
al., 2002 
USA HIV patients 
(n=39). 
African-Americans (n=44%), White 
(n=39%), Latinos (n=6%) and from 
other ethnic backgrounds (n=6%). 
Male (n=69%). 
SDM; CDM; and 
PDM 
Patients’ health literacy; and 
Length of experience with the 
HIV. 
8 
8 Clucas et 
al., 2011 
UK HIV patients 
(n=217) 
Women (n=32); heterosexual male 
(n=14); and homosexual male 
(n=166). White (n=165) and non-
White (n=48) [Black African, Asian 
or from other ethnic groups].  
SDM occurring 





Not reported 8 
Notations: CDM=Clinician-Led Decision-Making; CPA=Covert Paternalism; IA=Information giving approach; IDI=In-Depth Interview; LDI= Level of Decisional-
Making Involvement; MI=Motivational Interviewing; “n” = Number of Study Participants; PA=Paternalism Approach; PLA=Participant Learning Action; PDM= 





3.3.1 Overview of Selected Papers 
As presented in table 3.2, two of the selected studies were carried out in USA (Fuller et al., 
2016; Marelich et al., 2002), two in Netherland (Mulder et al., 2016; Vervoort et al., 2010), two 
in UK (Clucas et al., 2012; Griffith et al., 2007), one from Germany and Switzerland (Fehr et 
al., 2005) and one from Tanzania (Gourlay et al., 2014). Unsurprisingly, no study from Nigeria 
that meets the objectives of the review was retrieved. The participants include adult patients 
and/or healthcare providers and health officers. These include adult patient population in 
seven of the studies and health providers in only four of the studies. Only one study included 
health officials and HIV-negative individuals (Gourlay et al., 2014). The patient populations in 
the studies were mostly from African Background and White race, while there were fewer 
representations from the Caribbean, Latino and Asian-Pacific Island. Although the clinicians’ 
population in the study by Vervoort et al. (2010) were reported to comprise of only White 
Caucasians, there was no record of the race of the clinicians in the study by Mulder et al. 
(2016) or of the health workers and or the health officers in the studies by Fehr et al. (2005) 
and Gourlay et al. (2014) respectively. Based on the wide racial composition of the participants 
in these studies, it may be safe to assume that the review can fairly represent the views of 
HIV patients from many racial groups from different settings, especially the Africans and the 
African-Americans which could be similar to the views of Nigerians.  
Data in respect of HIV treatment decision-making from the reviewed studies fall into two theme 
categories which are: approaches used while making treatment decision and approaches 
used in adherence decision-making. These approaches and the factors that predict the 
adoption of each of them are discussed below.  
3.3.2 Decision Making Approach for HIV Treatment 
Evidence from seven of the studies shows that clinicians commonly attempt to share decision-
making with HIV patients about disease treatment options when starting, changing or 
interrupting treatment (Clucas et al., 2011; Fehr et al., 2005; Fuller et al., 2016; Griffiths et al., 
2007; Marelich et al., 2002; Mulder et al., 2016). They do this by providing the patients with 
detailed information about the disease and treatment options to help them prepare for the 
treatment (Clucas et al., 2012; Fehr et al., 2005; Griffiths et al., 2007; Mulder et al., 2016; 
Vervoort et al., 2010). They also give the patients time to decide when to start the therapy and 
to think about their personal motivation about treatment (Clucas et al., 2011; Fehr et al., 2005; 
Griffiths et al., 2007; Vervoort et al., 2010). They engage the patients in discussion about their 
lifestyles and psychosocial barriers that could prevent adherence to the treatment and ensure 




2010). Particularly, in the study by Vervoort et al. (2010), when the treatment regimen 
prescribed by the physician did not fit the lifestyle of the patients, the HIV nurse consultants 
discussed it with the patients and the physician to propose other regimens that will fit into the 
lifestyle of the patients. Similarly, in the study by Clucas et al. (2011) before making the 
decision to switch or stop treatment regimen, the doctors discussed issues leading to the need 
to make the decision with the patient and discuss the options with them. However, the doctors 
also checked with the patients to understand what role they want to take in making decisions 
(Clucas et al., 2011). Factors commonly reported in the studies to support SDM include: health 
literacy; trust in health providers; and patients’ long-time experience with HIV, and acceptance 
of the HIV status (Fuller et al., 2016; Marelich et al., 2002; Mulder et al., 2016).  
However, decision making was not shared with the patients in all situations. Particularly, the 
evidence from the only study carried out in Africa shows that paternalistic style is mostly used 
for medical care and ART treatment decisions, while SDM approach is rarely used (Gourlay 
et al., 2014). Meanwhile, instances of paternalism were also found in studies carried out in 
non-African settings (Fehr et al., 2005; Fuller et al., 2016; Mulder et al., 2016; Vervoort et al., 
2010). For instance, the study by Fuller et al. (2016) which was carried out in USA reported 
how a clinician forced a patient to keep to a treatment option, even though it was affecting the 
health of the patient and the patient was unhappy with it. In support of this experience, a 
patient reported an instance of his interaction with a clinician. 
“Which one do you prefer, to have your nails like this or to be healthy?” (Fuller 
et al., 2016).  
This instance indicates that the clinician was practising paternalism covertly under the guise 
of SDM. Similar practice of covert paternalism was reported in the study by Fehr et al. (2005) 
which was carried out in Germany and Switzerland. Consistent with the experience of the 
patients in the study carried out in USA (Fuller et al., 2016), the Swiss patients felt pressured 
to take a decision they were not ready to make, which led to anxiety and distress (Fehr et al., 
2005).   
Another instance which demonstrates the approach to paternalism was also described by 
Fuller et al. (2016) when the patients were given options about their treatment by clinicians 
without giving them adequate information or properly guide them to ensure that they make an 
informed decision (Fuller et al., 2016). This can be supported by the consultation account of 




“If I were just told, okay, you have to let’s say Atripla, Truvada, or Isentress, 
choose. Well, one is pink, one is blue and the other is orange. So, I’m like in the 
mood of pink” (Fuller et al., 2016). 
Practice of paternalism by clinicians was also reported in the study carried out by Fehr et al. 
(2005) where the patients were not concordant with the decision made in the consultation 
because they did not understand the information provided to them by the clinicians. 
However, there were instances where the clinicians may not be necessarily paternalistic, but 
because of patients’ passivity which may be due to many factors, the consultation may 
therefore take the shape of a clinician-led treatment decision-making approach (Fuller et al., 
2016; Gourlay et al., 2014; Marelich et al., 2002; Mulder et al., 2016). The factors leading to 
patients’ passivity include cultural beliefs and low level of health literacy.  
Cultural beliefs: Non-Western patients, especially the Africans and African-Americans were 
reported to tend to see the clinicians as knowledgeable and should know better than the 
patients, so they prefer to just listen and follow advice even if the outcome of the consultation 
is not what they wanted (Fuller et al., 2016; Gourlay et al., 2014; Mulder et al., 2016). Based 
on this belief and attitude of trust, some patients with African background were reported to be 
passive in treatment consultations (Gourlay et al., 2014; Fuller et al., 2016). This however, 
does not suggest that patients whose cultural beliefs may influence them to be passive will 
not participate in shared decision-making. This ability was demonstrated in the study by Fuller 
et al. (2016), where the attitude of a Latino man was changed through discussions with the 
clinicians to participate in SDM. This occurred despite the initial shock expressed by the Latino 
man when he first encountered the need to share treatment decisions with clinicians in USA, 
which was in stark contrast with his previous experience in Mexico (Fuller et al., 2016). 
Furthermore, irrespective of whether the patient is Western or non-Western, evidence from 
two studies shows that some HIV patients including the patients with Western backgrounds 
may prefer their clinicians to make treatment decisions for them (Fuller et al., 2016; Mulder et 
al., 2016). 
Low level of health literacy: Evidence from the study by Mulder et al. (2016) shows that 
patients’ passive attitude in decision making may not be solely attributable to being of non-
Western background. For example, some Dutch patients were also found to perceive that they 
were not as knowledgeable as their clinicians and so were not sure of their preferred role for 
treatment decision-making. Similar report was also made by Fehr et al. (2005) where some 
patients felt pressured to make a treatment decision they were not sure about because of lack 




decision making due to the length of time between the patients’ HIV status diagnosis and their 
encounter with the clinicians for treatment decision. From some of the studies, patients tend 
to be passive in clinical interactions when they are newly diagnosed but become more involved 
in treatment decision when they accept their status and get more experienced with time 
(Marelich et al., 2002; Mulder et al., 2016).  
Patients taking control of decision making 
Apart from shared treatment decision making or clinician-led approach to decision making, 
there are instances in some of the studies where patients were reported to tend to take control 
of the treatment decision making (Fuller et al., 2016; Marelich et al., 2002). Some patients 
were reported to be very aggressive and assertive by demanding for certain ART option when 
discussing their treatment with clinicians in the study by Marelich et al. (2002). This control 
taking approach by patients was reported to have the potential to result in the selection of 
wrong treatment option in some instance, which may not work for the patients (Marelich et al., 
2002). Although some of the patients are aware of this risk, they are still eager to retain the 
higher power in treatment decision-making.  
“I push for something, I get it, and I try it out and if it works for me, it works for 
me. If it does not work for me, I let the doctor know to do something different” 
(Marelich et al., 2002). 
3.3.3 Decision Making Approach for ART Adherence 
In respect of ART adherence issues, evidence from two of the reviewed studies from 
Netherland shows that although clinicians tried to share the decisions with patients, they tend 
to go beyond the need for SDM by also trying to motivate the patients by using a motivational 
interviewing approach to enhance their self-efficacy (Vervoort et al., 2010; Mulder et al., 2016). 
The nurses in the study by Vervoort et al. (2010) were reported to engage the non-adherent 
patients in in-depth questioning to explore the reasons for their behaviour to determine if the 
patient was motivated to change. However, when the non-adherence persists, some of the 
clinicians were reported in the two studies to resort to paternalistic approach with the hope 
that such approach will motivate the patients to adhere to their treatment (Vervoort et al., 2010; 
Mulder et al., 2016). For instance, Mulder et al. (2016) reported that clinicians used risk 
communication by informing the patients about the consequences of non-adherence to 
motivate them to adhere to their treatment. Similarly, Vervoort et al. (2010) reported that the 
nurses repeatedly warn the patients about the potential consequence of their behaviour, to 
provoke them to feel guilty or frustrated about being non-adherent, which the clinicians hoped 




treatment due to persistent non-adherence, with the hope that the patients may become more 
adherent when HIV-related symptoms reoccur (Vervoort et al., 2010). In this situation, the 
decision to stop the treatment was not left to the patient but was entirely dependent on the 
clinicians (Vervoort et al., 2010). 
3.4 Discussion of the Review Findings 
Evidence from the eight studies has shown that clinicians attempt to share decisions-making 
with HIV patients when starting, changing, when interrupting ART or when discussing ART 
adherence, but not in all situations. The overall finding of the review is therefore consistent 
with the findings of existing literature that shared decision-making may not be taking place as 
often as possible in clinical practice (Coulter and Collins, 2011; Da Silva, 2012). Exception to 
the practice of shared decision-making occurs due to improper practice of the approach, 
cultural views of the patients, health literacy level of patients, length of experience of patients 
with HIV and its acceptance, trust in the clinician as well as persistent nonadherence to ART. 
Although limited number of studies were reviewed in this chapter, the findings are 
contextualised in relation to the wider available literature on SDM and chronic conditions in 
the following sections. 
3.4.1 Clinicians’ Practice of SDM 
Existing studies have shown that clinicians tend to prefer covert paternalism instead of SDM. 
For instance, a qualitative study among primary care asthma nurses in UK has demonstrated 
that although clinicians held positive values about SDM and its potential to improve 
adherence, they only used it as a tool to support their own agenda, rather than as an 
expression of equality between clinicians and patients (Upton et al., 2011). This covert 
approach to paternalism has also been reported in a qualitative study carried out in Australia. 
In the study, most of the nurses deliberately gave patients limited information and were 
reluctant to collaborate with them by advocating or providing them with options towards 
reaching an informed decision (Henderson, 2003). These earlier reports are consistent with 
the report in this review where patients were given options but were not properly guided to 
make an informed decision or when they were technically forced to remain on a treatment 
option that they did not want (Fuller et al., 2016). This evidence suggests that even though 
clinicians theoretically agree to the importance of SDM, most of them still prefer to practise 
the older approach of paternalism (Longtin et al., 2010; Upton et al., 2011). A probable reason 
for the resistance of the clinicians to fully embrace the SDM approach is that the clinicians do 
not want to lose their identity of authority by delegating powers and responsibilities to the 




there is a need for further sensitization of the clinicians to change their perception of clinical 
treatment decision-making approach and to re-emphasize the importance of SDM. This may 
be especially important in African settings as the evidence from the study by Gourlay et al. 
(2014) revealed that the African clinicians tend to favour paternalism in almost all cases. 
3.4.2 Cultural Views of the Patients 
Although limited, the findings of this review also reflect the common opinion in literature that 
culture could affect the competence of both patients and clinicians to participate in SDM 
(Coulter, Parsons and Askham 2008; Levit et al., 2013; Longtin et al., 2010). This review 
reveals that patients with non-Western backgrounds are more likely to be passive in clinical 
consultation for HIV treatment. Specifically, HIV patients with African background and from 
the Caribbean were reported to be more likely to prefer their health providers to make 
treatment decisions for them, as they consider them to be medical authority whom they trust 
(Fuller et al., 2016; Gourlay et al., 2014; Mulder et al., 2016). A survey in the USA among 
diabetes patients reported similar findings that perceived power imbalance between the 
clinicians and African-Americans was a significant barrier to SDM (Peek et al., 2009). These 
patients were reported to be more likely to prefer their physicians to make treatment decisions 
for them because they see them as medical authority that they should avoid challenging (Peek 
et al., 2009). Another survey in the USA also reported that the passive attitude of the African-
Americans may not necessarily be due to their cultural perceptions alone but may also be due 
to experience of bias and discrimination or lack of cultural concordance between them and 
the physicians (Peek et al., 2010). From the study, African-American diabetic patients reported 
that their physicians were less likely to share information with them and tend to be domineering 
with them (Peek et al., 2010). These patients’ views can be corroborated with the finding from 
a qualitative study in the USA where clinicians were reported to be more verbally dominant 
with the Black HIV patients than the Hispanics and the White patients (Laws et al., 2014). The 
study also reported that while the clinicians engaged the Blacks and Hispanics patients in 
discussions about ART adherence, they tend not to discuss strategies to improve adherence 
with them, but they did with the White non-Hispanic HIV patients (Laws et al., 2014). Hence, 
the patients’ cultural-related passivity may not necessarily be the only challenge that prevents 
Black patients engaging in treatment decision-making, but also the attitude of their clinicians.  
Furthermore, a large survey in the USA has shown that passive role in treatment decision-
making is not the preferred role for all Black patients or patients with African background (Peek 
et al., 2011). In the study, African-American diabetes patients preferred shared decision-
making as much as the White patients and were more likely to report that they initiated 




assume that HIV patients will not want to actively participate in a treatment decision making 
because of their cultural or ethnic identity. This has been corroborated with the instance of 
SDM in the study by Gourlay et al. (2014) in this review. 
However, the preference of the Black or African HIV patients for a passive role in treatment 
decisions as reported in studies carried out in non-African settings in this review could be a 
reflection of their societal norms and the healthcare culture where they receive treatment. This 
societal norms and healthcare cultures may not only be associated with their current location 
where the studies were carried out but may be associated with the prevailing culture in the 
countries where the HIV patients came from. For instance, as reported by Fuller et al. (2016) 
the initial reluctance expressed by a Latino patient when he first encountered the need to 
share decision-making with clinicians was due to his previous experience in Mexico, where 
such an approach was not the norm. Although from a different context, the study by Gourlay 
et al. (2014) has also revealed that paternalism and higher clinician power in consultation are 
the norms in the rural area of Tanzanian. Therefore, the passive attitudes of the Black or 
African HIV patients in shared decision-making suggests that in their countries, sharing 
decision-making with the health provider may not be the norm.  
Moreover, the HIV patients’ initial preference for a passive role in treatment decisions does 
not mean that they will not participate in SDM if they are given appropriate decision support. 
This was demonstrated by the change in the attitude of the Latino man to participate in SDM 
through discussions with his clinicians despite being initially reluctant (Fuller et al., 2016). 
Therefore, irrespective of the cultural beliefs, clinicians need the skills to elicit each patient’s 
preferences and willingness to become more involved in their health care or to support them 
at whatever level that is comfortable for them (Coulter, Parsons and Askham, 2008; Cushing 
and Metcalfe, 2007; Legare and Witteman, 2013). This is important as this review also shows 
that irrespective of race, some HIV patients including the patients with Western backgrounds 
prefer their clinicians to make treatment decisions for them (Fuller et al., 2016; Gourlay et al., 
2014; Mulder et al., 2016).  
3.4.3 Patient’s Health Literacy 
Evidence from literature has consistently demonstrated that patients including African-
Americans with higher education and health literacy are more likely to engage in SDM and 
share responsibility with their health providers (Amalraj et al., 2009; Coulter and Collins, 2011; 
Da Silva, 2012; Peek et al., 2009; Smith et al., 2009; Yin et al., 2012). However, as pointed 
out by Nielsen-Bohlman (2004) low health literacy is not limited to the uneducated and poor, 




comprehend medical forms or doctor’s instructions. In addition, Da Silva (2012) in a review of 
literature summarised that one cannot clearly say based on available evidence that people 
from a certain level of education will be more or less likely to prefer SDM. Consistent with this 
view, evidence from a study in this review shows that some patients who were identified as 
having high level of education did not value SDM approach (Fuller et al., 2016).  
Lower health literacy on the other hand, has been shown to consistently predict lower self-
confidence among the patients which results in leaving medical decisions to the health 
providers (Amalraj et al., 2009; Da Silva, 2012; Peek et al., 2009; Smith et al., 2009; Yin et al., 
2012). Similarly, in this review patients who felt that they lack the knowledge and expertise to 
make medical decisions themselves were reported to be ambiguous about what their level of 
decisional involvement should be (Mulder et al., 2016). Rather than only due to level of 
education, this attitude was also associated with patients who were still experiencing the initial 
shock of being diagnosed with HIV and were not sure of what to do (Marelich et al., 2002; 
Mulder et al., 2016). However, further evidence from the review shows that this initial passivity 
is usually overcome, and patients become more involved in SDM as they become experienced 
with the disease and accept their HIV status (Marelich et al., 2002; Mulder et al., 2016).  
Although high literacy level is desirable for SDM, this review revealed that patients with high 
literacy level may also want to take leading role in the treatment decision-making (Fuller et al., 
2016; Marelich et al., 2002). This struggle for higher autonomy could however result in patients 
tending to disregard their clinicians’ advice and lead to the selection of the wrong treatment 
regimen by the patient (Fuller et al., 2016; Marelich et al., 2002). Therefore, clinicians need to 
be conscious of the fact that engagement of each patient in treatment decision may differ and 
as such they cannot all be supported with the same approach, but the clinicians should be 
prepared to accommodate each patient’s desire for autonomy (Da Silva, 2012). This was 
emphasised in the concordance scale used by Clucas et al. (2012) which revealed that the 
doctors need to ascertain the role that the patient wants to take in treatment decision. This 
process can promote shared decision even if it results in the patients preferring that the doctor 
should take the decision for them.  
3.4.4 Trust in Health Providers 
Trust between clinicians and their patients has been shown to be a potential barrier or 
facilitator of SDM in studies (Da Silva, 2012; Peek et al., 2009). In this review, patients’ trust 
in their health providers has also been found to have varying impact on SDM. While trust in 
the provider facilitated SDM in some instances reported in the studies, it was reported to lead 




2016). Similar to the report of the literature review by Da Silva (2012), because some patients 
had blind trust in their clinicians, the treatment decision ended up being made solely by the 
health providers (Fuller et al., 2016). Meanwhile, patients who did not trust their clinicians were 
reported to want to make the decisions themselves (Fuller et al., 2016). Therefore, clinicians 
need to be aware that patients’ trust in them may not necessarily predict concordance with 
the treatment decision. 
3.4.5 Patients’ Persistent Non-Adherence to ART 
In most studies in this review, it was reported that clinicians either directly or indirectly address 
adherence to ART with patients. This was done by involving them in the treatment decisions 
and trying to elicit information from the patients about barriers to adherence and by providing 
them with tailored information about their disease, treatment and resources such as social 
support to help them control their disease (Griffiths et al., 2007; Mulder et al., 2016; Vervoort 
et al., 2010). Beyond this approach, clinicians were also reported to use motivational 
interviewing (MI) to enhance the self-efficacy of the patients (Mulder et al, 2016; Vervoort et 
al., 2010). This approach is evidence-based as it is consistent with the prevailing evidence 
from a meta-analysis that patient’s self-efficacy is the most significant predictor of ART 
adherence or non-adherence (Langebeek et al., 2014a). Meanwhile, beyond the context of 
HIV and ART, self-efficacy is widely regarded in literature as the key predictor of health 
behaviour changes for a wide range of health behaviours (Isa et al., 2017; Dixon, 2008; 
Sheeran et al., 2016). This is because self-efficacy influences behaviour change by shaping 
both the formation of intention to change and the actual implementation of that intention 
(Dixon, 2008). Motivational Interviewing therefore appears to be very useful in this context 
because it aims to improve self-efficacy of the client to carry out a behaviour change (Miller 
and Rollnick, 2013, p.213). Unfortunately, the evidence supporting the use of MI in this review 
is low and involved very few participants and thus cannot be generalised. Coincidentally, apart 
from the widespread call for a shift in the paternalistic approach towards the adoption of SDM 
there is currently a growing consensus that what constitutes an ideal decision support 
counselling are approaches that draw on the principles of MI (Barry and Edgman-Levitan, 
2012; Coulter and Collins, 2011; Da Silva, 2012).  
However, when the clinicians in this review encountered patients with persistent non-
adherence or when the patients’ motivation to continue with the HIV treatment was low, they 
either confronted the patients with the consequences of non-adherence or asked the patients 
to stop the treatment (Mulder et al., 2016; Vervoort et al., 2010). This approach is paternalistic 
as the choice to stop the treatment was taken by the clinicians and not with the patient, while 




to the treatment. As observed by Upton et al. (2011), this attitudinal shift implies that the 
clinicians only embraced the SDM or the MI when the selected approach seemed to be 
improving the patient’s adherence outcome.  
Clinicians who resort to a controlling style of communication to motivate the patients may 
encounter a role-conflict when trying to adopt a patient-centred approach like the SDM or the 
MI (Mulder et al., 2016). For instance, physicians assume certain level of power during clinical 
interactions due to their medical training and credentials (Ariss, 2009; Joseph-Williams, Elwyn 
and Edwards, 2014; Lian and Robson, 2017; Nimmon and Stenfours-Hayes, 2016). Ironically, 
this medical knowledge base creates an imbalance of power between the clinicians and the 
patients, irrespective of the level of knowledge that the patient may possess. Therefore, based 
on findings from a systematic review Joseph-Williams, Elwyn and Edwards (2014) argue that 
knowledge provision and acquisition, as well as the expectation to contribute personal 
preferences are usually done in the context of a power imbalance between clinicians and 
patients. They stressed that patients do not only need knowledge, but also power to participate 
in SDM (Joseph-Williams, Elwyn and Edwards, 2014). Unfortunately, studies have shown that 
physicians often struggle to relinquish power to participate in a collaborative clinical interaction 
with patients, thereby leading to them switching to paternalism (Lian and Robson, 2017) or 
tagging the patients as problematic when they attempt to share the power position with the 
physicians (Ariss, 2009; Joseph-Williams, Elwyn and Edwards, 2014 Nimmon and Stenfours-
Hayes, 2016). Hence, there is a need for an improvement in clinicians’ approach to SDM 
and/or MI as revealed in this review to empower them to promote ART adherence among HIV 
patients even when the patients’ non-adherence behaviour is persistent or when they appear 
to lack motivation to adhere. 
3.5 Conclusion to the Chapter 
Despite the limited number of articles, evidence from Germany, Netherland, Tanzania, USA 
and UK reported in this review has established that clinicians attempt to share HIV treatment 
decisions with PLHIV in some situations while they use paternalistic approaches in other 
instances. The review also revealed that to promote ART adherence, clinicians may need to 
go beyond aiming for a SDM by also enhancing the self-efficacy or motivation of the HIV 
patients. While the evidence within the review that suggests the use of MI to complement SDM 
to promote adherence is limited and cannot be generalised, the review reveals that the 
techniques of MI could also provide the requisite skills base to effectively participate in SDM.  
Hence, the clinicians may benefit from a more robust skill set if they are empowered through 
MI training to complement their skills of SDM towards the goal of supporting HIV patients to 




decisions in non-Western countries are most likely to be made predominantly by the clinicians. 
Arguably, the societal or healthcare norms in such countries may not be initially compatible 
with the patient-centred approach of SDM or MI. However, ability of patients to overcome such 
initial shock in this review was demonstrated only in a study carried out in the context of a 
developed country; an outcome which might have been influenced by the high resources 
available in the context. Therefore, when promoting the adoption of SDM or MI in non-Western 
countries there is a need to consider not just the compatibility of the approaches with the 
societal and health care norms, but also to pay attention to the influence of the resources 
within the context of a developing country like Nigeria.     
3.6 Chapter Summary 
This chapter investigated how to enhance the adherence of HIV patients to ART through 
evidence-based approach to clinical consultation. A comprehensive review of the literature 
was carried out. Evidence from the review revealed that for ART adherence, clinicians may 
need to go beyond involving the patient in the treatment decision making by enhancing the 
motivation of the individual through a motivation enhancing strategy such as MI to improve 
the self-efficacy of the patient. While the evidence suggesting the need for a motivational 
enhancement strategy may not be generalisable, it will be unwise not to explore the potentials 
of such a promising approach in respect of ART adherence as explored in the chapter. 
However, such an approach will need to be considered in relation with the prevailing societal 
or health care norms and the available resources in a developing country like Nigeria. 
Finally, this chapter has contributed to the research question by demonstrating that patient-
centred approaches such as SDM or MI may not be readily adopted for practice in the clinical 
setting for clinical consultation for HIV treatment adherence in non-Western countries. This is 
because of the unknown potential impact of the clinical and community culture that may inhibit 





CHAPTER FOUR: MOTIVATIONAL INTERVIEWING FOR ANTIRETROVIRAL THERAPY 
ADHERENCE-LITERATURE REVIEW OF STUDIES IN DEVELOPING COUNTRIES 
4.0 Chapter Overview 
This chapter presents MI and its theory and discusses the current state of knowledge in 
respect of the theory that underpins it. The chapter also discusses the available evidence that 
supports adoption of MI as an approach to promote ART adherence. The chapter then 
presents a review of literature that is focused on exploring the challenges or facilitators to the 
use of MI in different settings for ART adherence in developing countries. The purpose of the 
review of literature is to understand how to use MI in diverse culture and contexts in developing 
countries. The findings from this review are expected to inform how to use MI for ART 
adherence support within the Nigerian culture and health care context. 
4.1 Introduction to the Chapter 
Motivational Interviewing (MI) is a collaborative, goal-oriented style of communication with 
particular attention to the language of change (Miller and Rollnick, 2013, p.29). It is a client-
centred therapeutic approach that operates within an empathetic interpersonal context (Miller 
and Rollnick, 2013, p.29; Moyers, 2014). The approach also uses techniques such as shared-
decision making and eliciting of change talk (Resnicow and McMaster, 2012). In MI, the role 
of the clinician is to guide the client to elicit and strengthen the client’s motivation for change 
(Miller and Rollnick, 2009; Resnicow and McMaster, 2012). In this regard, MI approaches 
behaviour change by focusing on enhancing the internal motivation of the clients rather than 
aiming to change their behaviour through external motivation (Miller and Rollnick, 2009; 
Moyers, 2014).  
To successfully guide the patients to enhance their inherent motivation towards a specific goal, 
the aim of the MI counsellor is to assist the individuals to resolve their ambivalence, which is 
considered as a normal stumbling block in changing complex, intractable behaviours that have 
both costs and benefits (Dewing et al., 2015; Miller and Rollnick, 2012; Moyers, 2014). 
Therefore, unlike other treatment approaches that focus on assisting patients to change 
behaviour, MI is mainly concerned with helping the patient to make decision for change and 
why the change should occur (Moyers 2014; Resnicow and McMaster, 2012).  
MI was introduced by William Miller in 1983 for use in addressing substance abuse but has 
since been applied to areas beyond addictions (Bisono, Manuel and Forcehimes, 2006, p.72). 
The client-centred but directive counselling style of MI emerged at a time when there was an 
increasing frustration with the prevalent traditional clinical belief that alcoholic patients should 




Rollnick met with William Miller and encouraged him to write more about how to implement 
the method (Moyers, 2004). Collaboration between the two individuals led to emphasis of the 
MI approach on client’s ambivalence, and the importance of eliciting language of change from 
the patient (Moyers, 2004). This emphasis on client’s ambivalence is one of the distinguishing 
factors between MI and other client-centred counselling approaches (Dewing et al., 2015; 
Miller and Rollnick, 2009). 
4.1.1 The Spirit and Techniques of MI  
The spirit of MI is based on four fundamental components: collaboration, evocation, 
acceptance and compassion (Miller and Rollnick, 2013, pp14-22).  
Collaboration: MI promotes a collaborative approach in which the clinician does not assume 
an authoritarian or expert role in the therapeutic relationship (Bisono, Manuel and Forcehimes, 
2006, p.73). Instead, the counsellor respects the client’s perspective and autonomy, while 
fostering a positive interpersonal atmosphere that is conducive to change but not coercive 
(Miller and Rollnick, 2013, p.15). 
Evocation: Contrary to the assumption that the client is lacking something that needs to be 
installed, MI emphasises that perspectives and values should be elicited from the client rather 
than being imparted (Bisono, Manuel and Forcehimes, 2006, p.73; Hettema, Steele and Miller, 
2005; Miller and Rollnick, 2013, p.20).  
Acceptance: Another spirit of MI is an attitude that shows profound acceptance of what the 
client brings (Miller and Rollnick, 2013, pp16-19). This involves the acceptance of the absolute 
worth of the client, expression of accurate empathy (an active interest in and effort to 
understand the internal perspective of another person), and autonomy support. Therefore, 
besides the acceptance of the inherent worth and potentials of every human being in MI (Miller 
and Rollnick, 2013, p.17), the approach requires that the clinician understands that it is up to 
the clients to decide whether they want to change or not, and how best to go about it (Bisono, 
Manuel and Forcehimes, 2006, p.73). The role of the clinician is therefore to respect the 
choices of the client and decisions regarding self-direction, even if they are divergent from 
what the clinician thinks is best for the client (Bisono, Manuel and Forcehimes, 2006, p.73; 
Miller and Rollnick, 2013, p.18). Lastly, acceptance involves another element termed as 
affirmation which requires that the clinician should seek to know and acknowledge the 
strengths and efforts of the clients (Miller and Rollnick, 2013, p.19). 
Compassion: A recently added element to the spirit of MI is the need to be compassionate 




Rolnick, 2013, p.20). According to Miller and Rollnick (2013, p.20) being compassionate in MI 
differs from the expression of personal feelings, sympathy or identification, but a deliberate 
commitment to the welfare and best interest of the client. 
Techniques of MI 
While the essence of MI lies in its spirit, specific techniques and strategies when used 
effectively help to ensure that the spirit is evoked (Resnicow and McMaster, 2012). In this 
regard, the MI counsellor relies heavily on skills or strategies such as: Open-ended questions; 
Affirming the clients; Reflective listening and Summarizing, which are all popularly referred to 
as the OARS (Bisono, Manuel and Forcehimes, 2006; Miller and Rollnick, 2013, p.32-34; 
Resnicow and McMaster, 2012). The OARS skills are strategically used to elicit and reinforce 
clients’ change talk. This is important, as it is the single factor that differentiates MI from other 
counselling approaches (Miller and Rollnick, 2009).  
4.1.2 Theoretical Underpinning for MI 
MI is an approach that was not derived from theory but arose from practical clinical experience 
in the field of alcohol treatment (Miller and Rollnick, 2012). Since its emergence into the field 
of health behaviour change in 1983, a theoretical understanding of how the MI approach is 
effective is still lacking (Allsop, 2007; Bjork, 2014). In recent years, an increasing number of 
researchers and practitioners have been promoting the use of self-determination theory (SDT) 
to understand how MI works (Gwardz et al., 2015; Resnicow and McMaster, 2012; Miller and 
Rollnick, 2012). While SDT grew up independently from MI, both approaches bear semblance 
in many areas. In this regard, the three human needs relevant for motivating behaviour change 
in SDT- autonomous regulation, relatedness and competence- are all directly addressed in MI 
(Deci and Ryan, 2012; Miller and Rollnick, 2012; Resnicow and McMaster, 2012).  
Even though there are many similarities between the SDT and the practice of MI, some salient 
and potential differences between them have been identified. For instance, while MI 
emphasises the quantity, intensity and sequence of change talk as essential elements of the 
behaviour change process, SDT places more emphasis on the quality of the change talk by 
asking whether the change intention has been fully internalized (Deci and Ryan, 2012; 
Resnicow and McMaster, 2012; Vansteenkiste and Sheldon, 2006). From the SDT 
perspective, a client’s change effort is expected to have a high likelihood of failure if it is based 
on introjected reasons or external pressure, even if the expression is strong in intensity 
(Vansteenkiste and Sheldon, 2006). In addition, while MI places more emphasis on the source 
of the autonomy by ensuring that the motivation, solutions and action plans emanates from 




even if the initial source of motivation is external (Resnicow and McMaster, 2012). Lastly, 
Resnicow and McMaster (2012) have also argued that contrary to the assumption in MI that 
clients possess both strong reasons for and against change, it is not clear how such 
simultaneous motivations are addressed in SDT, because the SDT continuum implies that 
motivation is discreet. 
While there is currently no consensus about a valid theory of how MI works, Miller and Rose 
(2009) proposed a causal chain for the processes and outcomes of MI (figure 4.1) (Allsop, 
2007; Bjork, 2014; Miller and Rollnick, 2012; Miller and Rose, 2009; Resnicow and McMaster, 
2012). From the causal chain, the therapeutic relationship (Empathy and Spirit) in MI has been 
hypothesized to have both direct impact on clients’ outcomes and facilitate the emergence of 
client language in favour of behaviour change (Miller and Rose, 2009; Moyer, 2014). However, 
evidence from a literature review has shown that the impact of the therapeutic relationship on 
the effectiveness of MI is inconsistent (Apodaca and Longabaugh, 2009). Despite this finding, 
Miller and Rose (2009) emphasised that MI without its spirit cannot be considered as MI.  
Figure 4.1: Causal Chain among Processes and Outcome Variables in MI
 
Adapted from: Miller and Rose (2009)  
Besides the therapeutic relationship which is associated with the relational component of MI 
in the existing causal chain, MI also has a technical component which is focused on differential 
evocation and reinforcement of clients’ change talk (Miller and Rose, 2009; Moyers, 2014). 
The technical component of MI (MI consistent methods) has also been hypothesized to be 
directly linked with clients’ change talk as well as to clients’ behavioural outcomes (Miller and 
Rose, 2009). This technical component is built on the assumption that behaviour change will 




causing the client to verbalize argument for not changing (sustain talk) is expected to favour 
behavioural status quo (Miller and Rollnick, 2013, p.158-159; Miller and Rose, 2009). Based 
on this assumption, the technical hypothesis regarding how MI works suggests that proficient 
use of the techniques of MI is expected to increase the likelihood of the emergence of clients’ 
change talk and to decrease sustain talk (Miller and Rose, 2009). Unlike the existing finding 
about the impact of the MI spirit, evidence from the review carried out by Apodaca and 
Longabaugh (2009) demonstrated that inconsistent MI behaviour was consistently associated 
with poor clients’ behavioural outcomes, while client change talk is consistently related to 
better behavioural outcome. 
4.1.3 MI and Antiretroviral Therapy Adherence 
Despite the lack of consensus on an appropriate theory to underpin the MI approach, it has 
been adopted to address many health behaviour challenges which includes medication 
adherence (Allsop, 2007; Easthall, Song and Bhattacharya, 2013; Mathes et al., 2013; 
McMaster and Resnicow, 2015). For instance, a recent meta-analysis of medication 
adherence interventions for chronic conditions that are based on cognitive-behaviour change 
techniques has shown that most interventions use the MI approach (Easthall, Song and 
Bhattacharya, 2013). Interventions evaluated in the review of 26 studies included those 
focused at improving patients’ adherence to HIV drugs in 14 of the studies. Similarly, another 
meta-analysis of 17 randomised controlled studies that tested MI for treatment adherence for 
chronic conditions also involved 10 studies that tested the potential of MI based interventions 
to promote ART adherence (Palacio et al., 2016). These bodies of evidence suggest that 
among chronic conditions, the potential to utilize MI to improve medication adherence has 
been investigated more with HIV than with other chronic conditions. Meanwhile, evidence from 
a systematic review of 21 trials that examined the effectiveness of adherence-enhancing 
interventions for HIV treatment has found that only the study that used MI reported statistically 
significant results for adherence (Mathes et al., 2013). Moreover, findings from another 
systematic review of five studies (Hill and Kavookjian, 2012) and an integrative review of 239 
articles (Dillard, Zuniga and Holstad, 2016), have led the researchers to conclude that MI can 
be an effective clinical method to improve HIV drug adherence among people living with HIV 
[PLHIV].  
While evidence abounds about the effectiveness of MI for improving HIV drug adherence, its 
implementation in routine care delivery is still scarce. This suggests that most of the successes 
of MI at improving ART adherence remain shrouded in academic papers. This observation 
has also been echoed by Haberer et al. (2017) that effective ART adherence interventions 




therefore, not surprising that the widespread successes of MI in academic journals have not 
led to its adoption in regular clinical practice in resource-limited countries like Nigeria which 
bears the highest burden of AIDS-related mortality globally (UNAIDS, 2017). Although the 
dearth of its practical application is a strong indication for the need to promote its wide scale 
deployment into real-life clinical practice, little is currently known about the contextual factors 
that might inhibit or enhance its regular application in routine care delivery in resource-limited 
settings.  
Against the background above, little is also known about how the cultural or healthcare norms 
in developing countries can influence its application. This is worth consideration because MI 
was developed within the cultures in USA and UK which are developed countries (Koken et 
al., 2012). It could therefore be argued that if MI is not properly practised due to the cultural 
context in which it is practised, HIV patients may not benefit equally from MI-based ART 
adherence counselling because of their cultural or ethnic backgrounds. Hence, Koken et al. 
(2012) emphasised the importance of ensuring that clinicians maintain fidelity to the spirit and 
techniques of MI when it is considered for use in different cultural and linguistic contexts. This 
is especially important in a highly multilingual and multicultural country like Nigeria (Pinon and 
Haydon, 2010).  
While it is usually assumed that the core processes of MI cross cultures very well as they rely 
heavily on semantic universals, it is also believed that certain cultural nuances could influence 
how the MI processes are applied (Miller and Rollnick, 2013, p.350). It has also been argued 
that certain cultural factors may play important role in the processes and outcomes of MI and 
that clarification of such factors will facilitate its cross-cultural adaptation (Miller and Rose, 
2009). Hence, knowledge about the influence of the context and culture on the application of 
MI for ART adherence in developing countries may enhance its implementation in Nigeria. 
Therefore, this review is focused on exploring the impact of languages, cultures and contexts 
on the application of MI for ART adherence in developing countries and how it has been 
adapted for use in such countries, with a view to understand how to utilise the approach in 
Nigeria.  
4.2 Methods of this Review 
To carry out this literature review, data search and study selection was based on the PEO 
format (Bettany-Saltikov, 2012, p.21). The PEO format was chosen because the review’s 
objective is primarily an exposure question and not necessarily an intervention question 
(Bettany-Saltikov, 2012, p.21). P refers to people or population, E for exposure and O for 




people, exposure and outcome data were considered relevant for inclusion of studies in the 
review.  
People or population: Population refers to the HIV patients or the health practitioners who 
counsel them to adhere to their ART. Studies were also included in the study if they were 
carried out in developing countries which includes Upper-Middle Income Economies, Lower-
Middle Income Economies and Low-Income Economies but excluding High Income 
Economies as defined by The World Bank (2018a).   
Exposure: Exposure in this review refers to the type of MI-based intervention used for ART 
adherence or the way the study participants are exposed to the MI approach. Based on 
findings from a scoping search, a criterion for exclusion of studies under this dimension of 
PEO is if the study did not actually apply MI approach for ART adherence. Another criterion 
for exclusion of studies is if the MI was not applied during a consultation or counselling session 
between the health practitioner and the patient.  
Outcome: Focus on outcomes in this review is restricted to data that is related to the 
experience of the study participants in respect of their exposure to the MI approach or the 
factors that might have facilitated or hindered the application of MI in the study. Hence, 
expected outcomes from the studies does not include report of ART adherence, but includes 
data relating to the feasibility or acceptability of the MI based interventions or experience that 
the study participants might have had with MI, health practitioners’ fidelity to MI, and the 
influence of contextual factors on the practice of MI. Influence of time on the applicability of 
MI is considered important to this review because existing evidence has consistently 
demonstrated that time constraints are the most frequently cited barrier to the implementation 
of shared decision-making (Legare and Witteman, 2013) or lifestyle counselling (van de Glind 
et al., 2012). It has also been frequently cited as a barrier to the implementation of MI in routine 
practices for other health settings in developed settings but outside ART care settings (Ostlund 
et al., 2014; Sargeant et al., 2008; Shannon Donovan-Hall and Bruton, 2017; Soderlund and 
Nilsen, 2009). Therefore, as cautioned by Emmons and Rollnick (2001) there is a need to 
consider dealing with time constraints specific to each health care setting when adapting MI 
for use across settings. 
Regardless of the focus of the review on diverse outcome data, description of certain terms 
that guided the study search in respect of health practitioners’ fidelity to MI is considered 




MI therapists’ fidelity assessment: Effectiveness of a complex intervention like MI can vary 
across studies, sites and therapists (Hettema, Steele and Miller, 2005; Miller and Rollnick, 
2014). However, a factor that has been insufficiently considered is the fidelity of the 
behavioural treatment that was provided during the intervention delivery (Miller and Rollnick, 
2014). Meanwhile, evidence has shown that therapist’s fidelity to MI techniques and spirit 
predicts patients’ behavioural outcomes (Koken et al., 2012). Therefore, to assess the fidelity 
of therapists to MI, several competence assessment tools have been developed. These 
include: MI Skill Code [MISC] (Miller et al., 2008); MI Treatment Integrity [MITI] coding system 
(Moyers, Manuel and Ernst, 2014); MI Target Scheme [MITS] (Allison, Bes and Rose, 2012); 
Behavioural Change Counselling Index [BECCI] (Lane, 2005); MI Sequential Code for 
Observing Process Exchanges [MI-SCOPE] (Moyers and Martin, 2006); Video Assessment 
of Simulated Encounters [VASE] (Rosengren et al., 2009) and OnePass coding system 
(McMaster and Resnicow, 2015; http://www.motivationalinterviewing.org/).  
MISC which is the first MI fidelity assessment tool was originally developed in 1997 as a 
method for evaluating the quality of MI from audiotapes and videotapes of individual 
counselling sessions (Miller et al., 2008; Moyers et al., 2005). MITI on the other hand was 
developed from the MISC, not to compete for the same task, but to accomplish different tasks 
(Moyers et al., 2005; Moyers et al., 2010). While MISC is typically more useful in conducting 
detailed process research to investigate critical elements and causal mechanisms of MI, MITI 
is more useful when simpler questions are the focus of the study (Moyers et al., 2010). 
Probably because of its simpler focus which could aid in the cross-settings application of the 
MI approach with optimum therapists’ fidelity and to enhance provision of targeted feedback 
for trainees, MITI is currently the most popularly used treatment fidelity tool for MI (McMaster 
and Resnicow, 2015; Moyers et al., 2010; Moyers, Manuel and Ernst, 2014).  
According to the MITI, there are two aspects to the assessment of therapists’ fidelity: Global 
spirit ratings and Behaviour counts. Global spirit scores in MI are intended to capture the 
rater’s overall impression of how well or poorly the therapist meets the intent of a scale 
(Moyers et al., 2010). The measure of the therapists’ behaviour on the other hand is carried 
out in MITI by assessing percent complex reflections, open questions, reflections to question 
ratio and percent MI consistency. While the Global spirit is an aggregate score of collaboration, 
evocation and autonomy support, the Behaviour counts include computation of percentage 
values for complex reflections to total reflections (complex + simple) counts, open to total 
question (open + closed) counts, MI consistent responses to total responses (MI consistent + 
MI-inconsistent) count, as well as the ratio of reflections to questions (Miller and Rollnick, 




average of 3.5 (on a 1-5 scale), ≥40% for percentage complex reflections, ≥50% for 
percentage open questions, ≥90% for percentage MI consistency and ≥1.0 for reflection-to-
question ratio. Conversely, the proficiency thresholds are: 4.0 for Global spirit; ≥50% for 
percent complex reflections; ≥70% percent open questions; ≥98% for MI consistency; and 
≥2.0 for reflection-to-question ratio (Miller and Rollnick, 2013, p.400). Although these 
competency and proficiency thresholds are currently widely used in studies, they are still 
considered to be provisional ratings based on expert opinions only as they lack normative or 
other validity data to support them (Miller and Rollnick, 2013, p.399; Moyers, Manuel and 
Ernst, 2014). However, until such data become available, researchers are encouraged to use 
the provisional ratings with other data to arrive at clinician’s basic competence and proficiency 
in using MI (Miller and Rollnick, 2013, p.399; Moyers, Manuel and Ernst, 2014). 
Study Search 
To carry out this literature review, eight electronic databases were searched for relevant 
studies. These include ASSIA, CINAHL, MEDLINE, PBSC, PsycARTICLES, PsycINFO, 
PubMed and Virology and AIDS Abstract. Study search was limited to those published 
between 1995 and 2018. The limitation for study search from 1995 is to account for all studies 
published since the introduction of ART for management of HIV (Baggaley et al., 2015; 
Granich et al., 2015). Study search was also limited to articles published in English language, 
due to lack of time to carry out translations. The search terms used for searching the studies 
from the databases were stringed together with Boolean operators in the following pattern: 
(Motivational Interviewing OR MI OR Motivational Interview) AND (Counselling OR 
Counseling OR Advice OR Consultation) AND (HIV drug OR HIV treatment OR Antiretroviral 
Therapy OR Antiretrovirals). This search string produced 1,911 articles. Screening of the 
articles for relevant titles yielded 78 articles that met the objectives of this review. One more 
relevant article (Yeagley et al., 2012) was retrieved through manual search of the journal of 
the Association of Nurses in AIDS care and one more study (Bofill et al., 2015) was retrieved 
from the manual search of the Journal of the International Association of Providers of AIDS 
Care (2002-2018). Another article (Evangeli et al., 2009) was also retrieved from the manual 
search through the reference of one of the retrieved articles from the electronic databases 
(Dewing et al., 2013). Hence, 81 relevant articles were retained for assessment after the study 






Table 4.1: Summary of Study Search for Review 
S/N Study Sources  Total Hit Relevant Titles 
1 Virology and AIDS Abstract 61 0 
2 ASSIA 613 5 
3 CINAHL 65 13 
4 MEDLINE 130 13 
5 PsycARTICLE 0 0 
6 PBSC 28 5 
7 PsycINFO 180 16 
8 PubMed 834 26 
9 Journal of the International Association 
of Providers of AIDS Care  
NA 1 
10 Journal of the Association of Nurses in 
AIDS care  
NA 1 
11 Reference Search NA 1 
 Total 1911 81 
N.B: Total search hits were “NA-Not Applicable” for the Manual Searches through Journals and 
References 
Duplicate titles were removed from the retained articles, leaving 37 articles for abstract 
screening. After the abstract screening 12 studies were excluded based on the inclusion 
criteria (Cook et al., 2009; Cooperman et al., 2007; Dilorio et al., 2003; Gwardz et al., 2015; 
Holstad et al., 2011; Koken et al., 2012; Laisaar et al., 2013; Outlaw et al., 2013; Parsons et 
al., 2007; Parsons, Rosof and Punzalan 2005; Uuskula et al., 2017; van Loggerenberg et al., 
2015b). The remaining 25 articles were retained for full text review. After the full text review 
17 studies were also excluded based on the inclusion criteria (Adamian et al., 2004; Allicock 
et al., 2017; Cooperman et al., 2012; Dilorio et al., 2008; Goggin et al., 2013; Golin et al., 
2006; Fox et al., 2016; Ingersoll et al., 2011; Konkle-Parker et al., 2010; Krummenacher et al., 
2011; Letourneau et al., 2013; Navarro et al., 2014; Pradier et al., 2003; van Loggerenberg et 
al., 2015a; Sutton et al., 2017; Thrasher et al., 2006; Yeagley et al., 2012). A summary of the 
excluded studies and the justification for exclusion is presented in Appendix 2. Justification for 
exclusion of the studies includes: because setting of study was in developed countries 
(Adamian et al., 2004; Allicock et al., 2017; Cook et al., 2009; Cooperman et al., 2012; Dilorio 
et al., 2008; Goggin et al., 2013; Golin et al., 2006; Gwardz et al., 2015; Holstad et al., 2011; 
Ingersoll et al., 2011; Konkle-Parker, Erlen and Dubbert, 2010; Krummenacher et al., 2011; 
Laisaar et al., 2013; Letourneau et al., 2013; Navarro et al., 2014; Outlaw et al., 2014; Parsons 
et al., 2007; Pradier et al., 2003; Uuskula et al., 2017; Yeagley et al., 2012); for not using MI 
in the study (Fox et al., 2016; Sutton et al., 2017; van Loggerenberg et al., 2015a; van 
Loggerenberg et al., 2015b); for being a pilot study of a randomised controlled trial included 
among the retrieved studies (Cooperman et al., 2007; Dilorio et al., 2003; Parsons, Rosof and 




The eight retained articles after full text review are all quantitative studies (Bofill et al., 2015; 
Dewing et al., 2013; Dewing et al., 2015; Evangeli et al., 2009; Evangeli, Longley and Swartz, 
2011; Holstad et al., 2012; Jones et al., 2016; Maneesriwongul, Prajanket, and 
Saengcharnchai, 2012) with different research designs. Among the quantitative studies, there 
was a cluster randomised controlled trial [RCT] (Dewing et al., 2015); a factorial experimental 
study (Jones et al., 2016); two single group cohort studies (Dewing et al., 2013; Evangeli, 
Longley and Swartz, 2011), three pre-and post-test studies (Bofill et al., 2015; Evangeli et al., 
2009; Maneesriwongul, Prajanket and Saengcharnchai, 2012), and a post-test only study 
(Holstad et al., 2012).  
Each of the retained studies was selected for inclusion in this review because of diverse 
reasons that are consistent with the inclusion criteria specified by the PEO. These reasons 
include: test of impact of training on the application of MI techniques during routine 
consultation for ART (Bofill et al., 2015); test of the fidelity of lay adherence counsellors to MI 
techniques during ART adherence counselling sessions (Dewing et al., 2013); test of the 
impact of MI training course on the counselling skills of lay adherence counsellors during ART 
adherence counselling sessions (Dewing et al., 2015); test for changes in the ability of lay 
adherence counsellors to use MI to promote ART adherence (Evangeli et al., 2009); test for 
changes in the MI skills of the lay adherence counsellors one year after training without any 
further training or supervision (Evangeli, Longley and Swartz, 2011); test for the feasibility and 
efficacy of a group MI intervention to promote adherence to ART (Holstad et al., 2012); impact 
of the use of MI techniques to optimise adherence and engagement in care among HIV 
patients (Jones et al., 2016); and test of the effectiveness of a MI based counselling 
intervention on ART adherence (Maneesriwongul, Prajanket and Saengcharnchai, 2012). 
Despite meeting the inclusion criteria, there is a need to evaluate the methodological quality 
of the studies included in a literature review to draw conclusions about the strength of the 
overall body of evidence included in it (Polit and Beck, 2008, pp.127-130). Therefore, before 
extracting data from the retained studies, the methodological quality assessment of the eight 
studies was carried out. 
Methodological Quality Assessment for the Retained Studies 
To carry out the methodological assessment for the retained studies in the review Mixed 
Method Appraisal Tool (MMAT) developed by Pluye et al. (2011) was adopted for this purpose. 
The MMAT was considered fit for this review because of its efficiency as it allows the use of 
one tool for appraising all types of empirical studies, rather than appraising the studies with 




Significant methodological challenges were found in six of the studies (Bofill et al., 2015; 
Dewing et al., 2015; Evangeli et al., 2009; Holstad et al., 2012; Jones et al., 2016; 
Maneesriwongul, Prajanket, and Saengcharnchai, 2012). The methodological challenges 
found among the studies include: sampling or selection bias (Bofill et al., 2015; Evangeli et 
al., 2009; Holstad et al., 2012; Jones et al., 2016; Maneesriwongul, Prajanket, and 
Saengcharnchai, 2012); attrition bias (Dewing et al., 2015); unclear validity and reliability of 
measurement instruments (Bofill et al., 2015; Evangeli et al., 2009). 
Sampling Bias: Sampling bias is a systematic overrepresentation or underrepresentation of 
a population segment in term of key characteristics (Polit and Beck, 2017, p.163). Possibility 
of sampling bias occurred in four studies (Bofill et al., 2015; Evangeli et al., 2009; Holstad et 
al., 2012; Maneesriwongul, Prajanket, and Saengcharnchai, 2012) due to the use of 
convenience sampling for selection of study participants. Although convenience sampling is 
commonly used by researchers, the price of using it is an increased risk of bias as it is the 
weakest form of sampling (Polit and Beck, 2017, p.163). The authors could have used more 
reliable form of sampling for quantitative studies such as probability sampling like random or 
systematic sampling methods to reduce sampling bias (Polit and Beck, 2017, p.163-165). 
Moreover, for one of the studies (Jones et al., 2016) involving randomisation of participants, 
there was also possibility of selection bias due to lack of description of the sequence 
generation for randomisation or allocation concealment (Akobeng, 2005).  
Attrition bias: Attrition bias which is a term commonly used in controlled trials can be 
described as the systematic difference between groups in respect of withdrawal from a study 
(Higgins and Green, 2008, p.195). This bias could occur due to incomplete data and lack of 
blinding of participants, personnel and outcome assessors (Higgins and Green, 2008, p.195). 
Attrition rate beyond 20% increases the possibility that effect estimates of randomised 
controlled trials could be biased (Pluye et al., 2011). Hence, attrition rate of 39.6% in the study 
carried out by Dewing et al. (2015) is higher than safe threshold. 
Validity and reliability: Validity refers to the ability of a measurement instrument to measure 
what it is supposed to measure, and reliability is the instrument’s ability to consistently and 
accurately measure the concept under study (Coughlan, Cronin and Ryan, 2007). If an 
instrument with already established validity and reliability is used in a study, there is no need 
for the researchers to outline its validity and reliability in their study, but if the instrument has 
been adapted in any way or is being used for a new population, it is recommended that the 
authors should indicate the validity and reliability of the new instrument (Coughlan, Cronin and 
Ryan, 2007). In the study carried out by Evangeli et al. (2009) the authors did not clearly 




was used in the study. Additionally, the questionnaire for MI techniques used to assess the 
self-reported frequency of the use of MI techniques in counselling sessions was adapted from 
the 11-item BECCI, but with the observation response format used in the BECCI changed to 
that of self-report. While it was not clear why the authors chose to use self-report instead of 
the observation process of BECCI which would have been more objective, it was not also 
clear how the authors ensured the validity and reliability of this instrument before use. 
Similarly, the findings of the study carried out by Bofill et al. (2015) suffer from poor validity 
due to the use of MI technique coding approach which does not involve established validated 
tools such as MISC, MITI or OnePass. Lastly, while the validity and reliability of the study 
carried out by Holstad et al. (2012) could have been enhanced by use of already validated 
tools for data collections and measurements, the authors did not specify the measuring tool 
used for data collection in respect of the satisfaction of patients with the MI sessions. Although 
the data collection tool was not reported by the authors of the study, they presented results of 
the satisfaction of the patients among the study findings. Based on this limitation, it is difficult 
to ascertain the reliability of such finding.   
Overall, two (Dewing et al., 2015; Evangeli, Longley and Swartz, 2011) of the retained studies 
have very high scores of eight out of eight total quality scores. Judgement of the 
methodological quality of the retained studies were based on the allocation of Likert scores 
zero, one and two to answers categories “no”, “can’t tell” and “yes” respectively on the adopted 
critique framework (see Appendix7) (Pluye et al., 2011). Since the highest achievable quality 
score was eight, it was assumed that the medium quality score will be four and any quality 
score below that benchmark was low. While one of the other studies had total scores of six 
(Maneesriwongul, Prajanket, and Saengcharnchai, 2012) and four studies had scores of five 
(Evangeli et al., 2009; Bofill et al., 2015; Holstad et al., 2012; Jones et al., 2016), one of the 
retained studies had the lowest quality score of three (Dewing et al., 2013). Since one the 
studies had a low quality while the others had higher scores above the quality benchmark, it 
could be argued that the overall methodological quality of the reviewed studies is averagely 
high. Total quality scores allocated to each study are presented along with the extracted data 
in Table 4.2. Findings from this review should therefore be interpreted with regards to the 
highlighted methodological limitations and the quality scores of the studies contributing to the 
findings.  
After the methodological quality assessment, full texts of the eight retained studies were 




4.3 Findings from the Review 
4.3.1 Overview of the Retained studies 
As presented in Table 4.2, the eight retained studies were carried out in four developing 
countries: four from South Africa (Dewing et al., 2013; Dewing et al., 2015; Evangeli et al., 
2009; Evangeli, Longley and Swartz, 2011); one from Thailand (Maneesriwongul, Prajanket 
and Saengcharnchai, 2012); two from Argentina (Bofill et al., 2015; Jones et al., 2016); and 
one from Nigeria (Holstad et al., 2012). Hence, the studies were carried out among HIV 
patients and health practitioners in three different continents: Africa; South America; and Asia. 
A total of 270 HIV patients were recruited into this review by the individual studies that focused 
on patients’ experiences or outcomes. In this regard, Holstad et al. (2012) recruited 60 women, 
Maneesriwongul, Prajanket and Saengcharnchai (2012) recruited 90 patients (male and 
female), while Jones et al. (2016) recruited 120 patients (male and female). For studies that 
focused on MI training for health providers, a total of 146 individuals were recruited into the 
review. For instance, Evangeli et al. (2009) recruited 17 female lay adherence counsellors 
(this include the 10 who participated in the follow-up evaluation in Evangeli, Longley and 
Swartz, 2011), Dewing et al. (2013) recruited 39 lay adherence counsellors and Dewing et al. 




Table 4.2: Extracted Data from the Reviewed Studies in Chapter Four 














Relevant Outcomes Quality  
1 Intervention: 

















Clinicians: in MI 
group were 3 
trained HW. For 
HPP were 3 
trained HW. 











and from other 
tribes (4.1%). 
Satisfaction: No significant 
differences between groups in 
how the sessions were liked. Six 
of the MI sessions scored higher 
in 3 MI-related indicators 
compared to the HPP sessions. 
Sessions five (SSK and skills) 
and six (pros/cons and 
ambivalence about using RRB) 
scored lower in MI related 
ratings. 
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lasted for 10 
minutes. 
Not relevant Fidelity assessed with MITI 2.0. 
Three of 14 counsellors 
achieved beginning proficiency 
in MI in respect of percent MI 
consistency.  
Counsellors who conducted 
some or all sessions in English 
showed a higher percentage of 
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Not relevant  Fidelity assessed with MITI 3.0. 
Significant difference between 
the two groups on all global 
dimensions except direction-
p=0.1289. 
Behaviour counts: MI 
counsellors delivered 
significantly more MI adherent 
statements and simple 
reflections (p=0.0002 and 




















Relevant Outcomes Quality  
5  Follow-up 
evaluation 
from Evangeli 
et al. (2009). 
South 
Africa 













Not reported MI fidelity assessed with MITI 
2.0. 
Data for 8 participants were 
reported. Global spirit improved 
between post-training and 
follow-up (p =0.05, r=0.49). No 
differences in reflection to 
question ratio between the same 
periods. Improved percentage 
complex reflections (p =0.09, 
r=0.42).  
Positive relationship between 
the percent MI adherent 
responses and length of 

























Relevant Outcomes Quality  
6 Video Record 
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Not reported. Not reported. Not reported. Physicians were willingness to 
try MI with patients. Seven of 12 
physicians felt MI would fit into 
their practice or that they would 
have enough time to use the 
techniques.  
Two weeks after the workshop: 
11 of 12 physicians responded 
to a survey. Most of the 
physicians endorsed using MI 
skills. Two physicians were not 
comfortable to use MI and 1 
reported not having enough time 
to use it. 9 of 12 physicians who 
submitted VR after MI training 




















Relevant Outcomes Quality  
7 Intervention 




























120 adult (61 
men and 59 
women) PP  
Not reported. Not reported. 
 


















Relevant Outcomes Quality  
8 Intervention: 
Training of 






























Fidelity analysed with MITI 3.0. 
Counsellors failed to achieve 
proficiency in MI. 
3 
Notations: AC-Ambulatory Clinic; CP-Clinician Participants; FL- First Languages; HPP- Health Promotion Program; HHS- HIV Healthcare Services; HIV+=HIV 
positive; HW- Health Workers; IDP-Infectious Diseases Physicians; IG-Intervention Group; LAC-Lay HIV Adherence Counsellors; LL-Local languages; n-
Number; NAP-Non-ART Adherent Patients; NGO- Non-Governmental Agencies; NIMR- Nigerian Institute of Medical Research; Options (an evidence-based 
intervention based on MI); PA-Patient Active; PI-Patient Inactive; PP-Patient Participants; PRA-Provider Active; RC-Routine Consultation; RRB-Risk Reduction 
Behaviours; SOC-Standard of Care; SSK- Safer Sex Knowledge; Study 1- Holstad et al. (2012); Study 2- Evangeli et al. (2009); Study 3- Maneesriwongul, 
Prajanket, and Saengcharnchai (2012); Study 4-Dewing et al. (2015); Study 5- Evangeli, Longley and Swartz (2011); Study 6-Bofill et al. (2015); Study 7- 




Ethnicities of Study Participants 
Although the study carried out by Maneesriwongul, Prajanket and Saengcharnchai (2012) 
involved only Thai patients, the studies carried out in Argentina did not report the ethnic 
characteristics of the study participants (Bofill et al., 2015; Jones et al., 2016). Conversely, the 
studies carried out in Nigeria reported recruiting patients from diverse ethnic groups. For 
instance, the study in Nigeria involved patients mainly from five ethnic groups: Hausa, Ibo, 
Yoruba, Efik and Ijaw (Holstad et al., 2012). However, the ethnicity of the health practitioners 
who participated in the study was not reported (Holstad et al., 2012). Similarly, the ethnicity of 
the study participants in the studies carried out in South Africa (Dewing et al., 2013; Dewing 
et al., 2015; Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011) was not reported. 
Hence, little is known about the ethnicity of the individuals who have been exposed to the MI 
approach in the existing studies.  
Languages of Study Participants  
Only the four studies which were carried out in South Africa reported the language 
characteristics of the health practitioners. For instance, Dewing et al. (2013) and Dewing et 
al. (2015) reported the first languages of the counsellors as Afrikaans or Xhosa, while Evangeli 
et al., (2009) also reported that counsellors in their study speak Xhosa, Afrikaans and English 
as first languages. Although Holstad et al. (2012) reported the ethnic groups of the patients in 
their study in Nigeria, it cannot be assumed that the individuals spoke the languages 
associated with their ethnic groups (Hausa, Ibo, Yoruba, Efik and Ijaw) because of inter-ethnic 
mobility and settlements in the country which could have led to the adoption of a different 
language by the individuals. Therefore, apart from the South African studies little attention was 
paid to the importance of the language characteristics of the individuals exposed to or using 
MI in the existing studies.  
Characteristics of the Study Patients 
Only three of the six studies were focused on patient outcomes and therefore presented 
patient characteristics. Adult HIV patients aged ≥18 were involved in these studies (Holstad 
et al., 2012; Jones et al., 2016; Maneesriwongul, Prajanket and Saengcharnchai, 2012). 
Moreover, in the study carried out in Nigeria, eligibility of the patient participants includes 
having been prescribed ART by the physicians and the ability to speak English (Holstad et al., 
2012). Although the eligibility for the Thai study includes patients who have been on ART for 
more than four weeks with <95% adherence to ART (Maneesriwongul, Prajanket and 




the patients. Meanwhile, eligibility of participants in the study carried out in Argentina includes 
being considered as non-adherent to first ART regimen or previously prescribed ART regimen 
(Jones et al., 2016). However, the study did not specify language restriction for eligibility of 
participants, rather the authors reported that they translated assessment materials into 
Spanish to enhance participation of the recruited participants. Although, the baseline level of 
adherence of patients was not assessed in the Nigerian study (Holstad et al., 2012), 
characteristics of the patient participants in this review indicate that MI has been tested with 
patients irrespective of their adherence level. Evidence from the reviewed studies also indicate 
that test of MI among patients who could not speak English is relatively limited. 
Study Settings 
While six studies were carried out in HIV care clinic contexts (Bofill et al., 2015; Dewing et al., 
2013; Dewing et al., 2015; Holstad et al., 2012; Jones et al., 2016; Maneesriwongul, Prajanket 
and Saengcharnchai, 2012), two studies were based on only data collected in MI trainings 
context and role plays among health practitioners (Evangeli et al., 2009; Evangeli, Longley 
and Swartz, 2011). However, only six studies involved the participation of health practitioners 
who work in the HIV clinical care context where the research was carried out (Bofill et al., 
2015; Dewing et al., 2013; Dewing et al., 2015; Evangeli et al., 2009; Evangeli, Longley and 
Swartz, 2011; Jones et al., 2016). Incidentally, these are only studies carried out in Argentina 
and South Africa but not in Nigeria and Thailand. This pattern of study practice suggests that 
only on few occasions were the existing knowledge about the applicability of MI in ART clinic 
contexts obtained with the involvement of health workers who support HIV patients in real life 
practice. 
Educational Characteristics of Health Practitioners  
Health practitioners who were trained to use MI in the reviewed studies ranged from individuals 
who had no professional qualification to those with high level of professional qualifications. 
For instance, the four studies carried out in South Africa involved training of lay adherence 
counsellors on how to carry out Options-which is an MI based ART adherence counselling 
approach. The lay adherence counsellors are individuals without any professional or 
paraprofessional certificate or degree education who carry out functions related to health care 
delivery (Evangeli et al., 2009; Dewing et al., 2013; Dewing et al., 2015). Contrary to the 
training of lay adherence counsellors in the South African studies, the four remaining studies 
involved health practitioners with relatively higher educational qualification. For example, the 
study carried out by Holstad et al. (2012) in Nigeria involved training of health practitioners 




Thai study were nurses (Maneesriwongul, Prajanket, and Saengcharnchai, 2012), while the 
studies carried out in Argentina involved infectious diseases physicians (Bofill et al., 2015; 
Jones et al., 2016).  
Languages used in the MI sessions 
In the Thai and Argentine studies, the language used to conduct the MI sessions were not 
reported (Bofill et al., 2015; Jones et al., 2016; Maneesriwongul, Prajanket, and 
Saengcharnchai, 2012). However, in the Nigerian study, English was the language in which 
the MI sessions were carried out (Holstad et al., 2012). While only some of the sessions 
analysed in the four South African studies were carried out in English language, other sessions 
were carried out in Xhosa or Afrikaans language (Dewing et al., 2013; Dewing et al., 2015; 
Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011). This pattern of MI practice in 
existing studies shows that MI has been carried out in local languages as well as in English in 
developing countries. 
4.3.2 Application and Adaptation of MI  
MI was applied in the reviewed studies in different formats. The formats mainly involved face-
to-face sessions, but some of the sessions of the MI based interventions in the study carried 
out by Maneesriwongul, Prajanket, and Saengcharnchai (2012) were also carried out through 
the telephone to complement the physical sessions. While MI based intervention was 
delivered in group sessions in one of the studies (Holstad et al., 2012), the interventions was 
delivered in one-to-one basis between the trained health practitioners and patients in all the 
other studies except two (Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011) where 
the sessions were carried out in role-plays between counsellors during MI training. Irrespective 
of whether the session was conducted in individual or group format, duration of the MI 
sessions carried out in the reviewed studies ranged between 10 to 120 minutes. 
MI was also utilised in different roles in all the studies. In two of the studies, MI was the 
counselling approach adopted for the delivery of all the components of the ART adherence 
intervention projects such as the Options (Dewing et al., 2013; Dewing et al., 2015), Keeping 
Healthy and Active with Risk Reduction and Medication Adherence (KHARMA) project 
(Holstad et al., 2012), and the MI along with counselling intervention carried out by 
Maneesriwongul, Prajanket, and Saengcharnchai (2012). In the two Argentine studies, MI was 
the consultation approach used by the physicians for the HIV treatment sessions (Bofill et al., 
2015; Jones et al., 2016). Meanwhile, in the last two studies, the MI counselling approach was 




irrespective of how MI was applied in each of the studies, the common factor is the need for 
health providers to develop MI skills. 
Outcomes 
Outcomes measured in the reviewed studies differ depending on the objective of each study. 
However, the outcome data extracted from the studies were the ones that were considered 
relevant to the objectives of this review irrespective of how many other outcome data that were 
reported in each study. Measured outcomes extracted from the reviewed studies include: 
feasibility and acceptability of the study interventions or the MI approach; fidelity of health 
practitioners to the MI; and impact of the MI training on the treatment consultation. 
4.3.3 Acceptability and Feasibility of the Intervention in Studies 
Acceptability of MI was assessed in only two of the reviewed studies (Bofill et al., 2015; Holstad 
et al., 2012). In this regard the authors of the Nigerian study assessed the satisfaction of the 
HIV patients about the group sessions in respect of certain factors termed “MI related 
indicators” (Holstad et al., 2012). The MI indicators examined by the authors include: whether 
patients talked more than the health practitioners; whether the patients felt listened to; and 
whether the patients felt understood (Holstad et al., 2012). The authors reported that they 
evaluated each of these indicators with each of the patient participants after each of the eight 
group sessions of the KHARMA project. Based on these indicators, the authors reported that 
there was no significant difference between the MI and control group in how well the sessions 
were liked, although six of the MI sessions were consistently scored higher by the patients in 
three MI-related indicators when compared to the control. However, it was also reported that 
sessions two of the MI group sessions were scored lower by the patients in respect of the MI 
related indicators compared to the control group (Holstad et al., 2012).  
Contrary to the Nigerian study, the Argentine study reported both feasibility and acceptability 
of MI among the physicians. The study revealed that immediately after the MI training all 
participating physicians were willing to use MI with their difficult patients and they found the 
MI techniques appropriate for understanding how to guide their difficult patients instead of 
imposing decisions on them (Bofill et al., 2015). Over half of the 12 participating physicians in 
the study also reported that they would have enough time to use the MI techniques during 
their regular clinic time schedule. After each of the physicians had practiced the MI approach 
with one difficult patient apiece, most of the physicians (nine out of 11) who responded 
reported feeling comfortable to use MI skills with their difficult patients and perceived having 
enough time to use the during their regular consultation session. However, two of the 




skills, while one of them reported not having enough time to use the approach during routine 
consultations. Evidence available in this review based on these data therefore revealed that 
while MI may be acceptable for use among some physicians, it may not be acceptable to 
others, while available time for regular clinical consultation sessions appears to be a significant 
predictor of its acceptability. In addition, evidence within this study also revealed that MI 
intervention may not always be more acceptable to patients, yet one needs to be cautious with 
this finding from the study carried out by Holstad et al. (2012) because its validity and reliability 
could not be ascertained. Overall, findings from these two studies indicate that current 
knowledge about the feasibility and acceptability of the use of MI for routine consultation in 
ART clinical context in developing countries is very limited and it is not yet conclusive. 
4.3.4 Fidelity of the Health Practitioners to MI 
Fidelity of the health practitioners to the techniques and spirit of MI was not assessed in four 
of the studies (Bofill et al., 2015; Holstad et al., 2012; Jones et al., 2016; Maneesriwongul, 
Prajanket, and Saengcharnchai, 2012), but in the four remaining studies which were all carried 
out in South Africa fidelity of health practitioners to MI was assessed by using the MITI coding 
system (Dewing et al., 2013; Dewing et al., 2015; Evangeli et al., 2009; Evangeli, Longley and 
Swartz, 2011). Therefore, it could not be ascertained whether MI was delivered with optimum 
quality in the studies carried out in Argentina, Thailand and Nigeria. 
Assessment of MI fidelity in the four studies revealed different but comparable levels of 
competencies among the health practitioners. In one of the four studies carried out by Dewing 
et al. (2013), health practitioners had challenges at achieving the basic level of MI 
competency. This conclusion could be reached based on the following data. Against 
recommended global ratings with basic competency score of 3.5 average and proficiency 
score of 4.0 average, mean score for MI spirit in this study was 2.6 (SD=0.8; range: 1.3-4.0). 
Despite the low average MI spirit score among the health practitioners, the health practitioners 
achieved maximum score of five for Direction which is a dimension of the global spirit (SD=0.0; 
range: 5.0-5.0). Overall, only nine of the 35 counsellors with audiotaped records in the study 
achieved basic competency for MI spirit with one among the nine counsellors achieving 
proficiency. Similarly, for MI behaviour counts in respect of recommended basic competency 
(BC) and proficiency (P) scores for percent complex reflections (BC ≥40% and P ≥50%), 
percent open-questions (BC ≥50% and P ≥70%), percent MI consistency (BC ≥90% and P 
≥98%) and reflection-to-question ratio (BC ≥1.0 and P ≥2.0) the health practitioners in the 
study also had challenges. For instance, only two and six of the counsellors achieved basic 
competencies for reflection-to-question ratio and percent MI consistency respectively. 




behaviours achieved proficiency in MI consistency, they constitute only 17% of the total 
population of counsellors.  
Similar pattern of MI fidelity challenge was reported in the study carried out by Evangeli et al. 
(2009). In their study, only a small proportion of the counsellors reached the level of MI basic 
competency in respect of percent MI consistency (three out of 14 counsellors who completed 
the post-test training assessment) compared with only one who achieved the basic 
competency at the pre-training assessment. A similar but not significant improvement was 
also reported in respect of the global spirit in which three of the counsellors achieved basic 
competency at the pre-training assessment compared to four in post-test assessment. While 
no counsellor achieved basic competency in reflections-to-questions ratio and percent 
complex reflections throughout the study, nine counsellors achieved basic competency in the 
post-training assessment compared to six in pre-training assessment for percent open-
questions. Therefore, statistically significant change in the skills level of the counsellors only 
occurred in respect of percent reflection-to-question ratio and percent MI consistency 
(p=0.011 and p=0.026 respectively). Moreover, in respect of the interaction of language with 
the MI skills of the lay counsellors, the authors noted that counsellors who conducted some 
or all counselling sessions in English showed a significantly higher percentage of complex 
reflections than those who did not (p=0.025).  
After 12 months without any supervision or further training, a follow-up assessment of the MI 
skills of eight out of the same cohort of lay adherence counsellors in the study carried out by 
Evangeli et al. (2009) revealed few improvements in the number of counsellors achieving 
basic competency in MI indices compared to the post-training assessment in the primary study 
(Evangeli, Longley and Swartz, 2011). For instance, three of the counsellors in the follow-up 
assessment achieved basic competency in MI spirit compared to two in the primary study. In 
respect of reflection-to-question ratio one of the follow-up counsellors also achieved basic 
competency even though none of them achieved similar competency in the primary study. 
Five of the follow-up counsellors also achieved basic competency in respect of percent open-
questions although only four of the six counsellors who achieved similar skill level in the 
primary study participated in the follow-up phase. For percent complex reflections only one of 
the follow-up counsellors achieved basic competency even though none of them achieved the 
competency in the primary study. Lastly, two of the follow-up counsellors also achieved basic 
competency in respect of MI consistency, although the two counsellors also achieved the 
same skill level in the primary study. Therefore, there were improvements in the number of 
counsellors achieving basic competency level in MI among without further training or 




also found a significant and positive association between the percent MI consistent responses 
at the follow-up stage of the study and the length of counselling experience of the lay 
adherence counsellors (p=0.03).  
Furthermore, Dewing et al. (2015) did not report if the intervention counsellors achieved basic 
level of MI competency in their study, they only reported significant differences between MI 
and the usual counselling group in respect of the MI global ratings and behaviour counts 
associated with the audiotaped sessions that they analysed for both study groups. The authors 
reported statistically significant difference between the two groups on all global spirit 
dimensions in favour of the MI group (Evocation [p=0.0004]; Collaboration [p=0.0005]; 
Autonomy support [p=0.0231] and Empathy [p=0.0064]) except for Direction [p=0.1289]. In 
respect of behaviour counts, MI intervention counsellors also delivered significantly more MI 
consistent statements and simple reflections than the control group counsellors (p=0.0002 
and p=0.0001 respectively). However, there was no significant difference in the behaviour of 
the two study groups in respect of the open-ended questions, close-ended questions and 
complex reflections. Based on these data, the authors summarised that the practice of the 
intervention counsellors was more consistent with a client-centred approach than the control 
counsellors. Although Bofill et al. (2015) did not assess fidelity of the health practitioners to MI 
they found similar impact of the MI training on the practice of the physicians by reporting that 
compared to pre-training level, scores for standard of care for the physicians significantly 
increased at post-training stage in respect of education, follow-up support and systematic 
planning. 
One can therefore infer that these bodies of evidence suggest that while the health 
practitioners in the South African studies struggled to achieve fidelity to MI, they were still able 
to practice the approach within their multilingual and cultural contexts to certain degree of 
competence. Meanwhile such conclusion could not be made yet for other developing settings 
including Nigeria. 
4.4 Discussion of the Review Findings 
The objectives of this review are to explore existing literature for knowledge about how MI has 
been adapted for use in different settings in the developing countries and the impact of 
languages, culture and context on its application in such countries, with a view to understand 
how to apply it in Nigeria. Data generated from the eight reviewed studies in this chapter 
revealed the following: MI can be applied or adapted for application in different formats; 
participation of health workers involved in the routine care for HIV patients is limited; 




adherence; limited time for routine clinical session may be a significant barrier; MI may not be 
feasible or acceptable to all; and importance of language for the implementation of MI in 
developing countries. Each of these findings and how they may influence the routine 
implementation of MI in Nigerian context are discussed further in the next few sections.  
4.4.1 Adaptation and Application of MI across Settings 
MI was applied in the reviewed studies in different formats. These include: face-to-face or 
telephone sessions; and one-to-one individualised sessions or group session format. This 
demonstrates that MI can be tailored to meet the needs of HIV patients irrespective of whether 
they could visit the HIV clinic or not for their medication adherence counselling. The group 
format also showed that the needs of patients who may prefer to learn more and be supported 
in group format rather than in individualised sessions can also be met. Although evidence of 
the potential use of the group format for MI could increase the population reach in respect of 
ART adherence promotion, it still falls within the clinical intervention and counselling/education 
tiers at the top of the five-step health impact pyramid which requires more of individual effort 
(Frieden, 2010). This is however, not a limitation of the MI approach as argued by Frieden 
(2010), “interventions at the top tiers of the health impact pyramid are designed to help 
individuals rather than the entire populations, but they could theoretically have a larger 
population impact if universally and effectively applied”. Hence, irrespective of the form in 
which MI is applied, whenever it is considered useful in a setting, the main aim should be how 
to ensure that it is universally and effectively applied. 
MI has been used in different roles such as being the consultation approach in ART treatment 
consultation session, as the main counselling session in multicomponent ART adherence 
intervention programs, as the counselling approach adopted for the delivery of all the 
components of ART adherence intervention, or as the intervention for ART adherence 
promotion itself. The versatility of the MI as evidenced in the reviewed studies is an indication 
of the increasing interest of experts in the client-centred approach of MI. Although, MI drew 
some influence from client-centred psychotherapeutic approaches promoted by Thomas 
Gordon, and Truax and Carkhuff, it is however mostly influenced by the client-centred 
psychotherapeutic approach promoted by Carl Rogers (Moyers, 2004). Despite the 
association between MI and the approach promoted by Carl Rogers, the two approaches differ 
due to the focus on direction in MI. It is therefore, not surprising that Dewing et al. (2015) 
reported that training in MI helped lay adherence counsellors to be more client-centred in their 
practice than those trained only in the Egan’s Skilled Helper Model, which is the client-centred 
model in which HIV lay adherence counsellors in the public sector in South Africa are trained 




Lastly, MI has been applied in the reviewed studies with HIV patients irrespective of whether 
they are adherent to the ART or not. However, feasibility of using it with this spectrum of 
patients based on their adherence status is still limited since only one of the reviewed studies 
explored the appropriateness of the approach with non-adherent patients.  
4.4.2 Participation of Regular Health Workers in Studies 
As Moyers (2014) argued, due to the focus on harnessing the underlying motivation of 
individuals for change, MI is sometimes the only intervention needed, as people who resolve 
ambivalence often move forward to make staggeringly complex changes without any further 
assistance. However, without being empowered with MI training to use it, clinicians who 
support HIV patients in regular practice may not have the necessary skills to counsel their 
patients. These clinicians could be motivated to use the skills they learn from research studies 
in real-life practice if they believe it could be helpful in their line of work, when their standard 
practice fails. This was demonstrated by Evangeli, Longley and Swartz (2011) who did not 
only report that there were no reductions in the MI skills level they observed among a sub-set 
of their primary study population a year after the initial training, but also found some 
improvement in the skills level of the counsellors. Based on this observation, the authors 
concluded that the lay adherence counsellors who remained in the service of their non-
governmental organisations might have been more motivated to practise and maintain their 
MI skills without any booster training or supervision (Evangeli, Longley and Swartz, 2011). 
Meanwhile, out of the studies reviewed in this chapter, only the South African and Argentine 
studies involved training of the health providers who worked in the HIV clinical care context 
where the research was carried out (Bofill et al., 2015; Dewing et al., 2013; Dewing et al., 
2015; Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011; Jones et al., 2016). This 
pattern of research approach to test MI in developing countries contexts may not be entirely 
helpful in respect of its dissemination, since most of its achievements remain hidden in the 
research write-ups, rather than being translated into real-life practice.  
4.4.3 Health Practitioners Can Practise MI Irrespective of Qualification 
According to the report of the evidence scan carried out by The Health Foundation (2011, 
p.21) various groups of individuals such as emergency workers, health educators, nurses, 
psychologist, psychiatrists, counsellors and general practitioners have been trained to carry 
out MI in different studies in different contexts. Although one of the reviewed studies (Evangeli 
et al., 2009) found a significant association between length of experience and fidelity to MI, 
such evidence is limited as it cannot be generalised to other contexts. Apart from being the 




finding from the study by Evangeli et al. (2009) is partly because the participants were all 
female lay adherence counsellors. Hence, once cannot assume that skills pattern observed 
among the female health practitioners will predict similar skills pattern among male health 
practitioners.  
However, overall evidence in this review suggests that whether the counsellors have no 
professional qualification or have professional qualifications in counselling, they can be trained 
to use MI for their line of work. This finding is consistent with findings reported by Naar-King 
et al. (2009), who carried out a randomised clinical trial using MI to improve retention of youth 
living with HIV in primary care and compared the fidelity and outcome of peer outreach workers 
to master’s level staff. They found that peer outreach workers can provide MI quality 
comparable to master’s level staff if they have adequate training and supervision. This 
enhances the feasibility and cost-effectiveness of using MI in real-life practice for ART 
adherence counselling, especially in resource-limited settings where clinical staff strength may 
be limited in respect of the availability of professional health workers. 
4.4.4 Influence of Time on the use of MI for ART adherence 
Evidence from some previous qualitative studies have consistently reported time as a potential 
barrier to the feasibility of using MI in routine practice (Sargeant et al., 2008; Shannon, 
Donovan-Hall and Bruton, 2017; Soderlund and Nilsen, 2009). Unfortunately, these previous 
studies were not focused on ART adherence but on other health challenges. In this current 
review, only one study provided evidence that is consistent with the finding in previous studies 
where one of the physicians reported not having enough time to practise the approach in 
routine consultation session (Bofill et al., 2015). However, because this evidence was obtained 
from one out of 12 physicians from one out of the eight reviewed studies knowledge about the 
influence of time on the practice of MI in routine practice in developing settings is still limited.  
It could be argued that the finding from the single participant in the Argentine study (Bofill et 
al., 2015) is consistent with the finding from a case study that tested the feasibility of using MI 
in routine clinical practice at an ART clinic in South Africa (Dewing et al., 2011). In the South 
African study time was cited as a potential barrier to use of MI by a lay adherence counsellor. 
However, the study was designed to address sexual risks and not ART adherence. While it 
could be assumed that similar contextual challenge due to time may be encountered if the MI 
approach is used for ART adherence support in the same clinic, this evidence is limited as it 
was obtained from one clinician and cannot be generalised to every context.  
Besides the constraint of effect of time, evidence from one of the reviewed studies has shown 




Swartz, 2011). However, this this evidence is also limited because it was not obtained in real-
life practice between counsellors and patients, but in role-plays between trained counsellors.  
Lastly, within the limit of the data available in this review, irrespective of whether the sessions 
were conducted in individual or group session format, duration of the MI sessions carried out 
in the studies ranged between 10 to 120 minutes. This evidence is also limited as none of the 
authors specifically explored the influence of time spent on each session on the application of 
the MI approach. Based on these evidence, further empirical studies are still needed to either 
buttress the findings about the influence of time on MI approach in this review or discount it, 
to further understand how to implement MI in real-life practice in developing countries.  
4.4.5 Knowledge about the Feasibility and Acceptability of MI 
Within the limit of the available evidence in this review, little is known yet about how feasible 
and acceptable the MI approach will be in the context of developing countries. For instance, 
acceptability of the MI approach was assessed in only two studies in this review (Bofill et al., 
2015; Holstad et al., 2012). Evidence from the reviewed studies has demonstrated that MI 
may not be universally accepted among patients or among the health practitioners in 
developing contexts. However, it was not clear if the views of the patients in this review from 
the Nigerian study (Holstad et al., 2012) could have been influenced because they 
experienced a poor-quality MI delivered by the health practitioners. This is because there was 
no report of the assessment of the fidelity of the health practitioners to MI in the study (Holstad 
et al., 2012).  
Meanwhile, findings from the Nigerian study (Holstad et al., 2012) appear to be consistent with 
findings from previous studies which suggests that patients from an African background may 
prefer a more directive approach than MI (Miller, Marolen and Beech, 2010; Swenson et al., 
2004). For instance, the study by Miller, Marolen and Beech (2010) explored the perception 
of diabetic African-American women about MI consultation and non-MI consultation style. In 
the study, two MI training videos depicting a simulated patient–physician consultation without 
the application of MI principles and one demonstrating MI principles (MI consultation) were 
presented to the women. As reported by the authors one of the patients questioned why the 
doctor was asking the patient about his decision instead of him [provider] telling the patient 
what to do, while another patient questioned why the doctor was not giving the patient much 
information when he is supposed to know more than the patient (Miller, Marolen and Beech, 
2010). Similarly, another study by Allicock et al. (2017) in which female African-American HIV 
patients were trained as peer counsellors revealed that the peer counsellors found the MI 




communication pattern promoted by MI may seem strange whenever patients from African 
background are first exposed to it and may not be readily acceptable to them. However, this 
assumption should not be deemed conclusive based on the evidence emanating from the 
Nigerian study (Holstad et al., 2012) because its validity and reliability could not be 
ascertained. 
Moreover, apart from the evidence emerging from the African context in respect of the views 
of patients, acceptability and feasibility of MI was not also universal among the physicians in 
the Argentine study (Bofill et al., 2015). Although the majority of the physicians found MI useful 
for their practice, the study only focused on using the MI approach with difficult non-adherent 
patients. It is however, not clear what qualifies a patient to be tagged as difficult. Besides the 
term “difficult” contravening the non-judgemental concept of MI, evidence from the study could 
not also represent the views of the participating physicians if they had practised the MI 
approach with more pliable non-adherent HIV patients. Therefore, this finding from the study 
cannot be generalised to other contexts as well as to other HIV patients. Based on the 
evidence available in this review, little is currently known about the feasibility and acceptability 
of MI for routine clinical practice for ART adherence support in developing settings.  
4.4.6 Language and Use of MI in Developing Countries 
While the language in which the MI sessions were carried out in the Thai study 
(Maneesriwongul, Prajanket, and Saengcharnchai, 2012) and the Argentine studies (Bofill et 
al., 2015; Jones et al., 2016) were not reported, English was the language in which all the 
sessions in the study carried out in Nigeria were conducted (Holstad et al., 2012). This is 
despite the existence of over 450 languages in Nigeria (Ayeomoni, 2012; Pinon and Haydon, 
2010). Although English is used for official and national functions in Nigeria, three indigenous 
languages (Hausa, Igbo and Yoruba) are also used for major official functions to conduct 
businesses, law and education (Akinnaso, 1991; Ayeomoni, 2012; Igboanusi, 2008; Federal 
Republic of Nigeria, 1999). It is therefore surprising that the study that tested use of MI for 
ART adherence in a highly multilingual country like Nigeria involved recruitment of only women 
who could speak English (Holstad et al., 2012). Testing the potential of MI for ART adherence 
in such a multilingual society like Nigeria in only English therefore leaves a lot to learn about 
the feasibility of implementing the approach in real-life clinical context.  
Contrary to the practice in the Nigerian study for ART adherence, English was used only for 
some of the sessions in the South African studies, while the other sessions were carried out 
in local languages such as Xhosa and Afrikaans (Dewing et al., 2013; Dewing et al., 2015; 




(Deumert, 2010). Based on this evidence, there is currently no evidence to support the 
reluctance of some researchers to use MI in other languages except English in multilingual 
communities. 
Moreover, use of MI in only English to promote ART adherence in contexts where the patients 
may not be adequately skilled to use English or where their social setting is not entirely 
structured in English, may not be helpful to the patients. The systematic review carried out by 
Mills et al. (2006a) revealed that “not understanding treatment instruction” was a significant 
patient-related barrier to ART adherence in both developed and developing nations. This lack 
of understanding can be associated with lack of or inadequate education, which can also mean 
difficulty to understand instructions provided in English. Although, Field and Caentano (2010), 
suggested the need for an ethnic match between patient and health practitioner to enhance 
the effectiveness of an MI-based intervention, this may not be feasible in resource-limited 
settings. Hence, there is a need to understand how to use MI with the patients in their 
languages which can also be practised by the available staff mix irrespective of the staff 
strength in their clinic context. 
In respect of fidelity to MI, evidence from this review revealed that the health practitioners in 
the South African studies found it difficult to achieve fidelity to MI (Dewing et al., 2013; Evangeli 
et al., 2009; Evangeli, Longley and Swartz, 2011). Despite this finding, one cannot safely 
assume based on this finding that the counsellors struggled with the use of MI because they 
are Africans, because previous studies in other contexts have established that MI is complex 
to learn and will take more than a single training workshop to learn (Bohman et al., 2012; Eno, 
2016; Moyers et al., 2007; Mullin et al., 2015; Ostlund et al., 2015; Shannon, Donovan-Hall 
and Burton, 2017). However, evidence from the study by Evangeli et al. (2009) revealed that 
lay adherence counsellors who conducted some or all counselling sessions in English showed 
a higher percentage of complex reflections than those who did not. The finding suggests that 
hybrid of languages could have been used in some of the sessions, while some sessions 
might have been carried out entirely with just one language. This is an indication of how health 
practitioners and patients may adapt use of languages to ensure effective communication in 
a multilingual clinical setting when practising MI. Even though this finding from the study by 
Evangeli et al. (2009) cannot be generalised, use of the hybrid of languages or entire use of 
local languages in this study seem to significantly inhibit the ability of the counsellors to 
achieve optimum fidelity to MI in respect of percent complex reflection. Unfortunately, this 
review could not obtain further evidence to corroborate this finding. Ironically, while several 
attempts have been made by experts to support the use of MI in other languages apart from 




(Brueck et al., 2009; Forsberg et al., 2008; Koken et al., 2012). Hence, little is known about 
the impact of the use of local languages on the fidelity of health practitioners to MI in HIV 
treatment context in multilingual settings. 
Meanwhile, limiting the use of MI to sessions between English speaking clinicians and patients 
may further prevent learning about fidelity in the local languages in developing countries. For 
instance, a recent study carried out to promote uptake of glaucoma surgery in Nigeria, which 
was designed to be carried out in English or Hausa languages was also designed to assess 
the fidelity of counsellors to MI only within the English sessions (Abdull et al., 2017). 
Surprisingly, all the MI sessions in the study were carried out in Pidgin or Hausa languages, 
which according to the authors prevented them from assessing the fidelity of counsellors to 
MI in all their study sessions (Abdull et al., 2017). This study design therefore, led to a missed 
opportunity to understand how to use MI in the local languages with fidelity or not. Hence, little 
is known about how to use MI in multilingual contexts in developing countries where languages 
may not only differ from English but can also be mixed within sessions without affecting the 
fidelity of the health practitioner.  
Finally, Evangeli et al. (2009) stated that an important determinant of the outcome in their 
study relates to the cultural communication style, because MI was developed within the 
Western communication context. Dewing et al. (2013) also stated that it is important to 
acknowledge that the counsellors and probably most of the South African patients in their 
study did not speak English as their first language. They further argued that since counselling 
is a product of Western cultures, some concepts of counselling may not exist in the language 
of the health practitioner in non-Western settings which may also be completely foreign to the 
culture that the health practitioner inhabits. Based on these arguments, to use MI in contexts 
with different languages apart from English or settings where the communication style differs 
from the cultures in developed countries, we need to know how to adapt the MI approach for 
use in such settings without affecting the fidelity of the health practitioners to the approach.  
4.4.7 Relevance of the Review Findings to Nigerian Context  
Existing evidence from this review has revealed that little is currently known about the 
feasibility and acceptability of using MI for routine consultation sessions for ART adherence 
in developing countries which includes Nigeria. Neither do we have sufficient knowledge about 
the influence of contextual factors such as time and length of counselling experience as well 
as cultural factors such as languages and communication patterns in multilingual settings on 
the practice of MI. However, the findings from the review have also reinforced existing 




developing countries to promote ART adherence irrespective of their professional 
qualification. 
Nigeria is not just highly burdened with HIV/AIDS prevalence and high rate of non-adherence 
to ART among the PLHIV, but the country is also a developing country that is shackled with 
limited resources (The World Bank, 2018a). Hence, as a resource-limited country the HIV 
clinics may be ill equipped to implement complex adherence interventions (Simoni et al., 
2010). Therefore, it may be prudent to consider a seamless integration of MI which has been 
shown to be the consistent element of some complex interventions in this review into the 
existing clinical care set up in Nigeria to support ART adherence. This is also consistent with 
the recommendation of Simoni et al. (2010) who suggested that even though independent 
strategies presented in their review were not clearly established or demonstrated as 
independent active ingredients, they may nonetheless offer approaches that might be 
cautiously considered for incorporation in clinical care. Although evidence from this present 
review differs in that MI was demonstrated as an active ingredient that can be independent 
and can easily be integrated to complement existing strategies in the HIV clinic. Based on 
these features, MI can be integrated into the limited-resource settings of the HIV clinic in 
Nigeria to empower the health providers to support their patients’ adherence to treatment. 
Findings from the network meta-analysis carried out by Mills et al. (2014) also support this 
view that instead of implementing a whole new complex structure to support ART adherence, 
an effective approach in Africa may be just to support existing standard care approach with 
intensive adherence counselling. However, as elicited in chapter two (page 38-39) not enough 
is known about the current approach to ART adherence counselling or consultation in Nigeria. 
One cannot assume that MI should be used to complement an existing approach that only 
little is currently known about, because the possibility of its ineffectiveness could inhibit the 
potentials of MI as well. Hence, as emphasised by Simoni et al. (2010) efforts need to be 
made to ensure that the efficacy of an evidence-based approach like MI is not compromised 
by being used in the local clinical context. 
Overall, within the limit of the studies reviewed in this chapter, little is known about how MI 
can be adapted into a highly multilingual society like Nigeria where clinical consultations may 
involve use of pure or hybrid forms of languages as had been revealed in this review, without 
compromising its efficacy and affecting its application by clinicians. It is also not known how 
feasible and acceptable the approach will be in the clinical context that the existing approach 
to ART adherence counselling inhabits. Therefore, application of MI to support ART 
adherence in the Nigerian context will require more knowledge than currently available in 




4.5 Chapter Summary 
This chapter has presented the description and history of MI. It has also presented evidence 
supporting its effectiveness at promoting ART adherence. It has also established that despite 
the large amount of evidence supporting the usefulness of the approach, little is currently 
known about how to use it in real-life practice, especially in Nigeria. This chapter has therefore 
presented a review of literature to examine the impact of the culture and context on the use of 
MI and how it has been adapted for use in developing countries to inform how to use the 
approach to promote ART adherence in Nigeria. Evidence from this review has shown that 
more needs to be known about the applicability of MI in Nigeria with a focus on how to adapt 
it for practice in the HIV clinical context in the country for ART treatment support.  
Finally, this chapter has also contributed to the research question by identifying the need to 
establish the transferability of MI to a Nigerian context. It is vital to ascertain whether following 
MI training health practitioners practice the approach with fidelity in the same context and 
culture within which they practise their existing adherence counselling approach. This also 
brings to the fore the importance of establishing and understanding the potential impact of the 
cultural and contextual factors that may inhibit or influence its adoption in routine practice for 






CHAPTER FIVE: METHODOLOGY AND RESEARCH DESIGN 
5.0 Chapter Overview 
This chapter discusses the justification for the philosophical and theoretical perspective that 
underpin this study. It also presents the conceptual framework for the study and the 
anticipated relationship between the concepts and variables. The chapter discusses the 
research methodology adopted for this study. The chapter also outlines the research design 
and the methods used in the study, which includes the strategies adopted for the selection of 
participants, ethical considerations for the study and how they were addressed, the study 
regimen, the data collection procedures and the methods used for the data analyses.  
5.1 Justification for Theoretical and Philosophical Stance 
The aim of this study is to explore the feasibility of using Motivational Interviewing (MI) to 
promote behaviour change for HIV treatment adherence in the clinical setting in Nigeria. As it 
has been clearly highlighted in chapter four, there may not only be a need to consider 
contextual adaptation but also cultural adaptation of the MI approach before implementing the 
approach in the HIV clinical settings in Nigeria without compromising its effectiveness. This 
finding from the literature review is plausible because cultural adaptations are useful when 
considering the need to apply evidence-based interventions to individuals who are not similar 
to those who participated in its primary development (Barrera and Castro, 2006). This study 
therefore draws on existing frameworks for cultural adaptation of evidence-based 
interventions (Bernal, Bonilla and Bellido, 1995; Barrera and Castro, 2006; Kumpfer et al., 
2008; Resnicow et al., 2000), because they do not only allow for assessment of the relevance 
or sensitivity of the intervention to the cultural elements but also contextual factors.   
As recommended by Kumpfer et al. (2008), once a suitable intervention has been selected to 
address the problem of a population, it should be tested in the new local context. They 
recommend that substantial cultural changes to the program should not be made until after 
several pilot tests. The first stage is to implement the program in its original form, except for 
minor changes such as its wording to match local culture and context. Then one should check 
to see what works well and not so well (Kumpfer et al., 2008). Since cultural adaptation is an 
ongoing process, it is the testing stage that is the focus of this study. Therefore, this study 
seeks to first implement MI in its original format with only language adaptation by encouraging 
clinicians to use it in their local languages and then to determine what works and not so well. 
Consistent with the prevailing practice in existing studies (Gwardz et al., 2015; Ingersoll et al., 
2011; Konkle-Parker et al., 2012; Yeagley et al., 2012), the feasibility of the MI approach in 




holds that there is an independent reality out there to be tested (Onwuegbezie, Johnson and 
Collins, 2009). However, uncertainty of the influence of cultural element such as the language 
and contextual factors on its practice in a country like Nigeria requires that the findings of the 
investigation should be understood in the context in which it is studied. Thus, this study adopts 
the critical realist ontological stance, which is concerned with the social and physical reality 
(Sarantakos, 2013, p.33).  
Critical realists believe that knowledge about this world is socially constructed (Denzin and 
Lincoln, 2011, p.11). They also believe that social phenomena are produced by mechanisms 
that are real which are not directly accessible to observation, but they are discernible only 
through their effects (Bryman, 2016, p.616; Sarantakos, 2013, p.33). Since the purpose of this 
study is partly to understand how the local languages or communications styles may affect 
the use of MI, such effects may not be directly discernible through mere observation of real-
life practice, but as the critical realists emphasised, by attempting to understand how these 
factors influence the behaviours of the counsellors when using MI. 
Beyond merely identifying the mechanisms that influenced the phenomenon of interest, critical 
realists also argue that we will only be able to understand and so change the social world if 
we identify the underlying mechanisms (Bryman, 2016, p.25). In fact, according to Bryman 
(2016, p.25) the prospect of transforming the status quo after identifying the generative 
mechanism is what makes critical realism critical. This argument fits into the purpose of this 
study which is to understand how languages and communication style as well as contextual 
factors may affect application of MI and to use that knowledge to culturally adapt it into the 
local context without compromising its effectiveness. 
Furthermore, critical realists believe that phenomena in the world are constructed by a society 
made up of human beings who think and have feelings, and as such, their interpretations of 
the world need to be considered, when trying to understand the phenomena they create 
(Denzin and Lincoln, 2011, p.11). This belief of the critical realists also fits with the objective 
of this study which seeks to explore and incorporate the perception of the participants into the 
body of knowledge to fully understand the feasibility of using MI in their local context.  
Lastly, critical realism favours the use of qualitative methods for the study of the social world 
by rejecting the positivistic rules and its standards of quantification, measurement and 
prediction (Sarantakos, 2013, p.33). However, it also rejects methodological individualism, as 
it rejects both objectivist and constructionist ontologies (Denzin and Lincoln, 2011, p.11; 
Sarantakos, 2013, p.33). As stated earlier, the purpose of this inquiry will not be satisfactorily 




explore the perception of participants to fully understand the phenomenon under study. 
Hence, both quantitative and qualitative methods are appropriate for use in this study. This is 
consistent with the view of Onwuegbezie, Johnson and Collins (2009) that the ontological, 
epistemological and axiological stance of critical theorists who largely endorse critical realism 
do not prevent the use of all quantitative and qualitative analysis techniques when appropriate. 
5.2 Conceptual Framework 
Figure 5.1: Conceptual Framework for the Study  
 
The conceptual framework (figure 5.1) for this study is primarily based on the theory that 
clinicians’ fidelity to techniques and spirit of MI predicts patients’ behavioural outcomes (i.e. 
ART adherence) (Koken et al. 2012). Hence, the conceptual framework presents the 
relationships between factors that could affect clinicians’ fidelity to MI and its acceptability in 
the HIV clinic as measures of its feasibility. The framework relies on the cultural adaptation 
framework for interventions as proposed by Bernal, Bonilla and Bellido (1995). The framework 
specified that eight cultural sensitivity elements and dimensions of interventions are worthy of 
consideration: Language; Metaphors; Persons; Content; Concepts; Goals; Methods and 
Context. This framework was selected because the specification of its dimensions aligns with 
the objectives of this study. For instance, the framework specified that language of the 
intervention which is a key carrier of the culture (Jiang, 2000; Modiano, 2001), should go 




Therefore, special effort needs to be made to ensure that the language of the intervention is 
relevant as a culturally sensitive intervention language increases its chances of being received 
as intended. This framework also suggests the need to consider how the metaphors 
(communication concepts and symbols) unique to the study population may affect 
engagement of the target group in the intervention. It is in respect of the language and 
metaphor dimensions that this study explores the use of MI in the major indigenous Nigerian 
languages, to tailor its use to the needs of all patients, including those with low literacy and 
inability to speak English.  
The person dimension of the framework also specifies the need to consider ethnic similarities 
between the clinician and the patient as a factor that may determine the therapeutic 
relationship for the intervention. Consideration of this dimension is important for this study as 
the target population is highly diverse in terms of language and culture and the achievement 
of a quality therapeutic partnership between the clinician and patient is one of the spirit of MI 
(partnership) which promotes patients’ engagement or disengagement (Miller and Rollnick, 
2013, p.15). 
The content dimension emphasises the need to consider cultural values, customs and 
traditions that are unique to a group as essential for treatment assessment and planning. This 
dimension is important to the purpose of this study because MI processes are susceptible to 
the influence of some cultural nuances. For instance, time orientation as a cultural factor may 
affect the co-creative planning process of MI, while cultural norms of politeness may also affect 
how and when clinicians proceed from one process of MI to another (Miller and Rollnick, 2013, 
p.350). Among the HIV patients in Nigeria, religious beliefs and activities as well as their high 
dependence on social support may also affect the engaging and planning processes of MI. 
The framework also specifies the need to consider how culturally sensitive the intervention 
concepts are, as well as how the goals of treatment are framed within the values, customs 
and tradition of the patients. It also specified the need to consider if the methods used to focus 
on the goal of the treatment and problem solving by the clinician is compatible to the culture 
of the patient. Consideration of these three dimensions align with the need to ascertain the 
feasibility of using the techniques and spirit of MI in the Nigerian. 
Lastly, the context dimension of the framework emphasises the importance of considering the 
social, economic and political context that may affect the relevance of the intervention to the 
target group. In Nigeria, factors such as non-availability of ART, stigma, inadequate health 
workers and other hospital system barriers could affect patients’ engagement in the MI 




engagement in the intervention procedures (Barrera and Castro, 2006), context factors may 
directly impact on the acceptability of MI. While all other dimensions may directly define the 
cultural sensitivity of each MI process, it is assumed that they may also determine its 
acceptability indirectly. This study will therefore assess the feasibility of using MI for ART 
adherence in Nigeria by considering the specified dimensions in this framework. 
5.3 Justification for Methodology  
As a study underpinned by critical realism, this project utilizes neither deductive nor inductive 
research strategies but retroductive reasoning (Bryman, 2016, p.25). The aim of retroductive 
research strategy is to discover underlying mechanisms that in some contexts explain 
observed regularities (Blaikie, 2010, p.87). However, apart from discovering the underlying 
mechanisms and their relevance, retroduction also emphasises the need to establish the 
features of the context in terms of the ways in which it facilitates or inhibits the operation of 
the identified mechanism(s) (Blaikie, 2010, p.87). Meanwhile, the logic of retroductive 
reasoning refers to the process of building hypothetical models of structures and mechanisms 
that are assumed to produce empirical phenomenon (Blaikie, 2010, p.87). Based on this logic, 
outcome of a retroductive based study is expected to result in making inferences about the 
causal mechanism(s) that lie behind and is responsible for regularities that are observed 
(Bryman, 2016, p.25). The central assumption in this study is that the feasibility of using MI in 
the clinical setting for HIV adherence counselling could be determined by considering the 
fidelity of counsellors to the approach and the acceptability of the approach by the study 
subjects. Hence, it can be assumed that the empirical phenomenon is the feasibility, while the 
regularities of focus are the fidelity to MI and its acceptability in the study context.  
Although, retroduction involves working back from the data, the central problem of a 
retroductive research is how to discover the structures and mechanisms that are proposed to 
explain the observed regularities (Blaikie, 2010, p.87). However, current level of knowledge 
has neither established the status of the target regularities, nor do we have sufficient 
knowledge about the context within which MI will be practised in Nigeria. In this regard, as 
presented in figure 5.2, the focus of this study goes beyond assessing the fidelity and 
acceptability to determine the feasibility of using MI, but also to determine the underlying 
mechanisms responsible for these regularities when observed within the context available for 





Figure 5.2: Retroductive Research Model for the Study 
 
Adapted from: Blaikie (2010, p.88) 
Fidelity of clinicians to the techniques and spirit of MI can be determined after empowering 
them with the MI skills through MI training (Allicock et al., 2017; Dewing et al., 2013; Evangeli 
et al., 2009; Miller and Mount, 2001; Moyers et al., 2007). Meanwhile, assessment of 
clinician’s fidelity to MI requires rating (assigning numerical data) of their performance from an 
observation record against standard indices, depending on the coding system that is used [i.e. 
MISC; MITI or OnePass] (McMaster and Resnicow, 2015; Miller et al., 2008; Miller and 
Rollnick, 2013, p.387-402; Moyers, Manuel and Ernst, 2014). This is consistent with the 
recommendation of Oh and Lee (2016) that observation of clinical encounters can be 
informative and can provide a different perspective when compared with the information 
obtainable from focus groups. They made this recommendation based on the argument that 
clinical interactions have the capacity to activate the core ingredients of MI and that the extent 
to which cultural congruence is achieved between the provider and client can determine the 
therapeutic alliance. The process for evaluating the MI fidelity therefore lends itself to 
observation as the data collection method, but also in a structured manner with the view of 
generating quantitative data. As pointed out by Gray (2014, p.422) “structured observation 
aims to observe and record behaviour in a holistic and systematic way, usually by making use 
of an observation guide or coding schedule”. The numerical data generated from this process 
will therefore be statistically analysed and inferences on the competence and fidelity of the 




Beyond mere assessment of the ability of the clinicians to use MI, the observation data also 
provides the opportunity to evaluate the impact of certain cultural and contextual factors on 
the fidelity of the clinicians. These include languages and communications patterns, time and 
length of counselling experience which are cultural and contextual factors that have been 
elicited in chapter four to have the potential to either facilitate or inhibit the ability of clinicians 
to use MI with optimum fidelity. Therefore, statistical tests will be carried out to determine the 
association between each of these factors and the fidelity of the trained clinicians in this study.  
The literature has also not established whether the MI approach will be readily acceptable 
among HIV patients and health practitioners with African background. It is therefore not certain 
how the MI approach will be accepted among ART adherence counsellors or HIV patients in 
Nigeria. Although MI is not currently the clinical approach to counselling in Nigeria, this study 
provides an opportunity to present it to the HIV clinical context and the target groups. This 
opportunity allows the individual assessment of each of the study participants, having 
experienced the approach in practice in relation to the usual ART adherence counselling 
practice in their clinic. To explore the perception of the participants about the MI approach in 
relation to the existing practice, observation records of the clinical interactions between the 
counsellors and patients alone will not suffice. In this regard, Oh and Lee (2016) argue that 
focus groups lack depth and are not generally useful for eliciting individual narratives which 
can be better captured through surveys, diaries and semi-structured interviews. Consistent 
with the preference of critical realism for qualitative methods and to explore the subjective 
views and opinions that the participants ascribe to MI in relation to their culture and context, 
the semi-structured interview appears to be the appropriate method to complement the data 
obtained from the structured observation in this study. In view of the above, a mixed research 
methods approach was adopted for this study. 
 
Research Objectives: 
 To understand the way conversations around ART adherence occur in clinical practice 
in Nigeria. 
 To identify the potential impact of a brief MI training programme on the practice of ART 
adherence counsellors in Nigeria. 
 To explore how the ART adherence counsellors and patients respond to the MI 
approach. 
 To identify factors that facilitate or hinder the adoption of MI for ART adherence 





5.3.1 Research Design 
Mixed method research (MMR) is a procedure that employs both quantitative and qualitative 
methods and strategies in the same project (Sarantakos, 2013, p.50). The procedures and 
extent of mixing in MMR vary significantly, ranging from formal qualitative analysis to a variety 
of mixing strategies (Sarantakos, 2013, p.50). Based on the need to obtain different but 
complementary data about the central phenomenon under study a convergent MMR design 
(Polit and Beck, 2017, p.215) was adopted for this study. Convergent design also known as 
triangulation design is one in which the qualitative and quantitative components are 
concomitant (Pluye et al., 2011; Polit and Beck, 2017, p.215). The purpose of a triangulation 
design is to answer related aspects of the same questions by interpreting qualitative and 
quantitative results (bringing data analysis together at the interpretation stage), or by 
integrating qualitative and quantitative data sets, or by transforming data (Pluye et al., 2011; 
Teddlie and Tashakkori, 2011 cited in Denzin and Lincoln, 2011, p.288). Based on the focus 
of this study, quantitative data were collected using structured observation while qualitative 
data were collected using semi-structured interview. For this study, the structured observation 
and the semi-structured interviews are triangulated to fully understand the feasibility of using 
MI for ART adherence in Nigeria. The diagrammatic structure for the mixture of the research 
approaches in this study is as presented in figure 5.3: 







5.3.2 Languages of Focus in the Study 
In Nigeria, between 450 and 512 languages are spoken (Ayeomoni, 2012; Pinon and Haydon, 
2010). These include English and three major local languages (Hausa, Igbo and Yoruba) 
spoken by majority of the polity (Akinnaso, 1991; Ayeomoni, 2012; Igboanusi, 2008; Federal 
Republic of Nigeria, 1999). Due to the high diversity of languages spoken in the country, it will 
be unwise to attempt to assess the feasibility of using MI with MI consistent behaviour across 
the wide spectrum of languages.  
Although there is currently no consensus estimate of the proportion of the population that 
speak one language or another, some existing data have shown that over 50% of Nigerian 
population speak Yoruba, Igbo and Hausa (Akinnaso, 1991; National Population Commission, 
2013), while, 54% of the population speak English language (Pinnon and Haydon, 2010). 
However, the majority of the English speakers in the country also speak the Nigerian Pidgin 
(Pinnon and Haydon, 2010), which has been argued to be probably the language with the 
highest number of users in the country or as the lingua franca in the informal domains 
especially among the non-Western educated masses (Akinnaso, 1991; Ayeomoni, 2012; 
Ihemere, 2006; Igboanusi, 2008). 
Based on this data and the fact that the principal investigator (PI) is from the Yoruba tribe, who 
also speaks Nigerian Pidgin and English, assessment of the influence of languages and 
communication styles on the MI fidelity of the ART adherence counsellors in this study will be 
limited to English, Nigerian Pidgin and Yoruba. This limited focus of study languages is partly 
based on the assumption that counsellors or patients who could not speak Yoruba, but Hausa 
and Igbo will be able to use either English or Nigerian Pidgin for routine clinical interactions. It 
is also partly based on the need to avoid risks of breach of confidentiality that may occur 
through professional translators, if data collected in Igbo or Hausa has to be translated by 
other persons and not by the PI.  
5.3.3 Study Setting 
This study was carried out in Abuja, Nigeria. Abuja is the Federal Capital Territory of Nigeria 
and its central function facilitates employment of workforce and settlement of individuals from 
all the ethnolinguistic groups in the country. Hence, this setting presents the opportunity to 
recruit members of almost every ethnolinguistic group available in Nigeria into the study.  
A general hospital was chosen as the study site based on the central function that it serves, 
as a secondary health facility in the hub and spokes model of HIV/AIDS care in Nigeria 




as the hubs and domicile of specialized HIV/AIDS services but have links with secondary 
health facilities. Within the network, patients can be referred from the secondary facilities to 
the tertiary facilities for specialized services, because they serve as the spokes to the tertiary 
health facilities. The secondary health facilities in turn serve as hubs to some primary health 
centres within the same network. The routine referral channel is from the primary to secondary 
and secondary to tertiary health facilities and vice versa. However, in exceptional situations 
such as where there is closer proximity, the primary health facilities may refer directly to the 
tertiary health facilities and vice versa (FMOH, 2010). Although HIV services have been 
decentralized to the primary/private or faith based health centres in the communities to provide 
better access to HIV patients, especially the hard to reach population, evidence has shown 
that there is still a need for more effort to ensure optimum decentralization of such services in 
Nigeria (Charurat et al., 2010; Maduka and Tobin-West, 2015; Onwujekwe et al., 2015). Since 
the decentralization of HIV services to the primary health facilities are not yet optimum, the 
secondary health facilities have the tendency to have better clinic capacity for ART services 
than the primary health facilities. They also have the potential to provide better access to hard 
to reach populations compared to tertiary health facilities (Oleribe et al., 2016). To examine 
the applicability of MI among a sample population that is similar to the population, general 
hospitals fit the purpose of this study. The study participants were selected from Wuse General 
Hospital. This hospital was chosen as it is the oldest general hospital in Abuja, with the largest 
HIV patient population. It also fits the purpose of this study because of its location in the central 
area of Abuja, thereby allowing more access to patients from all socio-economic groups. 
5.3.4 Ethical Consideration 
As recommended in the Belmont report, if there is any element of research in an activity, such 
activity should undergo review by an institutional review board for the protection of human 
participants (US Department of Health and Human Services [USDHHS] (2016). Hence, this 
study was approved by the Research Ethics Panel of the Faculty of Medical Science of Anglia 
Ruskin University (FREPnumber:15/16 087) and by the Federal Capital Territory Health 
Research Ethics Committee (FCTHREC) (FHREC/2016/01/77/26-10-16). This also ensures 
that the scientific value of the study is ascertained before it is carried out as specified by The 
British Psychological Society (2010). Copies of the ethical approvals from FREP and 
FCTHREC are presented in Appendix 3 and 4 respectively. 
Apart from the ethical principle of scientific value, The British Psychological Society also 
proposed ethical principles such as: 1) Respect for autonomy and dignity of persons; 2) Social 
responsibility; and 3) Maximising benefit and minimising harm. These principles are direct 




Respect for persons; 2) Justice; and 3) Beneficence (USDHHS, 2016). The study also 
complied with each of these three principles in different but also in some interconnected ways. 
Respect for autonomy and dignity of persons: This principle requires researchers to value 
the dignity and worth of all persons equally, with sensitivity to the dynamics of perceived 
authority or influence over others and with respect for people’s rights including those of privacy 
and self-determination (The British Psychological Society, 2010). The principle emphasis that 
researchers have a responsibility to develop and follow procedures for valid consent, 
confidentiality, anonymity, fair treatment and due process that are consistent with moral rights 
(The British Psychological Society, 2010).  
This study complied with this principle by ensuring that valid and informed consent was 
obtained from each participant before they participated in the study. This was carried out by 
informing the participants that their participation in the study is voluntary and they have the 
complete autonomy to decide whether to participate or not. They were also informed that they 
are free to withdraw from the study at any time without giving any reasons. To ensure that 
informed consent was obtained, comprehensive explanation about the study was provided for 
each participant to empower them to make decision on whether to participate or not. Where 
the participant lacked capacity to speak or write English, the study information was provided 
for them in alternative languages that they understood, and their consent procedure was 
audiotaped. The participants were not also offered any reward to participate in the study to 
avoid coercing them. This is based on the consideration that coercion infringes on the human 
right to autonomy and coerced participation compromises the validity of research data (The 
British Psychological Society, 2010). No participant took part in any study activity before 
consenting to the study. 
Furthermore, safeguarding of the confidentiality of the personal information provided by the 
study participants was assured before they consented to participate in the study. This was 
carried out by assuring the participants that the information or data collected about them will 
be appropriately anonymised and cannot be traced back to them or other parties, except in 
exceptional circumstances such as when requested by court order or regulatory requirements. 
Social responsibility: This principle requires that knowledge must be generated and used for 
beneficial purposes and such purposes can be broadly defined as those that not only support 
and reflect respect for the dignity and integrity of persons (both individually and collectively) 
but also contribute to the ‘common good’ (The British Psychological Society, 2010, pp.10-11). 
This also relates to Justice in the Belmont report which states that an injustice occurs when 




burden is imposed unduly (USDHHS, 2016). In this study, the participants (ART adherence 
counsellors and HIV patients) are expected to be the direct beneficiary of the study processes 
which include the MI training and eventual implementation of the approach for routine practice. 
The principle also specify that researchers should avoid creating unwarranted or unnecessary 
disruption to the social structure or the social context in which they work unless they judge 
that the benefits of the study outweigh the costs of such disruption (The British Psychological 
Society, 2010). The data collection from this study was designed to be carried out first during 
the usual ART adherence counselling or consultation sessions at the HIV clinic and later 
through interview over the telephone so as not to impose undue burden on the participants. 
Maximising benefit and minimising harm: This principle also specified that the 
responsibility of the researcher is to consider all research activities from the standpoint of the 
participants, with the aim of avoiding potential risks to the psychological well-being, mental 
health, personal values or dignity (The British Psychological Society, 2010). Occurrence of an 
adverse event due to participation in this study is not expected, because clinical trials that 
have used the MI approach have not yet reported adverse events. However, as a measure to 
mitigate against unexpected adverse events, all HIV patients were free to withdraw from the 
study at any time which includes if they feel uncomfortable with the MI approach or the 
research procedure. 
Meanwhile, the primary risk of being in this study for the patients is the potential for their 
identity as HIV patients to be known by others, while for the ART adherence counsellors there 
may be the fear of being judged by other health personnel in respect of their competence at 
using a new clinical approach. In this regard, the participants were assured that all records 
identifying them will be considered confidential and managed in accordance with the UK Data 
Protection Act, 1998 and the confidentiality guidelines of the Nigerian National Health Act 
(2014, p.20-23).  
5.3.5 Timeframe for the Study 
This study was carried out between 1st of March and 31st of December 2017. The Gantt chart 
in figure 5.4 presents the timeline details for how field activities for the study such as the 
recruitment of participants, MI training and the data collection procedures were implemented 
between 1st of March and 31st of August. Following the field activities, analyses of all data 





Figure 5.4: Gantt Chart depicting the Implementation of Field Activities 
 
 
5.3.6 Participant Sampling Procedure 
As stated earlier, all study activities which includes recruitment of participants were carried out 
in only one of the 13 General Hospitals in Abuja. The recruitment activities were carried out 
by the principal investigator (PI) within 14 weeks. Recruitment procedure for ART adherence 
counsellors took place over nine weeks, while that of the patients took 10 weeks.  The 
sampling framework for the study is as presented in figure 5.5: 
Figure 5.5: The Sampling Framework for the Study  
 
Participants for this study were recruited using a purposive sampling approach. Purposive 
sampling is very useful, when specific people, events or settings are chosen because they 
provide important information that could not be obtained from other sampling designs (Gray, 
2014, p.217). In this approach, the researcher exercises a degree of judgement about who 




the study (Gray, 2014, p.217; Sarantakos, 2013, p.177). Apart from being purposive, the 
sampling approach was also designed to be homogenous to ensure that the participants 
(counsellors and HIV patients) were individuals who have had and will have common 
experiences to share before or during the study processes. The inclusion and exclusion were 
defined to ensure that the selected participants were those who can provide the perspectives 
of interest: 
Inclusion Criteria 
 Health personnel who counsel HIV patients about ART adherence in the HIV clinic of 
the general hospital were eligible to participate in the study. 
 Adult HIV patients aged ≥18 or older who are already receiving ART services at the 
ART clinic were also eligible to participate in the study. 
Exclusion Criteria 
 Health personnel who do not counsel HIV patients about ART adherence were not 
eligible for the study. 
 HIV patients who are not receiving ART services from the general hospital selected for 
this study were not eligible. 
 Children and young people under 18 years living with HIV were also not eligible for the 
study. 
 HIV patients, who could not speak English, Nigerian Pidgin or Yoruba language were 
also not eligible for the study. 
 HIV patients who were very ill or hospitalised as at the time of the study were eligible 
for the study. 
Sample Size Justification 
Generalization of findings is not the central aim of this study as the sample size required for 
this stage of the cultural adaptation framework is small. However, as presented in figure 5.5 
all eligible adherence counsellors (nine health practitioners) and HIV patients presenting at 
the hospital within the recruitment period were approached to participate in the study. As 
recommended for pilot or exploratory studies (Gray, 2014, p.231) a sample size of 10 to 30 is 
usually sufficient, patient population within this range was expected to participate in this study. 
Based on direct observation of events at the study site by the PI, patient population that 
attends the Medical Outpatient Department (MOPD) for HIV care ranged from 128 to 295 




required for the study can be conveniently recruited within a month as projected in the 
research protocol. Based on this assumption all the patients presenting at the MOPD during 
the month of April 2017 were approached to participate in the study.  
5.3.7 Recruitment Procedure 
Antiretroviral Therapy Adherence Counsellors in this study refer to health personnel who 
counsel HIV patients about ART adherence during the HIV clinic sessions at the Medical Out-
Patient Department (MOPD) of the hospital. During the period of this study, eight clinical health 
practitioners and one non-clinical health worker were involved in providing ART adherence 
education and advice to patients at the MOPD. The HIV clinic sessions were held on Mondays 
for newly diagnosed patients and on Wednesdays for follow-up appointments. The nine 
individuals involved in the delivery of ART education and advice at the MOPD were eligible as 
adherence counsellors and were approached by the principal investigator (PI) to participate 
in the study. Each of the counsellors was given a participant information sheet (PIS) which 
they were encouraged to read. Two weeks later the PI contacted each of the counsellors to 
discuss the study and to ascertain whether they would like to participate or not. The 
counsellors were informed that as part of the study, they will be asked to inform all HIV patients 
about the study during their usual adherence counselling or consultation sessions and to refer 
those who are interested to the PI. After the meeting to discuss the study, each of the 
counsellors were given one week to make an informed decision to participate in the study by 
completing the Informed Consent Form (ICF). The PIS for the counsellors and the ICF are as 
presented in appendix 9 and 10 respectively. 
Patients in this study refer to HIV patients who are already receiving ART services at the 
MOPD. This is to ensure that each participant have had at least one experience of clinical 
consultation in respect of ART adherence with any of the recruited counsellors before the 
study and would still have one with any of the counsellors during the period of the study. 
According to the Integrated National Guideline for HIV Prevention Treatment and Care in 
Nigeria, the treatment schedule for HIV patients who are starting ART requires that adherence 
counselling should be offered to the patient at baseline (before treatment), 2 weeks, 4 weeks, 
8 weeks, 12 weeks and at every clinic appointment (FMOH, 2016, p.51). Therefore, 
irrespective of the ART adherence status of the HIV patient (naïve or experienced) adherence 
counselling is expected to be offered to them on an ongoing basis, starting from the point of 
initiation. Hence, all HIV patients who have been on ART or who have just been placed on 




However, because MI promotes autonomy of patients in treatment decision-making, only 
those who could make such decisions independently were considered eligible for this study. 
Although, young people aged 16 or 17 are considered to have capacity to make decision on 
their medical treatment in some countries (National Health Service, 2016), individuals are 
considered to be full of age in Nigeria when they are 18 and above (Federal Republic of 
Nigeria, 1999, chapter iii 29[4]a). Below the age of 18 in Nigeria a person may not be 
considered eligible to make independent decision in respect of his education or welfare 
(Federal Republic of Nigeria, 1999, chapter iv 35[1]d). On this basis, eligible patients in this 
study were limited to those who are aged 18 or above. 
All HIV patients presenting at the hospital for the Wednesday clinic sessions were informed 
about the study by the principal investigator (PI). Patients who were potentially interested in 
the study approached the PI who provided them with the PIS (see Appendix 8). Some patients 
were also informed about the study by the recruited counsellors during the Monday clinic 
sessions and those who were interested in the study were referred to the PI for further 
information. These patients were provided with a PIS. Each patient who collected the PIS was 
contacted two weeks after receiving the PIS via the telephone to arrange for a meeting for 
further discussions about participating in the study. This meeting was held within the hospital 
facility and it allowed the HIV patients to ask questions that arose from the PIS. After these 
discussions, HIV patients who wished to participate in the study signed the ICF on the same 
day. Although written informed consent is the usual approach, for two patients who lacked the 
capacity to write or speak English, their audiotaped verbal consents were obtained. One 
patient had the audiotaped consent witnessed by her sister and had the consent process 
carried out in Nigerian Pidgin by the PI. The other patient had her audiotaped consent process 
carried out in Yoruba without any witness.  
5.3.8 Motivational Interviewing Training and Delivery Process 
Existing evidence from systematic reviews (Barwick et al., 2012; Hall et al., 2015; Madson, 
Loignon and Lane, 2009; Soderlund et al., 2011) and meta-analyses (de Roten et al., 2013; 
Schwalbe, Oh and Zweben, 2014) of the literature has shown that the most commonly used 
methods for MI training are didactic instructions and experiential exercises. These experiential 
experiences may include role-plays or use of a standard patient (Madson, Loignon and Lane, 
2009). However, as noted by Madson, Loignon and Lane (2009) with some small variabilities 
the common approach to MI training in existing studies is to combine the didactic instructions 




A notable feature of the MI training in the existing studies is that the workshop trainings usually 
require minimum of nine to 16 hours structured in an average of a 2-day workshop (Barwick 
et al., 2012; de Roten et al., 2013; Madson, Loignon and Lane, 2009; Schwalbe, Oh and 
Zweben, 2014; Soderlund et al., 2011). It is worthy of note that fewer training hours such as 
below eight hours have been reported in some of the existing studies as well as the reports of 
some more intensive workshop schedules that lasted for up to 24 hours in total (Barwick et 
al., 2012; Madson, Loignon and Lane, 2009; Soderlund et al., 2011). These diverse training 
schedules were reported in the existing studies with or without post-workshop follow-up 
support that includes feedback/coaching. However, a common feature in the reports from the 
existing training studies is that the frequency, length and duration of the workshop and/or the 
post-workshop support moderate the ability of the trainees to use the MI in practice or for them 
to achieve a sustained practice change (Schwalbe, Oh and Zweben, 2014). Therefore, even 
though it has been suggested that MI training can be effective in short durations (Martino et 
al., 2007), evidence from the meta-analysis by Schwalbe, Oh and Zweben (2014) agrees with 
the findings of Miller et al. (2004) that suggest that the most efficacious training for integration 
of MI into practice is one that is longer in duration and integrates training, observation, 
feedback and coaching.  
Despite the direction of the evidence from existing studies on MI trainings, a key factor to 
consider for skills transfer apart from the trainee factors is the work environment factors where 
the skill is intended to be implemented (Baldwin and Ford, 1988; Elangovan and Karakowsky, 
1999). These factors refer to various aspects in the employee’s work environment which could 
be job-related or organisation-related that either facilitates or impedes effective transfer of the 
training (Elangovan and Karakowsky, 1999). Based on the consideration of the work 
environment factor, consultations with the recruited counsellors about possible periods that 
may be available for the training revealed that the time for training was very limited due to their 
busy work schedule. Therefore, a longer duration of MI training was not possible, and the 
training schedule had to be structured within the limited time available to the health 
practitioners since the focus was to adapt the training to fit their context.  
As clearly presented in figure 5.3 the first study activity after recruiting the ART adherence 
counsellors is the provision of a 3-day MI training for the counsellors. The MI training workshop 
was carried out in the conference room of the general hospital. Training materials (manual 
and PowerPoint slides) were prepared by Dr McMaster and the PI. The training workshops 
were held in English language on 21st of April, 5th of May, and 8th of May 2017. Some 
contributions were also made to the training materials by the adherence counsellors in terms 




Nigeria. These local statements were interpreted into Pidgin, Hausa, Igbo and Yoruba 
languages and the impact of such diversities on clinical communications were discussed in 
the second MI training workshop.  
The first training session which involved discussion about communication and what good 
communication is, introduction to MI, its history and evolution, and key skills, was led by the 
PI and lasted for approximately one hour. The second and third training workshops were led 
by Dr McMaster, who is an experienced MI trainer. She has run large clinical trials on MI in 
the USA (Resnicow et al., 2015) and regularly delivers MI training in Nigeria, Senegal, China 
and Singapore. Dr McMaster is a member of the Motivational Interviewing Network of Trainers 
(MINT) and a collaborator with Prof Stephen Rollnick (Resnicow, McMaster and Rollnick, 
2012). The second and third MI training workshops involved discussions about MI, the spirit 
of MI, skills and strategies used in MI, and lasted for approximately two hours each. The 
second and third sessions also involved role-plays between the recruited counsellors to 
engage each other by switching roles to practise skills of MI such as open-questions, 
reflections and strategies for eliciting change talk. The third training workshop included a 
simulated counsellor-patient role play between Dr McMaster and the PI to demonstrate use of 
MI in the clinical interactions according to a well-rehearsed vignette similar to the routine 
practice of the counsellors. The counsellors were then asked to make observations about what 
they learnt from the role play. At the end of the training, the counsellors were issued with a 
training certificate and were encouraged to use MI with the recruited patients in the study in 
the three languages (English, Nigerian Pidgin and Yoruba), depending on what language each 
counsellor and their patient may agree to use on individual cases.  
After the scheduled training sessions, the counsellors asked for more training practice to keep 
learning about how to use the MI. Subsequently, three more role-play sessions were carried 
out between two counsellors and the PI. Two of these follow-up role-play sessions were 
carried out in English, while the third one was carried out in Nigerian Pidgin. These follow-up 
practice sessions were audiotaped and transcribed for further feedback and learning purposes 
as requested by the counsellors. Real-life practice of MI by the counsellors with the recruited 
patients started on 10th of May 2017, immediately after the training workshops. Counsellors 








5.4 Data Collection 
The data collected were through: (1) a demographic questionnaire, (2) audiotaped records of 
the ART consultation session between MI trained counsellors and recruited patients, and (3) 
semi-structured interviews carried out through the telephone.  
5.4.1 Demographic Data 
The demographic questionnaire was used to collect information such as: the age; gender; 
ethnic background; first language spoken; other languages spoken; and the highest level of 
education of both patients and counsellors. For the counsellors, further information was 
collected in respect of the languages that they use to counsel patients, their occupational role 
in the hospital and their length of working experience after professional qualification. 
Questionnaires are the most commonly used data gathering tool for quantitative purposes 
(Coughlan, Cronin and Ryan, 2007). When a researcher has chosen a quantitative tool like a 
questionnaire, the validity and reliability of such instrument needs to be justified if it was not 
adopted as an off-the shelf tool with already known validity and reliability (Coughlan, Cronin 
and Ryan, 2007). Hence, validation of the reliability of the demographic questionnaire used in 
this study was carried out by pilot-testing with three master’s degree students and an 
undergraduate student attending Anglia Ruskin University who are Nigerians. It was also 
tested with two high school pupils in the UK and two retired older adults with Nigerian 
background. Test of the demographic data questionnaire among these individuals was not 
only to ensure its reliability but also to ensure that the questions are relevant to people at any 
age or educational level and to ensure that they are culturally acceptable in the Nigerian 
context. Feedback from each of the individuals was useful in the final draft of the questions 
and answer options used in the demographic questionnaire which was used for this study (see 
appendix 11). All demographic data were collected when each participant completed the 
consent process for this study. 
5.4.2 Observation of the Counselling Sessions 
HIV patients visit the MOPD for their routine clinical appointments to discuss the HIV treatment 
with the doctors (the counsellors). This process was not disrupted for this study. After 
consenting to the study, each of the recruited patients were allocated to meet any of the MI 
trained counsellors for the routine clinical appointment as part of the study activities. Each 
session between the counsellor and patients was audiotaped with a Dictaphone (Sony IC 
recorder). Recording of all the counselling sessions was carried out by each participating 




for recording purposes. The Dictaphone was returned to the PI after every session to transfer 
the data into a password protected computer.  
5.4.3 Semi-Structured Interviews 
Following each counselling session, patients were asked by the PI if they would like to be 
interviewed on the telephone to talk about their experience. The interviews were also 
audiotaped. The decision to conduct post-practice interviews through the telephone was to 
avoid delaying the HIV patients beyond the usual time they spend with their health provider. 
The primary literature review for this study has revealed that fear of spending long time in the 
HIV clinic contributes to non-adherence to ART among the patients (see chapter one). The 
choice of the telephone as the means of conducting the post-practice interview was therefore 
consistent with the ethical principle that specify the need to minimise harm to participants (The 
British Psychological Society, 2010). Hence, apart from the low-cost advantage of using the 
telephone (Gray, 2014, p.404), the medium was chosen for the interview so that the 
participants can schedule the time of the interview to suit their convenience. Even though, a 
potential disadvantage of using the telephone is the tendency to record high refusal rate (Gray, 
2014, p.404), the ethical requirement not to unduly burden the participants informed the choice 
of this data collection medium. One of the interviews had to be carried out within the hospital 
facility face-to-face because the audio quality from the patient’s mobile phone was too low and 
data from such interaction would not be useful for transcription purpose. 
For the counsellors, those who had recorded sessions for the study were invited by the PI to 
talk about their experience after the last patient in the study had been counselled. Due to the 
busy schedule of the counsellors, the interviews were also scheduled to be conducted through 
the telephone. These semi-structured interviews were also audiotaped.  
The interviews were carried out by using an interview guide. The interview guide was 
developed in English, but its content had to be interpreted into Yoruba and Pidgin by the PI 
when using it with only two patients. Design of the interview guide was guided by knowledge 
gained from literature reviews and by the conceptual framework of the study. The interview 
questions for the patients differ in some ways from the questions targeted to the counsellors. 
Although interview questions were drafted to be used in the guide, whenever the responses 
of the participants led to interesting or unexpected responses, probing questions were used 






Box 5.1: Guide for the Semi-Structured Interview  
For HIV Patients. 
 Tell me about your experiences when you visit the HIV clinic to talk about your HIV drugs-
think about what usually happened before we started this study? 
 Tell me what happened during the counselling session that you attended for this study? 
 What did you find particularly helpful during the counselling session that you attended for this 
study? 
 Tell me what you were not satisfied with during the counselling session that you attended for 
this study? 
 What do you think can affect the use of the approach that your counsellor used to talk with 
you for this study, if it is used on a regular basis? 
For ART adherence Counsellors. 
 What is the usual approach in your clinic to encourage a HIV patient to take his/her drugs-
think about what usually happened before we started this study? 
 What are the barriers that you usually face in encouraging HIV patients to take their HIV drugs 
as recommended, before we started this study? 
 How can you describe your experience with the counselling approach that you used for this 
study? 
 What do you remember from the training that you attended for this study? 
 Tell me about any areas of the training that seemed particularly useful for your kind of work? 
 Tell me any areas of the training that seemed difficult to practice in the place where you work? 
 Tell me how you were able to move between the usual counselling approach in your HIV 
clinic and the counselling approach that you learnt in the training? 
 After your experience with this study, what advice will you give a member of staff on how to 
encourage HIV patients to take their drugs? 
 What do you think can affect the use of the counselling approach that you used with your 
patients for this study, if it is used on regular basis? 
 
After using the interview guide with some of the patients, it became clear that they could not 
properly answer the last question in the guide, despite their experience in the study. Hence, 
the last question in the interview guide for the patients was discarded after using it for the first 
five patients. This is not a methodological problem as semi-structured interview gives 
researchers the freedom not to deal with all the questions in a guide in every interview (Gray, 





5.5 Data Analyses 
Data collected from this study were first analysed quantitatively and qualitatively, after which 
the results were integrated. 
5.5.1 Quantitative Data Analysis   
Quantitative data for this study were generated from the demographic questionnaire and the 
audiotaped MI-based adherence counselling sessions. Descriptive statistical analysis was first 
performed on both categorical and continuous data generated from the demographic 
questionnaire and in respect of frequency of use of the MI approach by the counsellors as well 
as the duration of each of the MI counselling sessions. All statistical analyses were carried out 
through IBM SPSS version 24. 
To analyse the recorded data obtained from the MI sessions, the audio data were labelled 
with study codes for the participating patients and counsellors respectively. Labelled audio-
recorded data were imported into NVivo Pro 11 for verbatim transcribing. After the transcripts, 
the sessions carried out with Yoruba and/or Pidgin were translated into English by the PI. 
Fidelity of the counsellors to MI was assessed by using OnePass coding system. Although 
MITI is the most commonly used coding system, OnePass involves the use of simpler coding 
process and lesser time consumption (McMaster and Resnicow, 2015). It has also been 
validated against the MITI, though with moderate concurrent validity, but with great potential 
in evaluating both traditional and novel interpretations of MI (McMaster and Resnicow, 2015). 
Unlike MITI, OnePass involves the use of impressionistic ratings rather than counts of MI-
consistent behaviours (McMaster and Resnicow, 2015).  
There are 23 different items for OnePass assessment of the fidelity of MI therapists, which are 
assessed on a 7-point scale. These include: 1) Agenda setting; 2) Open Questions; 3) Affirm 
Client; 4) Reflective Listening; 5) Action Reflections; 6) Evoke Change Talk; 7) Elicit 
Importance; 8) Elicit Confidence; 9) Address Values; 10) Respond to Affect; 11) Roll with 
Resistance; 12) Avoid Advice; 13) Provide Menu; 14) Support Autonomy; 15) Explore, Guide 
and Choose; 16) Summarise; 17) Arrange Follow-up; 18) Demonstrate MI; 19) Overall 
Conduct; 20) Talk Time; 21) Reflection Ratio; 22) Open-Closed Question Ratio; and 23) 
Complex-Simple Reflection Ratio (McMaster and Resnicow, 2015). All the recorded MI 
sessions were evaluated with 22 of the OnePass scoring items by the PI, except for action 
reflections which is considered complex for beginners of MI such as the counsellors in this 
study. Moreover, it is also an optional item among the OnePass items (McMaster and 
Resnicow, 2015). Some of the recorded sessions were also randomly selected for scoring by 




Dr McMaster was aided by the translated transcripts of the recorded sessions as she does 
not speak any of the local Nigerian languages, except English. Inter-rater reliability was 
assessed by using Spearman’s rank correlation, which is a statistical approach commonly 
used to measure agreement between ratings or ranking of data by two judges (Gray and 
Kinnear, 2012, pp.409-410). 
After coding of the recorded sessions with OnePass and the assessment of inter-rater 
reliability, generated data in form of OnePass scores were analysed by running paired-sample 
and one-sample t-tests. The paired sample t-test was used because it can be used to assess 
the consistency between the level of performance of participants under two different conditions 
(Gray and Kinnear, 2012, p.195). While the one-sample t-test can be used to test whether the 
means of two or more related samples of scores differ from a specified constant (IBM, 2011).  
Fidelity of each counsellor to the techniques of MI were assessed in relation with the 
proficiency thresholds as suggested in MITI. Use of the proficiency and competence 
thresholds specified by MITI was adopted for this study as there is currently no such thresholds 
for OnePass. The MITI thresholds was also used because it is the threshold recommended 
for users of MISC when greater compatibility with MITI score is desired (Miller et al., 2008). In 
this regard, McMaster and Resnicow (2015) have identified specific items within the 23 scoring 
items of OnePass that are directly equivalent to the global and behaviour dimensions in MITI. 
Global spirit scores (average of all the scores of OnePass items) for all the sessions were 
assessed with one-sample t-test.  
As elicited in the literature review, trend of improvement or decay of the MI techniques and 
spirit of the counsellors were also assessed by comparing the scores of their first MI practice 
sessions to their last sessions. Percentage MI-consistency among the counsellors was also 
assessed based on the OnePass equivalent items of percent MI-consistency on the MITI 
thresholds. According to McMaster and Resnicow (2015), the percent MI-consistency is 
equivalent to the scores of all the OnePass items except items 2, 4, 5 and 19-23.  
Correlation between time and language(s) used in the session as well as the length of 
experience of each counsellor with the mean of MI scores (global spirit) for each MI session 
were also assessed by using the Pearson Correlation and a Scattered plot. The Pearson 
correlation was used because it measures a supposed linear relationship between two 
variables that are measured at scale or continuous level (Gray and Kinnear, 2012, p.402). 
However, due to the susceptibility of Pearson correlation to be misleading as a measure of 
strength of association, scatterplot which has the potential to reveal the true nature of the 




complement the Pearson correlations. Confidence interval of 95% (p < 0.05) was used for the 
t-tests, Spearman’s rank correlation and the Pearson correlation.  
5.5.2 Qualitative Data Analysis 
The audiotaped records of the post-practice telephone interviews were also labelled with the 
study codes of each study participant that was interviewed. The labelled records were also 
imported into NVivo Pro version 11 and transcribed verbatim. Transcripts of the interviews 
carried out in Yoruba and/or Pidgin were also translated into English by the PI. Following the 
translations, the transcribed data were subjected to thematic analysis. Instead of using an 
inductive thematic analysis which involves development of codes and themes from the data, 
a theoretical thematic analysis which is more driven by the researcher’s theoretical or 
analytical interest (Braun and Clarke, 2006), was carried out in this study in respect of the 
feasibility of using MI in Nigerian context. This is because the data were collected by using an 
interview guide that was developed based on the specified dimensions of the conceptual 
framework and literature reviews. The thematic analytical guideline proposed by Braun and 
Clarke (2006) was adopted for this stage of the study because of its simplicity and clarity of 
the steps of the guideline. The six steps to thematic analysis as proposed by Braun and Clarke 
(2006) involves: familiarisation with the data; generating initial codes; searching for themes; 
reviewing the themes; defining the themes and producing the report. 
After the transcripts were completed, for the thematic analysis in this study, initial codes were 
generated after familiarisation with the data through first reading and re-reading of the texts. 
Codes were collated into potential themes after further study of the texts. A review of the 
themes was carried out by the PI in conjunction with both primary and secondary research 
supervisors. The review of themes involved checking whether the identified themes work with 
the coded references. Further analysis was carried out to refine and define the themes and 
associated sub-themes to ensure that they entail salient information relevant to the research 
objectives. Finally, appropriate example of references that best represents the themes were 
linked to them and the data analysis was presented in that format. Overall, steps were taken 
to ensure trustworthiness of the analysis by ensuring its credibility, dependability, 
confirmability and transferability. For instance, the thematic analysis was carried out using 
investigator triangulation. Investigator triangulation involves a systematic comparison of 
different researchers influence on an issue and the results of the research to detect or 
minimize biases resulting from the researcher as a person (Flick, 2014, p.183). In this regard, 
each member of the research team (PI, Dr McMaster and Prof Redsell) generated the themes 




an individual researcher’s perspective. This process enhances the dependability of the study 
as a measure of methodological rigour/trustworthiness (Ryan, Coughlan and Cronin, 2007). 
5.5.3 Data Integration  
Data from this study were integrated by using results from both analytical approaches 
(quantitative and qualitative) to comprehensively meet the four objectives of the study and to 
answer the research question. This approach justifies the need for triangulation, which allows 
for systematic extension of the possibilities of knowledge production by using a second 
methodological approach (Flick, 2014, p.184). 
5.6 Chapter Summary 
This chapter presented the justification of the research philosophy, theory and methodology. 
It also presented the conceptual framework and the mixed method design for the study. Lastly, 
the chapter presented the research procedures which includes: ethical processes, sampling 






CHAPTER SIX: QUANTITATIVE STUDY FINDINGS 
6.0 Chapter Overview 
This chapter presents the findings in respect of recruitment, participation in the MI training 
activities and participants’ involvement in data collection activities. It also presents the 
descriptive statistics of the demographic data collected from the study participants as well as 
the quantitative data generated from the audio recorded data from the MI practice sessions 
between the ART adherence counsellors and patients through OnePass coding system. The 
chapter presents the analyses of the fidelity of the adherence counsellors to MI spirit and 
techniques. Correlations between the language(s) used for the practice sessions, the time 
used for the practice sessions and the length of experience of the counsellors with the MI 
fidelity scores of the counsellors are provided. Lastly, assessment of the improvement or 
decay of MI skills among the counsellors through within-subject assessment of MI fidelity 
scores as well as the between-subject comparison of the MI fidelity scores for all the 
counsellors are provided. 
6.1 Screening and Recruitment 
A total of 785 patients presented at the clinic during the period of recruitment and they were 
all informed about the study by the principal investigator (PI) during the mandatory health talk 
session which holds before the start of routine HIV clinic sessions on Wednesdays and by the 
health practitioners when interacting with the patients during consultation sessions on 
Mondays. Eighty-six patients (approximately 11% of the patient population for the month) were 
screened for the study as presented in figure 6.1. Only 21 patients (approximately 24% of the 
screened patients) who met the eligibility criteria consented to participate in the study. 
Reasons for not consenting to participate in the study after collecting the Participant 
Information Sheet (PIS) were diverse. These include: telephone contact challenges (n=31); 
lack of incentive (n=1) from the PI; too busy (n=2); travelled or travelling out of town (n=3); 
failed to meet up with appointment to discuss the study with the PI (n=11); just got a new job 
(n=2) and so was not be able to meet up with the clinical appointment and PI for fear of losing 
the job; could only speak Hausa which is not included as a study language (n=1); being 
transferred to another clinic closer to the patient’s home (n=2) and will not be attending clinic 
at the study setting anymore; not actually receiving treatment in the study setting (n=1); staying 
too far from the study setting (n=1); and not interested for no stated reasons (n=10). While 
evidence from a review of guidelines has emphasised the need to provide compensation to 
enhance participants’ recruitment to research in sub-Saharan Africa (Puppalwar et al., 2015), 





Figure 6.1: Flowchart for Recruitment of Study Participants  
 
Although telephone contact challenges prevented the highest number of the patients from 
participating in the study, these communication challenges occurred in different ways. These 
include: switching off the phone (n=5); number not reachable (n=12); not answering the call 
(n=8); call forwarded (n=1); husband answering call and insisting the PI talks to him instead 
of the wife (n=1); telephone number not available (n=1); incomplete telephone number; and 
husband presence beside the wife prevented her from speaking further even though she 
answered the phone (n=1). Some of these communication challenges are unique to the 
Nigerian context. Apart from the unusual influence on the wife’s communication media by the 
husbands, disruption of telephone contact due to poor network quality is a well-documented 
challenge in Nigeria (British Broadcasting Corporation, 2012). Moreover, for some of this 
population, there are additional security issues such as theft of the mobile device which is a 
commonplace occurrence in Nigeria (Aworinde, 2016). 
From the practitioners’ cohort, every member of eligible staff within the hospital consented and 
participated in the study. This was a total of nine individuals (seven Doctors, one Nurse and 
one non-clinical health worker) involved in ART adherence counselling during the period of 






6.2 Characteristic of Study Participants 
Age and Gender of Participants 
The minimum age of the patient participants was 29 years with a range of 14 years, while the 
minimum age of the counsellors was 33 years with a range of 25 years. However, the age 
ranges represent approximated values because four of the patients and two of the counsellors 
declined to declare their ages. Meanwhile, as presented in figure 6.2, seven (33.3%) of the 
patients were male, and fourteen (66.7%) were female. In similar pattern, two (22.2%) of the 
counsellors were male, while the rest (77.8%) are female. 
Figure 6.2: Gender of Participants 
 
 
In the general population in Nigeria, HIV is more prevalent among females (3.5%) than the 
males (3.3%) (NACA, 2014, p.19). This gap in the burden of the disease has been attributed 
to higher early vulnerability and infections among girls and women relative to boys and men 
(NACA, 2014, p.19). While the gap in prevalence rate in the general population may be 
narrow, 66.3% (57) of the screened patient population (86) in this study were females, relative 
to the 33.7% (29) who were men. Therefore, the patient population in this study mirrors the 
gender inequality in the burden of the disease in the general population. This gender 
inequality could have accounted for more female participation in the study compared to men. 
Moreover, the patient population also suggest that there was no significant difference 


















Ethnic Backgrounds of Participants 
All the 30 study participants (patients and counsellors) came from 15 different ethnic groups 
in the country as presented in table 6.1. While a higher proportion of the study participants 
came from Ibo (26.7%), Tiv (16.7%) and Yoruba (13.3%) tribes, two (6.7%) participants came 
from Birom tribe (6.7%). All other ethnic groups were however represented by an individual 
(3.3%) each. The ethnic groups as presented in figure 6.3 represents five of the six 
geographical regions in Nigeria except the North-Eastern region of the country. The study 
population can therefore be assumed to represent majority of the tribes and cultures in the 
country. 
Table: 6.1: Ethnic Background of Participants 
 Frequency Valid Percent 
Valid 
Hausa 1 3.3 
Ibo 8 26.7 
Yoruba 4 13.3 
Estako 1 3.3 
Kuterb 1 3.3 
Tiv 5 16.7 
Surubu 1 3.3 
Efik 1 3.3 
Bette 1 3.3 
Eggom 1 3.3 
Idoma 1 3.3 
Birom 2 6.7 
Yala 1 3.3 
Becheve 1 3.3 
Igala 1 3.3 
Total 30 100.0 
Missing System 10  










Figure 6.3: Ethnic Distributions of Participants 
 
Source of Map only: Gayawan, Arogundade and Adebayo (2014) 
While 13 of the ethnic groups in the total population of participants are represented by the 
patient participants, unlike in the total participants group higher proportions came from Ibo 
(19%), Tiv (23.8%) and Birom (9.5%). As presented in table 6.2 all other ethnic groups are 
represented by relatively fewer individuals compared to those from Ibo, Tiv and Birom.  
 
Table 6.2: Ethnic Background of the Patients 
 
Frequency Valid Percent 
Valid 
Hausa 1 4.8 
Ibo 4 19.0 
Yoruba 1 4.8 
Tiv 5 23.8 
Surubu 1 4.8 
Efik 1 4.8 
Bette 1 4.8 
Eggom 1 4.8 
Idoma 1 4.8 
Birom 2 9.5 
Yala 1 4.8 
Becheve 1 4.8 
Igala 1 4.8 




Although the ethnic distribution among the patient participants is similar to the distribution 
among non-responders in respect of certain ethnic groups, there were significant differences 
in the ethnic representations in respect of other groups. For instance, while 29.2% (19) of the 
65 non-responders were Ibos and 3% (two) were Yorubas, 24.6% (16) were Hausas. This 
pattern of ethnic distribution among the non-responders showed that significant number of 
HIV patients who were screened for recruitment were Hausas which is in stark difference to 
the single representation among the actual participants.  
Moreover, unlike the wide distribution of ethnic groups among the patients, all the adherence 
counsellors came from just four ethnic groups which include: Estako; Ibo; Kuterb; and Yoruba. 
As presented in table 6.3, among the four ethnic groups Ibo and Yoruba have relatively higher 
representations with 44.44% and 33.3% compared to 11.1% representation from Estako and 
Kuterb respectively. 
Table 6.3: Ethnic Background of Counsellors 
 Frequency Valid Percent 
Valid 
Ibo 4 44.4 
Yoruba 3 33.3 
Estako 1 11.1 
Kuterb 1 11.1 
Total 9 100.0 
 
Languages Spoken by Participants 
The first languages spoken by the patients presents a similar pattern to the ethnic distribution 
among them. However, unlike the ethnic distribution pattern more individuals spoke Yoruba 
language, while Birom language has fewer numbers of speakers even though only one of the 
patients came from the Yoruba tribe while two came from Birom. None of the patient 
participants speaks English as first language but the other languages spoken as first 
languages include: Hausa; Surubu; Efik; Bette; Eggom; Idoma; Birom; Yala; Icheve; and Igala 
(see table.6.4 and Appendix 5). Unlike the patients, the first languages spoken by the 
counsellors are direct reflections of their ethnic backgrounds as presented in table 6.5. In total, 





Table: 6.4: First Languages Spoken by Patients 
 
Frequency Valid Percent 
Valid 
Hausa 1 4.8 
Igbo 4 19.0 
Yoruba 2 9.5 
Tiv 5 23.8 
Surubu 1 4.8 
Efik 1 4.8 
Bette 1 4.8 
Eggom 1 4.8 
Idoma 1 4.8 
Birom 1 4.8 
Yala 1 4.8 
Icheve 1 4.8 
Igala 1 4.8 
Total 21 100.0 
 
 
Table: 6.5: First Languages Spoken by Counsellors 
 Frequency Valid Percent 
Valid 
Igbo 4 44.4 
Yoruba 3 33.3 
Estako 1 11.1 
Kuterb 1 11.1 
Total 9 100.0 
 
Other Languages Spoken by Participants 
Apart from the first language spoken by study participants, they also speak other languages 
including English (see appendix 5). While all the adherence counsellors speak English 
(100%), only fourteen (66.7%) of the patients speak English as another language. In 
comparison with English, while all the adherence counsellors also speak Pidgin, sixteen 
(76.2%) of the patients speak Pidgin. However, these two languages are the most used among 
the study cohorts.  
Another language which some counsellors and patients speak is Hausa and as presented in 




speak the language. Other local languages such as Yoruba, Igbo and Birom are also spoken 
as another language by one patient (4.8%) respectively, while Idoma is spoken by two (9.5%) 
patients as another language. As presented in figure 6.5, only seven (23.33%) of the 30 study 
participants speak one language as other language, the rest speak between two and five 
languages as languages other than their first language. Therefore, languages used among 
this study cohorts presents the multilingual reality existing in Nigeria. 
Figure 6.4: Other Languages Spoken by Study Participants 
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Educational Attainment  
While three (14.3%) of the patients’ cohort have no formal education, as presented in table 
6.6 over 80% (17) of the patients had less than an ordinary diploma qualification. On the other 
hand, the lowest educational qualification among the counsellors was a higher national 
diploma which was possessed by only two (22.2%) individuals (see table 6.7). Therefore, 
significant proportion of the patient population may not have the literacy capacity to 
communicate comfortably with English during their treatment consultation sessions with the 
counsellors. 
Table: 6.6: Educational Attainment of Patients 
 Frequency Valid Percent 
Valid 
No schooling completed 3 14.3 
Primary school education 2 9.5 
Secondary school education 12 57.1 
Ordinary National Diploma 2 9.5 
Advanced degrees 1 4.8 
Any other qualification 1 4.8 
Total 21 100.0 
 
Table 6.7: Educational Attainment of Counsellors 
 Frequency Valid Percent 
Valid 
Higher National Diploma 2 22.2 
Bachelor's degree 3 33.3 
Advanced degrees 2 22.2 
Any other qualification 2 22.2 
Total 9 100.0 
Occupational Roles and Length of Experience of Counsellors 
The counsellors cut across different occupational roles which as presented in figure 6.6 
include seven (77.8%) medical doctors, a nurse (11.1%) and a non-clinical volunteer (11.1%). 
Moreover, the highest length of experience among the adherence counsellors after 
professional qualification was 33 years, while the shortest length of experience among the 
doctors was four years. However, the lowest length of experience was the lack of any 
professional experience of the non-clinical volunteer. Hence the average length of clinical 




Figure 6.6:  Occupational Roles of the Adherence Counsellors 
 
Languages Used for Counselling 
The adherence counsellors use different languages for counselling while carrying out their 
routine practice. As presented in figure 6.7, all the counsellors use either English and/or Pidgin 
(see appendix 5). However, two (22.2%) of the counsellors reported that they also use Hausa 
while two (22.2%) other counsellors use Igbo language, and only one of the counsellors 
(11.1%) reported using Yoruba language for routine consultation sessions with the patients. 
Moreover, while four (44.44%) of the counsellors use two different languages during their 
consultations others (55.56%) use up to three different languages for their routine clinical 
consultations (see figure 6.8). Hence, the clinical consultation for HIV treatment in the study 
setting allows for the practice of the prevalent multilingualism in the country. 
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Figure 6.8: Multilingual Approach to Counselling 
 
 
6.3. Participation of Counsellors in the MI Trainings 
As presented in table 6.8, all adherence counsellor attended more than one MI training 
session. However, two individuals missed a training session apiece, but at different days. One 
counsellor missed the last training session because of further education in school, while the 
other counsellor missed the first training session due to illness. Attendance rate in the 
scheduled MI training sessions was therefore 93%. Meanwhile, none of the clinicians failed to 
attend the MI training sessions due to lack of interest in the study or the training. This illustrates 
the high enthusiasm among the counsellors about the MI training. 











Doctor (x001) Attended Attended Attended 
Non-clinical staff (x002) Attended Attended Missed 
Doctor (x003) Attended Attended Attended 
Doctor (x004) Attended Attended Attended 
Doctor (x005) Attended Attended Attended 
Doctor (x006) Attended Attended Attended 
Nurse (x007) Attended Attended Attended 
Doctor (x008) Attended Attended Attended 
Doctor (x009) Missed Attended Attended 






























6.3.1 Setting of MI Training and Practice Sessions 
Before presentation of the outcomes that emerged from the interactions between the trained 
counsellors and the HIV patients, it is necessary to describe the context within which MI 
training and the MI practice sessions occurred to facilitate interpretation of the outcomes. In 
this regard, the MI training for the study was carried out in the conference room of the hospital 
which had adequate training facilities. However, despite the hot weather condition with a 
temperature ranging from 35-41°C during the period of the study, the air conditioning system 
in the conference room was dysfunctional throughout the training sessions. 
 
On the other hand, the consultation rooms in which the trained counsellors practised the MI 
approach with the patients were in the Medical Outpatient Department (MOPD) which is also 
the HIV clinic. As at the time of the study, there were three consultations rooms and a nurse’s 
station at the MOPD. The nurse at the clinic served partly as a receptionist to the clinic 
because all interactions between the nurse and the patients were preparatory to the 
consultation sessions between the patients and any of the doctors. Meanwhile, patients wait 
in a long corridor which does not only lead to the consultation rooms but also led to other 
departments in the hospital. Hence, the corridor did not only serve as a waiting space for the 
HIV patients, but also served as a passage way for other patients, clinicians and visitors to 
the hospital who have nothing to do with the MOPD. In addition, the positioning of the clinic 
corridor may increase the likelihood of exposing the patients and their health circumstance to 



















Figure 6.9: Consultation Rooms at the Study Setting 
 
N.B: “D” refers to Doctor; “N” refers to Nurse; and “P” refers to Patient 
 
Moreover, two of the consultation rooms in the clinic had two doctors’ tables which allows for 
two consultation sessions with two different patients to occur simultaneously. The 
arrangement of these consultation rooms does not also seem to promote safeguarding of the 
confidentiality of personal information from each HIV patient. Lastly, as presented in figure 6.9 
only five of the seven doctors in the study could attend to the waiting HIV patients at the MOPD 
at any given time. 
6.4. Participation in MI Practice Sessions for ART Adherence  
Involvement of adherence counsellors in each of the data collection activities is as presented 
in table 6.9. Only seven of the adherence counsellors (doctors) participated in the observed 
MI practice sessions. The two remaining counsellors could not participate because the 
volunteer no longer carry out adherence counselling for the HIV patients by the time the MI 
training sessions were completed, and the nurse could not get a patient to practice the 
approach with during the study period. Hence, only the seven doctors participated in the 
practice sessions analysed in this chapter.  
Three of the patients could not also participate in the practice sessions. Two of these patients 
initially missed their first appointment dates and could not visit the clinic for another session 




could not return for a re-scheduled session. Meanwhile, only one of the patients who 
participated, engaged in two different sessions on two different days, while all other patients 
participated in one session apiece.  
Table 6.9: Participant’s involvement in Practice Sessions 
Number of Study 
Participants 
Observation of MI session for ART adherence 






6.5. Clinical Encounters 
The clinical encounters between the counsellors and the patients (with study codes starting 
with “y”) started on 10th of May and ended on 30th of August 2017. As presented in table 
6.10, the time spent on each session ranged between 1:10 and 22:34 minutes. Languages 
used within the sessions include only English, English with Pidgin, English with Yoruba and 
Pidgin and combination of the three languages with Hausa. Although Hausa was not one of 
the specified languages of the study, some doctors used some common expressions such as 
“tor” and “ba” drawn from Hausa language in two of the sessions. Each of these expressions 
means “well” and “right?” respectively. Meanwhile, counsellors X005 and X008 used Yoruba 
or Hausa with English and Pidgin during the MI practice sessions (see table 6.10). However, 
the two counsellors did not report that they use either of the two languages for their routine 
consultation sessions. Similarly, counsellor X006 did not report using Yoruba for routine 
clinical consultations but used another common expression “abi” drawn from Yoruba 
language, which means “or” during one of the practice sessions. Therefore, the counsellors 
drew on their multilingual abilities to use the MI approach within the practice setting. 
Overall, English was used only in 11 (58%) out of the 19 sessions, while a hybrid of different 
local languages was used with English in the remaining sessions as presented in table 6.10. 
The most frequently used local language was Pidgin, which was used in the remaining (42%) 
sessions. While Yoruba was used as part of the hybrid of languages in four (21%) of the 
sessions, Hausa was used in similar pattern in only two (11%) of the sessions. Lastly, in 
respect of the frequency of counsellors’ involvement in the practice sessions, two (28.60%) of 
the counsellors carried out four sessions apiece, one (14.29%) counsellor carried out three 














Language (s) used in the 
sessions 
X001a X001Y016 7:08.9 31/05/2017 English 
X001b X001Y018 11:25.8 07/06/2017 English+Pidgin 
X003a X003Y021 21:26.6 14/06/2017 English+Pidgin 
X003b X003Y009 3:54.9 02/08/2017 English 
X004a X004Y008 6:09.2 10/05/2017 English 
X004b X004Y010 3:26.4 15/05/2017 English +Pidgin 
X004c X004Y017 10:20.0 31/05/2017 English 
X004d X004Y012 4:30.0 12/07/2017 English 
X005a X005Y005 8:23.4 10/05/2017 English 
X005b X005Y015 12:22.0 31/05/2017 English+Yoruba+Hausa+Pidgin 
X005c X005Y020 15:05.5 14/06/2017 English+Pidgin+Yoruba 
X006a X006Y007 18:35.0 10/05/2017 English 
X006b X006Y002 22:34.9 02/08/2017 English 
X006c X006Y001 13:10.3 21/08/2017 English+Pidgin 
X006d X006Y004 14:06.2 21/08/2017 English+Yoruba+Pidgin 
X008a X008Y007 10:58.7 05/07/2017 English 
X008b X008Y006 20:43.3 30/08/2017 English+Yoruba+Hausa+Pidgin 
X009a X009Y019 1:58.4 28/06/2017 English 
X009b X009Y003 1:10.8 23/08/2017 English 
Notations: Session codes ending with a, b, c or d indicate the chronological sequence with which the 
interaction occurred for each counsellor. 
6.6 OnePass Assessment of Fidelity to MI 
Scores generated for each of the 22 items of OnePass from the 19 practice sessions are 
presented in Appendix 6.  
6.6.1 MI Global Spirit Scores 
Global scores in MITI are equivalent to the average of all scores in OnePass (McMaster and 
Resnicow, 2015). Since the average of 22 OnePass items scored on a 7-point scale is 7.0, 
the maximum achievable score for Global Spirit in OnePass is also 7.0. Hence, an average 
score of 4.9 is the equivalent to the 3.5 MITI threshold score for basic competency in MI (Miller 
and Rollnick, 2013, p.400). One-sample t-test carried out on the 19 sessions revealed that 
none of the counsellors achieved basic competency in any of the sessions. The highest mean 
which was achieved by one of the counsellors (X008) was 4.18 as presented in table 6.11. 
While the paired sample t-test (see table 6.12) revealed that four of the counsellors (X001, 
X004, X005 and X008) demonstrated some improvements in MI spirit scores between their 
last and first sessions, only two individuals achieved statistically significant difference in skills. 
Conversely, two of the counsellors (X003 and X006) recorded loss of skills between the time 
points. However, only one counsellor (X003) has a statistically significant loss of skills. 




time points, missed one of the MI training sessions. This might have also accounted for the 
consistent lowest MI spirit scores achieved by the counsellor. 
Table 6.11: One-Sample T-Test for MI Spirit Scores 
Session 
Codes 
Test Value = 0 
Mean Std. Deviation Sig. (2-tailed) 95% Confidence Interval of the Difference 
Lower Upper 
X001Y016 1.2727 1.83048 .004 .4611 2.0843 
X001Y018 1.6364 2.34105 .004 .5984 2.6743 
X003Y021 3.1818 2.51919 .000 2.0649 4.2988 
X003Y009 .7727 1.68839 .044 .0241 1.5213 
X004Y008 .6818 .99457 .004 .2408 1.1228 
X004Y010 1.0455 1.67552 .008 .3026 1.7883 
X004Y017 3.6818 2.33781 .000 2.6453 4.7183 
X004Y012 3.9091 2.32807 .000 2.8769 4.9413 
X005Y005 .9545 1.55769 .009 .2639 1.6452 
X005Y015 2.1364 1.75378 .000 1.3588 2.9139 
X005Y020 3.0909 2.34844 .000 2.0497 4.1321 
X006Y007 3.0000 1.77281 .000 2.2140 3.7860 
X006Y002 1.8182 2.36314 .002 .7704 2.8659 
X006Y001 3.9091 1.87487 .000 3.0778 4.7404 
X006Y004 2.2273 2.36908 .000 1.1769 3.2777 
X008Y007 3.2727 2.37410 .000 2.2201 4.3253 
X008Y006 4.1818 2.83912 .000 2.9230 5.4406 
X009Y019 .6818 1.58524 .057 -.0210 1.3847 





























Pair 1 X001Y018 - X001Y016 .36364 2.51747 .505 1.47982 -.75255 
Pair 2 X003Y009 - X003Y021 -2.40909 2.59412 .000 -1.25892 -3.55926 
Pair 3 X004Y012 - X004Y008 3.22727 2.24525 .000 4.22276 2.23179 
Pair 4 X005Y020 - X005Y005 2.13636 3.09062 .004 3.50667 .76606 
Pair 5 X006Y004 - X006Y007 -.77273 2.20242 .115 .20377 -1.74923 
Pair 6 X008Y006 - X008Y007 .90909 2.54313 .108 2.03665 -.21847 
Pair 7 X009Y003 - X009Y019 .00000 2.22539 1.000 .98668 -.98668 
6.6.2 Percent MI-Consistency 
Consistency of the MI responses of the counsellors was assessed on 15 OnePass items that 
excluded: open questions; reflective listening; action reflection; overall conduct; talk time; 
reflections ratio; open-closed question ratio and complex-simple reflection ratio (see appendix 
6). According to the MITI, basic competency threshold for percent MI consistency is ≥90% 
(Miller and Rollnick, 2013, p.400). Hence, for the 7.0 average score on OnePass, an 
equivalent competency score for MI consistency is ≥ 6.3. A paired-sample t-test between the 
last and first sessions revealed that only two counsellors (X004 and X005) had statistically 
significant improvement in consistent MI responses between the time points (table 6.13). 
However, none of the counsellors achieved basic competency threshold for MI consistency.  


















Pair 1 X001Y018 - X001Y016 .86667 2.85023 .259 -.71174 2.44507 
Pair 2 X003Y009 - X003Y021 -2.46667 2.89992 .005 -4.07259 -.86075 
Pair 3 X004Y012 - X004Y008 4.06667 3.10453 .000 2.34744 5.78590 
Pair 4 X005Y020 - X005Y005 2.46667 3.48193 .016 .53844 4.39489 
Pair 5 X006Y004 - X006Y007 -.06667 2.81493 .928 -1.62552 1.49219 
Pair 6 X008Y006 - X008Y007 .66667 3.81101 .509 -1.44380 2.77713 





6.6.3 Influence of the Duration of Sessions on MI Spirit Scores 
A Pearson correlation test carried out on the mean of the scores of the 19 sessions and the 
time spent during the sessions showed a statistically significant and large correlation value of 
0.58 according to Cohen’s guideline (Gray and Kineer, 2012, pp.406). However, the scattered 
plot in figure 6.10 shows lack of association between the two variables. 
Figure 6.10: Scatterplot of MI Spirit Scores and Time Spent on Sessions 
 
6.6.4 Influence of Language on MI Spirit Scores  
A Pearson correlation test of the impact of the language (s) used during each of the sessions 
and the MI spirit demonstrated by the counsellors resulted in an insignificant medium 
correlation value of 0.35. This lack of association between the two variables was further 
corroborated by the scatterplot in figure 6.11. For instance, while the use of four languages by 
one of the counsellors (X008) resulted in the highest MI spirit score, use of the same language 
pattern by another counsellor did not produce same level of scores. On the other hand, use 
of only one language (English) did not result in a consistent level of MI spirit. Despite the lack 
of association between language (s) and the MI behaviour of the counsellors, the result shows 
that their multilingual potential facilitated the use of the techniques of the approach within their 





Figure 6.11: Scatterplot of Languages and MI Spirit Scores 
 
6.6.5 Length of Clinical Experience and MI Spirit Scores 
Lack of association was also found between the length of clinical experience of the counsellors 
and the MI spirit scores in the analysed sessions. Pearson correlation test between the two 
variables shows an insignificant and small correlation with a value of 0.25. The lack of 
association between the two variables was also corroborated by the scatterplot in figure 6.12. 
However, the scatterplot shows that the three sessions with the highest quality of MI were 










Figure 6.12: Scatterplot of Length of Experience and MI Spirit Scores 
 
6.6.6 Inter-Rater Reliability Test 
Lastly, the Cicchetti and Sparrow’s guideline for judging inter-examiner levels of agreement in 
psychology was used to interpret the Spearman’s rank correlation test for the inter-rater 
reliability. According to Cicchetti and Sparrow when a reliability coefficient for correlation is 
below 0.40 the clinical significance is poor, between 0.40 and 0.59 is fair, between 0.60 and 
0.74 is good, and between 0.75 and 1.00 is excellent (Cicchetti, 1994). In this regard, the 
Spearman’s rank correlation test carried out on the scores generated independently from three 
of the analysed sessions by the PI and by Dr McMaster resulted in poor to fair clinical reliability 
significance as indicated by the coefficients of correlation r ([X004Y012; r=0.23, p=0.30]; 
[X005Y015; r=0.31, p=0.16]; and [X006Y001; r=0.49, p=0.020]). 
6.7 Chapter Summary 
Findings from this chapter have revealed that individuals involved in counselling of HIV 
patients for ART adherence in the study setting included doctors and a nurse. The chapter 
has also revealed that apart from English, local Nigerian languages are also used for routine 
clinical consultation by the adherence counsellors, which are often used in a hybrid pattern. 
While the counsellors were enthusiastic about the MI training and its practice, they were not 
able to demonstrate basic MI competency during the practice sessions. Although some of the 
counsellors improved from their first session to their last sessions, others could not retain the 
skills they demonstrated in the first sessions. Irrespective of the low level of fidelity scores 
observed among the counsellors, there were no significant associations between the 




counsellors with their MI skills. However, it is evident form the findings that the multilingual 





CHAPTER SEVEN: QUALITATIVE STUDY FINDINGS 
7.0 Chapter Overview 
This chapter presents the study findings from the qualitative data generated from the semi-
structured interviews with the aim of meeting the first, second and third objectives of the study. 
It presents the findings as themes generated from the audiotaped records of the interviews 
carried out with the participant groups (HIV patients and counsellors) after the MI practice 
sessions.  
7.1 Description of Data Source and the Findings 
The data were collected from 12 out of 18 patients who participated in the clinical practice 
sessions for ART adherence and from six out of the seven doctors who participated in the 
sessions. Reasons for not participating in the semi-structured interview are largely due to 
telephone contact challenges. For instance, two of the six patients who did not participate in 
the interview could not be reached because they do not have functional mobile phone contacts 
at the time. Two other patients could not be reached because their mobile phones were 
switched off, while another patient was too busy at workplace to respond to the interview 
questions. However, the last patient did not answer several calls made to her mobile phone 
for the interview. This behaviour suggests that she was reluctant to participate, despite 
agreeing to be contacted for the interview. Meanwhile, one of the doctors could not also 
participate in the interview because of poor mobile phone connection.  
Guided by the objectives of the study four main themes emerged from the 18 audiotapes. The 
main themes generated are: 1) Socio-Cultural Factors; 2) Organisational Factors; 3) 
Counselling Approach; and 4) Impact of MI Training. While the first theme is related to the 
overarching context and culture in Nigeria and the study community, the second and third 
themes are related to the context of HIV adherence support and the features of the existing 
counselling approach for ART adherence respectively, the last theme is focused on the HIV 
treatment support after MI training. As presented in Table 7.1 sub-themes were identified and 
named for each of the themes, while child sub-themes were further identified and named for 








Table 7.1: Thematic Framework for Qualitative Findings 
Main Themes Sub-Theme Child Sub-Themes 
Socio-Cultural Factors 
Financial and Economic 
Situation of PLHIV 
N/A 




System and Structures N/A 
Patient-Clinician Relationship N/A 
Counselling Approach for 
Adherence 
Interactive and Encouraging 
approach 
N/A 
Commanding and Prescriptive 
Approach 
N/A 




Satisfaction with Practice 
Preferred MI Techniques 
Hybrid Approach 
Time 
Notations: “N/A” refers to Not Applicable 
Furthermore, figure 7.1 shows the position of the themes within the ecological model of 
behaviour change. The core concept of the ecological model is that behaviour has multiple 
levels of influences which often include intrapersonal (biological and psychological), 
interpersonal (social and cultural), organisational, community, physical environmental, and 
policy (Sallis, Owen and Fisher, 2008, p. 465). The model emphasizes the explicit 
consideration of these levels of influences to guide the development of more comprehensive 
interventions (Sallis, Owen and Fisher, 2008, p.466). Consistent with the concepts of the 
ecological model, each theme identified in this study occupies different level of influence. 
However, the themes do not only occupy specific level of influence independently, they also 
interact with themes in other levels of the ecological model or exert influence on other themes 











Figure 7.1: Qualitative Themes and Ecological Levels of Influence 
 
 
The themes and their relevant references are presented in the following sections. 
7.2 Socio-Cultural Factors 
Socio-cultural constraints that influence the experiences of both HIV patients and their doctors 
during the usual treatment consultation sessions include the economic situation of the country 
and the financial situations of the patients as well as the prevalent beliefs and attitudes in the 
study context.  
Financial and Economic situation of PLHIV 
The challenging economic situation of the country and the financial circumstances of some 
patients made it difficult for them to fund transportation to the clinic for check-up appointments 
and to collect medications. Some of the clinic doctors confirmed that due to financial 
limitations, patients cannot keep up with their HIV clinical appointments which affects their 
drug replenishment. Some of the doctors also found it difficult to motivate the patients to 
adhere to their medication regimen because of their poor financial situation. 
“because some people are out of us they…. ehm one day I tried one thing, I trek 
to the hospital one day that I supposed to come and see them, I don't have money. 
so, some of us have many personal problems that are…. some even don’t come, 




“and then you know their own environment because of the socio the poor economic 
situation, many of them don't eat well. have poor diet and ehn these are all 
challenges that ehn, the patients usually face. and some no money. ehn. it will be 
difficult for them to take it. so, you just see that ehn you ask them to ehn now take 
the dose every day, some of them cannot even come after you have finished the 
first dose ehn”. (A female Doctor, X005). 
Beliefs and Attitudes towards PLHIV 
Some of the doctors raised concerns about how lack of belief in the ART engendered by 
religious or traditional beliefs usually prevents concordance between them and patients in 
respect of HIV treatment. This is because preference for cure instead of the management 
capability of the ART makes some of the patients seek and adhere to religious or traditional 
solutions despite advice to adhere to the drugs treatment from the hospital.  
 “many of them visited unqualified eh...service provider. And ehm...some will visit 
eh...spiritualist. visit prophet. begin to think they will be healed. so [not discernible], 
even when you are trying to tell them that this drug, tell them to take their drug. 
before they know it, they will say that they went to one prayer house and they have 
prayed for them ehm with that they will not adhere the way you expect them to 
adhere to their medication”. (A female Doctor, X005). 
Meanwhile, some of the doctors also emphasised how high prevalence of stigma in Nigeria 
affects the HIV clinic in respect of population of patients visiting this clinic. This is because 
some of the patients avoid using the health facilities in their local communities due to the fear 
of stigmatisation and travel to the hospitals in the city where their health status can remain 
anonymous irrespective of the capacity of the clinic. This behaviour increases the number 
visiting this HIV clinic which does not have the capacity to deal with the high population. 
“some of them, ehm...the distance to clinic. that pulls out most people for clinic 
visits.  …. most of them come from afar, just because of social stigma”. (A female 








7.3 Organisational Factors  
Organisational constraints that impact on the experience of HIV patients and counsellors 
during the routine consultation sessions for ART are in relation with the system and structures 
as well as the relationship between the patients and clinicians. 
System and Structures 
Some of the study patients expressed concerns about the challenges that they face due to 
long queue of patients at the HIV clinic. For instance, one of the patients stated that the long 
queue formed by patients due to the low capacity of the clinic in respect of staff prevents them 
from discussing major problems they are facing with the doctors. Due to the high population 
of patients, the doctors try to finish the consultation sessions with each of the patients quickly, 
a situation which makes the doctors appear not to have adequate time to attend to such issues. 
Moreover, some of the patients become apprehensive whenever they are meant to attend the 
clinic for ART consultation, due to the anticipated delay which was partly attributed to the 
handling of patients’ care folders by the health workers in the records department. 
“so, only my experience that anytime when I come to the clinic, people are too 
much. and they don't have time to attend to all. and then sometime, eh.... because 
of the too much of people, they just fast …... they do every, so that the everything 
will be okay. so, but we don’t have eh...time to tell them about even our problem 
our big problem.”. (A male Patient, Y015). 
“anytime like maybe, it's about time for me to go over to that place, you know, it's 
always a kind of uhm [hiss] shaking. am always feeling like ah! how will I cope 
again, you know, for the stress and the rest of a thing, like maybe delaying aspect 
of it and all what not…… once the file is passed to the doctor, I don't see any delay 
from the doctor's side. but the point, the problem there is just for the folder to get 
to the doctor's table. that is just always where we experience the delay”. (A female 
Patient, Y004). 
Concerns of the patients about the impact of the clinic delays were also shared by the doctors 
as these factors affect their clinical interactions with the patients. In this regard, two of the 
doctors reported that the long waiting period that the patients endure before they meet with 
the doctors usually make them difficult to communicate with, as they are either angry or eager 
to leave the hospital at that time. One of the doctors emphasised that the long waiting period 
in the clinic occurs because there is no limit to the number of patients they attend to every 





“and the queue is so long in the clinic that it takes time before you even see all of 
them. so, when they are coming, some are already angry that they've been kept 
waiting.”. (A female Doctor, X008).  
“I think it is ……... because some of them don't really get what you are telling them 
and in a bit to rush up so, you just ah...they want to go as they actually came long 
through waiting for the whole crowd and all. they will just be telling you yes, 
……...and in our centres, most of our clinics are fully ehm packed. you know, … 
we don't have a limit to the number of patient's we see in a day”. (A female Doctor, 
X006). 
Meanwhile, one of the patients added that bribe collection takes place leading to favouritism 
by some of the records officers. Bribe collection by the record officers result in queue jumping 
in the clinic; a claim that was supported by other patients.  
“….. the record people, they are not even helping matter kind of. They are not 
doing their job, maybe kind of searching for the file, that we are, this ehn patients' 
file. they will be there looking for money. those that will come and give them 
money. Maybe those people came early, they will not concentrate on those ones, 
instead they will be collecting money and then those will be waiting for a very long 
time. and if you don't give them money, you end up going, the last.” (A female 
Patient, Y004). 
“normally I will waste time, the…. folder will go to somewhere come back, I will 
wait”. (A female Patient, Y012).  
“all along it has not been so poor. until the recent issue with my record. when my 
folder could not be found…... aside from that, both the attention and everything 
has been fine”. (A male Patient, Y002). 
Lastly, besides the issue of clinic delay, some of the patients were also concerned about lack 
of privacy in the clinic. For instance, one patient emphasised how this bothers him, because 
he believes that the situation could result in unwarranted disclosure of certain information 
about him. 
“…that environment that we are used to attend to doctor is very eh, it's a poor 




together in that ehn hall…. that place is supposed to be...it’s not for everybody 
eh.... anybody can never know what happens there. But that there, only that is 
section of…. these people. So that is the bothering me.” (A male Patient, Y015). 
Patient-Clinician Relationship 
One of the doctors explained that the major problem they have when interacting with their HIV 
patients before the MI training is a power differential which makes the patients believe that the 
doctors cannot truly empathise with them and are only keen to instruct them to adhere to the 
medication.  
 “because the barrier we've… always have with patients is this doctor relationship. 
ehn doctor-patient relationship. where the patient sees the doctor as someone 
from afar. who doesn't know what he is going through and just issues orders on 
how to take his drugs” (A female Doctor, X008). 
The same doctor further attributed the perception of the patients about distrust of genuine care 
from the doctors during consultation sessions to high prevalence of stigma in the society. This 
was confirmed by one of the patients who emphasised that attitude of the clinicians makes 
them feel discriminated and that such feeling makes them distrust the intention of the clinicians 
to care for them, and sometimes makes them want to change clinic. 
“…. you know in our society, there is stigmatization. So, they feel you don't know 
what they are going through.” (A female Doctor, X008). 
“not just even the doctors. the nurses, their approach to the…. clients in the 
facility……... the way they answer people and eh, talk about, look at the people as 
if maybe they are not part of human beings……some clients for the session feel 
that maybe people neglected them, people are discriminating them, they are I 
mean, discriminating them and……when you feel, feel this kind of a thing, you are 
challenged. you think………nobody is here caring for you.” (A male Patient, Y007). 
“I remember ehm two months back, somebody was eh telling me about… ehm 
challenge of uhm, she suffered, I mean her time of coming to the facility and eh 
because of that the doctor was talking to her anyhow, and she felt that she would 
even, she should, would have even changed the…. hospital, there to another 





According to this same patient (Y007), evidence of the discriminatory attitude of the doctors 
and other health workers towards them is the communication approach. This view was 
corroborated by another patient who reported how sad they feel sometimes after 
communicating with the doctors, who also tend not to listen when they attempt to express their 
challenges.  
“sometime, when we talk to them, …. they don’t listen to what we are talking about, or 
understand what, what they are doing. so, when we are talking to them, they will be 
telling us sometimes that they are not responsible for our sickness. They will be telling 
us all sort of things that make us feel bad.” (A female Patient, Y020). 
However, there was evidence of significantly blurred boundaries between the doctors and the 
patients which emerged from the responses of the patients. For example, doctors go as far as 
trying to help patients resolve personal life issues apart from the health challenges, and by 
opening communication channels beyond the HIV clinic hours for the patients. 
“I tell all my em, my personal thing and it, and it, she said he will do, he will try to 
help me in some eh area. She even collected....my...wife number, because we 
have some issue. But I tell her everything. So….it made…….me…. happy.” (A 
male Patient, Y015). 
Unfortunately, the relationships that may engender blurred boundaries is not consistently 
experienced by all the patients, because some of them seem to have favourite doctors. Two 
of the patients confirmed this by referring to the level of attention and care that they usually 
get from specific doctors in comparison with others. 
“no, everything has been okay. the...uhm the doctor ****** or what is that her name 
******.……. she has been good to me. She has been trying her best as a mother. 
She did the work, she always do her work as a doctor”. (A male Patient, Y005). 
“I have not met a doctor, since I have been coming to ****, I have never met a 
doctor like that doctor before. Because of what that doctor does for me whenever 
I come to ****, like this, I always like to come and see her in the office. Because, 
she will let me understand, she will let me, she will tell me how I will…… that I 
should…...she will explain everything to me. She will listen, she will let me know 





7.4 Counselling Approach for Adherence 
There were two different existing approaches used by the doctors to motivate their HIV 
patients to adhere to their drugs prior to the MI training. These include: interactive and 
encouraging approach as well as a prescriptive approach.  
Interactive and Encouraging Approach 
Two of the patients reported that the doctors usually interact with them at a certain level that 
enables them to express their health concerns, without holding back. This pattern of 
consultation involves the doctors listening to and understanding the patients properly before 
taking any actions on their concerns, while pleading with them to adhere to their drugs. 
Although one of the doctors confirmed that they encourage the patients to take the drugs, she 
also stressed that merely encouraging the patient is not effective as the patients end up 
struggling to adhere to their medications after talking with them; a challenge which she 
attributed to a lack of a standard approach to motivate the patients. 
 
“whenever I visit them…. I will explain myself very well to them. they will give me 
time, ask me how am feeling and I will tell them everything.” (A male Patient, 
Y019). 
 
“whenever I... go there, the doctor used to talk to me pertaining the drugs…. they 
will plead with you to continue the drug, don't stop it….I..do ask some questions 
when…...I have any reaction and the doctor will now take time and explain to me. 
if there is anything you will do, he will now go ahead and do it. If there is any other 
thing, he will tell me I should go on with the drugs I should not stop it…...” (A male 
Patient, Y006). 
 
“but we don't really know how to encourage them to take their drug. So, it was 
quite an issue initially for them, for these patients to comply to their medication. 
there was no standard approach initially……we don't really have any approach. 
So, it was really kind of difficult. We just try to encourage them to take their 







Commanding and Prescriptive Approach 
Five of the patients reported that they are usually given instructions to adhere to the drug or 
how to take it by the doctors. Common use of this prescriptive and commanding approach was 
also confirmed by five doctors who emphasised that their usual approach is not collaborative 
but mostly paternalistic. 
“well the counselling was okay. from what they said. they said we should stop 
keeping anything. we should always keep to our drugs and…try to make 
necessary things that we know is good for our health.” (A male Patient, Y005). 
“uhm...actually, it was more of prescriptive……as in like a routine. It wasn't 
collaborative.” (A female Doctor, X009). 
“the usual approach was more of an….autocratic approach. you must take your 
drugs. you must take them every day.” (A female Doctor, X001).  
Moreover, some of the patients also emphasised that they receive the prescriptive instructions 
by being shouted at or being scornfully told to return to the same drug even when they 
complain about negative experiences with the drugs. This was corroborated by one of the 
doctors who pointed out that they commonly confront their non-adherent patients with their 
test results to motivate them to adhere to the drug.  
“the way they counsel people before. they always, shout” (A male Patient, Y005).  
“they normally just eh...even if you have complaint, they will say look at you.... go 
and take drugs. So, go... and collect the, just try….and take the drug.” (A male 
Patient, Y015). 
 
“we normally see our patients and ehm the normal thing we do is scold those 
patients who don't take their drugs…. So, most of the time …. we use most of their 
results to actually challenge them and talk to them on the need …for their 
medication.” (A female Doctor, X006). 
Meanwhile, two patients were concerned about the lack of interest of the doctors in their 
challenges. They emphasised that even though they may tell the doctors that they do not have 
any problems, they expect the doctors to show genuine interest by asking probing questions, 
which does not usually happen. This concern was also corroborated by four of the doctors 




and why they are not adhering to the medications.  
“normally they will ask me, do you have any problem? I will say no..and that is all.” 
(A female Patient, Y012). 
“they won’t even ask you much questions that you will be able to start telling them 
maybe this is the problem you are having and and this is your challenge, this or 
whatever this is.” (A female Patient, Y004). 
“but before, you don't want to know whether they were, they have side effects….to 
be sure whether they are not even keeping it and coming to collect the drug…to 
take their drug…. whether they will adhere or not……we just tell them, take your 
drug in the morning, in the evening. By ordering them. We don't even want to have 
their own feeling, that do they like taking drug, the drug that you'll take throughout 
your lifetime…” (A female Doctor, X005).  
However, the doctors seem to be dissatisfied with the prescriptive approach as two of them 
blamed the use of the approach on the low capacity of the clinic to meet the needs of the high 
population of patients that they attend to, which in turn limits the time that they could spend 
with the patients. 
“That's actually what we do, and most of the time…. we don't normally take out 
time to even sit down with the patient. you know. ask and know what …. problems 
do they have, that I can solve them and can help them solve them. ehm but 
because ehm, we normally have a handful of patients….” (A female Doctor, X006). 
“the usual approach is this. We have so many patients in the clinic, going into 
hundreds per week and we have few doctors, so we are pressed for time. As much 
as possible we try to…issue the prescription and at the same time reach out to the 
patient.” (A female Doctor, X008). 
7.5. Impact of MI Training 
Study participants had diverse perceptions about the MI approach after the MI training and 
their experiences during the practice sessions. These perceptions were in relation to the 
clinical consultation practice with the approach and satisfaction with the approach. 
Practice Change 
While the patients observed certain differences in the practice of the doctors during the 




practice. For instance, patients reported feeling valued and accepted after the MI practice 
sessions. To some of the patients, the approach of the doctors in the session made them feel 
free of discrimination. According to the patients, this feeling goes beyond the clinical setting 
and they attributed this experience to the pattern of discussion they had with the doctor 
through which they felt like they were talking with someone who is keen to listen to and 
understand them. This report was corroborated by the doctors who reported that due to the 
MI training they tend to listen more to their patients during the consultations for ART. 
“I feel at home that very day. I was very very okay……the way she treat and eh 
she attended to me, make me…to come out bold….and say my mind out. and I 
feel like I belong to the society. So, I was very happy. So, I think that helps me a 
lot.” (A male Patient, Y007). 
“because I feel like somebody is ready to listen to me and she is ready to advise 
me……. So, I believe, she herself as, that attended to me two days back her mind-
set……make her to even listen to me, and attend to me, the way…I feel like they 
should be doing to other.” (A male Patient, Y007). 
“the counselling approach during this eh study ehn, was the…. Motivational 
Interviewing, which actually helped us to, ehn to that the patient, that we should 
listen more…. to these patients. So that makes the patients to be more 
responsive……and overall we also found out that eh it also saves time because 
we were able to listen more to the patients than we doing all the talking.” (A female 
Doctor, X005). 
Moreover, the patients observed certain differences in the attitudes of the doctors during the 
practice sessions which includes respect and an increased level of attention from the doctors 
to their concerns. This observation led the patients to emphasise that they would prefer that 
the same doctors attend to them every time. 
“what eh really happened with me, with my doctor in the session was, the doctor 
was nice….I am just recommending it….like one-on-one with my doctor yesterday 
was different to the other ones….we've been having… the particular one with the 
one yesterday was ehn he give us attention. He carefully explain everything to us, 
and to me especially.” (A male Patient, Y001).  
“in fact, as I see the one I met yesterday, with the previous one. In, fact, I even told 
her yesterday, why not she will be the doctor that will always attend to me. 




doctor they are not...doing good. they are doing good. but in the manner, the way 
she talked to me. She call me, she talked to me.” (A male Patient, Y006). 
Another shift in the practice approach of the doctors identified by the patients is in respect of 
the questions asked by the doctors. However, what was more appealing to the patients was 
not just the questions but how the questions revealed the interest of the doctors beyond their 
drug or health status to certain aspects of their personal lives that could affect their drug-taking 
behaviour or health outcomes. The doctors corroborated this practice change due to the MI 
training by emphasising the benefits of using open-questions during their consultation 
sessions. For instance, one of the doctors found it helpful to overcome common barriers to 
communication with their patient during clinical consultations as well as helping her to learn 
how to be respectful when asking the questions.   
“…ask about my family. Ask about my condition, the how drug is working in my 
body. So, the doctor attend to me very well……. that doctor that attend to me that 
day...I attend the hospital talk to me very well and attend and ask everything, even 
my … own personal problem which can cause drug not to work.” (A male Patient, 
Y015). 
“and they are more polite ways of asking these questions, as in from the MI, it's 
like would you like this?....MI study actually ehm..helped us to, you know, bring up 
lots of factors that, drawing out lot of factors that may have been causing you 
know, some...some breach in the communication pattern and the benefit to 
patients and also to doctors.” (A female Doctor, X006). 
Due to the doctors’ improved questioning approach, some of the patients were very pleased 
with the responses of the doctors to other aspects of their lives. Such aspects of their lives 
include fear of job loss due to stigmatisation, lack of job, family issues and social relations. 
This change in practice was confirmed by one of the doctors who reported how she focused 
discussion on stigma related issues with a patient, because that was the problem she identified 
during one of the MI practice sessions. 
“but I complained bitterly with her yesterday pertaining my job. sometimes they 
use to…. when you tell your...boss in the office, this is what you have. it will result 
to... a certain time that they will even sack you. But when I discussed this with her 
yesterday, she say whenever all these kind of situation happen I should let the 
doctors know about it. and they will know about that situation immediately in my 




this one am doing now.” (A male Patient, Y006). 
“Like there one of the patients that I say, that the problem was the social stigma.” 
(A female Doctor, X006). 
Furthermore, some of the doctors reported learning how to collaborate and empathise with 
their patients with the aim of improving adherence to medication based on the use of MI skills. 
For instance, they started collaborating more with and involving the patient’s view in making 
decisions on how to achieve medication adherence. However, in respect of empathy, one of 
the doctors stressed that the MI training did not only make her realise the need to empathise 
with HIV patients but also with all patients with chronic conditions.  
“another thing again was about the change talk and where, where…. allow them 
to move to, tell us what they wanted, and eh how they will go about it, and we also 
reason together… how they feel they will be able to adhere to their treatment.” (A 
female Doctor, X005).  
“I was able to see things from the patient's perspective……particular set of 
patients …. with all the patients that have ……. chronic diseases, that requires 
long term management. It has helped me to be able to see things in their 
perspective.” (A female Doctor, X001). 
Lastly, while the patients observed that they were enabled to express themselves during the 
MI practice sessions compared with their previous consultation experiences, the doctors 
reported learning how to better motivate their patients to adhere to their treatment through the 
MI approach. For instance, the patients were not only able to express themselves freely in the 
practice sessions, but they were also able to discuss their major concerns with the doctors.  
“and I was able to open up to her more than what …. I've been doing before that 
very day…. the way she treat and eh she attended to me, make me to be bold, to 
come out bold and …. say my mind out.” (A male Patient, Y007). 
“I express myself that the only reason that the only thing that …. could make me 
fear kind of is just that particular problem of recording, record people that are the 
one giving us the stress…. I could really express myself yesterday, unlike other 
days.” (A female Patient, Y004). 
 “well, initially we actually have no approach. but uhm most of the counselling…. 




……so now, we have a proper approach with the use of the MI….” (A female 
Doctor, X004). 
However, apart from practice change during the consultation sessions, changes arising from 
the MI approach occurred in respect of the inconsistent standard of consultation approach 
among the doctors and how widely the approach could be needed in the study context.  
Equalised Practice 
The doctors reported that the MI skills that they learnt during the training made the clinical 
consultation approach among them to be equitable. For instance, one of the doctors noted 
that before the MI training, patients usually have favourite doctors that they prefer to meet for 
their clinical appointments because they believed that only such doctors could meet their 
consultation needs. However, the preference for certain doctors among the patients no longer 
occur because they all seem to be practising the MI techniques which engender empathy. 
“because ehm, we feel like, before the MI, when the patient comes, is like spending 
more time ehn with them. that was like ehm eh, one eh whether two doctors is 
better and the patients will want to choose them, will want to go to that person. but 
after the MI training, we found that…. we even apply it to all our patients across 
board……in fact, they don't have to start choosing that they want to see this doctor, 
they want to see that doctor. but it now cuts across board. that all of us that went, 
that did the training, because we are now applying, and the patients now saw…” 
(A female Doctor, X005). 
Domino Effect 
Skills that the doctors learnt from the MI training were not only applied with HIV patients, but 
they started using them with other patients with chronic conditions such as hypertension and 
diabetes to motivate them to adhere to their medication. Moreover, one of the doctors also 
noted that contrary to what happened before the MI training and irrespective of what chronic 
condition their patients suffer from, the patients now feel more comfortable with the 
consultation approach of the doctors. This is even though the doctors were trained to use MI 
to promote medication adherence among their HIV patients for the study. This same doctor 
emphasised that the need to sustain adherence counselling for the patients after they have 
initiated treatment became obvious because of the MI skills that they learnt from the training. 
She stated that before the study, once the patients have been counselled about the drugs 
before they started treatment, the doctors no longer believe that the patients may need support 




view among the doctors. 
“…. I actually don't think this MI, the...approach should be just for HIV patients. We 
can also use it for other patients like ehm other patients that, diabetic patients. We 
use it to encourage them to take their medication and ehm hypertensive patients.” 
(A female Doctor, X004).  
“whether they are diabetic patients or hypertensive patients that the patients now 
feel more relaxed……. now we counsel them, the counselling is ongoing. at every 
visit we counsel them to adhere to their drugs, and before then, in fact, once we 
have counselled them we don't bother counselling them anymore. But now we 
found the need that counselling must be sustained. So, we don't just counsel them 
…. before … the testing… or before the treatment begins, but we found out that it 
is an ongoing ehn counselling approach…...” (A female Doctor, X005). 
Satisfaction with Practice 
The MI approach was mostly well accepted among the participant groups in the study and the 
participants stated diverse reasons to support their satisfaction with the approach. For 
instance, some of the doctors stated that the MI approach was very easy to use, and they 
found no aspect of it difficult to practice. They further stated that they had to shift from their 
previous consultation approach to the use of MI because they got better consultation 
outcomes with their patients in respect of communication. However, two of the doctors pointed 
out some difficulties that they encountered while using the MI. One of them noted that the 
approach was difficult to use because the patients decide the trend of the discussion in MI, 
but she further stressed that she felt the need to adopt the MI approach ahead of her previous 
approach because of the patients’ better responses. The second doctor pointed out that she 
found the MI approach difficult to practice because she is meant to share treatment decision 
making with the patient. To her, this makes the approach difficult because she believed that 
treatment of HIV has a narrow range of options unlike other diseases. 
“I don't think there is any aspect that actually was difficult…. it was quite an easy, 
in fact, since we have started applying……it's so much better for us... it's very 
easy.” (A female Doctor, X005). 
“…. it’s the client that are the...important, as in they determine what we are going 
to do with them. So….it was difficult quite alright, but I still feel they responded 
better to MI approach. I didn't see any reason why I should use the former 




interviewing.” (A female Doctor, X009). 
“well the part that was a little difficult was asking the patient to pick option. because 
there ain't, there aren't so many options to the patient's care as regard drugs or 
what to do in HIV infection.” (A female Doctor, X008). 
While some of the doctors stated having slight difficulties with the use of the MI, responses 
from eight of the patients revealed that they were all satisfied with the approach used by their 
doctors during the practice sessions. Specifically, one of the patients emphasised that if HIV 
patients have similar experience as he had with his doctor during the practice session, they 
will not be feeling shamed and stigmatized as they usually experienced before the study. This 
statement is consistent with the response of another patient who stressed that unlike the 
practice session that he attended for this study, he has concerns to talk about in respect of 
the previous consultation approach in the clinic. 
“if I have a patient, or have a client, or myself being to the facility and somebody 
attended to me that way she attended to me, I don't need to…. I mean come back 
with some of these things that maybe sometimes you go to facility and you see 
some people crying, some people coming back to regret why they are still alive. 
So, that very day was a very good day to me. Meeting with her and the way she 
spoke to me, I mean I was like should be the person I will always be meeting 
there.” (A male Patient, Y007). 
“the only thing that cannot, uhm…. satisfied with is that ehn...nothing…for the last 
one, if it was before, I have issue that I want to talk about, but for the last one that, 
ah doctor attended to me very well...” (A male Patient, Y015). 
Preferred MI techniques 
Interest of the doctors in the MI approach and the retention of the knowledge that they got 
from the MI training further demonstrates the extent to which they were satisfied with the 
approach. For instance, the six doctors who responded to the post-practice interviews recalled 
at least one MI technique and spirit that they learnt from the MI training and they described 
the purpose of the stated techniques. Commonly recalled skills among the doctors include: 
open-questions; confidence ruler; focusing; agenda mapping; identifying change talk; 






“I could remember the reflection aspect. I could also remember the open 
questions. we also talked about …. confidence ruler.” (A female Doctor, X004).  
“remember the spirit of eh motivational interviewing, most especially the aspect of 
eh asking an eh open ended question, and then ehm also finding the OARS ehn 
ehn. so, I think OARS- affirmation, reflection, then before we summarize…..with 
the MI approach the… DARN CAT approach change talk.” (A female Doctor, 
X005). 
Apart from retention of knowledge, some of the doctors favoured using certain techniques in 
practice. Two doctors favoured using open-ended questions, one of them favoured using 
confidence ruler and reflection, while affirmation was favoured by another doctor.  
“almost all the areas of the study were actually useful for my work, but …. I really 
like the confidence ruler because it actually helped us and guided us to engage 
these patients in making decisions. So, that was also a very good aspect for us. 
then, also on the reflection aspect.” (A female Doctor, X004) 
“as in, ever since the MI training. I've been using it a lot. you know, I noticed that 
when you ask the, when you give the question that is not direct, with patients about 
his or her problems, you tend to get more answers from them than when you are 
…. direct about it.” (A female Doctor, X006). 
Hybrid Approach 
There are indications that the doctors may not be adequately motivated to use the MI approach 
consistently with their patients, due to a prevailing perception about adherence counselling for 
ART among the counsellors. This perception is associated with the belief that not all HIV 
patients require the patient-centred approach of MI. In this regard, the doctors felt that they 
would only need to apply the MI approach if they consider that the patient’s circumstance does 
not require the existing approach to counselling in the clinic. Moreover, the doctors also want 
to decide how much of the MI techniques they need to use with the patients, even when they 
consider a patient’s circumstance suitable for the approach. For instance, one of the doctors 
suggested that application of the MI approach may be appropriate only when the patient is 
having issues with medication adherence and that they may have to select only few MI skills 
to use depending on the circumstance of the patient. This view was shared by three other 
doctors, among which one confirmed that she was not using the MI techniques 
comprehensively with all the patients she attended to but with only those she felt needed it. 




due to the high patient population that they attend to. This suggests that apart from the 
perception of the counsellors, low capacity of the clinic which makes it difficult for the doctors 
to adequately meet the needs of the high patient population may also affect the consistent 
application of the MI approach. 
“but we can actually use it, just that we won't use all, maybe we summarise some 
aspect of the study just take some key point and still use it for patient. so, like 
maybe I have a patient in front of me and the patient does not have any issue with 
his medication, am not going to be applying the….MI approach for that particular 
patient.” (A female Doctor, X004). 
“what I do with all the patient is that, ehm...I don't, I don't go in deeply with every 
patient. those that I feel, that will need…. some motivational interviewing … I carry 
it out for them.” (A female Doctor, X006). 
“if we have…… a more…. appropriate setting where we don't have such a large 
patient load, then it will be easier to go through all the … techniques of the……. 
motivational interviewing…… sometimes we might want to be nice but because of 
the pressure of work, there is always that tendency to reduce to trying asking 
questions concerning taking their drugs.….” (A female Doctor, X001). 
Time 
Time barrier was cited as a major concern to the possibility of practising MI in the clinic by 
some of the doctors. Four of them indicated that use of MI with all their patients will lead to 
longer clinical waiting time, because the MI approach takes longer time than their prescriptive 
approach, which may discourage their patients from coming to the clinic. Meanwhile, this time 
barrier is a longstanding threat to patient retention and engagement in the clinic context and 
it appears to be beyond the control of the doctors because it is associated with the low capacity 
of the clinic in respect of staff strength to meet the needs of the high number of patients that 
they attend to.  
“you know the patients that we have over here in Nigeria, there is quite a lot of 
patients. So, if we want to be using it on a very friendly its going to create more 
time, more patients waiting. and it's going to discourage some patients from 






“…… it's the time it takes…...I said it's so much easy to just oh! this patient is a, 
okay, what drug are you on? And just write the drugs and everybody goes….MI 
will take longer” (A female Doctor, X008). 
“that's the only part that makes it difficult to practice in our own setting…. where, 
time for our patient is actually very small.” (A female Doctor, X006). 
7.6 Chapter Summary 
This chapter has presented four main themes as well as the sub-themes that emerged from 
the qualitative data obtained from both study participant group (counsellors and HIV patients). 
The chapter discussed the prevailing socio-cultural and organisational factors that affect the 
existing approach to ART adherence counselling in the study context. Within this context, the 
prevalent consultation approach used to support the patients to take their drugs is largely 
commanding and prescriptive with few evidence of the use of encouragement. The chapter 
also found that although the MI approach was well accepted by both participant groups, the 
counsellors also found it very helpful for their practice. However, the prevailing organisational 
and socio-cultural constraints in the study context as well as the perception of some of the 
counsellors to HIV treatment support affected how they perceived the use of MI for routine 





















CHAPTER EIGHT: SYNTHESIS OF STUDY FINDINGS 
8.0 Chapter Overview 
This chapter presents an integrated synthesis of the quantitative and qualitative findings from 
the study to meet the four research objectives. The chapter therefore focuses on discussing 
the situation of the current approach to ART adherence counselling in practice in Nigeria, 
fidelity of the adherence counsellors to MI, acceptability of the approach in Nigeria and the 
factors that facilitate or inhibit its routine application.  
8.1 Current Approach to ART Adherence Counselling in Nigeria 
The qualitative findings in this study revealed that the prevailing approach used by the 
adherence counsellors to motivate HIV patients to adhere to HIV drugs in the study context is 
commanding and prescriptive with no focus on the assessment of adherence. The counsellors 
use this approach because they do not have a standard approach to motivate the HIV patients. 
However, the qualitative findings also show that the adherence counsellors were dissatisfied 
with the commanding and prescriptive approach, because they found it to be ineffective for 
their line of work.  
Lack of a standard approach is only a part of the challenges faced by the counsellors, because 
another part of their problem is that the existing approach is practised within a context plagued 
with both socio-cultural and organisational constraints. In this regard, the qualitative findings 
revealed that the counsellors deal with HIV patients who struggle with myriads of needs, top 
of which is their individual financial challenges. Apart from the difficulty faced by the 
counsellors to motivate the patients to adhere to their treatment due to the imbalance of priority 
created by financial challenges, some of the patients do not turn up for the ART consultation 
session because of the cost of transportation. Therefore, on one hand, the poor state of the 
economy of the country leading to lack of affordable public transport for most of the HIV 
patients who could not afford the available means of commercial transport contributes to 
making the job of the counsellors difficult. On the other hand, the qualitative findings have also 
shown that high prevalence of stigma and discrimination in the country prevents most of the 
HIV patients from getting employed to afford the available means of public transportation. 
Hence, even though the economic situation of the country and the financial challenges of the 
patients as well as the prevalent stigma and discrimination for HIV in the country are beyond 
the control of the adherence counsellors, these social-cultural factors affect the quality of their 
practice. 
Moreover, the qualitative findings show that without any standard and effective approach, the 




are primarily rooted in religious interventions instead of the medical approach that involves 
use of medications and adherence counselling. Therefore, the counsellors resort to the use of 
a power-based commanding approach to motivate the patients. Consequently, the counsellors 
face the problem of distrust from the patients due to power imbalance between them and the 
HIV patients. This power imbalance could be associated with the huge gap in the educational 
attainment between the counsellors and patients that is evident from the quantitative findings. 
The qualitative findings further revealed that counsellors are expected to motivate HIV patients 
who are very anxious to leave the ART consultation session or are angry because of the long 
waiting period in the hospital before they could have a chance to meet with the counsellors. 
While the long waiting period is primarily due to long queue resulting from high patient 
population, it is also due to favouritism engendered by bribing. In respect of the patient 
population, the qualitative findings revealed that stigma and discrimination contribute to the 
high number of patients who visit the clinic, because most HIV patients come to the clinic to 
avoid using the hospitals in their own communities. Unfortunately, the capacity of the clinic to 
meet the needs of the high population of patients is low in terms of staff strength. This can be 
corroborated with the quantitative data which established that the 785 HIV patients who 
presented in the clinic during the recruitment period were attended to by only seven doctors 
and a nurse, with an average of 112 patients per doctor per month. Despite this huge workload 
burden, the adherence counsellors are expected to provide each of the patients with good 
quality ART consultation session which includes effective adherence counselling.  
Although the burden of the workload due to the low capacity of the clinic on the practice of the 
counsellors is enormous, the patients in turn bear the consequence as they end up receiving 
a consultation time with poor quality. This is despite waiting for a long time in a corridor which 
may expose their health status to other community members who use the same corridor. The 
qualitative findings corroborate this threat in respect of the corridor by revealing the concerns 
of some of the patients about the likelihood of unwarranted disclosure of their health status 
due to the openness of the corridor.  
Lastly, this study revealed that the patients lack agency despite the high level of stress that 
they experience while accessing their routine HIV treatment support services. Due to lack of 
agency for the patients, the qualitative findings revealed that they became selective by 
demanding to see specific doctors that they believe could offer them a more interactive ART 
consultation session. The patients also resort to bribing to avoid the long queue in the clinic. 
Unfortunately, most of these patients struggle to earn a living due to the stigma and 
discrimination associated with their health condition, which prevents them from getting or 




expedite their consultation slot with the adherence counsellors who were not empowered with 
a standard approach to motivate them in consultation rooms that do not promote 
confidentiality.  
8.2 Fidelity of the Counsellors to MI 
Within the same context for the commanding and prescriptive approach to ART adherence 
counselling, the counsellors failed to achieve optimum fidelity to MI in respect of MI spirit and 
percent MI-consistent responses. However, statistically significant improvement in skills were 
demonstrated by two of the counsellors over the time points assessed in the study (the first 
and last practice sessions). Within the same period, two other counsellors lost significant 
quality of skills that they achieved from their first sessions. While these findings show that the 
adherence counsellors can use the skills of MI, they may struggle to practise the approach 
with optimum fidelity without further training support. These quantitative findings also revealed 
that the adherence counsellors can use the techniques of MI within their practice setting 
regardless of the language and cultural differences between them and the patients. This is 
because the counsellors practised the approached by using English and the local languages 
which include Hausa, Yoruba and Pidgin. Therefore, it can be inferred that this pattern of 
findings confirmed that the processes and methods of MI fit well with the numerous languages 
in Nigeria. 
8.3 Acceptability of MI among Study Sample 
There was a high level of enthusiasm about the MI approach among the adherence 
counsellors. This was evident in the quantitative findings in respect of the attitude of the 
adherence counsellors to the MI training activities and the frequency of use of the approach 
by each doctor with minimum of two MI practice sessions (coinciding with routine clinical 
sessions for the patients) during the period of the study. Some of the doctors used the 
approach during four sessions, while one doctor used it three times. The qualitative findings 
further corroborated the evidence of enthusiasm by revealing the extent of knowledge that the 
counsellors retained after the MI training and the declaration of some of the MI techniques as 
the preferred techniques by the doctors. The preferred techniques were found to be very 
relevant to the line of work of the adherence counsellors  
In addition to the enthusiasm of the counsellors, the qualitative findings show that there was 
a widespread satisfaction about the MI approach among the study cohorts (the six doctors 
and eight of the 12 HIV patients) irrespective of the low MI quality of the practice sessions. 
This level of satisfaction was associated with how the MI approach addressed most of the 




instance, the impact of the MI approach on the practice of the counsellors helped them to 
change the perception of some of the HIV patients about stigma. The approach also helped 
to bridge the power gap between the counsellors and HIV patients. Contrary to the 
inconsistent occurrence of blurred boundary between the adherence counsellors and patients 
before the study, the MI approach elicited a consistent approach to counselling among the 
doctors which eradicated the need for patients to be selective about who attends to them. The 
MI approach also helped the patients to freely express themselves within a collaborative 
consultation session, which was in stark contrast to their routine experiences before the study. 
More importantly, the MI approach provided the counsellors with a standard approach to 
motivate HIV patients which they found to be more efficient than their previous approach to 
counselling. This discovery and empowerment of the counsellors led to the application of the 
approach in consultations sessions with all other patients with chronic conditions, even though 
such practice extension was not required for this study. These influences of the MI approach 
on the practice and experience of the counsellors and patients respectively suggests that the 
approach is not only consistent with the cultural and contextual views of the adherence 
counsellors and HIV patients but can also improve them. Despite all the positive influences 
that the MI had on ART consultation practice in the study context, the qualitative findings 
revealed that some of the counsellors may not use the approach for routine practice because 
of some inhibiting factors.   
8.4 Facilitators and Inhibitors to the Routine Application of MI 
Critical realism emphasises the need to identify the underlying mechanisms that influence the 
observed regularities (Bryman, 2016, p.25). The regularities in focus for this study are the 
fidelity and acceptability of MI in Nigeria. Taking these regularities as the points of departure, 
the quantitative and qualitative findings in this study revealed the influence of different factors 
on the fidelity of the counsellors to MI and the acceptability of the approach in the study setting. 
Fidelity: The quantitative findings show that the adherence counsellors will need more training 
support to use the MI approach with optimum level of fidelity as well as to enable them to 
retain that level of skill. In this regard, it could be argued that the MI training may either be a 
facilitator or an inhibitor to the routine implementation of the approach, depending on the 
extent of the training support needs of the counsellors and how much of that need is met. This 
is because despite the overall low level of fidelity to MI among the counsellors in this study, 
some counsellors achieved a progressive pattern with the use of the approach while others 
declined, except for one who did not achieve any change in skills during the period of the 




with a group of trainees with wide range of abilities, the training needs of the adherence 
counsellors in this study will be different.  
Furthermore, this study found no correlation between the fidelity of the counsellors to MI with 
the time spent on each session, the language (s), and the length of clinical experience. Despite 
the lack of correlations, the quantitative findings revealed that the acceptable communication 
pattern in Nigeria which permits the use of hybrid of languages within a conversation facilitated 
the use of the MI skills applied in each session. This was especially valuable between the 
doctors and patients who could not use English properly. However, the qualitative findings 
show that perception of some of the doctors about the adherence support needs of patients 
could have contributed to the observed low level of fidelity among the counsellors. Therefore, 
hybrid of languages could facilitate routine practice of MI, while the perception of the 
counsellors could have an inhibiting effect on their fidelity to the approach. 
Acceptability: The qualitative findings show that despite the widespread satisfaction with the 
MI approach, the adherence counsellors may not be willing to use the MI approach due to 
their perception about ART adherence support and low capacity of the clinic in terms of 
numbers of counsellors. Although the burden resulting from the low clinic capacity could be 
attributed to the organisational policy and structure that failed to make provisions for adequate 
number of the clinical staff, it is also associated with stigma which contributes to the high 
population of patients visiting the clinic. However, because the use of MI addressed some of 
the pre-existing problems associated with ART consultation sessions in the study setting, 
which largely influenced satisfaction with the approach it could be inferred that the spirit and 
techniques of MI facilitated its acceptability among the study groups. Therefore, while 
perception of the counsellors and low clinic capacity are inhibitors to the acceptability of MI, 
the MI approach itself facilitated its acceptance in the study. 
Based on the above findings and guided by the retroductive reasoning for critical realism, 
figure 8.1 presents a complete hypothetical model for the feasibility of MI in Nigerian clinical 
setting for HIV treatment adherence. This model shows the connections between the identified 
generative mechanisms (facilitating and inhibiting factors), the observed regularities and the 
feasibility of the application of MI in Nigeria. Besides the identified generative mechanisms 
and after excluding the other contextual constraints that the study has shown that the use of 
MI can address, this model also presents the remaining contextual constraints that the study 
has not established a direct connection with in respect of the MI practice session. However, 
this study has established direct connections between the outstanding contextual constraints 
and the routine ART consultation sessions. These outstanding contextual constraints include 




constraints and Stigma. Although the outstanding contextual constraints have the potential to 
influence the quality of the ART counselling session whether MI or the commanding and 
prescriptive approach is used, this study found only an association between stigma and one 
of the identified generative mechanisms. Lastly, despite the influence of MI on anticipated 
stigma from the HIV patients as observed in this study, the high prevalence of stigma in Nigeria 
means that HIV patients will still be subjected to stigma by other health practitioners who were 
not trained to use MI or by the enacted stigma in the society. 
Figure 8.1 Hypothetical Retroductive Model for the Feasibility of MI in Nigeria 
 
8.5 Chapter Summary 
By triangulating the quantitative findings with the qualitative findings obtained from this study, 
this chapter has presented the synthesised findings that addressed the four research 
objectives. In this regard, this chapter has presented the situation of the current approach to 
ART adherence counselling in practice in Nigeria, fidelity of adherence counsellors to the MI 
approach, acceptability of the approach in Nigeria and the factors that may facilitate or hinder 




CHAPTER NINE: DISCUSSION 
9.0 Chapter Overview 
This chapter presents an integrated summary of the study findings and their relevance in 
relation to existing knowledge. The chapter further discusses the strengths and the limitations 
of the study.  
9.1 Integrated Summary of Findings  
The main purpose of this study is to determine whether MI can be used for ART adherence 
counselling or consultation sessions in the HIV clinical contexts in Nigeria. In this regard, this 
study has provided knowledge about the ability of ART adherence counsellors in Nigeria to 
practise MI with optimum fidelity. It has also provided knowledge about how acceptable the 
MI approach is in the HIV clinical setting for ART adherence counselling. Lastly, the study has 
also provided knowledge about the contextual and cultural factors that could facilitate or inhibit 
the application of MI for ART adherence support in Nigeria. The findings from this study 
contribute to knowledge in numerous ways which are discussed in relation to existing bodies 
of knowledge in the next few sections. 
9.2 Fidelity to MI in Nigeria  
Findings from this study revealed that the ART adherence counsellors struggled to achieve 
optimum fidelity to MI. This difficulty at achieving fidelity to MI after training is consistent with 
reports from previous studies that were carried out in different countries including South Africa, 
USA and Sweden (Allicock et al., 2017; Bean et al., 2012; Bohman et al., 2012; Dewing et al., 
2013; Dewing et al., 2014; Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011; Mullin 
et al., 2015; Ostlund et al., 2015; Eno et al., 2016). Meanwhile the sub-optimal level of fidelity 
in this study, the skills of some of the adherence counsellors improved over several practice 
sessions without further training or supervision. This pattern of finding is supported by the 
findings of another study that explored the fidelity of lay ART adherence counsellors to MI in 
South Africa (Evangeli, Longley and Swartz, 2011). The study demonstrated that MI skills of 
health practitioners can improve over time after initial training without any supervision and 
feedback session (Evangeli, Longley and Swartz, 2011). Conversely, studies of trained 
African-American peer counsellors (Allicock et al., 2017) and probation officers and 
community correction counsellors without specified racial background (Miller and Mount, 
2001) in USA have shown that trained therapists may not only struggle to retain their MI skills 
but also tend to revert to baseline skills level. Hence, the fidelity challenge observed in this 
study may not be due to the racial or ethnic background of the counsellors but because 




suggests that transferring of MI skills from training to practice may be more difficult among 
health practitioners trained to practise the approach with clients in the treatment context 
compared to therapists trained to use the techniques in controlled research settings. In 
recognition of the difficulty to learn the complex skills of MI, Miller and Moyers (2006) propose 
an eight-sequential stage model to learn the approach, which involves learning the earlier 
stages as a prerequisite before moving on to the more complex and more specific latter skills.  
Despite the low fidelity to MI among the counsellors in this study, significant improvement in 
the skills of some of the counsellors indicates that they might have the potential to achieve the 
optimum fidelity threshold if provided with skills enhancement support such as supervision 
and feedback (de Roten et al., 2013; The Health Foundation, 2011, pp.17-19) or booster 
training sessions (Dewing et al., 2014). Although evidence from a meta-analysis has 
demonstrated that skills of therapists may improve with or without feedback, it also suggests 
that feedback improves the skills of MI trainees on an average scale (de Roten et al., 2013). 
This has been confirmed among South African lay adherence counsellors who were exposed 
to a booster training session and supervision a year after initial training in South Africa (Dewing 
et al., 2014). Skills of the lay adherence counsellors in the study increased in many MI indices 
compared to slight improvements observed among lay counsellors in another South African 
cohort without the booster training and supervision (Evangeli, Longley and Swartz, 2011). 
However, counsellors in this current study were not exposed to such skill enhancement 
support. It can therefore be safely assumed that counsellors in this study could consistently 
practice MI with optimum fidelity if provided with ongoing MI skills enhancement support.  
The observed skills improvement over sessions among counsellors in this study has shown 
that skills enhancement support to improve MI skills also requires continued practice 
opportunities. This pattern of finding is supported by the findings from a South African study 
without a booster session and supervision. In the study, there were improvements in some MI 
indices among lay counsellors who remain employed 12 months after the MI training 
(Evangeli, Longley and Swartz, 2011). This pattern of findings is consistent with the argument 
made by Emmons and Rollnick (2001) that it is only with practice and experience with use of 
MI strategies that practitioners will be able to consolidate and refine their counselling skills. 
Hence, counsellors in this current study have the potential to improve their skills over time till 
they achieve consistent and optimum fidelity to MI if they remain in service to continue 
practising the MI skills when supporting their patients on daily basis.  
Meanwhile, findings from this study did not establish a valid association between the lengths 
of experience of the counsellors with their fidelity to the MI approach. Impact of the length of 




related knowledge, attitude, and behaviours after ten years of interprofessional workshops 
among health practitioners from diverse occupational roles (Cook et al., 2017). In the study, 
years of clinical experience predicted MI-consistent attitude among the cohort (Cook et al., 
2017). Evangeli, Longley and Swartz (2011) also found a positive and significant association 
between length of practice and fidelity of counsellors to some MI indices. While, evidence from 
these two previous studies are not sufficient to generalise, findings from this current study 
suggests that there is a possibility that MI could be used by health practitioners irrespective of 
their length of clinical experience. This is revelvant to the increasingly popular task shifting 
strategy which involves reassigning of certain tasks to health workers with shorter training and 
fewer qualifications to optimize the available human resources for the care of HIV patients 
(WHO, 2016, p.262). Unfortunately, the findings of this study revealed that contrary to the 
practice in South Africa in which lay counsellors carry out the ART adherence counselling for 
HIV patients (Dewing et al., 2013; Dewing et al., 2014; Dewing et al., 2015; Evangeli et al., 
2009; Evangeli, Longley and Swartz, 2011), such extent of task-shifting implementation has 
not been reached in the Nigerian context as there was no involvement of lay counsellors in 
the HIV treatment consultation.  
9.3 Acceptability of MI in Nigeria 
The prevailing counselling approach identified in this study for ART adherence during HIV 
treatment consultation is commanding and prescriptive. This finding indicates that while 
adopting the global focus of increased treatment coverage via universal access to the ART for 
all HIV patients (WHO, 2016), practice in the Nigerian clinical setting is more focused on the 
treatment prescription with little or no attention to whether the patients take the drug as 
expected or not. This is not unique to the Nigerian setting as similar findings have been 
reported in qualitative studies in South Africa (Coetzee, Kagee and Bland, 2016; Dewing et 
al., 2012). For instance, Coetzee, Kagee and Bland (2016) reported that the routine 
counselling provided for caregivers of children who are receiving HIV treatment in South Africa 
consisted of attendance recording, reporting of test results to the caregivers, emphasising 
dosing times and asking caregivers to name medications and dosage amounts. Meanwhile, 
the HIV caregivers were seldom asked to demonstrate how they measure the medication and 
they were not probed for problems regarding the treatment even when the test results reveal 
unsuppressed viral load (Coetzee, Kagee and Bland, 2016). Dewing et al. (2012) also reported 
that although Egan’s client-centred “Skilled Helper” counselling model is the predominant 
model used for HIV treatment counselling in Cape Town, the lay adherence counsellors in 
their study neither adhered to the Egan’s model nor to a client-centred approach to 
counselling. Rather, the counsellors mainly used information-giving and advice as strategies 




for ART adherence counselling in Nigeria and South Africa, which are the two countries with 
the highest burden of HIV/AIDS (UNAIDS, 2017) is at variance with the patient-centred 
approach recommended by the WHO (2003, p.3). However, the adherence counsellors and 
patients in this study were not satisfied with the prevailing commanding and prescriptive 
approach. 
Contrary to the views about the commanding and prescriptive approach, this study found that 
the adherence counsellors and HIV patients were all satisfied with the MI approach. The 
unanimous satisfaction about MI confirms the view of Miller and Rollnick (2013, p.349) that “it 
stretches the imagination to think of people who do not appreciate being welcomed, heard, 
understood, affirmed, and recognised as autonomous human beings”. They argued that 
because good listening crosses cultures well, these features of the MI are universally valued 
(Miller and Rollnick, 2013, p.349). Their argument was further corroborated in this study 
because the HIV patients preferred the MI approach to the prevailing approach to counselling 
in their HIV clinic irrespective of the low quality of the MI sessions. This indicates that 
application of some of the MI techniques was sufficient to meet the needs of the HIV patients 
in Nigeria. In this regard, the observed satisfaction with MI in this study was associated with 
the positive impacts of the approach on the consultation experiences of the patients and 
counsellors. These include impacts of the MI approach on some of the identified constraints 
to ART adherence consultation sessions in Nigeria such as lack of a standard approach to 
motivate patients to adhere, stigma, and inconsistent power relationships. 
Empowerment for Counsellors: Despite the frustration of the adherence counsellors in this 
study with the commanding and prescriptive approach, they continued to use the approach 
because they were not empowered with a standard and effective approach to motivate 
patients to adhere to medications for chronic conditions. However, this study revealed that the 
MI approach provide the adherence counsellors with a standard and effective approach to 
support the medication adherence of their patients. Due to the empowerment, the adherence 
counsellors became more confident to provide support for the HIV patients in respect of ART 
adherence. This confidence boost is consistent with findings from some previous studies. For 
instance, Sargeant et al. (2008) reported that many trainee clinicians felt more comfortable 
and/or confident when interacting with patients in need of lifestyle changes after they were 
empowered with MI training. Willie, Irwin and Morrow (2012) also reported a renewed 
inspiration and motivation to facilitate behaviour change among trainee clinicians after MI 
training workshop. Beyond facilitating the ability of the clinicians to motivate patients, Ostlund 
et al. (2014) also reported that MI training elicited the empathy of trainees towards patients 




consistency between the findings from the previous studies with this study, this study adds to 
knowledge by providing the evidence in respect of HIV treatment, because the previous 
studies were not carried out in the HIV clinic setting. Moreover, the finding from this study also 
reveals the ordeal that the adherence counsellors encounter on their job in Nigeria as they are 
tasked to carry out a key strategic element of the global fight against HIV without the requisite 
skills. This lack of requisite skills became more evident when the adherence counsellors 
started applying the MI approach to consultation sessions beyond the needs of this study.  
Impact on Stigma: Stigma is a major predictor of patients’ engagement in HIV care and 
adherence outcomes. Findings from this study has shown that MI has the potential to address 
anticipated stigma among the HIV patients in Nigeria. Some existing studies have also 
demonstrated the potential of MI to reduce stigma (Conner et al., 2015; Livingston et al., 2011; 
Luty, Umoh and Nuamah, 2009). For instance, a systematic review exploring the effectiveness 
of interventions to reduce stigma related to substance use disorder found that MI was an 
effective strategy to reduce social stigma (Livingston et al., 2011; Luty, Umoh and Nuamah, 
2009). Another study in the USA has shown that peer educator intervention for depressed 
older adults that include the use of MI produced significant reduction of internalised stigma 
(Conner et al., 2015). Principles of MI have also been drawn upon in the development of a 
religious based intervention to reduce HIV-related stigma in the USA (Derose et al., 2014). 
However, this current study has shown that without the design of complex interventions 
(Conner et al., 2015; Derose et al., 2014) or a brief MI intervention design (Luty, Umoh, 
Nuamah, 2009), MI counsellors can indirectly empower the patients to overcome anticipated 
stigma by using the approach in their routine clinical sessions. Considering the psychological 
stress that patients endure to overcome stigma and the threat it poses to the global fight 
against HIV, the finding from this study indicates that MI can contribute to the tool-kit to combat 
stigma. 
Impact on Power Imbalance: This study revealed that a major challenge faced by adherence 
counsellors in Nigeria to motivate HIV patients to adhere to ART is the power imbalance 
between the patients and the health practitioners. The study also established that after the MI 
training, the MI approach enhanced the ability of the adherence counsellors to empathise and 
collaborate with the HIV patients during routine ART consultation sessions. This is consistent 
with the findings of a cluster randomised controlled trial carried out in South Africa which 
compared the impact of a MI training and supervision on lay adherence counsellors with the 
usual counselling approach (Dewing et al., 2015). The study found that the practice of the 
counsellors who received the MI training was more consistent with client-centred approach to 




consultation sessions engendered by the MI was found to be helpful to the adherence 
counsellor and was satisfying to the HIV patients because it allowed them to freely express 
their challenges without being ignored or scorned.  
However, beyond the promotion of a collaborative ART consultation session this study found 
that use of the MI unified the counselling approach of the counsellors; an impact that reduced 
the workload burden on some of the counsellors that were frequently preferred to others by 
the HIV patients before the study. This finding about uniformity in practice approach after MI 
training is supported by some previous studies that have reported that after attending MI 
training, counsellors tend to perceive it to be better than their usual approach (Rubak et al., 
2006; Soderlund et al., 2011; Willie, Irwin and Morrow, 2012). Therefore, the MI approach has 
the potential to be helpful to healthcare policy makers when considering the need to 
standardise practice in clinical settings. 
9.4 Critical Realism and Study Findings 
Critical realism emphasises the need to go beyond mere declaration of the low fidelity to MI 
among the adherence counsellors and a widespread satisfaction to the approach, to analysis 
of the mechanisms, processes and structures that account for these results (Denzin and 
Lincoln, 2011, p.11). For instance, despite the widespread satisfaction with the MI approach, 
this study revealed that the approach may not be routinely used by the counsellors. Without 
exploring further than the statement of fidelity to MI and the satisfaction to the approach, 
knowledge of the factors that may inhibit the implementation of the approach in the Nigerian 
clinical context might have been missed. The central focus of critical realism is to discover the 
underlying mechanisms that could be manipulated to introduce changes that can transform 
the status quo (Bryman, 2016, p.25). Through the retroductive reasoning, this study found five 
factors that could directly facilitate or inhibit the routine application of MI in Nigeria (MI Training 
and Support; MI Spirit and Techniques; Languages; Perception of Counsellors about ART 
adherence support; and Low Clinic Capacity). However, the study also found five other factors 
with the potential to indirectly influence the use of MI since they operate as inhibitors in the 
context of ART adherence support in Nigeria. These factors include: Stigma; Bribing; Privacy 
issues in clinic; Religious/traditional beliefs; and Financial/Economic Constraints. Each 







9.4.1 MI Approach and MI Training in Nigeria 
Impact of the skills and techniques of MI on the acceptability of the approach in Nigeria have 
been highlighted earlier. This confirms that the principles and processes of the MI approach 
fit well within the Nigerian multicultural context. These include the autonomy support, 
collaboration and promotion of patients’ self-efficacy to cope with predictors of behaviour 
change such as stigma. In addition, this study also found that MI enhanced the self-efficacy 
of the adherence counsellors. Although the MI approach was primarily designed to promote 
client’s self-efficacy (Miller and Rollnick, 2013, p.214) this study corroborates the findings from 
previous studies that have reported that MI enhances the self-efficacy of the therapists (Iarussi 
et al., 2013; Marley et al., 2011). However, such MI dependent self-efficacy cannot be 
developed without MI training and support which has been found in this study to be needed 
on an ongoing basis to achieve optimum fidelity and to maintain the fidelity level of the 
adherence counsellors in Nigeria. 
Meanwhile, it could be argued that a five-hour total duration of MI training provided for the 
adherence counsellors could have limited their ability to use the MI skills as observed in this 
study. While, longer and more intensive training sessions for MI are commonly associated 
with greater improvements in skills than short or one-off sessions, there is currently no 
consensus about the best length of training for enhancing MI skills (The Health Foundation, 
2011, p.19). However, Miller and Rollnick (2013, pp.329-330) cautioned that attending a single 
workshop is unlikely to improve MI competence and that one should not expect practical skills 
to emerge from an introductory workshop. This reinforces the need for more training and 
support for the adherence counsellors. 
Despite the need for more training and support, this study has revealed that the clinical setting 
in Nigeria may not provide facilities with conditions that will enable proper learning in training. 
For instance, the MI training for this study was carried out in extreme heat with dysfunctional 
air-conditioning systems, immediately following a busy session of the clinic. This type of 
learning condition highlights the organisational constraints to professional development for 
health workers in Nigeria. Therefore, even if the MI training and an ongoing support for the 
ART adherence counsellors were designed and prepared, the learning environment in Nigeria 
may not be convenient for learning. It could therefore be argued that it might have been difficult 
for the adherence counsellors in this study to transmit the knowledge gained in this learning 






9.4.2 Languages and MI in Nigeria 
This study has demonstrated the importance of local languages in the healthcare context in 
Nigeria as they allowed the practice of MI in other languages apart from English. A more 
significant contribution of languages in this study is the role of pidgin within which facilitated 
MI conversations between the counsellors and HIV patients who do not speak the same first 
language. Although evidence from a recent study carried out in Northern Nigeria elicited the 
communication potentials of pidgin in the clinical context in Nigeria, its use was found as an 
unexpected outcome because the study was designed to be implemented in English and 
Hausa (Abdull et al., 2017). This current study however established that pidgin can 
satisfactorily bridge the gap in instances where the use of English language may fail in the 
Nigerian context. This is important not just for the HIV clinical context but also in Nigeria 
society where more individuals speak pidgin than English language as evident in this study. It 
is therefore, not surprising that the concerns for wider reach of health interventions has led to 
an increasing use of creolised languages like the Nigerian pidgin in studies (Bernstein et al., 
2010; Joseph et al., 2016; Lasser et al., 2009). Despite the potentials of the use of pidgin, the 
language policy in Nigeria has not adopted it for official use (Federal Republic of Nigeria, 
1999). 
To date, this study is the first to assess the use of MI in the local Nigerian languages apart 
from English with the fidelity of the counsellors in all the sessions assessed. Findings from 
this study add to existing knowledge about the use of MI in multilingual contexts by increasing 
the spectrum of languages in which it can be practised with optimum fidelity beyond the South 
Africa languages (Dewing et al., 2013; Evangeli et al., 2009) to include Pidgin and Yoruba 
languages. Although Hausa language was not included in the protocol of this study, use of 
some common words from the language in some sessions is consistent with the unexpected 
finding in the study by Abdull et al. (2017). However, the finding from this study also confirmed 
the finding by Evangeli et al. (2009) that MI sessions may be carried out not just with a single 
language but also with a hybrid of up to four languages in a multilingual society. Despite the 
low fidelity to MI in this study, use of one or multiple language was not associated with the 
competency of the counsellors. Hence, this study has demonstrated that MI can be carried 
out with not just English language but also with Nigerian local languages without any effect on 
the fidelity of the counsellors. Findings from this study therefore opened opportunities to 
increase the reach of evidence-based consultation approach like MI by ensuring that patients 
who cannot speak English can benefit equally from quality counselling or consultation 




Moreover, counsellors in this study used all languages that they usually utilise during their 
routine practice except for Igbo language, therefore this study was carried out with the same 
linguistic diversity obtainable in routine sessions in the study context. Hence, this study has 
added to knowledge about successful implementation of MI in treatment settings. However, 
further empirical studies are still needed to confirm the impact of the languages on the MI 
behaviour of health practitioners as this study was not designed for generalisation.  
Lastly, this study further revealed that the counsellors used languages that they did not 
acknowledge using for routine practice before the study. This shows that the study counsellors 
attempted to use their deeper linguistic competence to ensure that they practised the MI skills 
with their patients. This finding demonstrates the interest of the counsellors to practise MI 
skills, but also suggests how committed the counsellors could be if empowered with the right 
skills to work with.  
9.4.3 Low Clinic Capacity and MI in Nigeria 
One of the reasons why the adherence counsellors may not be motivated enough to use the 
MI on a regular basis is due to concerns about the time the approach takes compared to the 
commanding and prescriptive approach. Literature is awash with evidence citing lack of time 
as a barrier to the practice of MI for clinicians after being trained to use the approach in their 
treatment settings (Bofill et al., 2015; Ostlund et al., 2014; Shannon, Donovan-Hall and Bruton, 
2017; Sargeant et al., 2008; Soderlund et al., 2011; Soderlund and Nilsen, 2009). Consistent 
with the finding reported in this study, Soderlund and Nilsen (2009) reported that long queues 
and crowded premises often restrict the time available for pharmacists in their study to practise 
MI. Ostlund et al. (2014) also reported that primary care nurses in their study could not use 
MI in the context of every encounter because they often had too little time with patients and 
too many patients to be able to use MI properly. These bodies of evidence suggest that low 
clinic capacity in respect of staff strength is a common concern in health care settings globally. 
While these other studies were not carried out in the HIV treatment context, the majority of 
physicians attending to HIV patients in an Argentine study indicated having enough time to 
practise MI in their clinic context. However, the HIV clinic context in Argentina may not be 
comparable to the Nigerian context in terms of patient population based on the relatively 
higher burden of the disease in Nigeria (UNAIDS, 2017). In addition, from the last records 
available to The World Bank (2018b), Nigeria (2010 record) has approximately 11% of the 
number of physicians available per 1000 people in Argentina (2013 record). Therefore, 
findings from this study represents the workload burden of HIV treatment contexts with very 




Despite the huge workload, the adherence counsellors in this study felt the need to attend to 
all the patients who attend their clinic for treatment consultation on each HIV clinic day. 
Besides the need to use a patient-centred approach, this attitude demonstrates the 
commitment of the counsellors to the global fight against HIV/AIDS. While this is 
commendable from a public health perspective, this study established that the low capacity of 
the clinic is a consistent barrier to offer quality consultation session to the HIV patient. The low 
capacity of the clinic and the concomitant workload could result in psychological stress or 
breakdown for the adherence counsellors. For instance, a systematic review and meta-
analysis by Madsen et al. (2017) has established that work strain could precipitate clinical 
depression among employees. It may therefore be difficult to motivate the adherence 
counsellors to use the MI approach in this clinic context with low capacity to meet the demands 
of work. 
However, due to the lack of time because of the clinic capacity some of the adherence 
counsellors were eager to use the commanding and prescriptive approach so they could 
attend to all their patients, even though they knew it was not an effective approach. While the 
time spent on each MI session had no association with the observed fidelity in this study, the 
HIV patients were more satisfied with the MI compared with their consultation experiences 
before the study irrespective of the duration of the MI sessions. Therefore, the focus of the 
counsellors to attend to all patients which threatens their use of the MI approach on routine 
basis is at stark variance with the conversation needs of the patients they are eager to care 
for. Discordance in the consultation goal of the counsellors and the conversation needs of the 
patients has been reported in a previous study carried out by Shannon, Donovan-Hall and 
Bruton (2017) among respiratory clinicians in UK. In the study, the clinicians identified time as 
a significant barrier to their practice, yet they also acknowledged that taking time to listen and 
to respond to the patient’s needs and priorities is a worthwhile investment. This suggests the 
tendency for clinicians to cite time as an excuse for not practising MI even when their patients 
prefer them to. Legare and Witteman (2013) argued that perceived time constraint is the most 
frequently cited barrier to any change in clinical practice. They emphasised that health 
practitioners cite this time barrier even though there is no robust evidence that more time is 
required to engage in a patient-centred approach in clinical practice than to offer usual care 
(Legare and Witteman, 2013). This argument has been corroborated in a study carried out by 
Rubak et al. (2006) among general practitioners (GP) in Denmark. In the study, the GPs 
reported that the MI approach was not more time consuming than the traditional advice-giving 
approach (Rubak et al., 2006). Based on their argument, Legare and Witteman (2013) 




clinicians. Similar approach may also need to be adopted during MI training for clinicians, 
especially in the Nigerian context. 
9.4.4 Perception of Counsellors about ART Adherence Support  
Another reason that may inhibit the use of the MI approach with optimum fidelity by the 
adherence counsellors was the tendency to want to make the decision about when and how 
much of MI is needed for each HIV patient. Hence, some of the adherence counsellors hinted 
at picking and choosing patients to apply the MI approach with. This approach has the 
potential to lead to an inconsistent pattern of the use of the approach in routine practice or not 
using it at all. For instance, Soderlund and Nilsen (2009) reported that a facilitator to use of 
the MI approach by the pharmacists in their study is the freedom to determine appropriate 
clients and/or health-related behaviours for their MI counselling. However, within the same 
study, the pharmacists chose patients they consider easy to talk to. Diabetes and smoking 
were considered as favourable subjects, while the pharmacists avoided addressing certain 
health-related behaviours and alcohol abuse because they were deemed to be sensitive and 
relatively more difficult respectively (Soderlund and Nilsen, 2009). Based on this evidence, 
the adherence counsellors may avoid using the MI approach with the HIV patients who are 
not adhering to their treatment and presenting as difficult if they are the ones who decide 
whom to apply the approach with. Moreover, such approach will run contrary to the Nigerian 
National guideline for treatment of HIV which recommends an ongoing adherence counselling 
for all HIV patients on ART on every clinic visit (FMOH, 2016, p.91). In addition, this perception 
highlights the impact of the prevailing paternalistic approach in the study context on the 
attitude of the adherence counsellors, despite the MI training. This confirms the argument that 
the behaviour change of practitioners is as big a challenge as that of their clients (Emmons 
and Rollnick, 2001).  
Meanwhile, because MI is a behaviour change counselling approach and as some of the 
counsellors in this study argued, it may be more appropriate for use with patients with 
adherence issue with the HIV treatment. However, evidence from this study has revealed that 
the MI approach enabled the counsellors to focus the treatment discussions on social and 
personal life issues that could affect the drug-taking behaviours of the patients even when the 
patient did not report adherence issues. Moreover, this study also revealed that the patients 
want the counsellors to probe further than merely focusing the session on their drugs as they 
may have other issues which might be of higher priority to them than the HIV drugs. This is 
consistent with the argument of Emmons and Rollnick (2001) that it is important to 
acknowledge that efforts to target behaviour change in isolation from the social context in 




MI strategies to incorporate social contextual concerns (Emmons and Rollnick, 2001). 
Recognition of situations where the agenda of the patient and counsellors may not match is 
the reason why MI as a patient-centred approach supports agenda mapping which involves 
identifying one step to focus on within an ongoing process of change (Emmons and Rollnick, 
2001; Miller and Rollnick, 2013, p.106). According to Miller and Rollnick (2013, p.13) if done 
properly, agenda setting can provide a relief to clients who feel ensnared by their problems 
thereby giving them a chance to leave some things aside for a while as they focus on others. 
Therefore, the adherence counsellors in this study still need further training on the principles 
of MI to change their perception towards practising the approach in their clinic context. 
Furthermore, the tendency for the adherence counsellors to want to make judgements about 
how much of MI is needed for some patients is supported by the recommendations of Emmons 
and Rollnick (2001) that a brief form of MI will be required in a public health setting where time 
for most encounters are brief. Such brief approach could allow for selection of certain 
techniques of MI to apply with the HIV patients based on the implicit judgement of the 
readiness of the patients to change (Emmons and Rollnick, 2001). While the selective 
approach could meet the needs of the adherence counsellors within the limited time available 
to them, Emmons and Rollnick (2001) have advised that the brief form of MI may only be 
useful to jump-start the motivational approach. They emphasised that the brief approach may 
require repeated contacts in order to initiate the behaviour change process. Thus, the 
counsellors cannot rely on the brief form of MI in all situations depending on the stage of 
readiness for change of the patient. Since, the adherence counsellors in this study are still 
struggling to achieve optimum fidelity to MI, adoption of a selective application of the approach 
may further limit their ability to effectively support HIV patients to adhere to ART. Therefore, 
as cautioned by experts (Emmons and Rollnick, 2001; Miller and Rollnick, 2009) the 
adherence counsellors need to first see the MI approach as an interpersonal style shaped by 
the guiding principles of what triggers the behaviour change process, instead of being a 
collection of techniques from which they can draw some for application with a group of people. 
9.4.5 Stigma for HIV/AIDS in Nigeria 
According to the recent report from the United Nations, the estimated prevalence of stigma 
against people living with HIV/AIDS in Nigeria is 46.8% (UNAIDS, 2017, p.70). This estimate 
refers to people who reported that they would not buy vegetables from a shopkeeper living 
with HIV (UNAIDS, 2017). This high tendency for enacted stigma highlights the impact of the 
health condition on the source of income and livelihood of the HIV patients in Nigeria. It is 
therefore conceivable that the HIV patients would keep trying to avoid an unwarranted 




travel for long distance to use the HIV clinic to avoid using HIV clinics in their own communities 
is consistent with findings from a previous study in Nigeria (Okoye, Diekedie and Afemikhe, 
2015). Unfortunately, this study shows that the migratory strategy from the HIV patients 
towards a safer healthcare context increases the workload burden of the adherence 
counsellors if the clinic capacity is low in respect of staff strength to cope with the population. 
Consequently, the low clinic capacity makes it difficult for the adherence counsellors to provide 
quality ART counselling or consultation session for the patients. However, this study adds that 
stigma promotes distrusts for the counsellors among the patients. Trust is a fundamental 
requirement for the successful practice of the MI approach, because the MI therapists seek to 
creates a positive interpersonal atmosphere that is conducive to behaviour change (Miller and 
Rollnick, 2013, p.15). Hence, prevalence of stigma in Nigeria has the potential to make the 
practice of MI difficult for the adherence counsellors within the consultation session.  
In addition, the prevalent stigma in the society also result in the disengagement of the HIV 
patient if they feel that their HIV status has been made known to certain individuals because 
of the delay in the clinic, thereby creating a gap in the continuity of care for the patients. MI is 
not a magic panacea that requires one dose and exposure, the approach promotes the 
provision of ongoing support which is central to behaviour change (Emmons and Rollnick, 
2001) which is also consistent with the protocol for HIV treatment continuum. Therefore, if the 
patient is disengaged from the clinic because of stigma, provision of such ongoing support 
through MI will be disrupted, thereby threatening the effectiveness of the approach.  
Despite the high prevalence and impact of stigma on the lives of the HIV patients, this study 
shows that there is currently no protection for them in Nigeria. Ironically, the Nigerian 
government signed an anti-discrimination bill into law that protects the right and dignity of 
PLHIV in 2015 (UNAIDS, 2015). The law makes it illegal to discriminate against people based 
on their HIV status. However, this study has confirmed that the law has neither been 
implemented nor is it having any impact on the beliefs and attitudes of the study community 
as well as the health practitioners. 
9.4.6 Bribing in the HIV Clinic 
A global report in 2006 shows that bribery and corruption have the potential to prevent HIV 
patients from having access to the much-needed treatment and care (Transparency 
International, 2006). While some countries such as UK, Cote D’ivoire and Senegal have 
significantly improved in their transparency index since 2012, Nigeria’s transparency index 
remains at 27/100 and at 148th position out of 180 as at the last report in 2017 (Transparency 




by the non-clinical staff of the hospital is on one hand a reflection of the pervasive and 
prevalent corruption level in Nigeria. On the other hand, bribing in the hospital was due to lack 
of agency to protect the rights of the patients and to prevent them from extortion. The WHO 
recommends the need to offer safe, acceptable and appropriate clinical and non-clinical 
services in a timely fashion to HIV patients with the aim of improving health outcomes and 
quality of life in general (WHO, 2016, p.xliv). Actual practice which forced the patients to resort 
to bribing in this study shows that while the care provided for HIV patients in Nigeria is not in 
a timely fashion, it is also not consistent with the acceptable recommendations of the WHO. 
The experience of extortion may hinder the engaging process which is the relational 
foundation for MI. According to Miller and Rollnick (2013, p.37) the forces that undermine 
engagement often come from pressures outside the conversation. They stressed that the 
culture within a service which may include its design, procedures and protocols could render 
the patient passive. Hence, bribing in the HIV clinical setting has the potential to make MI 
difficult to practise by the adherence counsellors in Nigeria. 
9.4.7 Privacy issues in the HIV Clinic 
While integrating the HIV clinic in this study into the MOPD might have served to promote the 
confidentiality of the HIV patients, the health providers and the activities occurring in the clinic 
as specified by the WHO (2016, p.18), the location of the waiting corridor is a source of 
concern for the HIV patients. The patients’ concerns about the waiting corridor borders on the 
unfettered access of other service users in the hospital to the same waiting corridor where the 
HIV patients are kept for long before meeting the counsellors for the ART adherence 
consultation. Therefore, the structure of the hospital threatens the safety of the HIV patients 
as it has high tendency to expose them to the prevalent stigma in the country. Although the 
positioning of the waiting corridor creates a pressure outside the HIV treatment conversation 
between the counsellor and patients, the arrangement of the consultation rooms in the clinic 
further makes it more difficult for the confidentiality of the patients to be protected during 
consultation. This is because two different consultations sessions are carried out 
simultaneously in two of the three consultation rooms in the clinic. This may also make it 
difficult for the adherence counsellors to successfully engage with the HIV patients. According 
to Miller and Rollnick (2013, pp.26-27) one of the factors outside the immediate conversation 
that could undermine the engaging process is the client’s state of mind on entering the 
consultation room. Hence, having two different consultation sessions occurring 
simultaneously is likely to make the HIV patient feel uncomfortable about engaging properly 





9.4.8 Religious/Traditional Beliefs and MI in Nigeria 
Findings from this study support previous studies that have reported that traditional or religious 
beliefs could influence HIV patients to abandon their ART (Charurat et al., 2010; Ekwunife, 
Oreh and Ubaka, 2012; Falang, Akubaka and Jimam, 2012; Oku et al., 2013a; Oku et al., 
2013b; Oku et al., 2014; Olowokere et al., 2008). In this regard, studies have shown that most 
Africans prefer to construct their health conditions within their cultural (Sarfo, 2015) or religious 
belief systems (Chukwuneke et al., 2012). People whose health beliefs are shaped in this way 
tend to reject the biomedical model of healthcare system provided for them (Chukwuneke, 
2012) and may not return for follow-up treatment consultations. One could argue that MI 
should be practised in a manner congruent with the cultural and religious beliefs in Nigeria, 
based on the prevalent attitude to biomedical healthcare model in the African context. 
Fortunately, the MI provides the skill to support the patients despite the resistance that they 
may present due to their health beliefs by rolling with resistance (Resnicow and McMaster, 
2012). However, even if MI is practised with optimum fidelity, the adherence counsellors will 
not be able to support the HIV patients with the approach if they are not presenting for the 
consultation sessions in the clinic due to their health beliefs. 
9.4.9 Financial/Economic Constraint and MI in Nigeria 
According to a recent report in 2017, a large pocket of the Nigeria’s population lives in poverty 
and without adequate access to basic services (The World Bank, 2017). The World Data Lab 
(2018; http://worldpoverty.io/) estimated that 42.6% of the 195 million population of the country 
lives in extreme poverty. At the core of the high poverty level in the country is the lack of job 
opportunities (The World Bank, 2017). This study shows that one of the key basic services 
that could improve the quality of life of some of the HIV patients is the provision of affordable 
cost of transportation. While the financial circumstance of the individual HIV patients to cope 
with the available cost of transportation might have been worsened by the prevalent stigma in 
the country, the overarching economic situation of the country contribute to the chaotic life 
that the patients experience while trying to have access to care. This is because the patients 
could have access to basic and affordable means of transport if the economic situation of the 
country is better. Therefore, without addressing the economic situation of the country and 
devising a sustainable strategy to improve the financial circumstances of some of the HIV 
patients, the adherence counsellors will not be able to apply the MI approach if the patient 





9.5 Broader Perspective for Dissemination of MI in Nigeria 
The findings from this study have shown that the implementation of MI for ART adherence in 
Nigeria requires a wider consideration beyond the immediate clinical conversation for 
behaviour change and the expected outcome of such conversation. A narrow focus on the 
patient’s outcome such as in the previous studies in Nigeria (Abdull et al., 2017; Holstad et 
al., 2012) presents an incomplete picture that does not support the routine implementation of 
the approach in the real-life context. Such narrow focus on few but not all the identified factors 
in this study might result in poor patient’s outcomes that is not different from the status quo 
(Abdull et al., 2017) or a high level of positive patient outcomes that may not be generalisable 
(Holstad et al., 2012). Evidence from this study has shown that such limited approaches will 
amount to an unwarranted waste of resources. For instance, the study carried out by Abdull 
et al. (2017) involved the training of therapists to use MI in the English languages that could 
not be used in the actual practice setting. The second study by Holstad et al. (2012) also 
focused on the use of MI in only English language which this current study has shown as 
impractical all the times in the Nigerian clinical context.  Contrary to the limitations from the 
existing studies, this study has demonstrated the need to consider the feasibility of using MI 
in Nigeria from the different levels of the ecological model of behaviour change. These include: 
intrapersonal level (perception of the counsellors, and financial circumstance of patients); 
interpersonal level (MI training and support); organisational level (clinic capacity, privacy 
issues in the clinic, and bribing); community level (religious and traditional beliefs, stigma and 
languages); and policy level (economic situation of the country).  
9.6 Strengths and Limitations of the Study 
Several features of this study contribute to its strengths and its weaknesses. For instance, 
unlike in previous studies that have investigated the feasibility of using MI in routine clinical 
settings (Bofill et al., 2015; Ostlund et al., 2014; Ragaisis, 2017; Rubak et al., 2006; Shannon, 
Donovan-Hall and Bruton, 2017; Soderlund and Nilsen, 2009), this study explored the 
perspectives of both patients and health practitioners to inform knowledge. As recommended 
by Bowen et al. (2009) when disseminating and implementing an intervention in diverse 
practice systems, it is important to understand the perspectives of the different stakeholders 
who will affect and be affected by the intervention. Therefore, this study addressed the 
limitations of the previous studies by incorporating the perceptions of key stakeholders that 
are relevant for the implementation of MI for routine practice in HIV clinic for treatment 
adherence support. 
Although this study was not designed to generalise findings, the recruitment procedure led to 




distribution. For instance, the gender distribution pattern among the participants is consistent 
with the gender distribution among the HIV patients in Nigeria. In addition, there was no 
significant difference in the gender distribution among the study participants and the non-
responders to the study. Despite the small population of the study, the 30 individuals produced 
a linguistic distribution representing 15 ethnolinguistic groups in the country with at least a 
representation from five of the six geographical regions of the country. Hence, as specified by 
Ryan, Coughlan and Cronin (2007) the selection of the setting and the participants contribute 
to the transferability of the study because the findings could be relevant to individuals who 
were not involved in the study.  
As recommended by Pluye et al. (2011) the response rate in the structured observation phase 
can be considered acceptable as it was never below 80% (involving 25 out of 30) of the study 
participants. Although representativeness is usually expected to be the goal of the quantitative 
strand of a mixed method study (Gray, 2014, p.225) and so time sampling which involves 
selection of time periods during which observations will occur is usually recommended to 
enhance generalisability of observation data (Gray, 2014, p.430; Polit and Beck, 2017, p.173). 
However, due to the sensitivity and the need for confidentiality of personal information among 
the study cohorts, event sampling which involves waiting for the occurrence of events (Polit 
and Beck, 2017, p.173) between the counsellors and the HIV patients becomes necessary. 
Despite the problems of generalisation associated with the event sampling observation, the 
outcome data is significantly higher than 80% which is the threshold for response rate for 
quantitative studies without randomisation (Pluye et al., 2011). Even though participation was 
lowest among study cohorts during the post-practice interviews which involved 18 out of the 
total of 30 individuals, a relatively small sample size is often sufficient for qualitative studies 
because its purpose is not to generalise (Gray, 2014, p.225; Ryan, Coughlan and Cronin, 
2007). Hence, it could be argued that overall in the study chances of attrition bias is limited. 
Use of the mixed method approach in this study has enhanced depth of knowledge about the 
feasibility of using MI for ART adherence. Apart from the focus on generating diversity of views 
through the quantitative and qualitative approaches the qualitative findings from the study also 
led to the enrichment of the quantitative data. For instance, evidence about the fidelity to MI 
from the OnePass assessment was not only complemented by the qualitative findings, but it 
also provided further insight about the constraints to the routine practice of the approach. 
Therefore, as argued by Bryman (2016, Pp.647-648) the study design did not only provide 





Use of investigator triangulation at different points in this study also enhanced the credibility 
and reliability of the findings. For instance, involvement of the study supervisors (Dr McMaster 
and Prof Redsell) in the thematic analysis of the qualitative data serves to minimise bias that 
could have emerged from the principal investigator (PI) as a person (Flick, 2014, p.183). 
Additionally, involvement of the primary supervisor (Dr McMaster) in the assessment of the MI 
fidelity for the adherence counsellors through OnePass coding system serves to minimise 
measurement errors that might have stemmed from the PI.  
The study was also carried out in real clinical scenarios between the health practitioners and 
the recruited HIV patients without disruption to the existing care plan for the patients. For 
instance, observation records were planned and executed between the study groups during 
existing clinical appointment slots for each patient. This flexible study structure therefore 
allows for the transferability of the study findings to other HIV care clinical settings without a 
need for adaptations. Moreover, execution of the 19 observation schedules during real clinical 
appointments between the health practitioners and the patients confirms that the study 
subjects were comfortable in carrying out their routine activities during the observation. 
According to Gray (2014, p. 422) this unobtrusive observation pattern must have minimised 
bias that might be attributable to the observer. 
Despite all the highlighted strengths of the study, there are also certain limitations that could 
have introduced bias to the findings. For instance, limited training hours for the health 
practitioners could have affected their learning of the MI approach. Based on evidence from 
existing studies on MI training (Barwick et al., 2012; de Roten et al., 2013; Hall et al., 2015; 
Madson, Loignon and Lane, 2009; Schwalbe, Oh and Zweben, 2014; Soderlund et al., 2011) 
one would not expect to see significant changes to practice, or basic proficiency in MI after 
just five hours of workshop training. However, the hours used for the MI training in this study 
was limited because the health practitioners could not allocate more hours to the training due 
to their workload. Emmons and Rollnick (2001) have stressed that relatively limited time is 
typically available for training of General Practitioners (GPs) which can make training for the 
GPs considerably challenging. It is therefore not surprising that time constraint to training 
occurred in this study since the majority (78%) of the recruited adherence counsellors were 
doctors. This contributes to knowledge about the challenges that may occur during MI training 
when the trainees are not motivated by top down directive from their organisation to utilise the 
approach or because of lack of incentives (Mitcheson, Bhavsar and McCambridge, 2015; 
Moyers et al., 2007). This limitation could therefore have affected the reliability of the MI scores 




Moreover, because the PI was new to the use of OnePass coding system, there is a possibility 
that the MI fidelity scores allocated to the behaviours of the adherence counsellors could have 
been underestimated or overestimated which could have affected the inter-rater reliability 
assessment that resulted in a poor to fair clinical significance. Interrater reliability assessment 
involves having two or more observers independently applying the measure with the same 
people to see if the scores are consistent across raters (Polit and Beck, 2017, p.175). The 
poor to fair reliability coefficients of correlation suggests that there is a great room for 
measurement error between the two judges. However, the poor to fair reliability coefficients 
could also be because scores in OnePass are based on subjective impressions of the judge 
and not on behaviour counts as in MITI (McMaster and Resnicow, 2015). Hence, it may be 
difficult to achieve a high level of correlation between judges based on their impressions. 
However, the process of judgement between the two judges would need to be improved if the 
assessment is to be repeated.  
Additionally, intra-rater reliability across time was not tested in the study. Intra-rater reliability 
assessment would have allowed the determination of whether the same level of consistency 
was maintained for the same subjects over particular points in time by the same judge 
(Cicchetti, 1994). This limitation could have reduced the reliability of the study findings. 
Despite the improvement observed in the performance pattern of some of the health 
practitioners in this study, it is highly possible that they might have attempted to produce better 
practice as a result of being audio-recorded. It is also arguable that the performance of the 
health practitioners could have been worsened due to the audio-recording. This uncertainty 
could be attributed to social desirability bias which is a tendency for research participants to 
misrepresent attitudes or extreme response bias which is a tendency to express extreme 
attitudes (Polit and Beck, 2017, p.171). 
Furthermore, short duration of the study might have also limited the generalisability of the 
findings. According to Gray (2014, p.430) claims for generalisability of the study findings could 
be strengthened if the researcher is able to stay in the field long enough to observe or 
experience the full range of routines and behaviours that typify the case. It could therefore be 
argued that a longer study period could have allowed for the nurse practitioner who could not 
practise the MI approach with a patient during the study period to provide a recorded practice 
session. Such opportunity could have provided a different pattern to the reported fidelity to MI 
in this study. However, each patient that the nurse practitioner attends to still had to meet with 
any of the doctors who participated in this study for the HIV treatment consultation. Besides, 




for the encounter with the doctors. Hence, the duration of the study allowed for the collection 
of the fidelity data from the major practice individuals.  
Moreover, a longer study period could also have allowed the three patients who missed their 
scheduled appointment to participate in the study. However, lack of funding and inadequate 
resources for this study prevented the potential for such longer stay in the field. Hence, in 
respect of the patients, lack of prolonged engagement in the field as pointed out by Ryan, 
Coughlan and Cronin (2007) limits the credibility of the findings. 
This study also contravenes the existing recommendation for the study design for 
implementation test of feasibility of interventions. According to Bowen et al. (2009) a pre-and-
post study design is necessary to evaluate small scale demonstration project testing whether 
the intervention can be deployed in the target clinical setting using surveys and observations. 
Apart from the use of only post-training interviews instead of surveys for the evaluation of 
experiences of the participants, a pre-training assessment of MI fidelity was not carried out in 
this study, thereby preventing the opportunity of ascertaining the baseline skills level of the 
health practitioners. Therefore, the validity of the fidelity scores could have been limited as it 
could be argued that the health practitioners might have had similar skills as observed after 
the MI training before the MI training. However, the focus of the study was not to assess 
improvement in the skills of the health practitioners after training but to assess if they could 
use the MI approach. Since, none of the health practitioners in this study had prior experience 
with MI, it will be unfair to assess their MI skill levels before learning the MI approach.  
The fact that the study was also carried out in just one clinic limits the generalisability of the 
study findings. For instance, facilities and resources in other clinic settings might have 
provided a more comfortable setting for the MI training and create the opportunity for longer 
MI training hours for the health practitioners or could have resulted in different perceptions 
about the MI approach from the participants. However, due to lack of resources and funding 
for the current study, such multi-site approach could not be carried out. 
Overall, non-response bias which refers to the difference between the actual study participants 
and those who declined to participate in the study (Polit and Beck, 2017, 2017, p.167) also 
limits the generalisability of the study findings. Although all invited health practitioner agreed 
to participate in the study, only 21 of the 86 patients invited to participate in the study agreed 
to participate. Thus, it can be argued that the 65 patients who could not participate in the study 
could have produced different findings to what was reported in this study. While there are 
different reasons for not participating in the study, telephone contact challenges were the most 




further attrition during the study activities. Apart from just network challenges and loss of 
mobile devices, some of the telephone contact issues are associated with the cultural patterns 
in the study context. For instance, one of the invited patients could not engage with the PI to 
discuss the study to determine if she will participate because the husband would rather want 
to be listening to the conversation on telephone. This could be associated with the higher 
decision-making power enjoyed by men in the Nigerian context. Evidence from a study has 
shown that financial dependence on husbands or gender inequality in decision-making about 
health care in Nigeria prevents access of women to health care facilities (Azuh, Fayemi and 
Ajayi, 2015; Lamstein, 2017). However, gender roles in decision-making for health care in 
Nigeria differ depending on the geographical region. In this regard, evidence from a survey 
has demonstrated that women from the South-west region of Nigeria were more likely to make 
their own health care decisions than women from the North-west region (Osamor and Grady, 
2017). Therefore, these cultural factors and the significance of telephone contact challenges 
should be considered strongly when making decisions about implementing research in 
Nigeria.  
Patients also struggled to understand some of the post-practice interview questions thereby 
leading to reframing of the questions to assist them to make relevant contributions to the study. 
This challenge indicates that the interview questions were not easy to understand for the 
patients and the reframing of the questions might have introduced bias from the interviewer 
into the data which could have resulted from leading the patients (Bryman, 2016, p.475). This 
therefore, limits the procedural rigour of the study (Ryan, Coughlan and Cronin, 2007). 
Lastly, responses from both study cohorts (HIV patients and counsellors) to the interview 
questions were also narrow, suggesting that the interviewing guide must have limited the 
answers of the participants to cover areas that are needed by the researcher but not much 
from the perspectives of the participants. This must have led to the introduction of the 
interviewer’s bias and expectations (Bryman, 2016, p.475) into the study findings, thereby 
reducing the procedural rigour. This could also have been due to social desirability bias or 
extreme response biases due to the power imbalance between the researcher and the 
participants. For instance, due to a perceived higher power of the researcher by the 
researched (Raheim et al., 2016) the study participants might have attempted to meet the 
researcher’s need by misrepresenting their attitude or perceptions about the investigated 





9.7 Chapter Summary 
This chapter has presented the integrated summary of study findings in relation to existing 
knowledge in respect of the fidelity and acceptability to MI in Nigeria. The chapter also critically 
discussed the relevance of the factors identified with the potential to influence the 
implementation of MI in a routine clinical setting. Lastly, the chapter also presented the 











CHAPTER TEN: RECOMMENDATIONS AND CONCLUSION 
10.0 Chapter Overview 
This chapter presents the arguments for practice change and future research thinking based 
on the findings of this study. The chapter also presents a conclusive summary to the study 
and reflexivity. 
10.1 Recommendations 
Numerous issues have been highlighted in the findings from this study. These issues emerged 
from the implications that the study findings could have on the practice of the ART adherence 
counsellors and the HIV patients. The issues indicate the need for urgent modifications in the 
organisational and socio-cultural contexts in Nigeria to improve the conditions within which 
the adherence counsellors practise, the healthcare experiences and the quality of life of the 
HIV patients, and the practice approach to public health research.  
10.1.1 Implications for Practice   
Antiretroviral Therapy Support Policies 
This study has established that the approach to ART adherence support in real life practice in 
Nigeria contradicts the recommendations of the WHO global strategy on patient-centred 
services (WHO, 2016, p.280). The global strategy stressed that all people should have access 
to health services provided in a way that responds to their needs and that are equitable, safe, 
effective, efficient, timely and of an acceptable quality (WHO, 2016, p.280). This contradiction 
indicates that there is a wide gap between the publication of such recommendations for best 
practice and the actual practice in the HIV clinical contexts that are similar to the one described 
in this study, especially in Africa. Since similar findings have been reported in South Africa, 
there is a high likelihood that the practice in the HIV clinical contexts in other sub-Saharan 
African countries will be similar to what has been reported in this study about the Nigerian 
clinic (Coetzee, Kagee and Bland, 2016; Dewing et al., 2012). Little or nothing can be achieved 
in respect of ART adherence when the adherence counsellors do not explore the adherence 
status of the HIV patients during the routine clinical appointments, only to command them to 
continue taking the prescribed treatment. Ironically, the local guideline in Nigeria emphasises 
the need to assess adherence at every HIV clinic visit for the patients (FMOH, 2016, p.91). 
Therefore, beyond mere publication of global or national guidelines there is a need for regular 
monitoring of the implementation of the strategies highlighted in such public health guidelines. 
However, based on the findings of this study such implementation monitoring will need to be 




One of the organisational constraints identified in this study is the low clinic capacity in respect 
of staff strength. Task shifting is a strategy that can help to provide a cheaper work force that 
could reduce the workload of the doctors and the nurses (WHO, 2016). However, within the 
limit of the evidence available in this study, task shifting has not been adopted in the Nigerian 
context for ART adherence support; a situation contrary to the scaled-up use of lay adherence 
counsellors in South Africa (Evangeli et al., 2009; Evangeli, Longley and Swartz, 2011; 
Dewing et al., 2012; Dewing et al., 2013; Dewing et al., 2014; Dewing et al., 2015). 
Considering the workload burden on the doctors and the negative experiences of the HIV 
patients due to clinic delays and the low quality of the eventual consultation session that is 
available to the patients due to lack of time, policy makers need to expedite the implementation 
of the task shifting strategy in Nigeria. Unfortunately, actualising a system change with task 
shifting may be a difficult task due to the poor economic policy in the country which has a very 
low budget for the health sector. For instance, since 2012 the budget allocation for the health 
sector has been consistently dwindling from 6% to 5.6% (Budget Office of the Federation, 
2018). This pales significantly to the South African budget in 2017/2018 which allocated 13.5% 
to the health program of the nation. Compared to the situation in Nigeria, this budget 
proportion in South Africa appears to be stable (United Nations Children’s Fund, 2018). The 
low budget proportion highlights the low priority for the health of the 195 million population of 
in Nigeria where the budget provision for 469 national legislators was 1.7% of the national 
budget (Budget Office of the Federation, 2018). Therefore, it may be unfair to expect the 
hospital management to employ and train non-professionals to carry out treatment adherence 
counselling for HIV patients when there may not be adequate funding to accommodate such 
staff boost. Hence, the Nigerian government needs to be sensitised on the need to improve 
the economic policy for health in the country to also improve the work experiences of the 
health practitioners and healthcare experiences of the HIV patients. 
Agency for Patients 
Evidence from this study indicates the need to promote avenues through which the voices of 
the HIV patients could be heard and acted upon to a satisfactory conclusion. Lack of such 
agency resulted in the resignation of the HIV patients to part with money to have access to 
care that is expected to be free. There is currently no safe pathway for patients to seek redress 
for abuse, neglect or extortion that they experience while accessing healthcare in Nigeria. 
Although part 3 section 10 of the Nigerian National Health Act (2014) provides guideline for 
patients to lay complaints about how they were treated at a healthcare establishment with an 
assurance that such complaints will be investigated fairly. The policy statement emphasises 




manner that is visible for any person entering the establishment and that the procedure should 
be communicated to the service users on a regular basis. This policy procedure empowers 
the health administrators and practitioners as the defendant, jury and judge on the feedback 
from the patients in respect of the experience with the quality of the health care services that 
they receive. This arrangement could make the patients apprehensive that they may be 
victimised due to their complaints. Meanwhile, as evident in this study, the existing system 
within which the patients receive treatment and care also reinforces the stigma that they face, 
and this would impact on their willingness to complain to the health practitioners and 
administrators from the same system. Therefore, there is a need to establish a more inclusive 
policy that promotes equality and to address inequalities while accessing health services in 
Nigeria such as the NHS England Patient and Public Partners Policy (National Health Service, 
2017). 
Implementation of the Bill against Stigma and Discrimination 
The Nigerian government needs to go beyond mere establishment of the law to abolish stigma 
against people living with HIV (PLHIV), but to also establish a clear pathway to enforce the 
law when there are reported infractions. It could be argued that countries that have a well 
implemented and structured law against discrimination like the UK still report significant 
proportion of incidence of stigma at workplace, healthcare settings and the general society 
(Baylis et al., 2017; Stigma Index UK, 2015). Even though most (59%) of the PLHIV in the UK 
are aware of the Equality Act 2010 which provides protection against discrimination for HIV 
patients, majority (73%) of the respondents to a national survey did not seek redress despite 
reporting instances of discrimination (Stigma Index UK, 2015). From the survey, reasons that 
prevented the PLHIV from seeking redress under the provisions of the Equality Act 2010 
include lack of confidence that the outcome would be successful, feeling intimidated or scared 
and/or insufficient financial resources (Stigma Index UK, 2015). Therefore, while implementing 
the law against stigma in Nigeria is important, the government and non-governmental 
organisations also need to provide a framework that will embolden the HIV patients to report 
any infractions on their rights with an assurance that they will get justice irrespective of their 
financial status. In addition, beyond the implementation of the law against stigma, there is also 
a need for regular public education and sensitisation to address the prevalent myths and 






Review of Nigerian Language Policy for Healthcare Settings 
Findings from this study makes an argument in favour of the Nigerian Pidgin which the policy 
makers in the country need to take into cognizance. This evidence indicates the need to grant 
the Nigerian Pidgin similar status as the three major languages in the country (Hausa, Igbo 
and Yoruba), especially in healthcare consultation sessions. Although it has been argued that 
the Nigerian Pidgin should not be adopted for official purposes because of its lack of structure 
(Igboanusi, 2008). However, such strict stance of the language policy reduces the language 
options when the health practitioners are interacting with patients who speak different local 
language and who are not well educated to speak English. Unfortunately, such stance may 
further widen the power gap between the patients and the health practitioners.  
Need for Affordable Transportation System 
A key research need among public health experts is the need to identify and address economic 
barriers to health (Haberer et al., 2017). Unfortunately, there is currently no consensus about 
the best way to address the economic barriers to health. A major impact of economic barriers 
on the health of the HIV patients in this study is their inability to afford the cost of transportation 
to meet up with their clinical appointments. While the Nigerian government appropriated up to 
3.5% of the national budget for 2017 to transportation (Budget Office of the Federation, 2018), 
findings from this study show that there is currently no affordable means of transportation for 
low or no income earners in the country. There is therefore a need to alleviate the burden of 
transportation cost for some of the HIV patients who have little or no means of income due to 
their health condition. Similar to the travel concession scheme for the older adults and disabled 
people in the UK, the Nigerian government could introduce the travel concession scheme for 
the HIV patients who need such support. Although the transport cost concession could 
motivate patients to misreport their circumstances to qualify for the scheme, this problem could 
be mitigated by using objective measures or by making the approach universal (Haberer et 
al., 2017).  
Need to Introduce MI into the Curriculum of Health Practitioners 
Existing evidence has established that basic skills of MI are increasingly being integrated into 
the standard curriculum of medical, nursing, pharmacy and dental students in USA (The 
Health Foundation, 2011). Since, this study found that MI addressed the skills deficit of the 
health practitioners in respect of how to motivate patients with chronic conditions to adhere to 
their medications, introduction of the approach into the educational curriculum in the medical 




in respect of the benefits of including training in MI as part of the core curriculum of medical 
students (The Health Foundation, 2011), findings from this study suggest that the health 
practitioners in the Nigerian context could benefit from enhanced skills through the MI training. 
If effective, the curriculum plan which includes basic training in MI will have a huge impact on 
the practice of the health practitioners throughout the country. 
Addressing the Organisational Structural Problems 
The National Council is the highest policy making body on matters relating to health in Nigeria 
(National Health Act, 2014). Part of the responsibilities of the council is to ensure the delivery 
of basic health services to the people of Nigeria and to prioritize other health services that 
may be provided within the available resources. Based on the findings of this study and the 
need to ensure privacy and assure the patients of confidentiality, the National Council needs 
to address the structure of the consultation rooms and the waiting corridor for HIV patients in 
clinics with similar structure as described in this study. They also need to ensure that facilities 
where health practitioners learn is conducive for learning. 
10.1.2 Implications for Future Research 
MI Study in Multilingual Contexts 
Few existing studies have explored the applicability of MI in the local languages of multilingual 
contexts like Nigeria, Singapore and South Africa. Findings from this study show that more 
can be learnt about how to disseminate the MI approach if the potentials of the local languages 
are harnessed than by concentrating on standardising it in single languages as it is commonly 
practised in studies. McMaster and Griva (2015) stressed that practitioners are increasingly 
interacting with multiple cultures in urban centres with a large influx of nationalities (UK, USA, 
and Hong Kong) and in communities where there are multiple national languages and local 
dialects (Singapore and Nigeria). They asserted however that while linguistic differences in 
the formation of certain parts of speech could affect some parts of the training, trainees 
respond to the core materials in similar ways across cultures (McMaster and Griva, 2015). 
This study has shown the benefits of replicating the language pattern in the community in the 
study. Therefore, researchers need to strive to replicate more of the positive clients’ outcomes 







Need for a Large Population 
This study involved a small population because it was not designed to generalise findings. 
Therefore, there is a need for a multi-site study with a larger population of the target groups 
in Nigeria to ascertain the consistency of the factors within the hypothetical retroductive model 
obtained from this study. However, because most other African contexts have a high likelihood 
of sharing the same contextual characteristics with Nigeria, the hypothetical retroductive 
model could also be tested in other African countries to inform how to support HIV patients 
with their drug adherence.    
Broader Perspective to Public Health Research in Africa  
The findings of this study show that the common enthusiasm among researchers to fix the 
public health problems in Africa through evidence-based strategies that have worked in more 
developed contexts needs to be matched with the commitment to appreciate the uniqueness 
of the African context. For instance, public health researchers need to understand and take 
certain cultural and contextual barriers to research activities into cognizance during the 
planning and implementation of interventions studies in Africa. As elicited from this study, 
these barriers could be in respect of recruitment or training activities for health practitioners. 
Although it could be argued that the consideration of the contextual and cultural factors could 
make public health research in Africa to be more expensive and time consuming. However, 
as shown in this study, public health research may not produce outcomes that can adequately 
meet the needs of the target communities without an adequate understanding of the African 
context.  
10.2 Conclusion 
This study has shown that there is considerable promise to implementing MI to support 
behaviour change in HIV patients in Nigeria to adhere to the ART. The study also shows that 
the approach is acceptable within the Nigerian culture and context. While there is no 
conclusive evidence about the effect of the languages on the fidelity of counsellors to the 
approach, this study shows that the approach could be used within the same linguistic pattern 
that exist in the routine clinical setting in Nigeria. However, some contextual and cultural 
factors that could limit its potential need to be addressed before the approach can be 
effectively used for routine practice in the HIV clinic settings in the country. This will include 
the willingness of the government to enforce the law against stigma and discrimination for 
PLHIV and provision of a safe feedback system through which infractions on the rights of 
patients within the hospital system could be addressed. Meanwhile, the health policy makers 




for adequate training facilities for the health workers. More importantly, there is a need for 
more time to be dedicated for the training of the health practitioners to ensure that they practise 
the MI approach with optimum fidelity in their clinic context. 
 
10.2.1 Reflexivity  
Despite conscious attempts to reduce the influence of researcher’s bias on the study, as a 
human being my previous experiences during education, work and life must have impacted 
on my approach to this study. For instance, my first-degree background as a microbiologist 
informed my interest to understand the lived experiences of people living with HIV/AIDS 
(PLHIV). This led to my involvement in peer-education program in Nigeria in 2007 to prevent 
HIV and sexually transmitted infections (STI) sponsored by the UNAIDS. This opportunity 
allowed me to have several informal interviews with PLHIV and to understand the challenges 
that they face on daily basis while living with the virus. Since I was trained from my first-degree 
to pay more attention to the importance of statistics towards health decision-making and 
research goals, such thinking process steered my research interests towards quantitative 
methodology during my master’s degree in public health. However, when I embarked on this 
project the basic knowledge that I garnered during my master’s degree about the importance 
of qualitative research and my experience during the peer education program greatly 
influenced my thinking and steered my goal towards the need to understand how best to 
support the patients and clinicians beyond reducing them to statistical figures. This informed 
the decision for a mixed-method approach for this study despite my previous lack of formal 
experience with qualitative research processes. Therefore, my previous experiences through 
academic endeavours and with the PLHIV influenced my research approach decisions and 
largely during the designing of the methods and the analyses of the data. This was of course 
also complemented by my robust experience of the current socio-political situation in Nigeria 
and its impact on the people. 
My work experience in the hospital in the UK as a health practitioner also played a key role in 
the decision to implement the study in a clinical setting because of my familiarity with such 
context and the clinicians as well the patients. More importantly this experience allowed me 
to understand that despite the increasing advocacy for patient-centred care in the hospital 
system in the UK, some work-environment constraints still make it difficult for us to be 
consistently patient-centred in service delivery in real-life. This reflection from my own practice 
also contributed largely to how I designed the data collection process for the study and how I 




Meanwhile, my previous work and residence experiences in five geopolitical regions (North-
East, North-Central, South-West, South-South and South East) out of the six in Nigeria helped 
me to understand the common culture and basic elements in the languages used by Nigerians 
despite the diverse cultural and linguistic diversity. Additionally, my understanding of the 
widely used but informal Pidgin English language was not only helpful while I was designing 
the study but also when implementing it in the field and during data analyses. For instance, 
my cultural and linguistic competences were very helpful during the process of my data 
collection and for my analytical processes ranging from transcription to translation and the 
presentation of the findings. 
Lastly, this study process itself has not only improved my research skills in respect of 
qualitative research understanding, but it has also enriched my reasoning about health 
intervention designs, transfer, adaptation and implementation. This refers most especially 
towards the need to appreciate the influence of the relevant contextual factors from the 
different levels of the ecological model of behaviour change. Overall, the study process has 
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Appendix 1: Summary and Justification for the Exclusion of Studies in Chapter Two 
S/N Authors Name Reason for Exclusion 
1 Ndembi, 2015 The article was an editorial and not a study article 
2 Maduka and Tobin-West, 
2015 
The article was a letter to an editor about the qualitative findings of a study, not a full report of the study 
3 Aransiola et al., 2014 The study was focused on stigma and survival challenges and not about adherence to ART 
4 Olowokere, Fatiregun and 
Adewole, 2012 
The study was focused on knowledge and attitude and not on adherence to ART 
5 Olowokere, Fatiregun and 
Osagbemi, 2009 
The study was focused on awareness and attitudes of health, not on ART adherence  
6 Ejekam et al., 2014 Neither abstract nor article was available 
7 Ashraf et al., 2017 The article was retracted (Al-Mahmood, 2017) 
8 Odili, Obieche and Amibor, 
2016 
Adherence threshold was not clear 
9 Meloni et al., 2015 The article was focused on the predictors of loss to follow-up and pattern of adherence among patients 
who were not lost to follow-up. 
10 Ebonyi et al., 2015 The study was focused on interruption on ART and not on adherence to ART 
11 Uzochukwu et al., 2009 Adherence threshold was not clear 
12 Torpey et al., 2012 Only abstract was available 
13 Asekomeh, Ebong and 
Onwucheka, 2010 
Only abstract was available 
14 Goar et al., 2015 Discrepancy between the total number of participants recruited (160) in the study and number of 
participants who use substance compared to those who do not (165). 
15 Yunusa, Njoku and Obembe, 
2014 
Adherence threshold was not clear 
16 Adewuya et al., 2010 Adherence threshold was not clear 
17 Cornelius et al., 2018 The focus groups were conducted with PMTCT clients, male partners, young women and other community 
members. It is not clear how much of the evidence from the study was supplied by PMTCT clients and the 
partners. 
18 Ekwunife, Oreh and Ubaka, 
2012 





Appendix 2: Summary and Justification for the Exclusion of Studies in Chapter Four 
Number Author (s) of Study Reasons for Exclusion of Studies 
1 van Loggerenberg et 
al., 2015a 
The study did not actually use MI, but techniques based on the approach were used. 
2 Cook et al., 2009 The intervention used telephone counselling. 
3 Cooperman et al., 
2012 
The study was carried out in USA. 
4 Navarro et al., 2014 The study was carried out in Spain. 
5 Adamian et al., 2004 The study was carried out in USA. 
6 Allicock et al., 2017 The study was carried out in USA. 
7 Dilorio et al., 2008 The study was carried out in USA. 
8 Goggin et al., 2013 The study was carried out in USA. 
9 Golin et al., 2006 The study was carried out in USA. 
10 Gwardz et al., 2015 The study was carried out in USA. 
11 Ingersoll et al., 2011 The study was carried out in USA. 
12 Konkle-Parker et al., 
2010 
The study was carried out in USA. 
13 Krummenacher et al., 
2011 
The study was carried out in Switzerland. 
14 Thrasher et al., 2006 The study was carried out in USA. 
15 Yeagley et al., 2012 The study was carried out in USA. 
16 Uuskula et al., 2017 The study was carried out in Estonia. 
17 Pradier et al., 2003 The study was carried out in France. 
18 Holstad et al., 2011 The study was carried out in USA. 
19 Parsons et al., 2007 The study was carried out in USA. 
20 Outlaw et al., 2014 The intervention in the study did not involve a clinician-patient interaction, but a computer-
based session that can be completed by the patient online. 
21 van Loggerenberg et 
al., 2015b 
Because the study’s objective was focused on understanding what motivated patients to 
adhere to ART and not on application of MI. 






Number Author (s) of Study Reasons for Exclusion of Studies 
23 Koken et al., 2012 Because the article was a process report of how Motivational Interviewing Treatment Integrity 
(a MI fidelity assessment system) was adapted for use in Thai language and communication 
culture. 
24 Cooperman et al., 
2007 
This study was also excluded because it was the feasibility and the developmental phase of 
an intervention that has been further tested in a Randomized Controlled Trial [RCT] 
(Cooperman et al., 2012) 
25 Dilorio et al., 2003 This study was also excluded because it was the pilot study of an intervention that has been 
later tested in a RCT (Dilorio et al., 2008) 
26 Parsons, Rosof and 
Punzalan 2005 
This study was excluded because it was also a pilot study of an intervention that has been 
tested in another RCT (Parsons et al., 2007) 
27 Fox et al., 2016 MI was not used in the study. 
28 Sutton et al., 2017 MI was not used in the study. 
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Other Languages Spoken Languages Used for Counselling 
1 Y001 Tiv English and Pidgin N/A 
2 Y002 Tiv English and Pidgin N/A 
3 Y003 Surubu Hausa and Pidgin N/A 
4 Y004 Efik English and Pidgin N/A 
5 Y005 Bette English, Yoruba and Pidgin N/A 
6 Y006 Eggom English and Pidgin N/A 
7 Y007 Tiv English and Pidgin N/A 
8 Y008 Idoma English and Pidgin N/A 
9 Y009 Birom Pidgin N/A 
10 Y010 Igbo Pidgin N/A 
11 Y011 Igbo English N/A 
12 Y012 Yala English, Igbo and Pidgin N/A 
13 Y013 Icheve English N/A 
14 Y014 Tiv Pidgin N/A 
15 Y015 Yoruba English and Pidgin N/A 
16 Y016 Hausa Pidgin N/A 
17 Y017 Tiv English, Hausa, Ibo, Yoruba, Pidgin and Idoma N/A 
18 Y018 Igala English N/A 
19 Y019 Igbo English and Pidgin N/A 
20 Y020 Yoruba Pidgin and Birom N/A 
21 Y021 Igbo English and Pidgin N/A 
22 X001 Yoruba English and Pidgin English, Yoruba and Pidgin 
23 X002 Igbo English and Pidgin English and Pidgin 
24 X003 Igbo English, Hausa and Pidgin English, Igbo and Pidgin 
25 X004 Estako English, Hausa and Pidgin English, Hausa and Pidgin 
26 X005 Yoruba English and Pidgin English and Pidgin 
27 X006 Igbo English and Pidgin English and Pidgin 
28 X007 Kuterb English, Hausa and Pidgin English, Hausa and Pidgin 
29 X008 Yoruba English and Pidgin English and Pidgin 
30 X009 Igbo English and Pidgin English, Igbo and Pidgin 
N.B: Study codes for patients start with “Y” and for the counsellors “X”. N/A refers to Not Applicable.
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Appendix 7: Mixed Method Appraisal Tool Checklist 




Methodological quality criteria (see tutorial for definitions and examples) Responses 
Yes No Can’t 
tell 
Screening 
questions (for all 
types) 
 Are there clear qualitative and quantitative research questions (or objectives*), or a clear mixed
methods question (or objective*)?
 Do the collected data allow address the research question (objective)? E.g., consider whether the
follow-up period is long enough for the outcome to occur (for longitudinal studies or study
components).
Further appraisal may be not feasible or appropriate when the answer is ‘No’ or ‘Can’t tell’ to one or both screening 
questions. 
1. Qualitative 1.1. Are the sources of qualitative data (archives, documents, informants, observations) relevant to address 
the research question (objective)? 
1.2. Is the process for analyzing qualitative data relevant to address the research question (objective)? 
1.3. Is appropriate consideration given to how findings relate to the context, e.g., the setting, in which the 
data were collected? 
1.4. Is appropriate consideration given to how findings relate to researchers’ influence, e.g., through their 





2.1. Is there a clear description of the randomization (or an appropriate sequence generation)? 
2.2. Is there a clear description of the allocation concealment (or blinding when applicable)? 
2.3. Are there complete outcome data (80% or above)? 
2.4. Is there low withdrawal/drop-out (below 20%)? 
3. Quantitative
nonrandomized
3.1. Are participants (organizations) recruited in a way that minimizes selection bias? 
3.2. Are measurements appropriate (clear origin, or validity known, or standard instrument; and absence of 
contamination between groups when appropriate) regarding the exposure/intervention and outcomes? 
3.3. In the groups being compared (exposed vs. non-exposed; with intervention vs. without; cases vs. 
controls), are the participants comparable, or do researchers take into account (control for) the difference 
between these groups? 
3.4. Are there complete outcome data (80% or above), and, when applicable, an acceptable response rate 





4.1. Is the sampling strategy relevant to address the quantitative research question (quantitative aspect of 
the mixed methods question)? 
4.2. Is the sample representative of the population understudy? 
4.3. Are measurements appropriate (clear origin, or validity known, or standard instrument)? 
4.4. Is there an acceptable response rate (60% or above)? 
5. Mixed methods 5.1. Is the mixed methods research design relevant to address the qualitative and quantitative research 
questions (or objectives), or the qualitative and quantitative aspects of the mixed methods question (or 
objective)? 
5.2. Is the integration of qualitative and quantitative data (or results*) relevant to address the research 
question (objective)? 
5.3. Is appropriate consideration given to the limitations associated with this integration, e.g., the divergence 
of qualitative and quantitative data (or results*) in a triangulation design? 
Criteria for the qualitative component (1.1 to 1.4), and appropriate criteria for the quantitative component 
(2.1 to 2.4, or 3.1 to 3.4, or 4.1 to 4.4), must be also applied 
*These two items are not considered as double-barreled items since in mixed methods research, (1) there may be research questions (quantitative research)
or research objectives (qualitative research), and (2) data may be integrated, and/or qualitative findings and quantitative results can be integrated.
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Appendix 8: Information Sheet for HIV Patients 
Title of study: Motivational Interviewing for HIV drug adherence in Nigeria: A feasibility study. 
Who is conducting the study? 
This study will be carried out by Olakunle Lekan, Kayode who is a PhD student of the Faculty 
of Medical Sciences of Anglia Ruskin University, United Kingdom.  Kayode can be 
contacted for further information on phone: XXX or via email: 
XXX. This study will be supervised by Fiona McMaster (PhD) 
and Professor Sarah Redsell. 
Purpose of the study 
This study will look at how a counselling approach known as Motivational Interviewing (MI) 
can be applied to help HIV patients in Nigeria take their HIV drugs as recommended. 
Why have I been approached? 
You have been approached to help in this study because you are adult aged 18 years or older, 
who is receiving HIV drugs services. This study will take place at Wuse General Hospital in 
Abuja and it is expected that about 55 HIV patients like you will be recruited from the hospital 
to participate in the study. 
What do I have to do? 
Your involvement in this study will begin after you have agreed to participate by signing a 
consent form. If you are not able to sign the consent form, your verbal agreement will be 
audiotaped.  
After you have agreed to participate in the study, some details about you will be collected by 
Kayode. At the next meeting with your HIV drugs counsellors, they will use MI approach to 
talk to you about how to take your HIV drugs. The counselling session will be audiotaped and 
will last less than an hour. Kayode may be present during the counselling session, but that is 
if you consent to this.  
For the purpose of this study, you may be counselled in English, Yoruba or Nigerian Pidgin. 
However, the language in which you will be counselled will depend on an agreement between 
you and your HIV drugs counsellor.  
After your counselling session you will be invited to participate in a telephone interview with 
Kayode to talk about your experiences with the MI counselling approach. This telephone 
interview will last less than an hour and Kayode will talk to you in English. However, if you 
cannot speak English, provision will be made to carry out the telephone interview in any of the 
other study languages (Pidgin or Yoruba) in which you can communicate. The interview will 
also be audiotaped.  
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When will the study take place and for how long? 
This study is expected to be carried out within 6 months starting from 1st of March 2017 till 
31st of August 2017.  
 Will there be an adverse event? 
You are not expected to experience any side effect as a result of this study. However, if you 
feel emotional or experience any side effect as a result of this study, you should report it to 
your counsellor who will provide necessary care for you.  
What are the benefits to me?  
You may benefit directly from this study through improvement in the taking of your HIV drugs 
as recommended.  
Is my participation voluntary and how can I withdraw from the study? 
We recommend that you take your time to read this document carefully before signing the 
consent form. Efforts will be made by Kayode to ensure that you understand the information 
that has been provided for you about the study in this document before signing the consent 
form. To ensure this, Kayode will telephone you two weeks after you have collected this 
document to arrange to meet for further explanations regarding the study. This meeting will 
allow you to ask questions that may have arisen from this document. You will be expected to 
make a decision to participate in this study within one week after the meeting. Your 
participation in the study is voluntary and you may refuse to participate or withdraw from the 
study at any time without penalty or loss of benefits to which you are entitled. 
If you wish to withdraw from the study, you can inform Kayode or Dr. McMaster verbally or in 
writing through a letter or email. You do not have to give a reason for withdrawing from the 
study. Any data that we have collected from you before you withdraw from the study will be 
discarded.   
Will my identity be protected? 
The main risk of being in this study for you is that your identity as an HIV patient may be known 
by other people. Based on this, all information that may identify you will be considered private 
and managed in line with the UK Data Protection Act, 1998 and Nigerian National Health Act, 
2014. Hence, your identity will be concealed and if the findings from this study is published, 
your identity will be protected.  
Will the personal information I supply be protected? 
Apart from Kayode, Dr. McMaster and Professor Redsell, any information that you may supply 
as a result of this study will not be shared with any other persons. Such information may only 
be released if required by the Faculty Research Ethics Panel of Anglia Ruskin University 
(FREP), Federal Capital Territory Health Research Ethics Committee (FCTHREC) or by court 
order.  
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How will the data collected from the study be stored? 
The audiotapes for this study and other study documents will be stored in a locked filing 
cabinet until the end of the study. All electronic information obtained during the process of this 
study will be stored on computers that are password protected.  
Your agreement to participate in this study will be in effect until the study is completed. 
However, your information will not be reused for purposes other than the study described in 
this document without your written permission. All original data obtained during this study will 
be destroyed after the completion of the study. 
Will I be informed about the study’s findings? 
Kayode will ensure that you are informed in a timely manner during the study if information 
becomes available that may be relevant to your willingness to continue participating in the 
study. Kayode will also contact you at the end of the study to inform you of the findings of 
the study. 
How will I lodge my complaints if I have some concerns? 
In case you have concerns about any aspect of the study, you can talk first with 
Kayode (XXX). If your concern is not satisfactorily dealt with by Kayode, you can talk with 
Dr. McMaster (XXX). However, after talking with Dr. McMaster if your concerns are still 
not satisfactorily dealt with, you can lodge your complaint with Anglia Ruskin 
University via email: XXX or via letter addressed to The Secretary and Clerk, Anglia 
Ruskin University, Chelmsford, Essex, CM1 1SQ.  
YOU WILL BE GIVEN A COPY OF THIS DOCUMENT TO KEEP TOGETHER WITH A 
COPY OF YOUR CONSENT FORM 
Appendix 9: Information Sheet for Adherence Counsellors 
Title of study: Motivational Interviewing for HIV drug adherence counselling in Nigeria. 
Who is conducting the study? 
This study will be carried out by Olakunle Lekan, Kayode who is a PhD student of the Faculty 
of Medical Sciences of Anglia Ruskin University, United Kingdom. Kayode can be 
contacted for further information on phone: XXX or via email: 
XXX. This study will be supervised by Fiona McMaster (PhD) and Professor Sarah 
Redsell. 
Purpose of the study 
This study will look at how a counselling approach known as Motivational Interviewing 
(MI) can be applied to help HIV patients in Nigeria take their HIV drugs as recommended.  
Why have I been approached? 
You have been approached to help in this study because you are a healthcare personnel 
who 
counsels HIV patients to take their HIV drugs as recommended. This study will take place 
at Wuse General Hospital in Abuja. It is expected that approximately 10 health personnel 
like you who counsel patients to take their HIV drugs will be recruited to participate in the 
study. What do I have to do? 
Your involvement in this study will start after you have agreed to participate by completing 
the consent form that is provided with this document.  
After you have agreed to participate in this study, some details about you will be collected 
by Kayode. As part of the study, you will be asked to help recruit HIV patients. You will do 
this by informing HIV patients who are receiving HIV drugs services in the hospital where 
you work about the study during counselling sessions about their drugs. You will be asked 
to refer HIV patients who indicate interest to participate in the study to Kayode for 
further recruitment processes. As part of the study, you will also be required to attend a 3-day 
training course that will take place within the hospital where you work, to learn how to use 
the MI approach.   After the MI training, you will use the MI approach to counsel HIV 
patients who are recruited into this study about their HIV drugs on their next visit to 
the HIV clinic for HIV drugs counselling. Each counselling session will last less than an 
hour and will be audiotaped. Kayode may be present during the counselling session, but 
that is if you consent to this.  You may counsel the patients in English, Yoruba or Nigerian 
Pidgin. However, the language you will use to counsel the patients will depend on an 
agreement between you and the patients.  
At the end of the study, you will be invited to participate in a telephone study interview 
with Kayode to talk about your experiences with the MI approach. This telephone interview 
will last less than an hour and Kayode will talk to you in English.  
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When will the study take place and for how long? 
This study is expected to be carried out within 6 months starting from 1st of March 2017 till 
31st August 2017.  
Will there be an adverse event? 
Participation in this study is not expected to cause any harm to you.  
What are the benefits to me?  
By participating in this study, you will have the opportunity to benefit from the free MI training 
that will be directly delivered by Dr Fiona McMaster who is an established member of the 
Motivational Interviewing Network of Trainers (MINT). She delivers MI training regularly in 
Nigeria, Senegal, China, Singapore and in the UK. It is expected that this training will 
contribute to your professional development and you will be issued a certificate for the training. 
Is my participation voluntary and how can I withdraw from the study? 
We recommend that you take your time to read this document carefully before signing the 
consent form. Effort will be made by Kayode to ensure that you understand the information 
that has been provided for you about the study in this document before signing the consent 
form. To ensure this, Kayode will telephone you two weeks after you have collected this 
document to arrange to meet for further explanations regarding the study. This meeting will 
allow you to ask questions that may have arisen from this document. You will be expected to 
make a decision to either participate in this study or not within one week after the meeting. 
Your participation in the study is voluntary and you may refuse to participate or withdraw from 
the study at any time without penalty or loss of benefits to which you are entitled. 
If you wish to withdraw from the study, you can inform Kayode or Dr. McMaster verbally or in 
writing through a letter or email. You do not have to give a reason for withdrawing from the 
study. Any data that we have collected from you before you withdraw from the study will be 
discarded. 
Will my identity be protected? 
The main concern in this study for you as an HIV drug counsellor may be the fear of being 
judged by other health personnel on the basis of your ability to use a new clinical approach. 
Based on this, all information that may identify you will be considered private and managed in 
line with the UK Data Protection Act, 1998 and Nigerian National Health Act, 2014. Hence, 
your identity will be concealed and if the findings from this study is published, your identity will 
be protected.  
Will the personal information I supply be protected? 
Apart from Kayode, Dr. McMaster and Professor Redsell, any information that you may supply 
as a result of this study will not be shared with any other persons. Such information may only 
be released if required by the Faculty Research Ethics Panel of Anglia Ruskin University 
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(FREP), Federal Capital Territory Health Research Ethics Committee (FCTHREC) or by court 
order.  
How will the data collected from the study be stored? 
The audiotapes for this study and other study documents will be stored in a locked filing 
cabinet until the end of the study. All electronic information obtained during the process of this 
study will be stored on computers that are password protected.  
Your agreement to participate in this study will be in effect until the study is completed. 
However, your information will not be reused for purposes other than the study described in 
this document without your written permission. All original data obtained during this study will 
be destroyed after the completion of the study. 
Will I be informed about the study’s findings? 
Kayode will ensure that you are informed in a timely manner during the study if information 
becomes available that may be relevant to your willingness to continue participating in the 
study. Kayode will also contact you at the end of the study to inform you about the findings of 
the study. 
How will I lodge my complaints if I have some concerns? 
In case you have concerns about any aspect of the study, you can talk first with 
Kayode (XXX). If your concern is not satisfactorily dealt with by Kayode, you can talk with 
Dr. McMaster (XXX). However, after talking with Dr. McMaster if your concerns are still 
not satisfactorily dealt with, you can lodge your complaint with Anglia Ruskin 
University via email: XXX or via letter addressed to The Secretary and Clerk, Anglia 
Ruskin University, Chelmsford, Essex, CM1 1SQ.  
YOU WILL BE GIVEN A COPY OF THIS DOCUMENT TO KEEP TOGETHER WITH A 
COPY OF YOUR CONSENT FORM 
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Appendix 10: Informed Consent Form Th
Title of the study: Motivational Interviewing (MI) for antiretroviral therapy (ART) adherence 
in Nigeria: A feasibility study. 
Principal Investigator: This study will be carried out by Olakunle Lekan, Kayode who is a 
PhD student of the Faculty of Medical Sciences of Anglia Ruskin University, United 
Kingdom. Kayode can be contacted for further information on phone: XXX or via email: 
XXX.
Study Supervisors: This study will be supervised by Fiona McMaster (PhD) and 
Professor Sarah Redsell. 
1. I agree to take part in this study.  I have read the description of the study or have had it
translated to me in the language that I understand.  I understand what I have to do in the study
and all my questions have been answered to my satisfaction.
2. I understand that I am free to withdraw from the study at any time, for any reason and without
any penalty.
3. I have been informed that the confidentiality of the information that I provide in this study will
be safeguarded.
4. I have been informed that I am free to ask any questions at any time before and during the
study.
5. I have been provided with a copy of this form and the participant information sheet.
Data Protection:  I agree to the University1 processing of personal data which I have supplied. 
I agree to the processing of such data for any purposes connected with this study as outlined 
in the participant information sheet. 
Name of participant ………………………………………. 
Signed………………..… Date………………….. 
 I approve/disapprove that Olakunle can be present during the counselling session that I will
attend for this study only for the purpose of audiotaping the session.
Signed………………..… Date…………………… 
 I also approve that the counselling session that I will attend for this study and the post-study
interview that I will participate in can be audiotaped only for the purpose of this study.
Signed………………..… Date…………………… 
1 “The University” includes Anglia Ruskin University and its partner colleges 
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Statement of the Principal Investigator obtaining informed consent: 
I have fully explained details of this study to _______________________________ and have 
given him/her sufficient information, including about risks and benefits of the study, to make 
an informed decision. 
Date: _____________________  
Signature: ____________________________ 
Name: ______________________________ 
YOU WILL BE GIVEN A COPY OF THIS FORM TO KEEP 
--------------------------------------------------------------------------------------------------------- 
If you wish to withdraw from the study, please complete the form below and return to 
Olakunle. 
Title of the study: ……………………………………………………………………………………… 




FREP approval Number: 15/06 087 and FCTHREC approval number: 
FHREC/2016/01/77/26-10-16 
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Appendix 11: Demographic Data Form 
STUDY TITLE: Motivational Interviewing (MI) for HIV drugs adherence in Nigeria: a 
feasibility study 
Purpose of the study 
This study will look at how a counselling approach known as Motivational Interviewing (MI) can 
be applied to help HIV patients in Nigeria take their HIV drugs as recommended. 
We therefore would like to ask a few questions about you. You can answer each question by 
ticking the boxes next to the answer options provided. However, if your answer choice (s) 
involve (s) those where you are asked to specify, kindly write your appropriate response on 
the spaces provided. 
SECTION A: Questions in this section are required to be completed by both HIV patients and 
antiretroviral therapy adherence counsellors. 
1. How old are you?
a) Please specify………......................... 
b) Prefer not to say
2. Which of these gender categories describes you best?
a) Male     
b) Female
c) Prefer not to say




d) Any other Nigerian tribe  . Please specify…………………….. 











d) Any other Nigerian language       . Please specify…………………….. 
e) Prefer not to say  
 
5. Which other language (s) do you speak apart from your first language (mother’s 
tongue)? 
 





f) Any other language       . Please specify………………………. 
g) Prefer not to say 
 
6. Which of these is the highest level of education that you have completed? 
 
a) No schooling completed 
b) Primary school education 
c) Secondary school education 
d) Technical/Vocational training 
e) Ordinary National Diploma (OND) 
f) Higher National Diploma (HND) 
g) Bachelor’s degree 
h) Advanced degrees 
i) Any other qualification                              . Please specify……………………….. 









SECTION B: Questions in this section are required to be completed only by health personnel 
who counsel HIV patients about their HIV drugs adherence. 
7. Which language(s) do you use when talking to HIV patients about their HIV 
drugs? 
 





f) Any other language       . Please specify……………………… 
g) Prefer not to say 
 
8. Which of these describe your occupational role (s)? 
 
a) A Nurse  
b) A trained HIV counselling and Testing Counsellor 
c) A Medical Doctor/Physician 
d) Any other profession        . Please specify…………………………… 
e) Prefer not to say 
 
9. How long have you been practising after your professional qualification? 
 
a) Less than 1 year  
b) 1 year 
c) More than 1 year         . Please specify……………… 
d) Prefer not to say 
 
 
 
 
Thank you! 
 
 
 
 
 
 
 
 
 
